data_6s3w_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6s3w _Structure_validation_residue.Date_analyzed 2020-03-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.734 0.222 . . . . 0.54 111.871 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.546 HD13 ' N ' ' B' ' 5' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.9 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.546 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.66 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.526 HD11 ' O ' ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 1.19 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 342' ' ' PRO . 4.0 m . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.51 109.872 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 112.205 0.446 . . . . 1.17 112.205 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 259' ' ' VAL . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.716 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 1.13 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 1.07 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.526 ' O ' HD11 ' B' ' 6' ' ' ILE . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 1.04 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.82 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 1.06 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 1.04 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 1.21 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.86 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.413 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 4.19 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 3.36 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.408 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 1.2 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.62 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.998 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 1.11 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 275' ' ' GLY . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 3.0 109.493 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.72 112.594 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.998 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.73 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.98 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 1.57 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.57 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 1.03 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 1.11 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.574 HG21 ' N ' ' A' ' 283' ' ' GLU . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 2.19 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.488 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 1.04 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 2.08 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.417 ' CD ' HD22 ' A' ' 285' ' ' LEU . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.4 112.669 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 1.25 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.488 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 1.23 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 1.07 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.79 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.568 ' HB1' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 1.04 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.7 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 1.03 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.76 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 3.17 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 1.23 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.6 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 3.08 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.593 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.22 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.665 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.98 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.637 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.608 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 1.44 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.13 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.683 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 1.03 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 312' ' ' VAL . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 1.05 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 1.03 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 1.05 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 309' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 1.05 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.568 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.57 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.74 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 1.07 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.97 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 1.46 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.85 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.3 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.91 112.521 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 2.18 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 325' ' ' PRO . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.65 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.39 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 4.66 110.786 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 1.11 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 1.08 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 1.11 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.664 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.9 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 1.14 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 336' ' ' ARG . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.95 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 3.0 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 281' ' ' LEU . 30.6 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.852 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 3.0 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.42 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.675 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 1.03 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 1.11 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.94 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.77 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo . . . . . 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.69 120.077 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 N--CA 1.476 0.473 0 N-CA-C 112.773 0.259 . . . . 0.54 112.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.9 109.964 -172.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.66 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 1.19 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.51 111.575 -176.299 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.334 -0.617 . . . . 1.17 109.334 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.429 ' HB3' HH21 ' A' ' 336' ' ' ARG . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 1.13 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.745 HD11 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 1.07 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.632 ' O ' HD11 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 1.04 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.82 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 1.06 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 1.04 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 1.21 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.86 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 308' ' ' ALA . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 4.19 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 3.36 110.952 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 1.2 113.582 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.62 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.962 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 1.11 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 3.0 108.97 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.72 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.962 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.73 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.784 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.98 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 1.57 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.409 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 1.03 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 1.11 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 2.19 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.512 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 1.04 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 2.08 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.53 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.4 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 285' ' ' LEU . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 1.25 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.427 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 1.23 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.606 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 1.07 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.79 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 1.04 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.7 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 1.03 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.76 109.202 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 3.17 109.384 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 1.23 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.6 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 3.08 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.22 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.747 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.98 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.606 ' HB3' HG22 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.632 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 1.44 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.13 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 1.03 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.683 ' O ' HG22 ' A' ' 312' ' ' VAL . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 1.05 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 1.03 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.586 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 1.05 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 1.05 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.537 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.57 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.74 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 1.07 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.97 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 288' ' ' GLY . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 1.46 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.85 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.688 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.3 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.91 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 2.18 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 325' ' ' PRO . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.65 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.39 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . 0.53 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 4.66 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 1.11 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 1.08 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.456 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 1.11 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.706 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.661 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.9 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.661 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 1.14 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.688 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.95 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.706 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 3.0 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.646 ' H ' HD11 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 3.0 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.468 ' CD ' HD11 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.42 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.442 HD12 HG22 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 1.03 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.559 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 1.11 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.784 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.94 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.522 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.77 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 276' ' ' MET . 31.6 Cg_exo . . . . . 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.69 118.122 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.231 0.136 0 N-CA-C 111.054 -0.402 . . . . 0.54 111.054 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 256' ' ' ASP . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.9 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.66 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 339' ' ' ILE . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 1.19 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.51 110.639 -175.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 1.17 110.128 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.739 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.415 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 1.13 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 1.07 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' HD11 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 1.04 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.82 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 1.06 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 1.04 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 1.21 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.86 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.607 HE21 HG11 ' A' ' 315' ' ' VAL . 2.3 mp0 -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.578 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 4.19 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 3.36 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 1.2 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.62 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.438 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 1.11 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 3.0 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.72 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.606 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.73 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.98 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 1.57 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 1.03 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 1.11 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.749 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 2.19 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.516 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 1.04 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 2.08 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HD2' HD22 ' A' ' 285' ' ' LEU . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.4 113.591 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.442 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.68 ' O ' HD11 ' A' ' 285' ' ' LEU . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 1.25 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.516 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 1.23 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 1.07 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.79 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.7 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 1.03 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.76 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 3.17 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 1.23 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.419 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.6 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.474 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 3.08 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.22 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.538 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.98 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.617 ' HB3' HG23 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.655 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 1.44 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.13 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 1.03 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 1.05 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 1.03 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.643 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 1.05 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 1.05 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.57 112.273 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.74 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 1.07 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.97 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 318' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 1.46 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.85 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.421 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.3 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.91 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 2.18 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.539 HD12 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.65 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.39 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 4.66 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 1.11 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.539 HG21 HD12 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 1.08 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.441 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 1.11 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.9 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 1.14 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.584 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.95 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 3.0 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.749 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 3.0 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.489 ' HG2' HD11 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.42 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.468 HD13 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 1.03 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.587 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 1.11 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.819 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.94 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.77 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo . . . . . 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.69 119.075 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.823 -0.491 . . . . 0.54 110.823 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.9 110.539 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.66 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 1.19 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.51 110.946 -175.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.801 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 121.384 0.611 . . . . 1.17 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 259' ' ' VAL . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 260' ' ' ASN . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 1.13 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 1.07 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.598 ' O ' HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 1.04 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.82 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 1.06 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.573 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 1.04 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 1.21 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.86 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.604 HE21 HG13 ' A' ' 315' ' ' VAL . 2.3 mp0 -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.532 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 4.19 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 3.36 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 1.2 113.253 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.62 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.81 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 1.11 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 3.0 108.373 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.72 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.829 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.73 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 341' ' ' LYS . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.98 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.475 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 1.57 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.489 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 1.03 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 1.11 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 2.19 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.568 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 1.04 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 2.08 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.4 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 285' ' ' LEU . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.632 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 1.25 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 1.23 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 1.07 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.79 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 313' ' ' ARG . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 1.04 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.7 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 1.03 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.76 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 3.17 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 1.23 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.6 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.481 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 3.08 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.22 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.98 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.643 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 1.44 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.13 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.727 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 1.03 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.721 ' O ' HG21 ' A' ' 312' ' ' VAL . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 1.05 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 1.03 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 308' ' ' ALA . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 1.05 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.721 HG21 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 1.05 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 293' ' ' ALA . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.57 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.74 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.604 HG13 HE21 ' A' ' 265' ' ' GLN . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 1.07 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.97 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.657 HG23 ' SD ' ' A' ' 321' ' ' MET . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 1.46 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.85 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.3 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.91 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 2.18 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.521 HD23 ' HD2' ' A' ' 325' ' ' PRO . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.65 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.39 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 4.66 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 1.11 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 1.08 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 1.11 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.655 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.9 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 1.14 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.801 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.95 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 283' ' ' GLU . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 3.0 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.5 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.56 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 3.0 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.465 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.42 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.482 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 1.03 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.525 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 1.11 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CD2' ' HB2' ' A' ' 308' ' ' ALA . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.94 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.77 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.829 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo . . . . . 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.69 118.396 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 111.307 -0.305 . . . . 0.54 111.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.9 111.256 -168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.66 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 339' ' ' ILE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 1.19 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.51 111.886 -173.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 120.52 0.2 . . . . 1.17 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.641 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 1.13 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 1.07 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 262' ' ' VAL 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 1.04 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.82 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 1.06 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 1.04 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 1.21 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.86 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 4.19 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 3.36 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 1.2 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.62 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 1.007 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 1.11 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 3.0 109.266 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.72 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 1.007 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.73 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.98 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 1.57 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 1.03 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 1.11 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 2.19 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.711 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.53 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 1.04 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 2.08 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.4 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 1.25 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.53 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 1.23 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.606 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 1.07 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.711 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.79 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 1.04 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.7 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 1.03 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.76 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 3.17 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.408 ' HB3' HG13 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 1.23 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.719 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.6 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.627 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 3.08 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.22 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.98 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.627 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.619 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 1.44 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.13 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.641 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 1.03 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 312' ' ' VAL . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 1.05 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 1.03 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 1.05 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 309' ' ' VAL . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 1.05 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.57 112.433 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.692 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.74 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 1.07 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.97 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 288' ' ' GLY . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 1.46 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.85 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.627 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.82 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.3 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.91 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 2.18 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.65 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.767 ' N ' HD13 ' A' ' 324' ' ' LEU . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.39 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 4.66 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 1.11 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.583 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 1.08 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.58 ' N ' HD12 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 1.11 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.638 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.9 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 1.14 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.82 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.95 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 3.0 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.641 ' NH2' ' HB2' ' A' ' 255' ' ' ASP . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 3.0 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.42 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 1.03 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 1.11 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.94 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.649 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.77 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.69 118.097 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.857 -0.094 . . . . 0.54 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.9 110.292 -174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.66 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 339' ' ' ILE . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 1.19 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.51 110.937 -178.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 1.044 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 119.666 -0.207 . . . . 1.17 111.555 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 259' ' ' VAL . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 1.13 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 1.07 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.528 ' O ' HG11 ' A' ' 262' ' ' VAL 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 1.04 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.82 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 1.06 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 259' ' ' VAL . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 1.04 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.52 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 1.21 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.86 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.64 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.558 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 4.19 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 3.36 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 1.2 113.149 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.62 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.821 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 1.11 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 3.0 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.72 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.821 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.73 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.98 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 1.57 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 1.03 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 1.11 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 2.19 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 1.04 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 2.08 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.448 ' CD ' HD23 ' A' ' 285' ' ' LEU . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.4 112.839 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 1.25 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.54 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 1.23 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.529 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 1.07 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.79 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 1.04 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.7 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 1.03 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.76 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 3.17 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 1.23 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.6 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.601 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 3.08 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.601 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.22 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.98 109.485 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.627 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 1.44 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.13 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 1.03 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.632 ' O ' HG21 ' A' ' 312' ' ' VAL . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 1.05 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.586 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 1.05 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 1.05 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.57 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.7 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.74 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 1.07 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.97 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 1.46 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.85 114.666 -163.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.72 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.3 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.91 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 2.18 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.539 HD23 ' HD2' ' A' ' 325' ' ' PRO . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.65 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.39 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 4.66 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 1.11 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 1.08 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 1.11 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.9 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 1.14 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 1.044 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.95 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 3.0 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.6 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.67 ' H ' HD13 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 3.0 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.42 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.508 HD11 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 1.03 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.636 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 1.11 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.94 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.518 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.801 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo . . . . . 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.69 116.957 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.015 0.34 . . . . 0.54 111.845 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.578 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.9 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.525 ' N ' HD12 ' B' ' 4' ' ' LEU . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.66 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 259' ' ' VAL . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 1.19 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.51 110.454 -173.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 109.466 -0.568 . . . . 1.17 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.555 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.741 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 1.13 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 1.07 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.624 ' O ' HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 1.04 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.82 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 1.06 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 1.04 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.59 ' HB3' HD12 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 1.21 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.86 106.57 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.589 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 4.19 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 3.36 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 1.2 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.62 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 1.027 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 1.11 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 3.0 109.102 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.72 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 1.027 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.73 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.804 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.98 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 1.57 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.587 HG13 HG23 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 1.03 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 1.11 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 2.19 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 1.04 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 287' ' ' ASP . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 2.08 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.4 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.6 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 1.25 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 284' ' ' MET . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 1.23 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.533 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 1.07 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.79 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 1.04 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.7 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 1.03 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.76 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 3.17 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 1.23 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.6 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 3.08 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.22 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.849 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.98 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.618 ' HB3' HG22 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.623 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 1.44 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.13 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 1.03 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.699 ' O ' HG21 ' A' ' 312' ' ' VAL . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 1.05 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 1.03 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 1.05 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 309' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 1.05 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.57 112.961 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.589 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.74 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 1.07 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.97 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.646 HG22 ' SD ' ' A' ' 321' ' ' MET . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 1.46 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.85 118.885 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.3 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.91 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 2.18 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 ' HD2' ' A' ' 325' ' ' PRO . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.65 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.39 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 4.66 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 1.11 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 1.08 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 1.11 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.636 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.9 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 1.14 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.95 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 3.0 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 2.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.681 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 3.0 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.405 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.42 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 1.03 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.583 ' O ' HG21 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 1.11 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.804 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.94 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.606 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.77 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo . . . . . 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.69 117.259 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 110.443 -0.637 . . . . 0.54 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.9 111.11 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.66 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 339' ' ' ILE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 1.19 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.51 112.814 -169.602 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 258' ' ' ILE . 7.0 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 115.568 1.692 . . . . 1.17 115.568 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.534 ' O ' HG21 ' A' ' 259' ' ' VAL . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 1.13 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 1.07 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.539 ' O ' HD12 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 1.04 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.82 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 1.06 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.488 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 1.21 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.86 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 4.19 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 3.36 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 1.2 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 1.005 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 1.11 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 3.0 108.856 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.72 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 1.005 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.73 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.98 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 1.57 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.593 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 1.03 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 1.11 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 2.19 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.458 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 1.04 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.527 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 2.08 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.444 ' CD ' HD22 ' A' ' 285' ' ' LEU . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.4 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.729 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 1.25 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.458 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 1.23 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.527 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 1.07 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.679 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.79 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 313' ' ' ARG . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 1.04 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.7 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 1.03 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.76 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 3.17 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 1.23 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.613 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.6 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 3.08 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.22 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.725 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.98 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.594 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 1.44 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.13 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.759 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 1.03 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 312' ' ' VAL . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 1.05 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 1.03 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 1.05 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 309' ' ' VAL . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 1.05 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.495 ' CD ' ' HB1' ' A' ' 293' ' ' ALA . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.57 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.74 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 1.07 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.97 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 321' ' ' MET . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 1.46 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.85 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.629 ' HG2' ' O ' ' A' ' 318' ' ' ILE . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.3 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . 0.472 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.91 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 2.18 108.671 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.65 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.39 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . 0.418 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 4.66 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 1.11 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.522 ' CG2' HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 1.08 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 1.11 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.9 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 1.14 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.583 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.95 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.713 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 3.0 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.485 ' HG2' HG12 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 3.0 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.461 ' HD3' HD12 ' A' ' 281' ' ' LEU . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.42 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 1.03 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.602 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 1.11 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.759 ' CD2' ' HB3' ' A' ' 308' ' ' ALA . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.94 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.686 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.77 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo . . . . . 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.69 118.937 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 N-CA-C 110.452 -0.634 . . . . 0.54 110.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.9 111.289 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.66 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.563 HG21 ' O ' ' A' ' 339' ' ' ILE . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 1.19 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.51 111.541 -173.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.663 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 111.953 0.353 . . . . 1.17 111.953 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 259' ' ' VAL . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 1.13 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.663 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 1.07 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.518 ' O ' HD12 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 1.04 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.51 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.82 107.249 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 1.06 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 1.04 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 1.21 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.86 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.564 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.642 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 4.19 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 3.36 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 1.2 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.62 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 1.11 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 3.0 108.848 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.72 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.669 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.73 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.792 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.98 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 1.57 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.474 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.534 HG11 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 1.03 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 1.11 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 336' ' ' ARG . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 2.19 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.496 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 1.04 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.576 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 2.08 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.45 ' CD ' HD22 ' A' ' 285' ' ' LEU . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.4 112.752 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 1.25 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 1.23 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.576 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 1.07 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.79 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.519 ' HB2' ' NE ' ' A' ' 313' ' ' ARG . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 1.04 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.7 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 1.03 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.76 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 3.17 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG13 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 1.23 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.6 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 3.08 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.22 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.402 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.98 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.644 ' HB2' HG22 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.634 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 1.44 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.13 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 1.03 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 312' ' ' VAL . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 1.05 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 1.03 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 1.05 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 1.05 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.519 ' NE ' ' HB2' ' A' ' 293' ' ' ALA . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.57 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.564 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.74 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.67 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 1.07 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.97 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 1.46 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.85 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.793 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.3 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.91 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 2.18 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 325' ' ' PRO . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.65 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.39 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 4.66 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 1.11 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 1.08 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 1.11 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.638 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.9 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 1.14 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.793 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.95 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 3.0 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 3.0 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.485 ' CD ' HD11 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.42 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.479 HD13 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 1.03 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.563 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 1.11 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.94 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.574 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.77 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo . . . . . 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.69 118.492 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 111.022 -0.415 . . . . 0.54 111.022 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.9 111.023 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.66 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 339' ' ' ILE . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 1.19 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.51 110.769 -177.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 258' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 110.298 -0.26 . . . . 1.17 110.298 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 1.13 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 1.07 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.577 ' O ' HD11 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 1.04 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.82 106.959 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 1.06 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 1.04 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 1.21 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.86 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.597 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 267' ' ' ARG . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 4.19 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 3.36 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 1.2 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.62 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 1.11 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 3.0 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.72 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.679 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.73 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.98 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 1.57 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 1.03 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 1.11 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.711 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 2.19 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 333' ' ' TYR . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 1.04 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.735 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 2.08 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.451 ' HD2' HD21 ' A' ' 285' ' ' LEU . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.4 113.697 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.529 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.735 ' O ' HD11 ' A' ' 285' ' ' LEU . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 1.25 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 1.23 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 1.07 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.79 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 1.04 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.7 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 1.03 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.76 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 3.17 109.445 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.423 ' HB3' HG13 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 1.23 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.6 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.453 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 3.08 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.22 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.422 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.98 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.594 ' HB3' HG22 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.642 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 1.44 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.13 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 1.03 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 312' ' ' VAL . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 1.05 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 1.03 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 1.05 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 309' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 1.05 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.57 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.74 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 1.07 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.97 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 1.46 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.85 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.706 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.3 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.91 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 2.18 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.507 HD21 ' HD2' ' A' ' 325' ' ' PRO . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.65 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.39 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 4.66 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 1.11 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 1.08 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.468 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 1.11 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.65 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.9 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 1.14 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.706 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.95 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 3.0 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.756 ' HD3' ' N ' ' A' ' 337' ' ' ARG . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 3.0 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.756 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.42 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 1.03 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 1.11 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 308' ' ' ALA . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.94 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.516 ' HB3' HG11 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.679 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo . . . . . 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.69 117.308 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo . . . . . 0 C--O 1.231 0.159 0 N-CA-C 111.498 -0.231 . . . . 0.54 111.498 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.487 ' HB2' HH22 ' A' ' 336' ' ' ARG . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.9 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.66 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 339' ' ' ILE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 1.19 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 341' ' ' LYS . 3.2 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.51 111.381 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.641 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.6 mp . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 120.858 0.361 . . . . 1.17 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.512 ' O ' HG21 ' A' ' 259' ' ' VAL . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 1.13 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.536 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 1.07 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 255' ' ' ASP 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 1.04 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.82 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 1.06 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 1.04 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.531 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 1.21 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.86 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.581 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' ' 308' ' ' ALA . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 4.19 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 3.36 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 1.2 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.62 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.989 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 1.11 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 3.0 109.327 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.72 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.989 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.73 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.774 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.98 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 1.57 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.419 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.578 HG11 HG23 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 1.03 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 1.11 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 2.19 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.624 ' SD ' HD12 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 1.04 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 2.08 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.4 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 285' ' ' LEU . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.631 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 1.25 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.535 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 1.23 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 1.07 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.79 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 1.04 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.7 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 1.03 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.76 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 3.17 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 1.23 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.6 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 3.08 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.22 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.728 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.98 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.612 ' HB3' HG22 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.628 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 1.44 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.13 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.676 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 1.03 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 312' ' ' VAL . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 1.05 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 1.03 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 1.05 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 1.05 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.57 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.581 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.74 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 1.07 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.97 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.624 HD12 ' SD ' ' A' ' 284' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 1.46 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.85 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.416 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.3 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.91 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 2.18 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 325' ' ' PRO . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.65 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.795 ' N ' HD13 ' A' ' 324' ' ' LEU . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.39 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 4.66 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 1.11 112.415 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.605 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 1.08 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 1.11 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.9 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 1.14 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.95 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 3.0 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.7 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.697 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 3.0 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.42 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.507 HD13 ' CG2' ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 1.03 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 1.11 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.774 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.94 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.468 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.77 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.604 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo . . . . . 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.69 119.17 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 CA--C 1.528 0.198 0 CA-C-O 120.792 0.247 . . . . 0.54 111.855 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.528 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.9 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.485 ' N ' HD11 ' B' ' 4' ' ' LEU . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.66 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 259' ' ' VAL . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 1.19 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.51 111.356 -176.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 108.36 -0.978 . . . . 1.17 108.36 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.724 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 1.13 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 1.07 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.601 ' O ' HD13 ' B' ' 6' ' ' ILE 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 1.04 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.82 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 1.06 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 1.04 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.586 ' HB3' HD12 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 1.21 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.86 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.578 ' OE1' HG13 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 4.19 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 3.36 110.572 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 1.2 113.71 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.62 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.939 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 1.11 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 275' ' ' GLY . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 3.0 110.46 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 274' ' ' ASN . 1.0 OUTLIER -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.72 112.21 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.939 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.73 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.98 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 1.57 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.457 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 1.03 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.672 HD23 ' OE1' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 1.11 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 283' ' ' GLU . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 2.19 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.686 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 1.04 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 2.08 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.426 ' CD ' HD23 ' A' ' 285' ' ' LEU . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.4 112.437 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 1.25 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 312' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 1.23 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.688 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 1.07 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.686 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.79 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 1.04 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.7 110.257 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 1.03 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.76 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 3.17 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 1.23 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.584 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.6 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 3.08 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.22 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.98 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.617 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 1.44 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.13 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 1.03 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.72 ' O ' HG21 ' A' ' 312' ' ' VAL . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 1.05 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 1.03 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 308' ' ' ALA . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 309' ' ' VAL . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 1.05 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.57 112.901 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.74 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 1.07 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.701 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.97 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 318' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 1.46 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.85 116.142 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.546 ' HE1' ' HA ' ' A' ' 321' ' ' MET . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.3 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.91 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 2.18 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.65 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.39 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 4.66 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 1.11 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.509 ' CG2' HD23 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 1.08 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 1.11 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.59 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.656 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.9 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 1.14 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.95 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.59 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 3.0 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.672 ' OE1' HD23 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.571 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 3.0 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.42 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 1.03 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 1.11 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.94 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.77 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo . . . . . 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.69 117.444 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.448 ' HG3' ' NE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo . . . . . 0 C--O 1.23 0.118 0 N-CA-C 110.65 -0.558 . . . . 0.54 110.65 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.9 110.83 -173.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.66 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 1.19 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.51 110.952 -176.452 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 258' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.75 -0.833 . . . . 1.17 108.75 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.653 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 1.13 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 1.07 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD12 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 1.04 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.525 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.82 107.004 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 1.06 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 1.04 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.525 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 1.21 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.86 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.597 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 4.19 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 3.36 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 1.2 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.62 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 1.0 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 1.11 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.454 ' C ' ' H ' ' A' ' 275' ' ' GLY . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 3.0 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.72 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 1.0 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.73 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.98 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 1.57 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.573 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 1.03 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 1.11 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 2.19 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 1.04 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.661 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 2.08 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.402 ' CD ' HD22 ' A' ' 285' ' ' LEU . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.4 112.974 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.582 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.678 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 1.25 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 284' ' ' MET . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 1.23 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.661 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 1.07 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.79 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 1.04 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.7 110.695 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 1.03 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.573 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.76 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 3.17 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 1.23 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.6 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 3.08 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.22 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.98 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.606 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.626 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 1.44 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.13 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 1.03 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.775 ' O ' HG22 ' A' ' 312' ' ' VAL . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 1.05 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 1.03 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 1.05 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 1.05 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.57 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.74 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 1.07 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.97 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.539 HD12 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 1.46 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 261' ' ' LEU . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.85 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.405 ' OE2' HD12 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.533 ' HA ' ' HE3' ' A' ' 321' ' ' MET . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.3 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.91 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 2.18 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 325' ' ' PRO . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.65 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.498 ' HD2' HD22 ' A' ' 324' ' ' LEU . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.39 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 4.66 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 1.11 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 1.08 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 1.11 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.703 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.9 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 1.14 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 336' ' ' ARG . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.95 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.703 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 3.0 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.3 OUTLIER -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.69 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 3.0 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.448 ' NE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.42 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.419 HD12 ' CG2' ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 1.03 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.612 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 1.11 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.94 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.543 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.77 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.69 117.914 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.519 -0.274 0 CA-C-O 120.917 0.299 . . . . 0.54 112.087 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.458 HD12 ' N ' ' B' ' 5' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.9 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.66 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.636 ' CG2' ' HA ' ' A' ' 340' ' ' PHE . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 1.19 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.51 110.813 -176.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.733 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 8.3 mt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 114.463 1.283 . . . . 1.17 114.463 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.615 ' O ' HG21 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 1.13 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 1.07 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 255' ' ' ASP 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 1.04 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.82 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 1.06 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 1.04 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 1.21 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.86 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 4.19 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 3.36 110.738 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.408 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 1.2 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.62 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.99 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 1.11 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 3.0 109.2 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.72 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.99 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.73 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.832 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.98 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 1.57 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.552 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 1.03 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 1.11 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 2.19 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.644 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 1.04 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 2.08 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.433 ' CD ' HD22 ' A' ' 285' ' ' LEU . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.4 112.598 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.502 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 1.25 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 1.23 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.597 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 1.07 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.644 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.79 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 1.04 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.7 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 1.03 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.76 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 3.17 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 1.23 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.6 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.682 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 3.08 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.22 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.688 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.98 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.682 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.663 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 1.44 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.13 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.644 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 1.03 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 312' ' ' VAL . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 1.05 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 1.03 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 1.05 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.57 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.74 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 1.07 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.97 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 1.46 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.85 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.557 ' HE2' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.3 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.91 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 2.18 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.484 HD21 ' HD2' ' A' ' 325' ' ' PRO . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.65 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.39 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 4.66 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 1.11 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 1.08 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 1.11 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.51 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.9 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 1.14 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.733 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.95 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.51 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 3.0 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.696 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 3.0 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.461 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.42 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.48 HD12 HG22 ' A' ' 258' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 1.03 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.596 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 1.11 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.832 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.94 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.596 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.77 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo . . . . . 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.69 118.032 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.517 -0.358 0 CA-C-O 120.634 0.181 . . . . 0.54 112.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.9 111.374 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.66 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.579 HD11 ' O ' ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 1.19 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.51 110.882 -177.045 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 110.065 -0.346 . . . . 1.17 110.065 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.715 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 1.13 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 1.07 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.579 ' O ' HD11 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 1.04 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.82 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 1.06 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 1.04 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 1.21 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.86 106.274 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.638 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 4.19 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 3.36 109.716 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 1.2 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.62 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.88 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 1.11 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 3.0 107.527 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.72 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.88 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.73 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.98 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 1.57 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.527 HG13 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 1.03 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.55 HD12 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 1.11 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 2.19 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.653 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.456 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 1.04 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.654 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 2.08 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.654 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.4 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 1.25 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.456 HG12 ' CG ' ' A' ' 284' ' ' MET . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 1.23 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.464 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 1.07 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.653 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.79 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 1.04 109.655 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.7 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 1.03 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.76 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 3.17 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 1.23 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.6 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 3.08 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.22 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.566 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.98 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 295' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.624 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 1.44 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.13 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 1.03 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 312' ' ' VAL . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 1.05 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 1.03 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 1.05 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.731 ' O ' HG21 ' A' ' 315' ' ' VAL . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 1.05 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' A' ' 292' ' ' ASN . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.57 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.74 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 1.07 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.97 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.543 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 1.46 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.85 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.606 ' HE3' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.3 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.91 112.801 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 2.18 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.529 HD23 ' HD2' ' A' ' 325' ' ' PRO . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.65 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' HD23 ' A' ' 324' ' ' LEU . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.39 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 4.66 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 1.11 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 1.08 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.45 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 1.11 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.9 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 1.14 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.606 ' CG ' ' HE3' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.95 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 3.0 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.7 OUTLIER -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.843 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 3.0 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.472 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.42 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.531 HD13 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 1.03 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.578 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 1.11 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.94 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.77 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.1 Cg_exo . . . . . 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.69 117.546 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.459 0.108 . . . . 0.54 111.883 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.9 110.72 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.66 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 339' ' ' ILE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 1.19 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.51 111.33 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 258' ' ' ILE . 1.8 mp . . . . . 0 C--O 1.221 -0.425 0 N-CA-C 111.899 0.333 . . . . 1.17 111.899 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 1.13 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 1.07 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD12 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 1.04 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.518 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.82 107.251 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 1.06 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 1.04 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 1.21 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.86 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.583 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.424 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 4.19 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 3.36 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 272' ' ' ALA . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 1.2 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.62 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 269' ' ' PRO . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 1.11 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 275' ' ' GLY . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 3.0 109.559 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.497 HD21 ' N ' ' A' ' 274' ' ' ASN . 0.9 OUTLIER -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.72 111.523 172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.636 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.73 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.98 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 1.57 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.411 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.598 HG11 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 1.03 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 1.11 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.665 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 2.19 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.485 ' SD ' HD12 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 1.04 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.637 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 2.08 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.637 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.4 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 285' ' ' LEU . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 1.25 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.443 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 1.23 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.449 ' CG2' HD13 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 1.07 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.79 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 1.04 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.7 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 1.03 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.76 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . 0.411 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 3.17 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 1.23 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.6 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.59 ' CB ' ' HE2' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.809 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 3.08 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.22 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.401 ' CD1' ' HE1' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.98 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.809 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.632 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 1.44 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.13 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.638 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 1.03 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.737 ' O ' HG22 ' A' ' 312' ' ' VAL . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 1.05 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 1.03 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.593 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 1.05 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 1.05 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.531 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.57 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.583 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.74 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 1.07 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.97 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 1.46 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.85 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.831 ' HE3' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.3 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.91 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 2.18 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.784 HD13 ' C ' ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.65 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.766 ' N ' HD13 ' A' ' 324' ' ' LEU . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.39 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 4.66 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 1.11 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 1.08 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.581 ' N ' HD12 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 1.11 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.666 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.9 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.666 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 1.14 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.831 ' CG ' ' HE3' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.95 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 3.0 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 2.6 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.767 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 3.0 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.52 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.42 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.545 HD13 HG23 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 1.03 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.626 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 1.11 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.807 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.94 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.493 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.77 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo . . . . . 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.69 117.275 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.725 0.219 . . . . 0.54 111.676 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.9 111.136 -171.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.66 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 339' ' ' ILE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 1.19 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.51 111.803 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.914 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.47 -0.196 . . . . 1.17 110.47 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.582 ' O ' HG21 ' A' ' 259' ' ' VAL . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 1.13 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.634 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 1.07 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 255' ' ' ASP 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 1.04 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.82 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 1.06 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 1.21 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.86 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.586 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 4.19 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.517 HH22 ' HA ' ' A' ' 342' ' ' PRO . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 3.36 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 1.2 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.62 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 1.11 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 3.0 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.72 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.75 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.73 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.98 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 1.57 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 1.03 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 1.11 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.602 HG23 ' N ' ' A' ' 283' ' ' GLU . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 2.19 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 1.04 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 2.08 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.686 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.4 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 1.25 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 1.23 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 1.07 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.79 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.517 ' HB3' ' CD ' ' A' ' 313' ' ' ARG . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 1.04 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.7 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 1.03 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.76 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 3.17 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 1.23 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.6 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 3.08 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.22 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.464 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.98 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.622 ' HB3' HG23 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.625 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 1.44 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.13 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 1.03 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 312' ' ' VAL . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 1.05 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 1.03 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 1.05 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 1.05 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' CD ' ' HB3' ' A' ' 293' ' ' ALA . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.57 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.678 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.74 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 1.07 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.97 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 1.46 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.85 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.404 ' OE2' HD12 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.3 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.91 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 2.18 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.491 HD23 ' HD2' ' A' ' 325' ' ' PRO . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.65 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.39 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 4.66 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 1.11 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 1.08 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 1.11 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.618 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.9 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.618 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 1.14 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.914 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.95 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.482 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 3.0 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.567 ' HB3' HD13 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 3.0 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.53 ' CD ' HD11 ' A' ' 281' ' ' LEU . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.42 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 1.03 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.593 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 1.11 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.94 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' B' ' 7' ' ' SER . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.77 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.75 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.69 116.056 -167.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--O 1.234 0.311 0 N-CA-C 111.412 -0.265 . . . . 0.54 111.412 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.458 ' HB2' HH22 ' A' ' 336' ' ' ARG . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.9 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 339' ' ' ILE . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.66 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 339' ' ' ILE . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 1.19 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.51 111.08 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.862 0.363 . . . . 1.17 110.249 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 1.13 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.612 HD11 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 1.07 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.489 HG23 HH21 ' A' ' 336' ' ' ARG . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 1.04 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.82 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 1.06 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 1.04 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 1.21 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.572 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 4.19 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 3.36 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 1.2 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.62 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 1.11 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 275' ' ' GLY . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 3.0 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.72 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.73 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.98 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 1.57 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.66 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 1.03 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 336' ' ' ARG . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 2.19 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 1.04 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.538 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 2.08 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.422 ' CD ' HD22 ' A' ' 285' ' ' LEU . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.4 113.014 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 1.25 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 1.23 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.538 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 1.07 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.79 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.41 ' HB2' ' CD ' ' A' ' 313' ' ' ARG . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 1.04 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.7 111.224 175.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 1.03 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.66 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.76 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 3.17 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 1.23 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.728 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.6 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.735 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 3.08 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.22 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.566 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.98 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.735 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.572 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 1.44 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.13 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 1.03 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 1.05 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 1.03 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 1.05 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 309' ' ' VAL . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 1.05 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.443 ' HG2' HG22 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.57 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.74 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 316' ' ' GLY . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 1.07 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.97 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.56 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 1.46 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.85 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.828 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.3 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.91 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 2.18 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 325' ' ' PRO . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.65 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 324' ' ' LEU . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.39 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 4.66 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 1.11 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 1.08 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 1.11 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.9 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 1.14 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.828 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.95 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.474 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 3.0 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.559 ' HB3' HD13 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.639 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 3.0 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.42 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 340' ' ' PHE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 1.03 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 1.11 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.94 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.543 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.77 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.69 115.198 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 84.4 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 N-CA-C 112.716 0.237 . . . . 0.54 112.716 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 255' ' ' ASP . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.9 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.66 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.644 HG21 ' O ' ' A' ' 339' ' ' ILE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 1.19 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.51 112.08 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.766 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.804 0.335 . . . . 1.17 110.285 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.523 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 260' ' ' ASN . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 1.13 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.766 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 1.07 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.49 ' O ' HD11 ' B' ' 6' ' ' ILE 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 1.04 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.82 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 1.06 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 1.04 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.517 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 1.21 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.86 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.607 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.56 ' CD1' ' HA ' ' A' ' 308' ' ' ALA . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 4.19 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 3.36 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 1.2 113.34 170.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.62 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.921 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 1.11 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 3.0 108.688 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.72 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.921 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.73 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.98 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 1.57 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 1.03 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.615 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 1.11 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 2.19 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 1.04 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.715 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 2.08 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.437 ' HD2' HD21 ' A' ' 285' ' ' LEU . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.4 113.777 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.542 ' HB3' HD12 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.548 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.715 ' O ' HD11 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 1.25 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.48 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 1.23 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 1.07 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.79 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 1.04 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.7 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 1.03 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.76 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 3.17 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 1.23 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.6 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.556 ' CB ' ' HE3' ' A' ' 276' ' ' MET . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 3.08 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.22 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.509 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.98 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.631 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 1.44 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.13 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 311' ' ' ALA . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 1.03 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.725 ' O ' HG22 ' A' ' 312' ' ' VAL . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 1.05 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 1.05 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 1.05 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.481 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.57 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.607 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.74 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 1.07 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.724 ' O ' ' HG2' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.97 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.56 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 1.46 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.85 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.691 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.3 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.91 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 2.18 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.65 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.39 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 4.66 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 1.11 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 1.08 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.48 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 1.11 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.68 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.664 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.9 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 1.14 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.691 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.95 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.68 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 3.0 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.638 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 3.0 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.42 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 282' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 1.03 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 1.11 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.94 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.473 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.77 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.2 Cg_exo . . . . . 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.69 118.35 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 N-CA-C 111.592 -0.195 . . . . 0.54 111.592 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.478 ' CB ' HH22 ' A' ' 336' ' ' ARG . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.9 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.66 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 339' ' ' ILE . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 1.19 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.51 110.121 -177.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.71 ' O ' HD13 ' A' ' 258' ' ' ILE . 1.4 mp . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 109.5 -0.555 . . . . 1.17 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ASP . . . . . 0.589 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.62 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 1.13 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 1.07 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.58 ' O ' HD11 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 1.04 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.82 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 1.06 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.641 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 1.04 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.512 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 1.21 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.86 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.634 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 4.19 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 3.36 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 1.2 113.09 167.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.62 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.931 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 1.11 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 275' ' ' GLY . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 3.0 109.872 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.72 112.794 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.931 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.73 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.98 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.527 HG22 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 1.57 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 1.03 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 1.11 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.705 HD11 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 2.19 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.523 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 1.04 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 2.08 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.479 ' HD2' HD23 ' A' ' 285' ' ' LEU . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.4 113.548 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.589 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.453 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.684 ' O ' HD13 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 1.25 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.523 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 1.23 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 1.07 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.79 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 1.04 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.7 111.294 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 1.03 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.607 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.76 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 3.17 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 1.23 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.6 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.601 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.684 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 3.08 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.601 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.22 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.98 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.684 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.636 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 1.44 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.13 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 1.03 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 312' ' ' VAL . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 1.05 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 1.03 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 1.05 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 1.05 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.4 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.57 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.667 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.74 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 1.07 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.97 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . 0.464 HG23 ' SD ' ' A' ' 321' ' ' MET . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 1.46 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.85 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.531 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.3 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.91 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 2.18 108.472 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.474 HD23 ' HD2' ' A' ' 325' ' ' PRO . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.65 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.39 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 4.66 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 1.11 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 1.08 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 1.11 109.632 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' SER . . . . . 0.676 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.9 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.676 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 1.14 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.531 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.95 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 3.0 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 3.0 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.705 ' H ' HD11 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.42 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 1.03 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ILE . . . . . 0.63 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 1.11 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.94 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' LYS . . . . . 0.466 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.77 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.489 ' CD ' ' HZ ' ' A' ' 304' ' ' PHE . 24.4 Cg_exo . . . . . 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.69 118.309 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.805 ' HB1' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.7 -0.482 . . . . 1.84 109.7 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -95.95 124.46 52.06 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.975 -0.379 . . . . 1.37 109.975 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo -49.77 120.99 6.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.736 2.291 . . . . 0.54 111.871 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.546 HD13 ' N ' ' B' ' 5' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.9 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.546 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.66 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.526 HD11 ' O ' ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 1.19 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.556 ' HB2' ' OE1' ' A' ' 343' ' ' GLU . 4.0 m -110.16 -7.43 14.89 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.51 109.872 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.653 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 4.7 t -100.38 156.45 17.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.716 -1.129 . . . . 2.81 110.696 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.29 -127.28 1.06 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.336 -1.105 . . . . 1.85 110.336 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' B' ' 12' ' ' ARG . 18.7 p-10 -53.97 147.94 11.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.796 0.331 . . . . 3.39 110.825 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.81 58.77 4.46 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.622 1.677 . . . . 5.81 110.055 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' B' ' 10' ' ' ASN . 1.2 ppt_? -77.24 -166.32 0.71 Allowed 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 111.173 -2.74 . . . . 5.91 111.456 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.571 -0.728 . . . . 7.77 109.872 172.865 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 228' ' ' LEU . 23.5 p80 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.246 0.546 . . . . 40.49 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.61 176.2 10.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.001 -0.545 . . . . 40.11 111.316 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 66.78 -78.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.648 0.779 . . . . 39.42 111.841 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -147.0 19.32 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.069 0.461 . . . . 37.42 110.656 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 224' ' ' HIS . 62.3 tp -139.65 88.5 2.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.871 -0.604 . . . . 36.38 110.218 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.29 -61.19 1.97 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.658 0.742 . . . . 34.76 110.893 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 232' ' ' LEU . 12.1 pt-20 -168.53 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.438 -1.255 . . . . 32.58 108.896 -168.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.23 -30.44 62.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.842 -0.799 . . . . 31.1 108.842 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.483 ' H ' ' HG3' ' A' ' 230' ' ' GLU . 16.5 tp -78.44 55.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 30.58 109.889 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 25.3 t -142.44 106.64 4.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.652 . . . . 27.95 109.746 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.98 56.7 4.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.364 0.602 . . . . 27.34 110.454 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -74.17 -65.99 0.78 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.286 -0.87 . . . . 25.64 109.978 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 12.2 p -146.49 -153.36 0.48 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.66 -1.237 . . . . 24.1 107.66 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.14 84.98 7.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.944 -0.761 . . . . 24.03 108.944 172.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -125.91 97.99 5.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 23.07 110.673 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -78.8 69.52 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.399 0.619 . . . . 21.17 110.21 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -82.85 57.53 3.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.562 -0.745 . . . . 19.97 111.455 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.64 64.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.838 -0.619 . . . . 18.08 110.806 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.5 tp -105.12 90.11 3.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.797 -0.638 . . . . 16.58 110.129 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.6 178.54 7.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.049 -0.523 . . . . 14.16 110.782 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.3 -175.82 2.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 13.65 111.559 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -52.87 145.4 12.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.681 0.993 . . . . 12.06 113.681 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 247' ' ' GLY . 11.1 p -107.4 172.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.838 -1.074 . . . . 10.09 109.866 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -100.01 117.94 6.03 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.28 -0.873 . . . . 7.81 111.919 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.8 p -96.08 -73.81 0.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.977 0.418 . . . . 6.56 110.597 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.418 ' C ' HG11 ' A' ' 250' ' ' VAL . 0.0 OUTLIER -71.95 -59.4 2.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.523 0.678 . . . . 4.79 111.11 175.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.418 HG11 ' C ' ' A' ' 249' ' ' GLU . 7.9 m -149.09 -147.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 114.249 -1.341 . . . . 2.76 111.174 -169.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.617 ' HB ' ' OD2' ' A' ' 255' ' ' ASP . 4.8 p 53.66 73.87 0.35 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.465 1.126 . . . . 1.48 108.943 -168.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -61.88 -139.48 0.01 OUTLIER Glycine 0 C--N 1.319 -0.401 0 CA-C-N 113.648 -1.615 . . . . 1.61 113.49 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.866 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 8.5 p -82.44 16.88 1.9 Allowed 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 123.251 1.5 . . . . 2.23 111.219 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -85.96 -55.29 4.02 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.574 -3.012 . . . . 1.17 112.205 -167.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.617 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.487 ' CG ' ' H3 ' ' A' ' 224' ' ' HIS . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.866 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 1.13 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 1.07 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.526 ' O ' HD11 ' B' ' 6' ' ' ILE . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 1.04 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.82 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 1.06 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 1.04 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 1.21 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.86 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.653 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.413 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 4.19 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 3.36 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.408 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 1.2 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.62 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.998 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 1.11 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.609 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 3.0 109.493 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.72 112.594 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.998 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.73 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.98 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 1.57 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.57 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 1.03 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 1.11 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.574 HG21 ' N ' ' A' ' 283' ' ' GLU . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 2.19 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.488 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 1.04 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 2.08 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.417 ' CD ' HD22 ' A' ' 285' ' ' LEU . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.4 112.669 175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 1.25 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.488 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 1.23 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 1.07 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.79 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.568 ' HB1' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 1.04 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.7 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 1.03 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.76 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 3.17 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 1.23 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.6 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 3.08 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.593 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.22 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.665 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.98 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.637 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.608 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 1.44 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.13 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.683 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 1.03 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 312' ' ' VAL . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 1.05 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 1.03 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 1.05 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 309' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 1.05 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.568 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.57 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.74 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 1.07 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.97 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 1.46 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.85 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.3 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.91 112.521 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 2.18 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 325' ' ' PRO . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.65 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.39 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 4.66 110.786 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 1.11 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 1.08 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 1.11 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.664 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.9 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 1.14 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 336' ' ' ARG . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.95 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 3.0 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 281' ' ' LEU . 30.6 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.852 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 3.0 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.42 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.675 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 1.03 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 1.11 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.94 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.77 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo -28.94 169.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.69 120.077 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.556 ' OE1' ' HB2' ' B' ' 7' ' ' SER . 11.0 pt-20 -152.61 129.24 10.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.805 -2.452 . . . . 2.54 107.719 174.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 59.85 64.06 1.36 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.677 0.621 . . . . 2.26 112.677 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -175.1 4.93 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 1.22 111.153 171.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.2 m -72.35 -32.39 66.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.971 0.891 . . . . 1.92 111.015 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.609 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 113.805 -1.543 . . . . 3.39 112.17 -163.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.187 0.042 . . . . 1.84 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t70 70.45 105.71 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 123.836 0.71 . . . . 1.37 110.968 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -43.71 128.68 6.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.55 2.833 . . . . 0.54 112.773 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.9 109.964 -172.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.66 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 1.19 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 13.0 p -114.7 -6.79 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.51 111.575 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.678 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.8 t -94.79 153.62 17.66 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 2.81 110.37 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.79 103.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.763 -0.935 . . . . 1.85 110.763 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' B' ' 12' ' ' ARG . 58.9 t30 -128.13 170.08 13.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.704 -0.48 . . . . 3.39 109.704 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.16 47.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.863 1.316 . . . . 5.81 111.272 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' B' ' 10' ' ' ASN . 34.5 ptt180 -110.11 159.27 17.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 112.758 -2.019 . . . . 5.91 109.774 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.76 -0.638 . . . . 7.77 110.206 177.642 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.749 0.309 . . . . 40.49 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.71 86.48 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.964 0.411 . . . . 40.11 109.976 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.446 ' HD3' ' OE1' ' A' ' 230' ' ' GLU . 0.0 OUTLIER -134.67 61.17 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.918 0.389 . . . . 39.42 110.583 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.12 -25.85 66.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 37.42 110.723 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.38 -9.98 59.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 36.38 111.274 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 44.84 71.87 0.24 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.851 0.719 . . . . 34.76 112.627 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 226' ' ' ARG . 7.9 pt-20 -75.34 107.62 7.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.376 0.608 . . . . 32.58 110.14 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.62 -45.03 12.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 31.1 110.132 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.1 mt 59.27 74.45 0.44 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.241 0.544 . . . . 30.58 111.45 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.0 p -103.22 29.9 5.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.807 0.813 . . . . 27.95 109.274 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -83.35 6.98 17.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.877 -1.056 . . . . 27.34 111.161 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 2.1 m -69.23 162.03 27.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.343 -0.614 . . . . 25.64 109.343 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 5.3 p -146.33 129.95 16.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.418 . . . . 24.1 109.888 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.29 126.13 35.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.714 0.769 . . . . 24.03 109.303 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -152.04 94.94 2.01 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.395 -1.275 . . . . 23.07 109.318 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -131.52 -63.49 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.505 -0.77 . . . . 21.17 110.137 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 54.97 51.73 13.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.445 0.64 . . . . 19.97 110.412 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 148.74 42.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.156 -0.929 . . . . 18.08 111.362 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.68 133.89 39.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.618 -0.719 . . . . 16.58 109.569 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.461 ' HB2' ' OD2' ' A' ' 330' ' ' ASP . . . -78.36 164.55 24.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.389 0.614 . . . . 14.16 111.429 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.0 158.81 20.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.253 -0.885 . . . . 13.65 110.855 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -94.82 146.24 24.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.326 -0.852 . . . . 12.06 111.735 -173.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 247' ' ' GLY . 9.9 p -104.96 -179.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.056 -0.72 . . . . 10.09 109.056 173.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.459 ' H ' ' CG2' ' A' ' 246' ' ' VAL . . . -75.53 121.75 6.51 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 115.747 -0.661 . . . . 7.81 112.379 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.1 p 50.73 79.2 0.09 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.981 0.912 . . . . 6.56 111.638 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.636 ' C ' HG21 ' A' ' 250' ' ' VAL . 0.2 OUTLIER -127.2 -93.62 0.47 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.901 -0.591 . . . . 4.79 112.266 -177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.636 HG21 ' C ' ' A' ' 249' ' ' GLU . 18.1 m 56.79 -179.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 115.919 1.822 . . . . 2.76 115.919 164.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.493 ' HB ' ' OD1' ' A' ' 255' ' ' ASP . 22.6 p -71.85 102.9 2.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.004 -1.907 . . . . 1.48 111.527 -172.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -91.44 60.12 2.94 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.785 -1.098 . . . . 1.61 113.516 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 60.09 12.93 3.47 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.401 1.096 . . . . 2.23 110.289 -177.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.3 OUTLIER -81.43 -32.49 32.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.535 -1.666 . . . . 1.17 109.334 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.493 ' OD1' ' HB ' ' A' ' 251' ' ' THR . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 1.13 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.745 HD11 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 1.07 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.632 ' O ' HD11 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 1.04 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.82 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 1.06 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 1.04 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 1.21 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.86 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.678 ' HE3' ' O ' ' B' ' 8' ' ' SER . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 4.19 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' B' ' 8' ' ' SER . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 3.36 110.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 1.2 113.582 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.62 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.962 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 1.11 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.608 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 3.0 108.97 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.72 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.962 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.73 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.784 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.98 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 1.57 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.409 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 1.03 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 1.11 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 2.19 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.512 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 1.04 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 2.08 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.53 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.4 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 285' ' ' LEU . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 1.25 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.427 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 1.23 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.606 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 1.07 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.79 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 1.04 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.7 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 1.03 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.76 109.202 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 3.17 109.384 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 1.23 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.6 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 3.08 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.22 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.747 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.98 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.606 ' HB3' HG22 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.632 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 1.44 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.13 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 1.03 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.683 ' O ' HG22 ' A' ' 312' ' ' VAL . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 1.05 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 1.03 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.586 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 1.05 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 1.05 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.537 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.57 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.74 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 1.07 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.97 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 288' ' ' GLY . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 1.46 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.85 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.688 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.3 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.91 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 2.18 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 325' ' ' PRO . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.65 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.39 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.53 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 4.66 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 1.11 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 1.08 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.456 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 1.11 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.706 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.661 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.9 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.661 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 1.14 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.688 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.95 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.706 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 3.0 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.0 OUTLIER -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.646 ' H ' HD11 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 3.0 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.468 ' CD ' HD11 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.42 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.442 HD12 HG22 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 1.03 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.559 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 1.11 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.784 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.94 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.522 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.77 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 31.6 Cg_exo -28.2 155.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.69 118.122 176.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -156.34 113.82 3.22 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.492 -2.14 . . . . 2.54 107.475 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 28.5 t70 60.59 75.86 0.39 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.533 0.682 . . . . 2.26 111.359 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.617 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -80.63 -73.39 0.37 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.765 0.793 . . . . 1.22 111.703 175.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.1 t 177.77 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.811 -1.54 . . . . 1.92 108.969 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.608 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 CA-C-N 112.322 -2.217 . . . . 3.39 112.328 -167.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.314 -0.624 . . . . 1.84 109.314 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.81 128.42 63.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 123.719 0.637 . . . . 1.37 111.18 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo -56.23 119.28 6.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.66 2.24 . . . . 0.54 111.054 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 256' ' ' ASP . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.9 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.66 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 339' ' ' ILE . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 1.19 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -107.12 -16.73 14.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.51 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 16.1 t -68.86 -174.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.994 -1.003 . . . . 2.81 110.015 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.6 91.92 0.41 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 109.981 -1.248 . . . . 1.85 109.981 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -59.93 141.17 56.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.435 1.112 . . . . 3.39 113.265 -165.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -168.7 23.05 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.904 -1.953 . . . . 5.81 107.47 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -137.24 38.88 2.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.055 -1.884 . . . . 5.91 110.678 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.534 -0.757 . . . . 7.77 110.035 178.774 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.446 ' HB3' ' CD ' ' A' ' 230' ' ' GLU . 12.2 t-80 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.378 -0.23 . . . . 40.49 110.378 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.1 mmt -95.0 -46.58 6.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.314 0.578 . . . . 40.11 109.552 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -152.54 -37.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.256 -0.883 . . . . 39.42 110.451 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.06 165.72 11.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 37.42 111.132 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.73 145.94 30.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.704 -0.851 . . . . 36.38 108.704 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 58.61 52.06 7.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.304 0.573 . . . . 34.76 110.047 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.446 ' CD ' ' HB3' ' A' ' 224' ' ' HIS . 57.9 mt-10 -62.79 121.84 14.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.064 -0.971 . . . . 32.58 111.277 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.49 130.59 43.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.477 -0.783 . . . . 31.1 110.251 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.443 HD11 ' N ' ' A' ' 233' ' ' SER . 2.9 pp -81.41 -18.67 44.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 30.58 111.845 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 232' ' ' LEU . 8.7 t -108.16 133.69 52.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.9 -0.778 . . . . 27.95 108.9 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 75.31 5.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.814 0.34 . . . . 27.34 110.923 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.5 p 55.45 -172.68 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.282 1.033 . . . . 25.64 112.598 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 7.0 m -98.22 -51.49 3.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.268 0.556 . . . . 24.1 110.34 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.53 161.42 22.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.088 -0.96 . . . . 24.03 109.984 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.44 ' HD2' ' C ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER 66.13 97.88 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.699 0.624 . . . . 23.07 110.531 -178.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 238' ' ' ARG . 43.1 mt-30 75.25 175.67 0.23 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.062 -0.972 . . . . 21.17 110.307 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 57.76 50.8 10.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.024 -0.534 . . . . 19.97 111.046 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.41 -56.88 13.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.563 . . . . 18.08 109.996 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.63 97.03 8.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.109 -1.071 . . . . 16.58 108.109 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -101.13 142.04 33.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.049 -0.523 . . . . 14.16 111.089 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.26 -172.5 2.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 13.65 109.705 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.92 134.64 48.61 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.461 0.648 . . . . 12.06 111.439 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 247' ' ' GLY . 8.7 p -106.34 172.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 10.09 110.679 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 246' ' ' VAL . . . -126.59 41.54 1.61 Allowed Glycine 0 C--N 1.309 -0.923 0 CA-C-N 114.573 -1.194 . . . . 7.81 111.946 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -172.51 82.45 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.374 -0.602 . . . . 6.56 109.374 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.59 -135.68 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.222 0.534 . . . . 4.79 111.417 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 m -158.96 -169.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.285 -0.871 . . . . 2.76 110.128 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.735 ' HB ' ' HH ' ' A' ' 333' ' ' TYR . 16.3 p -105.32 2.4 28.84 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 113.201 0.815 . . . . 1.48 113.201 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 44.33 37.66 4.76 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 124.413 1.071 . . . . 1.61 115.396 170.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.741 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.2 OUTLIER 58.7 14.74 3.31 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 118.327 1.063 . . . . 2.23 112.353 -176.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -84.96 -38.54 19.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.782 -1.099 . . . . 1.17 110.128 -177.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.739 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 1.13 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 1.07 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' HD11 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 1.04 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.82 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 1.06 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 1.04 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.616 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 1.21 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.86 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.607 HE21 HG11 ' A' ' 315' ' ' VAL . 2.3 mp0 -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.578 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 4.19 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 3.36 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 1.2 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.62 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.438 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 1.11 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 3.0 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.72 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.606 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.73 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.98 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 1.57 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.531 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 1.03 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 1.11 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.749 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 2.19 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.516 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 1.04 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 2.08 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HD2' HD22 ' A' ' 285' ' ' LEU . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.4 113.591 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.442 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.68 ' O ' HD11 ' A' ' 285' ' ' LEU . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 1.25 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.516 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 1.23 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 1.07 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.79 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.7 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 1.03 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.76 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 3.17 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 1.23 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.419 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.6 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.474 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 3.08 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.22 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.538 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.98 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.617 ' HB3' HG23 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.655 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 1.44 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.13 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 1.03 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 1.05 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 1.03 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.643 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 1.05 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 1.05 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.57 112.273 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.74 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 1.07 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.97 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 318' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 1.46 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.85 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.421 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.583 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.3 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.91 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 2.18 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.539 HD12 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.65 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.39 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 4.66 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 1.11 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.539 HG21 HD12 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 1.08 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.441 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 1.11 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.9 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 1.14 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.735 ' HH ' ' HB ' ' A' ' 251' ' ' THR . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.95 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 3.0 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.749 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 3.0 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.489 ' HG2' HD11 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.42 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.468 HD13 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 1.03 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.587 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 1.11 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.819 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.94 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.77 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo -31.72 171.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.69 119.075 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -151.6 128.73 11.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 111.862 -2.426 . . . . 2.54 108.707 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 52.3 73.23 0.35 Allowed 'General case' 0 C--N 1.321 -0.671 0 O-C-N 124.206 0.941 . . . . 2.26 113.43 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.11 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.958 0.885 . . . . 1.22 110.431 170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -169.52 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.991 -1.459 . . . . 1.92 108.208 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.305 -1.35 0 CA-C-N 112.954 -1.93 . . . . 3.39 110.174 -177.492 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.033 0.012 . . . . 1.84 111.033 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.75 125.75 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 O-C-N 123.657 0.598 . . . . 1.37 110.945 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.32 117.53 4.3 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 121.867 1.711 . . . . 0.54 110.823 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.9 110.539 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.66 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 1.19 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p -108.94 -29.28 8.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.51 110.946 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.655 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 m -70.36 148.68 48.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.948 -1.023 . . . . 2.81 110.746 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.62 108.81 0.35 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.917 -1.273 . . . . 1.85 109.917 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -141.97 164.31 30.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.944 0.402 . . . . 3.39 110.33 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.6 1.5 4.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.579 -0.737 . . . . 5.81 110.849 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -57.07 173.32 0.23 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.567 -1.197 . . . . 5.91 111.999 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.789 . . . . 7.77 110.323 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.923 0.392 . . . . 40.49 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.7 ptp -163.3 35.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 40.11 109.544 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -126.38 120.9 31.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.512 -0.767 . . . . 39.42 110.685 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 55.06 50.25 15.78 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.579 0.55 . . . . 37.42 111.679 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.09 56.28 3.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.835 0.826 . . . . 36.38 109.941 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -113.35 98.22 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.052 -0.976 . . . . 34.76 109.376 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.64 113.51 6.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 32.58 111.543 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.86 76.38 1.62 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.751 -0.659 . . . . 31.1 110.057 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.87 65.4 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.492 . . . . 30.58 109.702 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 m -104.06 -70.91 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.234 -0.439 . . . . 27.95 110.719 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 52.71 1.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.284 0.564 . . . . 27.34 110.077 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.677 ' HB ' ' OE1' ' A' ' 237' ' ' GLU . 7.5 p -81.35 -47.54 13.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.092 -0.958 . . . . 25.64 110.984 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 m 68.88 86.66 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.1 -0.5 . . . . 24.1 111.152 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 235' ' ' THR . 5.3 mp0 -99.89 -22.33 15.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.046 0.927 . . . . 24.03 109.725 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.49 93.54 8.8 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.409 -1.269 . . . . 23.07 110.696 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -66.04 -49.95 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.662 -0.699 . . . . 21.17 109.961 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 56.75 66.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 19.97 111.274 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.72 -15.28 28.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.234 0.54 . . . . 18.08 110.743 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.66 100.3 6.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.882 -0.784 . . . . 16.58 108.882 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -144.03 135.24 25.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.999 -0.546 . . . . 14.16 111.191 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.47 -173.6 4.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.834 -0.621 . . . . 13.65 110.126 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 249' ' ' GLU . 4.2 pt-20 -54.81 122.82 11.59 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.523 0.678 . . . . 12.06 110.929 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 247' ' ' GLY . 7.2 p -88.35 155.71 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.003 0.906 . . . . 10.09 112.642 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 246' ' ' VAL . . . 70.85 -114.01 5.07 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.136 -1.393 . . . . 7.81 111.26 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -123.68 -11.66 7.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.643 0.258 . . . . 6.56 111.391 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 245' ' ' GLU . 1.8 pm0 -141.11 -113.81 0.13 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.13 -0.693 . . . . 4.79 109.13 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.517 ' O ' HD12 ' A' ' 332' ' ' LEU . 4.3 m -155.09 -179.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.11 0.481 . . . . 2.76 111.291 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.499 ' HB ' ' HH ' ' A' ' 333' ' ' TYR . 7.3 p -111.3 9.04 21.63 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.149 -0.932 . . . . 1.48 112.856 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.31 -122.2 20.3 Favored Glycine 0 C--N 1.315 -0.631 0 O-C-N 123.853 0.721 . . . . 1.61 111.864 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.843 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.0 m -119.01 16.15 13.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.191 0.996 . . . . 2.23 109.278 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.801 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp -79.68 -44.31 21.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.219 -1.809 . . . . 1.17 109.913 -164.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 259' ' ' VAL . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 260' ' ' ASN . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 1.13 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.754 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 1.07 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.598 ' O ' HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 1.04 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.82 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 1.06 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.573 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 1.04 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 1.21 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.86 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.604 HE21 HG13 ' A' ' 315' ' ' VAL . 2.3 mp0 -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.655 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 4.19 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 3.36 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 1.2 113.253 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.62 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.81 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 1.11 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.678 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 3.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.72 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.829 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.73 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 341' ' ' LYS . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.98 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.475 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 1.57 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.489 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 1.03 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 1.11 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 2.19 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.568 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 1.04 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 2.08 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.4 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 285' ' ' LEU . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.632 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 1.25 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 1.23 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 1.07 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.79 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 313' ' ' ARG . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 1.04 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.7 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 1.03 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.76 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 3.17 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 1.23 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.6 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.481 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 3.08 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.22 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.98 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.643 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 1.44 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.13 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.727 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 1.03 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.721 ' O ' HG21 ' A' ' 312' ' ' VAL . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 1.05 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 1.03 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 308' ' ' ALA . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 1.05 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.721 HG21 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 1.05 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 293' ' ' ALA . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.57 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.74 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.604 HG13 HE21 ' A' ' 265' ' ' GLN . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 1.07 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.97 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.657 HG23 ' SD ' ' A' ' 321' ' ' MET . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 1.46 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.85 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.3 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.91 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 2.18 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.521 HD23 ' HD2' ' A' ' 325' ' ' PRO . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.65 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.39 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 4.66 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 1.11 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 1.08 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 1.11 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.655 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.9 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 1.14 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.801 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.95 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 283' ' ' GLU . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 3.0 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.5 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.56 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 3.0 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.465 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.42 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.482 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 1.03 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.525 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 1.11 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CD2' ' HB2' ' A' ' 308' ' ' ALA . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.94 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.77 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.829 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo -28.18 150.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.69 118.396 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -155.53 110.07 2.92 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.215 -2.266 . . . . 2.54 106.862 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.81 71.66 0.57 Allowed 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.903 0.752 . . . . 2.26 111.641 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -78.35 -164.71 0.58 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.898 -0.592 . . . . 1.22 109.767 171.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.5 m -66.99 -30.91 71.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.982 0.896 . . . . 1.92 110.752 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.678 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 113.832 -1.531 . . . . 3.39 111.978 -162.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.443 -0.577 . . . . 1.84 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -111.34 115.97 51.52 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.952 -0.388 . . . . 1.37 109.952 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.79 119.69 6.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.987 2.458 . . . . 0.54 111.307 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.9 111.256 -168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.66 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 339' ' ' ILE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 1.19 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 4.6 p -104.57 -19.48 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.51 111.886 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.522 ' C ' ' HG ' ' A' ' 263' ' ' SER . 8.8 t -70.12 -174.36 0.79 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.507 -0.769 . . . . 2.81 109.806 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.6 85.35 0.32 Allowed Glycine 0 CA--C 1.503 -0.686 0 N-CA-C 111.12 -0.792 . . . . 1.85 111.12 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.77 168.0 27.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.78 -0.71 . . . . 3.39 110.299 -170.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.1 -18.89 60.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 5.81 111.874 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -73.42 49.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.987 -0.551 . . . . 5.91 112.062 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.778 -0.629 . . . . 7.77 111.113 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.798 0.332 . . . . 40.49 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 61.4 ttp -81.56 118.46 22.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.205 -0.452 . . . . 40.11 109.91 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -101.95 124.64 47.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 39.42 110.322 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.86 137.11 57.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.584 . . . . 37.42 111.001 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.2 -54.95 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.918 -0.771 . . . . 36.38 108.918 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -156.83 -59.6 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.551 -0.75 . . . . 34.76 109.506 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.42 107.81 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 32.58 112.639 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.65 80.34 7.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.263 -0.88 . . . . 31.1 109.479 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.23 -48.95 77.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 30.58 110.948 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 37.7 m -109.97 57.78 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.64 -0.709 . . . . 27.95 111.093 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.07 -30.77 65.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 27.34 109.558 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.567 HG21 ' H ' ' A' ' 236' ' ' THR . 0.2 OUTLIER 59.58 -157.56 0.33 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.066 -0.97 . . . . 25.64 110.98 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.567 ' H ' HG21 ' A' ' 235' ' ' THR . 2.6 m 65.1 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.549 0.74 . . . . 24.1 110.86 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.91 -6.05 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.138 0.494 . . . . 24.03 110.856 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.86 30.15 1.24 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.785 -0.643 . . . . 23.07 110.874 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 60.07 -142.82 0.55 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.101 -0.5 . . . . 21.17 110.829 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 67.38 67.46 0.39 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.663 0.602 . . . . 19.97 110.215 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.94 167.64 0.23 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.882 -1.054 . . . . 18.08 112.069 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 54.8 tp -68.48 125.55 26.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 16.58 110.597 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -77.14 126.67 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 14.16 110.702 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.72 -178.58 5.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.428 -0.582 . . . . 13.65 109.428 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -73.03 114.54 11.3 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.268 0.556 . . . . 12.06 110.841 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.38 155.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.158 -0.928 . . . . 10.09 110.962 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.64 -55.9 4.72 Favored Glycine 0 C--N 1.309 -0.955 0 CA-C-N 114.679 -1.146 . . . . 7.81 111.586 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.1 p -90.64 55.8 3.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.646 0.736 . . . . 6.56 109.358 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.48 ' HB2' HG22 ' A' ' 250' ' ' VAL . 1.8 pt-20 -99.04 -88.17 0.34 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.226 -0.897 . . . . 4.79 112.696 -173.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 249' ' ' GLU . 3.2 m -139.4 -160.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.346 -0.843 . . . . 2.76 112.956 -166.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.66 ' H ' HD12 ' A' ' 332' ' ' LEU . 1.8 t 43.85 70.74 0.29 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-O 123.005 1.383 . . . . 1.48 109.973 -171.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -63.18 -137.61 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 111.826 -2.443 . . . . 1.61 114.812 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.87 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 6.4 p -74.25 6.04 3.94 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 122.924 1.345 . . . . 2.23 111.591 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp -81.76 -45.82 15.09 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 110.901 -2.863 . . . . 1.17 111.413 -167.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.641 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.87 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 1.13 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 1.07 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 262' ' ' VAL 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 1.04 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.82 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 1.06 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 1.04 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.522 ' HG ' ' C ' ' B' ' 8' ' ' SER . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 1.21 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.86 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 4.19 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 3.36 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 1.2 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.62 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 1.007 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 1.11 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.626 ' HA ' ' CD2' ' A' ' 347' ' ' LEU . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 3.0 109.266 175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.72 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 1.007 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.73 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.98 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 1.57 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 1.03 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 1.11 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 2.19 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.711 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.53 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 1.04 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 2.08 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.4 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.532 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 1.25 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.53 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 1.23 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.606 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 1.07 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.711 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.79 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 1.04 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.7 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 1.03 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.76 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 3.17 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.408 ' HB3' HG13 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 1.23 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.719 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.6 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.627 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 3.08 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.22 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.98 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.627 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.619 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 1.44 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.13 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.641 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 1.03 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 312' ' ' VAL . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 1.05 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 1.03 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 1.05 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 309' ' ' VAL . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 1.05 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.57 112.433 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.692 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.74 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 1.07 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.97 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 288' ' ' GLY . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 1.46 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.85 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.627 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.82 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.3 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.91 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 2.18 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.65 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.767 ' N ' HD13 ' A' ' 324' ' ' LEU . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.39 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 4.66 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 1.11 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.583 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 1.08 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.58 ' N ' HD12 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 1.11 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.638 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.9 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 251' ' ' THR . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 1.14 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.82 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.95 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 3.0 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.641 ' NH2' ' HB2' ' A' ' 255' ' ' ASP . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 3.0 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.42 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 1.03 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 1.11 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.94 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.649 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.77 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo -32.19 166.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.69 118.097 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 18.1 mm-40 -152.93 126.13 8.58 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.855 -1.975 . . . . 2.54 108.174 174.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 53.32 76.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.05 0.844 . . . . 2.26 112.969 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 345' ' ' LEU . 0.4 OUTLIER -83.53 -83.4 0.14 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.159 0.981 . . . . 1.22 110.216 169.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 5.0 t -179.47 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.236 -1.802 . . . . 1.92 108.569 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.626 ' CD2' ' HA ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 111.982 -2.372 . . . . 3.39 111.952 -169.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.564 0.221 . . . . 1.84 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 69.57 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.937 -0.574 . . . . 1.37 111.139 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo -49.11 123.55 10.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.54 111.857 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.9 110.292 -174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.66 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 339' ' ' ILE . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 1.19 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -109.04 -12.6 14.83 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.51 110.937 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.487 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.8 t -73.11 -174.44 1.55 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.199 -0.909 . . . . 2.81 109.757 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.53 90.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.382 -0.913 . . . . 1.85 112.273 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.93 166.96 31.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.781 -0.822 . . . . 3.39 108.781 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -44.86 -60.23 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.679 0.612 . . . . 5.81 111.379 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 44.3 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.62 1.341 . . . . 5.91 114.62 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.92 -1.036 . . . . 7.77 110.225 178.358 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.643 0.259 . . . . 40.49 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.6 mmm -132.94 -69.47 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.357 -0.383 . . . . 40.11 110.767 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 60.09 99.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.87 0.731 . . . . 39.42 111.409 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.6 73.09 5.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 37.42 110.041 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 228' ' ' LEU . 2.4 pt? -77.74 53.27 1.1 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.521 0.676 . . . . 36.38 111.434 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.72 3.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.744 -0.662 . . . . 34.76 109.952 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.21 108.33 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.613 0.721 . . . . 32.58 110.535 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -92.8 -8.01 44.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.485 -0.78 . . . . 31.1 110.23 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.0 123.36 47.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 30.58 109.87 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.6 p -70.27 -34.95 73.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.095 -0.502 . . . . 27.95 109.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.7 t70 48.43 71.47 0.35 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 124.114 0.884 . . . . 27.34 111.399 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m 72.93 -34.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.778 -0.646 . . . . 25.64 112.304 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 234' ' ' ASP . 25.8 m -75.37 81.74 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.051 0.453 . . . . 24.1 110.157 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -112.42 -15.79 13.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.166 -0.47 . . . . 24.03 111.284 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 0.2 OUTLIER -64.36 106.13 1.06 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.267 -0.879 . . . . 23.07 110.387 177.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 240' ' ' GLN . 5.1 tp-100 -82.72 169.46 16.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.693 -0.685 . . . . 21.17 109.8 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 239' ' ' GLN . 47.4 mt-30 74.29 129.99 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.746 0.654 . . . . 19.97 111.301 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.58 138.6 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.674 -0.694 . . . . 18.08 111.273 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.22 143.92 31.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 16.58 110.212 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -76.22 159.47 30.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 14.16 110.545 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.05 -164.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.25 0.969 . . . . 13.65 112.642 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -51.82 136.68 27.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.791 -0.64 . . . . 12.06 111.774 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.59 156.76 4.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.702 0.763 . . . . 10.09 111.462 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.22 -102.67 2.91 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.397 -1.274 . . . . 7.81 111.44 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m 49.13 49.58 19.35 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.945 0.403 . . . . 6.56 111.951 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 2.3 pt-20 -89.84 -99.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.014 0.911 . . . . 4.79 111.802 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.491 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 14.7 m -141.44 174.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.796 -1.547 . . . . 2.76 111.8 -170.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.428 ' HB ' ' OH ' ' A' ' 333' ' ' TYR . 5.0 p -109.3 19.25 19.61 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.78 -1.555 . . . . 1.48 111.889 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 47.84 -124.01 9.8 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.837 -1.074 . . . . 1.61 112.155 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.701 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 4.2 m -120.12 22.64 11.34 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 123.11 1.433 . . . . 2.23 108.62 168.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 1.044 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER -80.72 -38.44 28.79 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.2 -2.273 . . . . 1.17 111.555 -165.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 259' ' ' VAL . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 1.13 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 1.07 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.528 ' O ' HG11 ' A' ' 262' ' ' VAL 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 1.04 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.82 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 1.06 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 259' ' ' VAL . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 1.04 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.52 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 1.21 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.86 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.64 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.558 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 4.19 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 3.36 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 1.2 113.149 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.62 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.821 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 1.11 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.536 ' HA ' ' CD2' ' A' ' 347' ' ' LEU . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 3.0 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 347' ' ' LEU . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.72 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.821 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.73 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.98 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 1.57 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 1.03 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 1.11 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 2.19 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 1.04 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 2.08 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.448 ' CD ' HD23 ' A' ' 285' ' ' LEU . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.4 112.839 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 1.25 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.54 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 1.23 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.529 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 1.07 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.79 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 1.04 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.7 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 1.03 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.76 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 3.17 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 1.23 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.6 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.601 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 3.08 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.601 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.22 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.98 109.485 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.627 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 1.44 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.13 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 1.03 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.632 ' O ' HG21 ' A' ' 312' ' ' VAL . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 1.05 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.586 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 1.05 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 1.05 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.57 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.7 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.74 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 1.07 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.97 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 1.46 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.85 114.666 -163.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.72 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.3 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.91 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 2.18 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.539 HD23 ' HD2' ' A' ' 325' ' ' PRO . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.65 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.39 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 4.66 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 1.11 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 1.08 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 1.11 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.9 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 1.14 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 1.044 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.95 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 3.0 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.6 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.67 ' H ' HD13 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 3.0 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.42 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.508 HD11 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 1.03 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.636 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 1.11 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.94 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.518 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.801 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo -47.3 171.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.69 116.957 -177.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -151.88 112.53 4.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 112.596 -2.093 . . . . 2.54 107.862 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.57 83.57 0.16 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.578 -1.192 . . . . 2.26 113.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.468 ' CB ' HD23 ' A' ' 347' ' ' LEU . 1.1 mm? -88.42 -166.17 1.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.905 -0.776 . . . . 1.22 108.905 161.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.9 t -69.33 -43.48 73.6 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.541 1.163 . . . . 1.92 109.534 169.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 CA-C-N 112.893 -1.958 . . . . 3.39 112.361 -166.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.491 ' H1 ' ' HA ' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.847 -0.427 . . . . 1.84 109.847 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -42.85 115.65 1.77 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.331 1.019 . . . . 1.37 112.277 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo -47.53 119.35 3.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.346 2.697 . . . . 0.54 111.845 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.578 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.9 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.525 ' N ' HD12 ' B' ' 4' ' ' LEU . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.66 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 259' ' ' VAL . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 1.19 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -68.49 -70.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.51 110.454 -173.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.706 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 20.3 m -158.66 165.29 34.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.939 -0.476 . . . . 2.81 111.303 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.516 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -86.65 147.0 21.01 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.246 -0.888 . . . . 1.85 111.585 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -77.12 122.29 24.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.782 0.801 . . . . 3.39 110.657 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -175.41 25.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.678 -1.601 . . . . 5.81 107.471 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -93.82 161.16 14.43 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.115 -1.857 . . . . 5.91 111.727 -167.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.382 -0.827 . . . . 7.77 109.825 177.68 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.561 -0.163 . . . . 40.49 110.561 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 53.2 ttm 56.95 62.52 2.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.185 0.517 . . . . 40.11 111.122 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -145.85 26.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.032 -0.531 . . . . 39.42 110.404 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 68.44 -65.08 0.28 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 37.42 110.651 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.46 137.76 32.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.185 -0.672 . . . . 36.38 109.185 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -139.92 -63.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.775 -0.193 . . . . 34.76 110.616 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.99 106.68 0.04 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.946 0.778 . . . . 32.58 110.868 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.8 tt -132.41 82.99 2.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.738 -0.664 . . . . 31.1 109.544 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.9 tp -149.67 60.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.961 -0.563 . . . . 30.58 109.856 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -63.85 -59.14 4.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.761 -0.654 . . . . 27.95 110.568 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -151.52 -70.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 27.34 110.98 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 p 53.64 122.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.485 1.114 . . . . 25.64 113.419 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.1 m -98.62 84.43 3.15 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.715 . . . . 24.1 109.508 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.88 -16.63 14.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.809 0.814 . . . . 24.03 111.063 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.96 118.65 18.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.344 -1.298 . . . . 23.07 110.454 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 58.95 68.72 0.79 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.841 0.713 . . . . 21.17 111.05 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -67.9 140.37 56.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.949 -0.569 . . . . 19.97 111.254 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.9 118.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.067 0.854 . . . . 18.08 111.74 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.61 118.79 21.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.619 -0.718 . . . . 16.58 110.326 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -80.56 133.0 35.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.648 -0.705 . . . . 14.16 111.197 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.83 -172.37 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 13.65 110.694 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.92 150.4 28.85 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.958 0.725 . . . . 12.06 112.958 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.486 HG21 ' N ' ' A' ' 247' ' ' GLY . 14.4 p -104.28 168.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.223 -0.899 . . . . 10.09 110.719 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.486 ' N ' HG21 ' A' ' 246' ' ' VAL . . . 123.19 -67.98 0.48 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.534 -0.757 . . . . 7.81 113.697 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.6 m -62.73 -65.39 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.077 0.465 . . . . 6.56 112.067 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.682 ' C ' HG21 ' A' ' 250' ' ' VAL . 1.4 pt-20 -109.35 -94.65 0.41 Allowed 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 112.792 0.664 . . . . 4.79 112.792 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.682 HG21 ' C ' ' A' ' 249' ' ' GLU . 8.2 m 48.53 -171.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 125.152 1.532 . . . . 2.76 114.864 171.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 250' ' ' VAL . 29.9 p -65.26 114.32 4.65 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.313 -1.312 . . . . 1.48 110.172 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -76.93 -137.86 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.033 -0.985 . . . . 1.61 110.806 172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.813 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.6 m -84.32 20.56 1.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.029 0.918 . . . . 2.23 110.291 171.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp -82.9 -40.3 20.37 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 113.507 -1.679 . . . . 1.17 109.466 -168.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.555 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 1.13 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 1.07 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.624 ' O ' HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 1.04 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.82 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 1.06 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 1.04 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.59 ' HB3' HD12 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 1.21 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.86 106.57 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.589 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.706 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 4.19 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 3.36 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 1.2 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.62 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 1.027 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 1.11 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.539 ' HA ' HD22 ' A' ' 347' ' ' LEU . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 3.0 109.102 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.72 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 1.027 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.73 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.804 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.98 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 1.57 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.587 HG13 HG23 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 1.03 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 1.11 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 2.19 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 1.04 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 287' ' ' ASP . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 2.08 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.4 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.6 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 1.25 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 284' ' ' MET . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 1.23 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.533 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 1.07 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.79 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 1.04 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.7 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 1.03 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.76 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 3.17 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 1.23 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.6 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 3.08 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.22 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.849 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.98 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.618 ' HB3' HG22 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.623 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 1.44 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.13 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 1.03 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.699 ' O ' HG21 ' A' ' 312' ' ' VAL . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 1.05 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 1.03 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 1.05 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 309' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 1.05 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.57 112.961 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.589 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.74 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 1.07 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.97 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.646 HG22 ' SD ' ' A' ' 321' ' ' MET . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 1.46 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.85 118.885 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.3 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.91 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 2.18 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.54 HD22 ' HD2' ' A' ' 325' ' ' PRO . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.65 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.39 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 4.66 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 1.11 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 1.08 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 1.11 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.636 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.9 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 1.14 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.95 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 3.0 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 2.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.681 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 3.0 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.405 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.42 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 1.03 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.583 ' O ' HG21 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 1.11 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.804 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.94 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.606 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.77 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo -38.26 170.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.69 117.259 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -152.19 119.8 6.07 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 112.78 -2.009 . . . . 2.54 107.847 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.6 t70 58.28 71.48 0.58 Allowed 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.734 0.646 . . . . 2.26 112.587 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.423 ' HB3' HD23 ' A' ' 347' ' ' LEU . 0.8 OUTLIER -79.62 -79.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.144 1.449 . . . . 1.22 108.716 167.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.5 ' HB3' HD13 ' A' ' 347' ' ' LEU . 0.4 OUTLIER -177.3 -44.53 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 111.739 -2.482 . . . . 1.92 106.492 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.796 0 CA-C-N 111.539 -2.573 . . . . 3.39 111.736 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.602 ' H1 ' ' HA ' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.217 -0.66 . . . . 1.84 109.217 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -113.16 116.09 47.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 121.055 -0.258 . . . . 1.37 110.443 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo -55.67 117.56 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.276 1.984 . . . . 0.54 110.443 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.9 111.11 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.66 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 339' ' ' ILE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 1.19 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.462 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 2.4 p -91.86 -12.44 33.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.51 112.814 -169.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 263' ' ' SER . 42.7 m -132.67 167.19 20.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.085 0.469 . . . . 2.81 111.641 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.12 79.57 0.18 Allowed Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.927 -1.269 . . . . 1.85 109.927 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' B' ' 12' ' ' ARG . 12.8 p-10 -160.69 168.9 23.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.785 -0.82 . . . . 3.39 108.785 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -79.34 49.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.008 1.385 . . . . 5.81 110.916 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.493 ' CZ ' ' HB2' ' B' ' 8' ' ' SER . 19.9 ptt180 -78.35 -170.29 1.97 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 112.5 -2.136 . . . . 5.91 110.77 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.002 -0.523 . . . . 7.77 110.261 175.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.769 -0.456 . . . . 40.49 109.769 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 94.0 mmm -140.71 49.33 1.7 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 40.11 111.008 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 63.42 33.38 13.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.012 -0.54 . . . . 39.42 111.813 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.16 20.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 37.42 110.138 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.99 142.09 56.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.547 -0.751 . . . . 36.38 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -56.77 3.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.68 . . . . 34.76 110.342 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.93 106.29 17.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.923 0.868 . . . . 32.58 111.333 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.42 -28.56 7.17 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.791 -1.095 . . . . 31.1 109.829 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.41 -74.34 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.434 -0.803 . . . . 30.58 111.341 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -82.25 165.77 20.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 27.95 110.636 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -123.23 33.25 5.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 27.34 110.749 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.2 m 59.07 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.664 -0.698 . . . . 25.64 111.298 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.2 m 54.08 52.19 13.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.666 0.746 . . . . 24.1 110.818 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -92.93 -10.31 36.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.479 -0.782 . . . . 24.03 110.905 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.456 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 27.2 mmt180 -105.1 43.81 1.08 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.049 -0.978 . . . . 23.07 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -137.5 72.4 1.42 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.263 -0.643 . . . . 21.17 109.263 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -71.28 66.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.754 -0.657 . . . . 19.97 111.332 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.84 -44.5 0.35 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 18.08 109.915 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 63.1 tp -91.5 112.92 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 16.58 109.607 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -63.4 142.38 58.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.049 0.452 . . . . 14.16 111.179 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.68 176.34 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 13.65 110.951 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 140.2 56.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.572 0.701 . . . . 12.06 111.947 -174.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 247' ' ' GLY . 9.9 p -119.14 178.64 2.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.237 -0.892 . . . . 10.09 109.975 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.429 ' H ' HG23 ' A' ' 246' ' ' VAL . . . -62.67 125.11 34.53 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.59 -1.004 . . . . 7.81 110.59 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m -66.49 84.5 0.1 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.221 0.452 . . . . 6.56 112.221 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.551 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 1.7 pt-20 -98.39 -80.04 0.46 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.322 0.582 . . . . 4.79 110.555 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.551 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 5.9 m -149.04 -142.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.649 -1.159 . . . . 2.76 110.309 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.662 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 30.4 p 50.61 70.02 0.57 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.911 0.862 . . . . 1.48 110.395 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.65 -151.96 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.3 -1.318 . . . . 1.61 112.593 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -51.74 68.79 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.915 -0.756 . . . . 2.23 109.547 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 258' ' ' ILE . 7.0 mt 16.61 -70.48 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.502 1.921 . . . . 1.17 115.568 157.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.602 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 1.13 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 1.07 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.539 ' O ' HD12 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 1.04 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.82 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 1.06 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.488 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 1.21 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.86 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 4.19 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 3.36 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 1.2 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 1.005 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 1.11 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.59 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 3.0 108.856 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.72 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 1.005 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.73 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.98 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 1.57 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.593 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 1.03 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 1.11 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 2.19 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.458 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 1.04 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.527 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 2.08 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.444 ' CD ' HD22 ' A' ' 285' ' ' LEU . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.4 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.729 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 1.25 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.458 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 1.23 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.527 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 1.07 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.679 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.79 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 313' ' ' ARG . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 1.04 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.7 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 1.03 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.76 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 3.17 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 1.23 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.613 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.6 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 3.08 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.22 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.725 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.98 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.594 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 1.44 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.13 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.759 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 1.03 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 312' ' ' VAL . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 1.05 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 1.03 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 1.05 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 309' ' ' VAL . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 1.05 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.495 ' CD ' ' HB1' ' A' ' 293' ' ' ALA . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.57 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.74 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 1.07 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.97 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 321' ' ' MET . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 1.46 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.85 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.629 ' HG2' ' O ' ' A' ' 318' ' ' ILE . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.3 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.472 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.91 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 2.18 108.671 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.65 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.39 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.418 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 4.66 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 1.11 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.522 ' CG2' HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 1.08 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 1.11 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.9 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 1.14 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 251' ' ' THR . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.95 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.713 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 3.0 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.485 ' HG2' HG12 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 3.0 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.461 ' HD3' HD12 ' A' ' 281' ' ' LEU . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.42 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 1.03 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.602 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 1.11 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.759 ' CD2' ' HB3' ' A' ' 308' ' ' ALA . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.94 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.686 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.77 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo -28.62 165.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.69 118.937 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 13.5 pt-20 -146.37 125.62 13.02 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.669 -2.06 . . . . 2.54 108.852 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.5 t70 48.73 76.67 0.11 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.655 0.983 . . . . 2.26 113.655 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 342' ' ' PRO . 1.6 mm? -85.29 -166.58 1.55 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 -28.19 69.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.943 0.878 . . . . 1.92 112.073 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.59 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.355 -1.293 . . . . 3.39 111.841 -161.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.59 ' H1 ' ' CD2' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.031 -0.729 . . . . 1.84 109.031 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.87 113.69 16.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 121.244 -0.182 . . . . 1.37 110.593 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.12 117.99 3.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.346 2.031 . . . . 0.54 110.452 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.9 111.289 -168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.66 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.563 HG21 ' O ' ' A' ' 339' ' ' ILE . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 1.19 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p -67.26 -65.29 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.51 111.541 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.774 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 69.7 m -156.32 177.62 11.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.224 -0.658 . . . . 2.81 109.224 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.524 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -72.09 -150.42 1.03 Allowed Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 119.975 -1.107 . . . . 1.85 111.159 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -73.34 163.46 28.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.348 -0.612 . . . . 3.39 109.348 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -41.55 -57.43 2.25 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.132 0.895 . . . . 5.81 112.864 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 48.81 -161.15 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.736 0.779 . . . . 5.91 112.264 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 7.77 109.937 176.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.242 0.544 . . . . 40.49 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 23.2 ttt -105.83 -51.69 2.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.077 -0.51 . . . . 40.11 109.667 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -167.69 149.37 5.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.657 -0.868 . . . . 39.42 108.657 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -77.03 80.3 3.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.074 0.464 . . . . 37.42 111.277 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.78 71.47 4.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.965 -0.561 . . . . 36.38 109.808 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.81 86.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 34.76 111.243 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.61 105.77 5.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.544 . . . . 32.58 111.079 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 32.2 tp 47.1 48.79 15.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.595 0.712 . . . . 31.1 110.516 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.0 80.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 30.58 109.76 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 31.9 m -91.17 82.16 5.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.84 -0.618 . . . . 27.95 109.773 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.401 ' C ' ' HG1' ' A' ' 235' ' ' THR . 37.3 t70 65.18 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.142 0.902 . . . . 27.34 110.799 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 234' ' ' ASP . 73.2 p 55.07 123.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.028 1.122 . . . . 25.64 114.028 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.5 m -86.55 -25.01 25.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.506 -0.77 . . . . 24.1 111.131 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -166.08 107.79 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.432 1.11 . . . . 24.03 108.632 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.748 ' N ' ' HD3' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -105.91 -22.02 13.01 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.22 -1.809 . . . . 23.07 110.494 -167.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 74.5 -101.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.954 -1.021 . . . . 21.17 111.695 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 53.92 -169.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.199 0.312 . . . . 19.97 110.982 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.84 -38.22 62.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 18.08 109.763 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.87 76.65 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.297 -0.865 . . . . 16.58 109.477 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -74.34 164.06 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.347 -0.842 . . . . 14.16 111.494 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.24 -9.7 54.4 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 123.817 1.77 . . . . 13.65 110.059 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.5 146.56 53.83 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 110.173 -3.194 . . . . 12.06 110.082 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.453 HG21 ' H ' ' A' ' 247' ' ' GLY . 0.8 OUTLIER -128.78 177.34 6.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.267 0.556 . . . . 10.09 110.196 -177.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 331' ' ' SER . . . 126.29 -50.45 0.88 Allowed Glycine 0 C--N 1.309 -0.927 0 CA-C-N 115.277 -0.874 . . . . 7.81 113.502 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.2 p -101.04 67.96 1.22 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.492 0.552 . . . . 6.56 112.492 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.565 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 2.0 tp10 -102.18 -75.05 0.61 Allowed 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.202 0.525 . . . . 4.79 110.099 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.756 ' C ' HG22 ' A' ' 251' ' ' THR . 28.9 m -149.65 -161.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.961 -1.018 . . . . 2.76 111.674 -175.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 250' ' ' VAL . 0.1 OUTLIER 175.44 86.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.165 -1.791 . . . . 1.48 106.165 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -54.75 -147.51 0.01 OUTLIER Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.395 -1.275 . . . . 1.61 113.253 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.853 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 23.7 m -75.99 20.33 0.19 Allowed 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.577 -0.955 . . . . 2.23 111.737 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.663 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.5 OUTLIER -88.09 -44.27 11.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.584 -1.644 . . . . 1.17 111.953 -163.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.57 ' CG ' ' HG1' ' A' ' 251' ' ' THR . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.853 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 1.13 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.663 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 1.07 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.518 ' O ' HD12 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 1.04 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.51 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.82 107.249 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 1.06 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 1.04 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.524 ' CA ' ' HA2' ' B' ' 9' ' ' GLY . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 1.21 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.86 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.564 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.774 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 4.19 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 3.36 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 1.2 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.62 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.493 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 1.11 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.596 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 3.0 108.848 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.72 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.669 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.73 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.792 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.98 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 1.57 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.474 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.534 HG11 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 1.03 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 1.11 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 336' ' ' ARG . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 2.19 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.496 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 1.04 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.576 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 2.08 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.45 ' CD ' HD22 ' A' ' 285' ' ' LEU . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.4 112.752 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.568 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 1.25 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 1.23 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.576 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 1.07 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.79 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.519 ' HB2' ' NE ' ' A' ' 313' ' ' ARG . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 1.04 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.7 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 1.03 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.76 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 3.17 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG13 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 1.23 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.6 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 3.08 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.22 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.402 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.98 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.644 ' HB2' HG22 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.634 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 1.44 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.13 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 1.03 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 312' ' ' VAL . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 1.05 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 1.03 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 1.05 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 1.05 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.519 ' NE ' ' HB2' ' A' ' 293' ' ' ALA . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.57 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.564 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.74 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.67 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 1.07 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.97 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 1.46 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.85 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.793 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.3 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.91 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 2.18 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 325' ' ' PRO . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.65 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.39 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 4.66 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 1.11 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 1.08 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 1.11 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.638 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.9 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 250' ' ' VAL . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 1.14 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.793 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.95 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 3.0 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 3.0 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.485 ' CD ' HD11 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.42 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.479 HD13 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 1.03 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.563 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 1.11 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.94 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.574 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.77 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo -32.27 165.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.69 118.492 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -150.63 109.53 3.88 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.282 -2.236 . . . . 2.54 107.632 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.02 88.18 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.699 1.0 . . . . 2.26 113.699 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 347' ' ' LEU . 1.5 mm? -89.19 -166.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 1.22 110.052 166.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 4.8 t -59.58 -37.61 78.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.079 0.942 . . . . 1.92 111.138 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.596 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 113.957 -1.474 . . . . 3.39 112.105 -164.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.84 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.18 -0.674 . . . . 1.84 109.18 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -123.05 108.03 32.66 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.998 -0.281 . . . . 1.37 110.659 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo -50.42 118.44 4.04 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.363 2.042 . . . . 0.54 111.022 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.9 111.023 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.66 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 339' ' ' ILE . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 1.19 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p -94.43 -21.19 19.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.51 110.769 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 8.3 t -69.56 -174.61 0.72 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.32 -0.855 . . . . 2.81 110.413 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 263' ' ' SER . . . 122.48 106.82 1.89 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.196 -0.526 . . . . 1.85 111.828 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' B' ' 12' ' ' ARG . 53.4 t30 -160.7 168.28 25.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.631 -0.877 . . . . 3.39 108.631 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -77.33 45.07 0.45 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.465 1.126 . . . . 5.81 111.109 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' B' ' 10' ' ' ASN . 99.2 mtt180 -57.58 149.73 20.73 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.158 -1.837 . . . . 5.91 110.867 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.327 -0.844 . . . . 7.77 109.834 179.017 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.374 -0.232 . . . . 40.49 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 81.3 mtp 69.48 -77.87 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 124.065 0.853 . . . . 40.11 111.507 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -162.6 118.11 1.86 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.331 -0.395 . . . . 39.42 110.53 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.76 6.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.435 -0.58 . . . . 37.42 109.435 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.45 -95.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.264 -0.174 . . . . 36.38 110.958 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 65.6 -48.2 0.39 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.767 0.827 . . . . 34.76 112.582 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 319' ' ' PRO . 11.0 pt-20 -63.06 114.55 3.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.539 0.685 . . . . 32.58 110.835 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.15 154.3 41.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.862 -1.063 . . . . 31.1 110.896 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.32 60.18 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.461 0.648 . . . . 30.58 111.956 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.5 p -77.55 73.0 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.071 -0.513 . . . . 27.95 110.734 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.26 -20.77 63.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.193 -0.458 . . . . 27.34 111.153 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.7 m -58.01 -32.18 67.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.751 -0.463 . . . . 25.64 109.751 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 323' ' ' GLN . 11.6 m 72.8 -61.42 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 24.1 112.475 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 236' ' ' THR . 15.9 tt0 64.58 116.31 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.422 1.106 . . . . 24.03 111.525 -171.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -132.65 -35.08 1.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.233 -1.349 . . . . 23.07 109.722 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -86.14 158.57 19.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.357 -0.838 . . . . 21.17 109.565 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 58.69 55.05 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.138 0.494 . . . . 19.97 110.822 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.07 -12.8 56.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 18.08 111.473 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 246' ' ' VAL . 3.5 tm? -75.6 -45.55 36.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.914 -0.772 . . . . 16.58 108.914 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 63.8 137.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.397 0.888 . . . . 14.16 113.397 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.16 -166.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.266 1.026 . . . . 13.65 113.015 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.27 151.37 5.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 12.06 112.119 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' HA ' HD12 ' A' ' 242' ' ' LEU . 5.3 p -78.89 153.44 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.654 0.74 . . . . 10.09 111.926 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 143.7 -52.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.236 -1.347 . . . . 7.81 111.936 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.5 m -102.94 96.55 6.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.901 0.381 . . . . 6.56 110.32 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -50.19 134.12 22.81 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.175 0.988 . . . . 4.79 111.783 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.9 m 36.4 -134.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 112.08 -2.327 . . . . 2.76 114.641 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.493 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 30.5 p 51.58 74.64 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.251 1.024 . . . . 1.48 109.955 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.12 57.16 0.25 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.617 -1.629 . . . . 1.61 114.692 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.654 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.3 OUTLIER 57.16 18.43 4.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.269 1.033 . . . . 2.23 111.083 -177.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -82.22 -37.83 25.44 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.633 -1.621 . . . . 1.17 110.298 -172.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.403 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 1.13 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 1.07 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.577 ' O ' HD11 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 1.04 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.82 106.959 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 1.06 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 1.04 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 1.21 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.86 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.597 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 267' ' ' ARG . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 4.19 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 3.36 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 1.2 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.62 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 1.11 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 3.0 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.72 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.679 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.73 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.98 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 1.57 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 1.03 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 1.11 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.711 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 2.19 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.591 ' HE1' ' O ' ' A' ' 333' ' ' TYR . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 1.04 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.735 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 2.08 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.451 ' HD2' HD21 ' A' ' 285' ' ' LEU . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.4 113.697 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.529 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.735 ' O ' HD11 ' A' ' 285' ' ' LEU . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 1.25 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 1.23 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 1.07 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.79 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 1.04 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.7 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 1.03 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.76 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 3.17 109.445 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.423 ' HB3' HG13 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 1.23 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.6 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.453 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 3.08 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.22 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.422 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.98 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.594 ' HB3' HG22 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.642 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 1.44 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.13 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.734 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 1.03 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 312' ' ' VAL . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 1.05 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 1.03 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 1.05 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 309' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 1.05 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.57 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.74 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 1.07 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.97 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.555 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 1.46 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.85 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.706 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.3 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.91 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 2.18 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.507 HD21 ' HD2' ' A' ' 325' ' ' PRO . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.65 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.39 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 4.66 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 1.11 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 1.08 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.468 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 1.11 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.65 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.9 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 1.14 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.706 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.95 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 3.0 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.84 ' CZ ' ' HB3' ' B' ' 1' ' ' ALA . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 3.0 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.756 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.42 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 1.03 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 1.11 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.734 ' CD2' ' HB2' ' A' ' 308' ' ' ALA . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.94 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.516 ' HB3' HG11 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.679 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo -35.77 170.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.69 117.308 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -146.34 118.05 8.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.92 -1.945 . . . . 2.54 108.963 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.15 81.74 0.08 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 114.335 1.235 . . . . 2.26 114.335 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.8 mm? -85.85 -167.92 2.03 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.103 -1.443 . . . . 1.22 107.103 160.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 347' ' ' LEU . 1.9 m -73.16 -38.76 66.09 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.833 1.301 . . . . 1.92 108.84 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 346' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 112.73 -2.032 . . . . 3.39 111.147 -169.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.47 0.176 . . . . 1.84 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.6 t70 63.13 107.4 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.723 0.639 . . . . 1.37 111.982 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo -51.12 119.81 5.89 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.663 2.242 . . . . 0.54 111.498 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.487 ' HB2' HH22 ' A' ' 336' ' ' ARG . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.9 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.66 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 339' ' ' ILE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 1.19 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 3.2 p -100.09 4.07 44.36 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.51 111.381 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.618 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 6.3 t -126.17 153.03 45.2 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.417 -0.81 . . . . 2.81 110.256 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.84 -129.73 3.21 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.418 -1.473 . . . . 1.85 109.418 165.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -53.78 138.4 35.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.25 0.525 . . . . 3.39 109.789 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.5 -15.15 58.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.449 -0.796 . . . . 5.81 110.894 -172.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 55.09 -160.19 0.18 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.042 -0.981 . . . . 5.91 112.1 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.199 -0.905 . . . . 7.77 110.284 177.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.572 0.225 . . . . 40.49 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -159.83 128.91 5.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.276 -0.268 . . . . 40.11 110.276 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 79.04 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.624 -0.262 . . . . 39.42 111.21 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.8 23.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.021 -0.536 . . . . 37.42 112.146 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 20.2 tp -140.06 14.01 2.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.079 0.466 . . . . 36.38 110.213 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 63.71 173.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.211 -0.904 . . . . 34.76 112.745 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -159.01 140.85 13.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.102 -0.954 . . . . 32.58 108.619 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.1 tp 52.26 67.97 0.89 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.517 0.675 . . . . 31.1 110.262 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -126.37 37.42 4.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 30.58 110.42 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -58.49 -47.44 84.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.629 -0.714 . . . . 27.95 110.365 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.29 54.53 8.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.032 0.92 . . . . 27.34 109.369 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.76 155.25 37.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.983 -1.008 . . . . 25.64 110.681 -174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 15.1 m 70.84 -42.79 0.54 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.383 0.673 . . . . 24.1 112.019 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.04 -7.72 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 24.03 111.219 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? -51.13 121.03 5.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.438 -0.801 . . . . 23.07 110.979 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.73 -53.16 5.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 21.17 111.24 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -91.97 29.6 1.57 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.171 0.51 . . . . 19.97 112.07 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -163.03 125.42 2.63 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.638 -0.71 . . . . 18.08 110.794 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.1 tp -107.94 -25.77 11.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 16.58 109.816 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.77 128.46 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.28 -0.873 . . . . 14.16 112.235 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.15 -174.18 3.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.124 -0.944 . . . . 13.65 110.41 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.28 129.71 41.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.094 0.473 . . . . 12.06 110.459 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 247' ' ' GLY . 14.4 p -76.63 167.95 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.409 0.623 . . . . 10.09 110.522 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.433 ' N ' HG23 ' A' ' 246' ' ' VAL . . . 109.86 -120.97 5.86 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.079 -0.964 . . . . 7.81 111.718 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -86.03 70.79 10.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.343 0.592 . . . . 6.56 110.399 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.689 ' C ' HG23 ' A' ' 250' ' ' VAL . 3.0 pt-20 -92.46 -104.75 0.12 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.738 -0.665 . . . . 4.79 111.128 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.689 HG23 ' C ' ' A' ' 249' ' ' GLU . 3.4 m 47.38 -178.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 115.624 1.713 . . . . 2.76 115.624 168.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.465 ' HB ' ' HH ' ' A' ' 333' ' ' TYR . 8.4 p -83.33 -2.64 56.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.154 -1.385 . . . . 1.48 110.604 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 55.62 -126.01 38.37 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.13 -0.941 . . . . 1.61 112.274 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.765 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -114.08 16.86 18.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.224 1.011 . . . . 2.23 109.259 171.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.641 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.6 mp -83.94 -40.12 18.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.208 -1.814 . . . . 1.17 110.242 -165.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.512 ' O ' HG21 ' A' ' 259' ' ' VAL . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 1.13 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.536 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 1.07 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 255' ' ' ASP 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 1.04 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.82 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 1.06 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 1.04 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.569 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 1.21 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.86 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.581 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.618 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 4.19 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 3.36 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 1.2 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.62 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.989 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 1.11 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.65 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 3.0 109.327 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.72 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.989 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.73 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.774 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.98 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 1.57 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.419 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.578 HG11 HG23 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 1.03 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 1.11 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 2.19 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.624 ' SD ' HD12 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 1.04 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 2.08 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.4 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 285' ' ' LEU . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.631 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 1.25 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.535 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 1.23 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 1.07 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.79 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 1.04 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.7 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 1.03 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.76 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 3.17 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 1.23 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.6 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 3.08 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.22 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.728 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.98 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.612 ' HB3' HG22 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.628 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 1.44 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.13 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.676 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 1.03 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 312' ' ' VAL . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 1.05 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 1.03 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 1.05 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 1.05 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.57 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.581 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.74 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 1.07 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.97 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.624 HD12 ' SD ' ' A' ' 284' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 1.46 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.85 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.416 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.3 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.91 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 2.18 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 325' ' ' PRO . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.65 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.795 ' N ' HD13 ' A' ' 324' ' ' LEU . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.39 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 4.66 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 1.11 112.415 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.605 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 1.08 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 1.11 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.9 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 1.14 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.95 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 3.0 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 1.7 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.697 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 3.0 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.42 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.507 HD13 ' CG2' ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 1.03 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 1.11 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.774 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.94 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.468 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.77 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.604 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo -28.51 166.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.69 119.17 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.504 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 10.1 pt-20 -150.03 125.89 10.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.298 -2.228 . . . . 2.54 108.185 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.2 t70 53.53 76.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.097 0.777 . . . . 2.26 113.097 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -87.47 -168.5 2.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.16 -0.473 . . . . 1.22 110.047 167.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.5 t -62.41 -32.15 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.96 0.886 . . . . 1.92 111.349 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.65 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.063 -1.426 . . . . 3.39 112.276 -161.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.985 -0.376 . . . . 1.84 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.22 130.35 94.74 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 1.37 110.273 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -54.32 127.96 28.02 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.813 2.342 . . . . 0.54 111.855 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.528 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.9 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.485 ' N ' HD11 ' B' ' 4' ' ' LEU . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.66 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 259' ' ' VAL . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 1.19 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -63.81 -70.12 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.51 111.356 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.727 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 95.8 p -159.87 163.45 34.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.425 0.631 . . . . 2.81 112.152 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.565 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -89.98 118.95 5.4 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 114.818 -1.083 . . . . 1.85 111.527 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.97 167.68 24.12 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.131 -1.063 . . . . 3.39 108.131 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.26 3.45 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.584 0.707 . . . . 5.81 110.311 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -47.98 135.84 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.763 -1.108 . . . . 5.91 110.833 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.546 -0.74 . . . . 7.77 110.94 -178.391 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 119.676 -0.202 . . . . 40.49 110.737 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.7 ptm 43.83 43.93 5.42 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.767 0.667 . . . . 40.11 111.025 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.68 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.052 -0.976 . . . . 39.42 111.255 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -119.06 97.29 5.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.357 -0.383 . . . . 37.42 110.967 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.11 -27.21 68.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 36.38 109.678 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.85 152.05 48.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.157 -0.929 . . . . 34.76 109.258 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -158.27 109.24 2.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.888 0.375 . . . . 32.58 111.178 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 232' ' ' LEU . 19.2 tp 59.24 172.11 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.58 -0.736 . . . . 31.1 112.399 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' H ' ' HG ' ' A' ' 231' ' ' LEU . 2.5 tt 58.07 76.6 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.926 -0.768 . . . . 30.58 108.926 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 m 57.61 55.1 5.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.681 -0.691 . . . . 27.95 109.772 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.59 -48.68 69.02 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.103 -0.953 . . . . 27.34 111.145 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.12 127.68 17.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.626 -0.716 . . . . 25.64 110.99 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.7 m -161.69 -62.33 0.05 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.366 -0.834 . . . . 24.1 109.517 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -103.34 -40.44 6.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.623 0.725 . . . . 24.03 110.305 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.53 88.26 6.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.62 -1.173 . . . . 23.07 110.084 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.71 -42.71 4.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 21.17 110.387 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 242' ' ' LEU . 54.7 mt-30 -67.54 143.69 56.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.762 -0.654 . . . . 19.97 110.944 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 72.38 -14.98 0.51 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.831 0.707 . . . . 18.08 112.257 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 240' ' ' GLN . 62.3 tp -103.06 -69.29 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.433 . . . . 16.58 110.422 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.92 174.97 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.814 -0.63 . . . . 14.16 110.746 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.7 -164.1 0.8 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.135 -0.484 . . . . 13.65 110.838 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -50.33 155.19 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.476 -0.784 . . . . 12.06 112.185 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 247' ' ' GLY . 12.2 p -64.38 160.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.751 0.786 . . . . 10.09 111.183 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 101.76 22.34 10.31 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.704 -1.135 . . . . 7.81 111.504 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -84.96 88.62 7.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 6.56 109.774 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -61.52 2.16 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.142 0.972 . . . . 4.79 111.819 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 252' ' ' GLY . 14.9 m -147.53 -144.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 113.694 -1.594 . . . . 2.76 110.724 -165.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.0 p 68.72 -23.04 0.14 Allowed 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 124.226 1.01 . . . . 1.48 112.549 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.22 21.96 41.79 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-O 119.43 -0.65 . . . . 1.61 114.669 168.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 67.08 15.96 10.2 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.153 0.978 . . . . 2.23 110.515 -176.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 258' ' ' ILE . 0.6 OUTLIER -80.58 -31.34 36.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.774 -1.557 . . . . 1.17 108.36 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.724 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 1.13 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 1.07 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.601 ' O ' HD13 ' B' ' 6' ' ' ILE 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 1.04 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.82 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 1.06 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 1.04 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.586 ' HB3' HD12 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 1.21 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.86 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.578 ' OE1' HG13 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.727 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 4.19 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 3.36 110.572 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 1.2 113.71 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.62 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.939 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 1.11 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.435 HH11 ' HB2' ' A' ' 347' ' ' LEU . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 3.0 110.46 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 274' ' ' ASN . 1.0 OUTLIER -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.72 112.21 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.939 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.73 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.98 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 1.57 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.457 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 1.03 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.672 HD23 ' OE1' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 1.11 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.637 HG22 ' N ' ' A' ' 283' ' ' GLU . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 2.19 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.686 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 1.04 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 2.08 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.426 ' CD ' HD23 ' A' ' 285' ' ' LEU . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.4 112.437 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 1.25 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 312' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 1.23 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.688 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 1.07 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.686 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.79 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 1.04 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.7 110.257 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 1.03 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.76 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 3.17 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 1.23 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.584 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.6 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 3.08 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.22 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.98 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.617 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 1.44 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.13 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 1.03 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.72 ' O ' HG21 ' A' ' 312' ' ' VAL . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 1.05 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 1.03 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 308' ' ' ALA . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 309' ' ' VAL . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 1.05 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.57 112.901 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.74 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 1.07 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.701 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.97 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 318' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 1.46 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.85 116.142 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.546 ' HE1' ' HA ' ' A' ' 321' ' ' MET . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.3 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.91 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 2.18 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.65 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.39 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 4.66 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 1.11 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.509 ' CG2' HD23 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 1.08 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 1.11 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.59 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.656 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.9 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 1.14 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.95 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.59 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 3.0 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.672 ' OE1' HD23 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.571 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 3.0 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.42 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 1.03 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 1.11 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.94 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.77 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo -34.94 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.69 117.444 177.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -143.26 105.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.148 -1.842 . . . . 2.54 107.558 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.9 90.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.825 -1.08 . . . . 2.26 113.407 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 342' ' ' PRO . 2.8 mm? -90.06 -95.1 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.403 1.097 . . . . 1.22 108.316 166.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 5.1 t -177.11 -47.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 104.567 -2.383 . . . . 1.92 104.567 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.495 HD13 ' OXT' ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 CA-C-N 110.577 -3.011 . . . . 3.39 107.002 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.077 -0.342 . . . . 1.84 110.077 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.09 128.37 90.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.202 -0.454 . . . . 1.37 111.402 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.448 ' HG3' ' NE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo -50.34 119.26 4.81 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.905 2.403 . . . . 0.54 110.65 176.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.9 110.83 -173.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.66 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 1.19 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.429 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 10.8 p -103.45 -14.29 16.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.51 110.952 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.539 ' HB2' ' CB ' ' A' ' 263' ' ' SER . 18.0 m -71.53 -174.81 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.322 -0.854 . . . . 2.81 110.259 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.74 87.42 0.14 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.556 -0.83 . . . . 1.85 112.165 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.3 151.55 39.53 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.825 . . . . 3.39 108.774 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.37 9.32 4.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.397 0.617 . . . . 5.81 111.362 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -56.43 152.85 10.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.263 -0.881 . . . . 5.91 110.584 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.172 -0.467 . . . . 7.77 111.28 -177.296 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.769 -0.456 . . . . 40.49 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.5 mmt 54.8 53.36 10.6 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.929 -0.578 . . . . 40.11 110.039 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 66.83 -67.04 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.113 -0.948 . . . . 39.42 110.681 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -163.24 127.58 2.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.751 -0.659 . . . . 37.42 109.435 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.46 -42.84 82.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 36.38 109.742 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -84.39 98.91 10.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.841 -0.618 . . . . 34.76 109.982 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.48 119.23 24.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.582 -0.735 . . . . 32.58 110.777 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.7 143.59 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.981 -0.554 . . . . 31.1 109.692 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -128.78 146.74 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.657 -0.497 . . . . 30.58 109.657 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 235' ' ' THR . 45.8 m -141.26 65.59 1.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.083 0.468 . . . . 27.95 110.01 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -81.01 33.84 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.555 0.693 . . . . 27.34 110.986 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 233' ' ' SER . 9.0 t -86.2 -170.84 3.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.36 -0.837 . . . . 25.64 110.151 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 m -83.46 70.41 10.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.879 -1.055 . . . . 24.1 110.412 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.1 23.34 2.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.01 0.91 . . . . 24.03 109.746 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -77.67 -51.5 10.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.398 -0.819 . . . . 23.07 109.607 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.35 -65.19 0.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.595 -0.73 . . . . 21.17 109.722 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 54.56 54.63 9.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.834 -0.621 . . . . 19.97 110.173 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -167.52 126.07 1.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.298 -0.865 . . . . 18.08 110.428 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.6 tp -80.98 64.97 5.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.515 0.674 . . . . 16.58 109.763 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -145.38 147.47 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.449 -0.796 . . . . 14.16 110.416 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.33 -176.94 4.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.714 -0.476 . . . . 13.65 109.714 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.83 130.33 42.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.121 0.486 . . . . 12.06 111.248 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.446 HG22 ' H ' ' A' ' 247' ' ' GLY . 7.1 p -112.68 174.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.739 -0.664 . . . . 10.09 110.556 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.446 ' H ' HG22 ' A' ' 246' ' ' VAL . . . 115.45 142.04 7.56 Favored Glycine 0 C--N 1.31 -0.902 0 CA-C-N 114.999 -1.0 . . . . 7.81 111.835 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.1 p -67.56 -53.52 27.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.485 0.66 . . . . 6.56 110.597 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.74 -89.37 0.13 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.476 -0.784 . . . . 4.79 110.988 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' A' ' 251' ' ' THR . 9.2 m -143.74 -149.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.045 -0.979 . . . . 2.76 111.086 -170.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.3 p 73.09 -23.44 0.21 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.002 0.921 . . . . 1.48 112.975 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.36 27.22 24.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 115.907 1.123 . . . . 1.61 115.907 166.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.56 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 66.37 13.76 9.37 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.319 1.059 . . . . 2.23 111.325 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 258' ' ' ILE . 0.6 OUTLIER -82.84 -33.69 27.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.199 -1.364 . . . . 1.17 108.75 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.653 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 1.13 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 1.07 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD12 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 1.04 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.525 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.82 107.004 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 1.06 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 1.04 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' B' ' 8' ' ' SER . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 1.21 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.86 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.597 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 4.19 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 3.36 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 1.2 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.62 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 1.0 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 1.11 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.454 ' C ' ' H ' ' A' ' 275' ' ' GLY . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 3.0 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.788 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.72 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 1.0 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.73 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.98 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 1.57 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.573 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 1.03 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 1.11 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 2.19 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 1.04 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.661 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 2.08 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.402 ' CD ' HD22 ' A' ' 285' ' ' LEU . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.4 112.974 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.582 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.678 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 1.25 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 284' ' ' MET . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 1.23 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.661 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 1.07 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.616 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.79 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 1.04 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.7 110.695 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 1.03 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.573 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.76 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 3.17 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 1.23 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.6 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 3.08 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.22 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.98 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.606 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.626 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 1.44 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.13 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 1.03 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.775 ' O ' HG22 ' A' ' 312' ' ' VAL . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 1.05 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 1.03 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 1.05 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 1.05 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.57 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.74 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 1.07 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.97 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.539 HD12 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 1.46 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 261' ' ' LEU . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.85 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.405 ' OE2' HD12 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.533 ' HA ' ' HE3' ' A' ' 321' ' ' MET . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.3 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.91 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 2.18 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 325' ' ' PRO . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.65 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.498 ' HD2' HD22 ' A' ' 324' ' ' LEU . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.39 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 4.66 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 1.11 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 1.08 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 1.11 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.703 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.9 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 1.14 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 336' ' ' ARG . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.95 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.703 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 3.0 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.3 OUTLIER -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.69 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 3.0 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.448 ' NE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.42 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.419 HD12 ' CG2' ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 1.03 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.612 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 1.11 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.94 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.543 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.77 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo -33.85 172.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.69 117.914 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 9.3 pt-20 -138.13 122.34 18.1 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 112.551 -2.113 . . . . 2.54 108.506 174.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.788 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 4.5 p-10 39.71 83.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.125 1.528 . . . . 2.26 115.125 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 273' ' ' ARG . 3.3 mm? -84.23 -174.91 5.54 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.543 -0.54 . . . . 1.22 109.543 164.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.7 t -75.16 -30.67 60.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.018 0.913 . . . . 1.92 109.664 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.449 ' C ' HD21 ' A' ' 274' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.192 -1.367 . . . . 3.39 110.975 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.497 ' H2 ' HD22 ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.431 ' C ' HH22 ' A' ' 336' ' ' ARG . 29.8 t70 -132.9 111.92 13.42 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.986 -0.375 . . . . 1.37 109.986 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.84 119.18 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.805 3.003 . . . . 0.54 112.087 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.458 HD12 ' N ' ' B' ' 5' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.9 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.66 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.636 ' CG2' ' HA ' ' A' ' 340' ' ' PHE . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 1.19 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -93.24 -22.61 18.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.51 110.813 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.451 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 11.2 t -66.33 -176.18 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.223 -0.899 . . . . 2.81 109.625 174.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.518 ' HA3' ' CE3' ' A' ' 266' ' ' TRP . . . 122.42 86.52 0.82 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.11 -1.043 . . . . 1.85 112.288 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -159.49 155.88 27.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.172 0.511 . . . . 3.39 110.219 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.9 -19.37 65.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.795 -1.093 . . . . 5.81 111.584 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 47.31 98.05 0.01 OUTLIER 'General case' 0 C--O 1.237 0.397 0 N-CA-C 114.455 1.279 . . . . 5.91 114.455 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.559 -1.2 . . . . 7.77 110.405 -179.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.374 -0.602 . . . . 40.49 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.0 mmt -120.14 26.45 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.538 . . . . 40.11 111.727 -171.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -85.73 -19.83 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 39.42 110.572 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.95 60.49 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.674 0.749 . . . . 37.42 109.898 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.36 132.66 34.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.05 -0.977 . . . . 36.38 109.371 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.73 -63.84 1.36 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.483 -0.326 . . . . 34.76 110.932 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 68.61 116.96 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.945 0.778 . . . . 32.58 110.179 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.75 74.62 7.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.561 -0.745 . . . . 31.1 111.838 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.62 97.69 9.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 30.58 109.606 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 m -44.16 -64.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.004 -0.998 . . . . 27.95 113.197 -170.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -132.82 -77.71 0.49 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.876 -0.33 . . . . 27.34 110.969 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.6 m -71.84 -65.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.773 -0.455 . . . . 25.64 109.773 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.3 m -154.56 -70.68 0.13 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.719 -0.474 . . . . 24.1 109.719 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 50.14 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.511 1.624 . . . . 24.03 112.536 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -112.59 45.99 1.25 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.395 -2.184 . . . . 23.07 108.703 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -73.92 -49.81 23.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.014 -0.994 . . . . 21.17 110.112 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' A' ' 249' ' ' GLU . 54.9 tt0 -71.18 97.76 1.58 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.282 -0.417 . . . . 19.97 110.724 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -94.47 124.29 38.41 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.163 -0.471 . . . . 18.08 110.172 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 55.0 tp -83.55 99.16 9.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.958 0.409 . . . . 16.58 110.446 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -137.49 174.04 11.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 14.16 110.636 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 43.73 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.348 1.03 . . . . 13.65 112.448 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.08 160.57 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.723 -0.671 . . . . 12.06 111.96 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.57 160.59 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.51 0.672 . . . . 10.09 110.717 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.66 62.91 1.81 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 114.79 -1.095 . . . . 7.81 111.583 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.8 t -126.0 82.36 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.165 0.507 . . . . 6.56 110.558 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 328' ' ' THR . 1.5 pm0 -110.16 -112.35 0.32 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.019 -0.537 . . . . 4.79 110.582 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.492 ' H ' ' CG ' ' A' ' 249' ' ' GLU . 3.4 m -149.77 -171.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.92 0.867 . . . . 2.76 112.31 -170.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' B' ' 1' ' ' ALA . 1.5 p -135.43 86.97 2.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.588 -1.642 . . . . 1.48 107.327 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 254' ' ' LEU . . . -55.15 -158.78 0.01 OUTLIER Glycine 0 C--N 1.317 -0.486 0 CA-C-N 113.183 -1.826 . . . . 1.61 113.478 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.455 ' C ' ' HG ' ' A' ' 257' ' ' LEU . 32.6 p -45.52 -60.4 2.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.54 -0.911 . . . . 2.23 108.54 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.733 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 8.3 mt 11.76 -68.9 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.179 -1.828 . . . . 1.17 114.463 156.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.615 ' O ' HG21 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 1.13 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 1.07 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 255' ' ' ASP 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 1.04 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.82 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 1.06 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 1.04 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 1.21 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.86 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 4.19 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 3.36 110.738 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.408 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 1.2 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.62 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.99 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 1.11 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.548 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 3.0 109.2 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.72 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.99 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.73 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.832 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.98 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 1.57 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.552 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 1.03 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 1.11 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.696 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 2.19 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.644 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 1.04 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 2.08 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.433 ' CD ' HD22 ' A' ' 285' ' ' LEU . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.4 112.598 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.502 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 1.25 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 1.23 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.597 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 1.07 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.644 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.79 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 1.04 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.7 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 1.03 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.76 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 3.17 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 1.23 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.6 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.682 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 3.08 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.22 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.688 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.98 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.682 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.663 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 1.44 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.13 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.644 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 1.03 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 312' ' ' VAL . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 1.05 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 1.03 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 1.05 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.57 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.74 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 1.07 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.97 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 1.46 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.85 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.557 ' HE2' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.3 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.91 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 2.18 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.484 HD21 ' HD2' ' A' ' 325' ' ' PRO . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.65 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.39 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 4.66 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 1.11 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 1.08 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 1.11 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.51 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.9 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 1.14 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.733 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.95 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.51 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 3.0 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.696 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 3.0 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.461 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.42 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.48 HD12 HG22 ' A' ' 258' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 1.03 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.596 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 1.11 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.832 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.94 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.596 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.77 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo -35.84 177.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.69 118.032 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -155.41 122.9 5.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.73 -2.486 . . . . 2.54 107.138 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 60.71 77.35 0.33 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.04 0.837 . . . . 2.26 112.641 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.42 -167.67 1.79 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 1.22 110.001 167.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 32.5 t -61.31 -53.76 52.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.989 0.899 . . . . 1.92 111.818 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.548 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 113.527 -1.669 . . . . 3.39 111.455 -165.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.536 ' H1 ' ' NH2' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.929 -0.397 . . . . 1.84 109.929 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -174.08 102.19 0.29 Allowed Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.441 -0.948 . . . . 1.37 108.441 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.79 118.33 2.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.708 2.272 . . . . 0.54 112.032 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.9 111.374 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.66 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.579 HD11 ' O ' ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 1.19 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p -102.89 -13.35 16.98 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.51 110.882 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.6 t -76.03 -173.06 2.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.026 -0.988 . . . . 2.81 109.778 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.06 80.83 0.11 Allowed Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.759 -0.936 . . . . 1.85 110.759 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.406 ' HB3' ' HG2' ' B' ' 12' ' ' ARG . 4.5 t-20 -145.35 157.28 44.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.699 -0.482 . . . . 3.39 109.699 -173.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.94 2.16 15.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.329 0.585 . . . . 5.81 110.882 -176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' B' ' 10' ' ' ASN . 22.0 ptt180 -57.38 145.58 32.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.128 -0.942 . . . . 5.91 111.161 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.595 -0.717 . . . . 7.77 110.027 176.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.846 0.355 . . . . 40.49 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.44 -41.08 9.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.023 0.439 . . . . 40.11 110.504 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -81.92 -51.29 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 39.42 110.248 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -104.73 118.46 36.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 37.42 109.515 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 228' ' ' LEU . 3.2 mm? -74.95 136.91 41.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.498 -0.319 . . . . 36.38 111.495 -174.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 56.96 -173.55 0.07 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.169 0.918 . . . . 34.76 112.563 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -77.8 -161.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.101 -0.954 . . . . 32.58 108.967 168.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.37 -66.63 0.9 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.844 -0.799 . . . . 31.1 108.844 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 96.4 mt 50.23 52.16 15.29 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.662 0.601 . . . . 30.58 111.951 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.9 t -128.44 89.91 2.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.941 -0.572 . . . . 27.95 109.788 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.7 94.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.218 0.532 . . . . 27.34 110.014 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m -91.8 -15.83 27.68 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 25.64 110.591 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.8 m -67.01 -40.24 87.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.601 . . . . 24.1 111.701 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 64.22 9.05 4.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.437 0.695 . . . . 24.03 111.977 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 241' ' ' ALA . 16.6 tpt180 -116.45 82.27 1.76 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.616 -0.512 . . . . 23.07 109.616 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -71.82 -68.41 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.113 -0.494 . . . . 21.17 110.104 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -159.02 103.04 1.66 Allowed 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.7 -0.682 . . . . 19.97 110.726 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 238' ' ' ARG . . . -117.79 -9.01 10.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 18.08 110.283 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.95 130.22 42.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.469 -0.787 . . . . 16.58 110.35 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -103.9 163.46 12.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.3 -0.409 . . . . 14.16 111.115 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.32 170.01 10.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.844 -0.616 . . . . 13.65 110.332 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.71 138.57 42.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.973 -0.558 . . . . 12.06 111.273 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 247' ' ' GLY . 8.2 p -104.27 175.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 10.09 110.0 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.451 ' H ' ' CG2' ' A' ' 246' ' ' VAL . . . 116.29 -2.52 20.58 Favored Glycine 0 C--N 1.311 -0.847 0 CA-C-N 115.46 -0.791 . . . . 7.81 111.885 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t 60.21 48.98 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.355 0.598 . . . . 6.56 111.115 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' A' ' 250' ' ' VAL . 3.9 mm-40 -87.62 -102.53 0.08 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.843 0.83 . . . . 4.79 112.413 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 249' ' ' GLU . 1.0 OUTLIER -151.25 -157.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.163 -1.38 . . . . 2.76 110.074 -166.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.564 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 1.1 t 42.85 67.08 0.67 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.728 1.251 . . . . 1.48 110.233 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -59.59 -154.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 112.432 -2.167 . . . . 1.61 113.225 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.772 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.7 m -73.18 24.07 0.06 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.944 0.878 . . . . 2.23 111.658 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp -83.12 -45.88 13.43 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.704 -1.589 . . . . 1.17 110.065 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 1.13 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 1.07 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.579 ' O ' HD11 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 1.04 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.82 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 1.06 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 1.04 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 1.21 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.86 106.274 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.638 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 4.19 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.434 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 3.36 109.716 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 1.2 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.62 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.88 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 1.11 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 3.0 107.527 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.72 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.88 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.73 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.98 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 1.57 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.527 HG13 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 1.03 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.55 HD12 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 1.11 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 2.19 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.653 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.456 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 1.04 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.654 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 2.08 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.654 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.4 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 1.25 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.456 HG12 ' CG ' ' A' ' 284' ' ' MET . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 1.23 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.464 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 1.07 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.653 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.79 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 1.04 109.655 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.7 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 1.03 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.76 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 3.17 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 1.23 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.6 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 3.08 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.22 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.566 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.98 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 295' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.624 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 1.44 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.13 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 1.03 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 312' ' ' VAL . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 1.05 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 1.03 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 1.05 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.731 ' O ' HG21 ' A' ' 315' ' ' VAL . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 1.05 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' A' ' 292' ' ' ASN . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.57 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.74 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 1.07 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.97 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.543 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 1.46 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.85 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.606 ' HE3' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.3 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.91 112.801 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 2.18 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.529 HD23 ' HD2' ' A' ' 325' ' ' PRO . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.65 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' HD23 ' A' ' 324' ' ' LEU . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.39 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 4.66 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 1.11 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 1.08 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.45 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 1.11 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.9 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 1.14 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.606 ' CG ' ' HE3' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.95 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 3.0 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 0.7 OUTLIER -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.843 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 3.0 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.472 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.42 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.531 HD13 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 1.03 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.578 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 1.11 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.94 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.77 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.569 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 32.1 Cg_exo -27.46 160.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.69 117.546 172.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -145.41 104.7 3.95 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 112.549 -2.114 . . . . 2.54 106.936 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.62 89.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.938 0.774 . . . . 2.26 112.444 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.569 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.3 OUTLIER -82.53 -178.95 7.26 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.733 169.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.3 t -71.67 -35.22 70.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.392 1.092 . . . . 1.92 109.075 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.305 -1.366 0 CA-C-N 113.272 -1.785 . . . . 3.39 110.689 -173.023 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.517 ' H2 ' HD21 ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.44 -0.578 . . . . 1.84 109.44 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -95.13 119.58 65.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.174 -0.306 . . . . 1.37 110.174 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.68 128.63 26.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.126 2.55 . . . . 0.54 111.883 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.9 110.72 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.66 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 339' ' ' ILE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 1.19 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p -67.85 -59.68 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.51 111.33 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.644 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 75.1 m -153.52 -176.76 5.96 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.143 -0.348 . . . . 2.81 110.682 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.478 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -79.22 -138.05 1.52 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.635 -0.793 . . . . 1.85 112.549 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.45 158.51 29.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.312 -0.255 . . . . 3.39 110.312 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.37 -52.38 37.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.625 0.578 . . . . 5.81 111.417 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 52.02 108.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.397 1.258 . . . . 5.91 114.397 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.282 -1.327 . . . . 7.77 109.694 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.786 0.327 . . . . 40.49 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 98.0 mmm -120.0 91.42 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 40.11 110.249 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -130.6 -62.16 0.93 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 39.42 110.128 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.572 -0.74 . . . . 37.42 111.797 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tt -115.32 -50.57 2.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.771 -0.826 . . . . 36.38 108.771 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.7 -23.92 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.45 -0.795 . . . . 34.76 110.611 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 232' ' ' LEU . 1.5 pm0 -69.09 107.96 3.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.021 -0.536 . . . . 32.58 110.966 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 231' ' ' LEU . 1.6 tm? 65.32 -9.68 0.21 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.811 0.845 . . . . 31.1 112.127 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 230' ' ' GLU . 39.0 tp -79.61 62.23 3.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.71 0.767 . . . . 30.58 110.538 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.3 t -159.43 -76.36 0.07 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.143 -0.935 . . . . 27.95 109.044 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.7 t70 51.38 52.52 14.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.81 0.814 . . . . 27.34 110.008 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.1 p -122.47 159.01 28.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.111 -0.949 . . . . 25.64 110.688 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.7 m 61.14 86.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.582 0.552 . . . . 24.1 111.548 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -69.13 -26.42 64.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.797 0.808 . . . . 24.03 110.521 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.65 ' HD3' ' O ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -59.2 -38.09 79.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.159 -1.382 . . . . 23.07 109.751 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.36 67.64 1.43 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 21.17 109.358 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -77.22 89.66 3.68 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.58 -0.736 . . . . 19.97 110.185 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 63.29 -94.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 18.08 111.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.584 ' O ' HD12 ' A' ' 242' ' ' LEU . 1.6 tm? -123.56 8.34 8.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.623 0.725 . . . . 16.58 109.727 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.36 127.77 33.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.491 -0.777 . . . . 14.16 112.374 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.9 p30 43.65 -164.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.636 1.21 . . . . 13.65 114.049 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.435 ' HG3' HH22 ' A' ' 238' ' ' ARG . 5.6 pt-20 -49.71 128.06 17.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.825 -1.08 . . . . 12.06 111.76 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 247' ' ' GLY . 14.9 p -86.89 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.765 . . . . 10.09 110.766 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 246' ' ' VAL . . . -124.26 42.44 1.56 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.992 -1.003 . . . . 7.81 112.365 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.7 p -88.17 80.49 7.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.776 0.322 . . . . 6.56 110.865 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -65.88 -77.25 0.07 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.22 1.01 . . . . 4.79 111.783 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.421 HG23 HG23 ' A' ' 251' ' ' THR . 5.1 m -153.36 -162.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.969 -1.923 . . . . 2.76 110.562 -165.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.526 ' H ' HD13 ' A' ' 332' ' ' LEU . 4.7 p 68.54 -4.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.38 1.072 . . . . 1.48 112.598 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 46.61 -111.27 0.66 Allowed Glycine 0 C--N 1.32 -0.306 0 C-N-CA 121.09 -0.576 . . . . 1.61 112.418 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.8 m -135.18 24.08 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 123.033 1.397 . . . . 2.23 108.856 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 258' ' ' ILE . 1.8 mp -83.71 -42.82 16.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 112.362 -2.199 . . . . 1.17 111.899 -166.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 1.13 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 1.07 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD12 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 1.04 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.518 ' C ' HD21 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.82 107.251 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 1.06 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 1.04 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 1.21 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.86 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.583 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.644 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.424 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 4.19 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 3.36 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 272' ' ' ALA . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 1.2 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.62 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 1.11 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.466 ' NH1' ' HB3' ' A' ' 347' ' ' LEU . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 3.0 109.559 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.497 HD21 ' N ' ' A' ' 274' ' ' ASN . 0.9 OUTLIER -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.72 111.523 172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.636 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.73 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.98 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 1.57 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.411 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.598 HG11 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 1.03 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 1.11 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.665 HD12 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 2.19 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.485 ' SD ' HD12 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 1.04 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.637 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 2.08 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.637 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.4 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 285' ' ' LEU . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 1.25 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.443 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 1.23 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.449 ' CG2' HD13 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 1.07 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.79 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 1.04 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.7 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 1.03 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.76 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . 0.411 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 3.17 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 1.23 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.6 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.59 ' CB ' ' HE2' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.809 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 3.08 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.22 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.401 ' CD1' ' HE1' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.98 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.809 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.632 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 1.44 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.13 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.638 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 1.03 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.737 ' O ' HG22 ' A' ' 312' ' ' VAL . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 1.05 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 1.03 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.593 ' O ' HG12 ' A' ' 315' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 1.05 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 1.05 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.531 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.57 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.583 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.74 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 1.07 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.97 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 1.46 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.85 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.831 ' HE3' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.3 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.91 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 2.18 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.784 HD13 ' C ' ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.65 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.766 ' N ' HD13 ' A' ' 324' ' ' LEU . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.39 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 4.66 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 1.11 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 1.08 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.581 ' N ' HD12 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 1.11 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.666 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.9 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.666 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 1.14 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.831 ' CG ' ' HE3' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.95 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 3.0 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 2.6 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.767 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 3.0 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.52 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.42 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.545 HD13 HG23 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 1.03 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.626 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 1.11 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.807 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.94 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.493 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.77 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo -36.01 172.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.69 117.275 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -144.57 106.9 4.36 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.086 -1.87 . . . . 2.54 108.551 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 52.62 84.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.194 -0.912 . . . . 2.26 112.226 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.468 ' HB2' ' ND2' ' A' ' 274' ' ' ASN . 0.4 OUTLIER -71.99 177.38 4.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.323 0.582 . . . . 1.22 111.889 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.9 t -64.67 -40.88 96.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 123.017 1.389 . . . . 1.92 108.676 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.466 ' HB3' ' NH1' ' A' ' 273' ' ' ARG . 8.5 mp . . . . . 0 C--N 1.304 -1.397 0 CA-C-N 112.105 -2.316 . . . . 3.39 110.767 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.069 -0.345 . . . . 1.84 110.069 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.07 121.13 59.91 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.116 -0.493 . . . . 1.37 110.893 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo -57.2 121.6 10.34 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.681 2.254 . . . . 0.54 111.676 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.9 111.136 -171.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.66 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 339' ' ' ILE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 1.19 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p -60.87 -67.19 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.51 111.803 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.648 ' HB3' ' NH2' ' A' ' 268' ' ' ARG . 68.1 p -155.44 -178.0 6.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.556 -0.293 . . . . 2.81 110.952 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.45 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -83.67 -174.06 50.13 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.047 -0.596 . . . . 1.85 112.402 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' B' ' 11' ' ' ASP . 2.9 t-20 -124.5 170.03 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.953 -0.758 . . . . 3.39 108.953 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' B' ' 10' ' ' ASN . 27.7 t70 72.39 -3.84 2.2 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-O 122.268 1.033 . . . . 5.81 110.245 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' B' ' 10' ' ' ASN . 47.6 mtm105 -54.85 140.43 36.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.728 -1.578 . . . . 5.91 111.735 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.514 -0.755 . . . . 7.77 110.009 178.205 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.376 -0.231 . . . . 40.49 110.376 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 61.98 20.94 11.96 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.502 0.501 . . . . 40.11 112.123 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -130.13 70.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 39.42 110.834 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.91 150.9 40.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.887 -0.597 . . . . 37.42 110.035 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.87 -14.96 61.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 36.38 110.861 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 60.03 -162.74 0.25 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.656 0.597 . . . . 34.76 112.062 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.31 -155.29 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.236 -0.893 . . . . 32.58 110.189 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt -96.12 97.97 9.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.245 -0.889 . . . . 31.1 109.864 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.28 -25.91 60.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 30.58 110.417 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.7 t -92.66 -12.66 30.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.379 -0.601 . . . . 27.95 109.379 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 34.3 t70 63.9 -82.05 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.829 -1.078 . . . . 27.34 112.091 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 p -129.05 129.94 45.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.182 0.515 . . . . 25.64 111.468 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 p -107.22 -72.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.689 -0.687 . . . . 24.1 110.807 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.43 -176.12 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.539 -0.3 . . . . 24.03 111.446 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? 43.76 58.82 3.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.165 0.986 . . . . 23.07 112.944 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -155.35 133.49 11.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.726 -0.67 . . . . 21.17 109.687 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.53 90.39 0.16 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.918 -0.583 . . . . 19.97 111.052 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -117.52 -57.21 2.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 18.08 110.006 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -86.94 116.7 25.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.709 -0.678 . . . . 16.58 109.329 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -133.27 -170.54 2.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.925 -0.58 . . . . 14.16 110.146 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.08 166.16 2.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.518 0.675 . . . . 13.65 111.221 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 245' ' ' GLU . 1.0 OUTLIER -68.25 132.69 47.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.047 -0.979 . . . . 12.06 111.51 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 247' ' ' GLY . 7.2 p -107.08 177.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.077 -0.965 . . . . 10.09 109.423 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.451 ' H ' ' CG2' ' A' ' 246' ' ' VAL . . . -74.94 65.42 2.23 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.66 -0.7 . . . . 7.81 112.037 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 p -108.65 105.56 15.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.84 0.352 . . . . 6.56 110.79 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.64 -61.14 2.37 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.862 0.839 . . . . 4.79 111.194 172.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 332' ' ' LEU . 4.0 m -150.27 -163.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 113.899 -1.501 . . . . 2.76 111.294 -168.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.718 ' HB ' ' OD2' ' A' ' 255' ' ' ASP . 20.4 p 50.91 73.98 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.472 1.13 . . . . 1.48 109.079 -168.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -60.38 -147.47 0.01 OUTLIER Glycine 0 C--N 1.313 -0.725 0 CA-C-N 113.273 -1.785 . . . . 1.61 113.071 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.786 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.3 m -73.86 15.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.771 0.796 . . . . 2.23 111.102 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.914 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp -84.86 -43.32 14.24 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.183 -1.371 . . . . 1.17 110.47 -168.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.718 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 1.13 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.634 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 1.07 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 255' ' ' ASP 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 1.04 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.82 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 1.06 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.561 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 1.21 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.86 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.586 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 4.19 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.648 ' NH2' ' HB3' ' B' ' 8' ' ' SER . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 3.36 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 1.2 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.62 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 1.11 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 3.0 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.72 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.75 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.73 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.98 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 1.57 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 1.03 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 1.11 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.602 HG23 ' N ' ' A' ' 283' ' ' GLU . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 2.19 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 1.04 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 2.08 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.686 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.4 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 1.25 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 1.23 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 1.07 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.79 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.517 ' HB3' ' CD ' ' A' ' 313' ' ' ARG . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 1.04 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.7 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 1.03 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.76 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 3.17 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 1.23 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.6 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 3.08 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.22 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.464 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.98 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.622 ' HB3' HG23 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.625 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 1.44 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.13 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 1.03 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 312' ' ' VAL . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 1.05 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 1.03 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 1.05 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 1.05 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' CD ' ' HB3' ' A' ' 293' ' ' ALA . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.57 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.678 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.74 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 1.07 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.97 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 1.46 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.85 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.404 ' OE2' HD12 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.3 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.91 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 2.18 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.491 HD23 ' HD2' ' A' ' 325' ' ' PRO . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.65 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.39 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 4.66 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 1.11 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 1.08 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 1.11 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.618 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.9 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.618 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 1.14 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.914 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.95 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.482 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 3.0 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.567 ' HB3' HD13 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 3.0 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.53 ' CD ' HD11 ' A' ' 281' ' ' LEU . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.42 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 1.03 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.593 ' O ' HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 1.11 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.94 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' B' ' 7' ' ' SER . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.77 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.75 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo -72.97 -179.01 3.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.69 116.056 -167.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -151.71 105.39 3.13 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.51 -2.132 . . . . 2.54 107.761 165.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.6 t70 65.33 84.09 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.158 -0.928 . . . . 2.26 112.05 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.46 -165.84 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 1.22 109.785 168.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.3 t -69.93 -44.07 70.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.282 1.039 . . . . 1.92 108.83 172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.304 -1.375 0 CA-C-N 113.399 -1.728 . . . . 3.39 110.835 -176.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.408 ' HB2' ' HD3' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.45 0.167 . . . . 1.84 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 61.89 107.77 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 124.067 0.854 . . . . 1.37 111.18 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.11 118.95 5.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.47 2.113 . . . . 0.54 111.412 -175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.458 ' HB2' HH22 ' A' ' 336' ' ' ARG . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.9 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 339' ' ' ILE . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.66 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 339' ' ' ILE . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 1.19 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p -70.8 -68.61 0.42 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.51 111.08 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.604 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 65.4 p -149.35 -177.59 5.93 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.481 -0.488 . . . . 2.81 111.264 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -85.49 -123.1 1.26 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.547 -0.751 . . . . 1.85 113.367 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' B' ' 12' ' ' ARG . 64.6 t30 -64.28 168.45 5.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.692 -0.754 . . . . 3.39 111.635 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.96 8.58 0.69 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.998 -1.001 . . . . 5.81 111.873 -175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' B' ' 10' ' ' ASN . 68.2 mtt180 59.67 -163.11 0.24 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.858 -1.065 . . . . 5.91 112.182 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.441 -0.79 . . . . 7.77 109.518 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.841 0.353 . . . . 40.49 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -117.0 -32.46 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 40.11 110.707 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 74.11 -49.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.658 0.783 . . . . 39.42 111.361 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -118.59 69.4 0.8 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.093 0.473 . . . . 37.42 111.031 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.87 44.22 2.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.305 -0.628 . . . . 36.38 109.305 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 34.76 110.703 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.24 117.35 25.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.171 -0.468 . . . . 32.58 109.898 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.52 68.85 10.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 31.1 111.193 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp 61.64 -170.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.444 0.64 . . . . 30.58 111.922 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.4 t -104.11 149.08 25.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 27.95 109.18 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.85 -34.39 73.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.224 0.535 . . . . 27.34 109.592 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.8 p -144.22 130.16 19.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.11 -0.95 . . . . 25.64 109.868 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.4 p -101.6 -37.33 8.42 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.285 0.564 . . . . 24.1 110.876 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.39 97.36 9.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.441 -0.799 . . . . 24.03 109.867 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.5 mmp_? -126.85 138.51 53.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.021 -0.536 . . . . 23.07 111.038 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.64 -0.22 57.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.668 -0.696 . . . . 21.17 110.694 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 63.31 44.37 5.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.037 -0.983 . . . . 19.97 110.811 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.84 -150.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 18.08 111.331 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.4 106.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.353 0.597 . . . . 16.58 110.828 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -105.36 159.97 15.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 14.16 109.899 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.41 164.13 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 13.65 110.486 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.49 55.73 3.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.386 1.088 . . . . 12.06 112.197 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.09 -4.04 9.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 124.752 2.215 . . . . 10.09 108.505 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 169.46 56.97 0.03 OUTLIER Glycine 0 C--N 1.266 -3.309 0 CA-C-N 108.641 -3.891 . . . . 7.81 110.373 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 p -57.61 -64.56 0.86 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 6.56 110.944 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.692 ' C ' HG22 ' A' ' 250' ' ' VAL . 4.6 pt-20 -128.25 -111.3 0.28 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.642 -0.708 . . . . 4.79 110.249 171.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.692 HG22 ' C ' ' A' ' 249' ' ' GLU . 7.3 m 50.31 172.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 115.544 1.683 . . . . 2.76 115.544 167.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.56 93.46 5.62 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.411 -1.722 . . . . 1.48 108.102 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -72.3 -139.4 0.29 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 113.575 -1.648 . . . . 1.61 113.112 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.844 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -71.18 9.81 0.68 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.447 0.642 . . . . 2.23 110.946 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp -79.56 -45.89 18.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.517 -1.219 . . . . 1.17 110.249 -166.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.844 ' HG ' ' O ' ' A' ' 253' ' ' SER . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 1.13 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.612 HD11 ' O ' ' A' ' 254' ' ' LEU . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 1.07 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.489 HG23 HH21 ' A' ' 336' ' ' ARG . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 1.04 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.82 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 1.06 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 1.04 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 1.21 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.604 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 4.19 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 3.36 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 1.2 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.62 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 1.11 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.494 ' HD3' ' CD2' ' A' ' 347' ' ' LEU . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 3.0 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.72 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.73 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.98 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 1.57 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.66 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 1.03 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 336' ' ' ARG . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 2.19 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 1.04 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.538 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 2.08 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.422 ' CD ' HD22 ' A' ' 285' ' ' LEU . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.4 113.014 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 1.25 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 1.23 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.538 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 1.07 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.625 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.79 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.41 ' HB2' ' CD ' ' A' ' 313' ' ' ARG . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 1.04 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.7 111.224 175.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 1.03 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.66 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.76 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 3.17 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 1.23 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.728 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.6 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.735 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 3.08 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.22 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.566 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.98 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.735 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.572 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 1.44 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.13 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 1.03 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 1.05 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 1.03 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 1.05 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 309' ' ' VAL . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 1.05 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.443 ' HG2' HG22 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.57 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.74 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 316' ' ' GLY . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 1.07 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.97 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.56 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 1.46 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.85 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.828 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.3 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.91 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 2.18 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 325' ' ' PRO . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.65 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 324' ' ' LEU . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.39 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 4.66 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 1.11 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 1.08 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 1.11 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.9 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 1.14 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.828 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.95 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.474 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 3.0 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.559 ' HB3' HD13 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.639 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 3.0 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.42 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 340' ' ' PHE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 1.03 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 1.11 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.94 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.543 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.77 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo -45.47 178.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.69 115.198 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -139.88 107.33 5.56 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.716 -1.583 . . . . 2.54 108.373 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.493 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 33.7 t70 54.44 86.63 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.17 -0.923 . . . . 2.26 113.155 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.6 mm? -79.55 -169.05 1.76 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.342 -0.614 . . . . 1.22 109.342 166.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.514 ' HB3' HD13 ' A' ' 347' ' ' LEU . 1.0 OUTLIER -68.93 -45.99 69.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 123.119 1.438 . . . . 1.92 108.078 168.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 346' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.85 0 CA-C-N 112.013 -2.358 . . . . 3.39 111.195 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.677 0.275 . . . . 1.84 111.329 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.51 90.13 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.339 -0.846 . . . . 1.37 111.555 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 84.4 Cg_exo -43.73 128.4 6.75 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.859 3.04 . . . . 0.54 112.716 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 255' ' ' ASP . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.9 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.66 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.644 HG21 ' O ' ' A' ' 339' ' ' ILE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 1.19 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p -98.29 -19.93 17.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.51 112.08 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 263' ' ' SER . 8.7 m -110.62 162.04 15.13 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.119 -0.491 . . . . 2.81 111.117 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.59 -124.62 2.17 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.359 -1.096 . . . . 1.85 110.359 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -60.5 149.49 34.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.322 0.561 . . . . 3.39 110.117 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.26 -12.64 59.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.591 -0.731 . . . . 5.81 111.013 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 49.55 -157.74 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.529 -0.76 . . . . 5.91 112.181 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.901 0 CA-C-O 118.43 -0.795 . . . . 7.77 110.02 174.078 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.749 -0.463 . . . . 40.49 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.2 mtp 64.99 93.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.878 -0.601 . . . . 40.11 111.568 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -90.97 64.06 5.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 39.42 109.595 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -141.56 82.08 1.8 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.656 . . . . 37.42 110.158 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 29.4 tp -77.83 -29.06 50.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 36.38 110.052 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -120.49 97.59 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.879 -0.6 . . . . 34.76 110.869 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.39 126.28 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.243 0.544 . . . . 32.58 109.913 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.57 -36.15 73.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.608 . . . . 31.1 111.082 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.46 71.09 9.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.1 0.476 . . . . 30.58 110.684 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.1 p -149.57 25.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.592 0.71 . . . . 27.95 110.147 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.82 20.43 4.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.384 -0.825 . . . . 27.34 110.603 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.5 p -83.33 129.79 35.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.564 -0.744 . . . . 25.64 110.317 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 16.0 p -128.82 99.02 5.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.002 0.429 . . . . 24.1 111.567 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.56 87.68 4.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.287 0.565 . . . . 24.03 109.752 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 4.8 mmp_? -124.44 29.63 6.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.616 -0.72 . . . . 23.07 111.043 -173.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.54 129.61 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.843 0.354 . . . . 21.17 110.325 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -138.7 151.53 47.23 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.777 -0.647 . . . . 19.97 110.178 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -111.88 124.03 51.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.4 -0.364 . . . . 18.08 110.816 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.85 -58.73 2.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.117 -0.697 . . . . 16.58 109.117 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 59.01 124.25 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.952 0.882 . . . . 14.16 113.181 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -81.25 163.27 23.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.318 -0.855 . . . . 13.65 111.231 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.49 161.32 17.87 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.979 -1.01 . . . . 12.06 111.2 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 247' ' ' GLY . 9.4 p -65.48 159.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 10.09 111.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 246' ' ' VAL . . . 80.08 58.78 2.72 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.054 -0.976 . . . . 7.81 110.942 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.4 p -56.52 -58.92 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 6.56 111.289 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 1.4 pt-20 -106.16 -85.67 0.49 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.308 0.575 . . . . 4.79 112.127 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.453 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 5.6 m -146.38 -157.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.986 -1.006 . . . . 2.76 111.697 -169.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.507 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 18.4 p 60.15 64.08 1.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.369 1.081 . . . . 1.48 110.032 -172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.448 ' O ' HD11 ' A' ' 254' ' ' LEU . . . -68.26 66.53 0.37 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 113.745 -1.57 . . . . 1.61 115.329 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.723 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 64.4 m 57.8 10.55 1.12 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.579 1.18 . . . . 2.23 112.593 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.766 ' O ' HD11 ' A' ' 258' ' ' ILE . 0.3 OUTLIER -84.23 -37.93 21.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 113.306 -1.77 . . . . 1.17 110.285 -171.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.523 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 260' ' ' ASN . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 1.13 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.766 HD11 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 1.07 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.49 ' O ' HD11 ' B' ' 6' ' ' ILE 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 1.04 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.82 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 1.06 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 1.04 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 1.21 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.86 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.607 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.56 ' CD1' ' HA ' ' A' ' 308' ' ' ALA . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 4.19 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 3.36 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 1.2 113.34 170.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.62 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.921 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 1.11 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.602 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 3.0 108.688 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.72 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.921 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.73 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.98 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 1.57 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 1.03 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.615 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 1.11 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 2.19 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 1.04 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.715 HD11 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 2.08 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.437 ' HD2' HD21 ' A' ' 285' ' ' LEU . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.4 113.777 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.542 ' HB3' HD12 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.548 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.715 ' O ' HD11 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 1.25 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.48 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 1.23 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 1.07 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.79 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 1.04 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.7 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 1.03 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.76 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 3.17 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 1.23 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.6 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.556 ' CB ' ' HE3' ' A' ' 276' ' ' MET . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 3.08 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.22 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.509 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.98 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.631 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 1.44 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.13 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 311' ' ' ALA . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 1.03 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.725 ' O ' HG22 ' A' ' 312' ' ' VAL . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 1.05 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 1.05 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 1.05 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.481 ' NE ' ' HB1' ' A' ' 293' ' ' ALA . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.57 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.607 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.74 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 1.07 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.724 ' O ' ' HG2' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.97 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.56 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 1.46 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.85 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.691 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.3 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.91 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 2.18 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.65 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.39 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 4.66 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 1.11 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 1.08 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.48 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 1.11 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.68 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.664 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.9 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 1.14 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.691 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.95 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.68 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 3.0 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.638 ' HB3' ' CD1' ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 3.0 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.42 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 282' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 1.03 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.644 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 1.11 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.94 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.473 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.77 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.2 Cg_exo -28.51 161.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.69 118.35 176.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -153.57 118.0 4.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.746 -2.024 . . . . 2.54 108.074 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.02 68.73 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.341 -0.845 . . . . 2.26 113.221 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -80.17 -166.7 1.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.858 0.361 . . . . 1.22 110.442 168.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -57.23 -32.14 66.23 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.986 0.898 . . . . 1.92 111.51 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.602 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 CA-C-N 114.365 -1.289 . . . . 3.39 111.783 -163.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.451 -0.574 . . . . 1.84 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.08 126.47 87.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 123.306 0.379 . . . . 1.37 110.855 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo -52.76 119.98 6.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.718 2.279 . . . . 0.54 111.592 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.478 ' CB ' HH22 ' A' ' 336' ' ' ARG . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.9 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.66 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 339' ' ' ILE . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 1.19 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 57.6 p -105.67 -13.59 15.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.51 110.121 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.617 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 t -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.648 -1.16 . . . . 2.81 109.844 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.23 109.96 0.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 1.85 111.397 173.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -155.1 160.81 41.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.312 -0.625 . . . . 3.39 109.312 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -49.17 -61.96 1.79 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.344 0.403 . . . . 5.81 110.9 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 53.82 174.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.419 0.896 . . . . 5.91 113.419 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.638 -0.71 . . . . 7.77 109.461 177.019 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.998 0.428 . . . . 40.49 110.445 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.1 mmt -111.58 25.56 11.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.128 0.49 . . . . 40.11 110.78 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -105.57 -28.71 10.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.549 -0.751 . . . . 39.42 110.139 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 48.05 58.31 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.86 0.725 . . . . 37.42 111.14 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.81 76.27 10.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 36.38 110.992 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.64 -78.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.573 -0.74 . . . . 34.76 109.767 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.08 100.0 4.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.679 -0.692 . . . . 32.58 109.49 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.97 87.77 4.78 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.792 -1.095 . . . . 31.1 109.929 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 79.8 mt -82.92 48.47 1.36 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.443 -0.798 . . . . 30.58 110.951 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 33.9 m -98.27 10.25 41.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.385 0.612 . . . . 27.95 110.207 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.63 77.94 5.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 27.34 110.536 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.9 m -98.16 -70.75 0.71 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.411 -0.813 . . . . 25.64 110.118 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 2.9 m 56.38 56.93 5.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.387 0.613 . . . . 24.1 110.953 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.47 -12.02 3.51 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.571 -0.741 . . . . 24.03 112.214 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 3.4 mmp_? -70.89 133.98 46.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.149 -0.478 . . . . 23.07 110.744 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -97.68 -165.82 1.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.516 -0.311 . . . . 21.17 110.421 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 67.67 72.24 0.33 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.86 0.725 . . . . 19.97 111.776 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -92.32 -152.23 0.3 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.895 -0.593 . . . . 18.08 110.593 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.405 HD11 ' C ' ' A' ' 242' ' ' LEU . 3.5 tm? -71.63 113.1 8.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.133 0.492 . . . . 16.58 109.863 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.31 145.11 24.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.025 -0.534 . . . . 14.16 110.701 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -69.28 160.0 32.04 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.423 0.63 . . . . 13.65 110.073 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.04 139.95 40.2 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.066 -0.97 . . . . 12.06 112.11 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 247' ' ' GLY . 10.0 p -109.52 168.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.939 -1.028 . . . . 10.09 109.691 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.426 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -96.21 112.18 4.38 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 114.557 -1.201 . . . . 7.81 111.572 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -40.9 99.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 6.56 110.635 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.446 ' C ' HG23 ' A' ' 250' ' ' VAL . 1.6 pm0 -94.29 127.46 40.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.927 -0.579 . . . . 4.79 111.274 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 252' ' ' GLY . 19.8 m 34.81 -146.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 112.893 -1.958 . . . . 2.76 114.623 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.445 ' H ' HD13 ' A' ' 332' ' ' LEU . 1.3 p 65.43 -16.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.606 1.162 . . . . 1.48 112.336 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.13 -121.8 26.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.528 -0.368 . . . . 1.61 112.484 176.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.722 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.3 m -125.31 23.76 7.52 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.01 1.385 . . . . 2.23 108.38 169.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.71 ' O ' HD13 ' A' ' 258' ' ' ILE . 1.4 mp -87.11 -35.13 18.84 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 112.392 -2.185 . . . . 1.17 109.5 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . 0.589 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 1.13 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 254' ' ' LEU . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 1.07 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.58 ' O ' HD11 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 1.04 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.82 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 1.06 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.641 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 1.04 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.512 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 1.21 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.86 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.634 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.617 ' HE3' ' O ' ' B' ' 8' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 4.19 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 3.36 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 1.2 113.09 167.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.62 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.931 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 1.11 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 275' ' ' GLY . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 3.0 109.872 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.72 112.794 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.931 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.73 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.98 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.527 HG22 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 1.57 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.607 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 1.03 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 1.11 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.705 HD11 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 2.19 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.523 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 1.04 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 2.08 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.479 ' HD2' HD23 ' A' ' 285' ' ' LEU . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.4 113.548 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.589 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.453 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.684 ' O ' HD13 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 1.25 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.523 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 1.23 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 1.07 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.79 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 1.04 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.7 111.294 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 1.03 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.607 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.76 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 3.17 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 1.23 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.6 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.601 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.684 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 3.08 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.601 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.22 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.98 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.684 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.636 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 1.44 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.13 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 1.03 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 312' ' ' VAL . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 1.05 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 1.03 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 1.05 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 309' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 1.05 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.4 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.57 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.667 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.74 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 1.07 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.97 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.464 HG23 ' SD ' ' A' ' 321' ' ' MET . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 1.46 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.85 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.531 ' HE2' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.3 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.91 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 2.18 108.472 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.474 HD23 ' HD2' ' A' ' 325' ' ' PRO . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.65 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.39 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 4.66 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 1.11 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 325' ' ' PRO . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 1.08 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 1.11 109.632 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' SER . . . . . 0.676 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.9 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.676 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 1.14 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.531 ' CG ' ' HE2' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.95 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 3.0 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 282' ' ' ILE . 3.0 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.705 ' H ' HD11 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.42 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 1.03 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ILE . . . . . 0.63 ' O ' HG21 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 1.11 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.94 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . 0.466 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.77 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.489 ' CD ' ' HZ ' ' A' ' 304' ' ' PHE . 24.4 Cg_exo -29.22 163.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.69 118.309 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 11.1 mm-40 -159.24 126.44 4.75 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.027 -2.351 . . . . 2.54 107.434 172.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.59 60.07 0.38 Allowed 'General case' 0 C--N 1.316 -0.866 0 O-C-N 124.282 0.988 . . . . 2.26 112.464 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 342' ' ' PRO . 1.8 mm? -80.97 -172.08 3.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -74.46 -30.64 61.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.119 0.961 . . . . 1.92 109.931 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.131 -1.395 . . . . 3.39 110.965 -171.49 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.734 0.222 . . . . 0.48 111.871 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.709 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.26 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.548 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.01 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.676 HD13 HG13 ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 0.34 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 342' ' ' PRO . 4.0 m . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.05 109.872 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.677 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 112.205 0.446 . . . . 0.47 112.205 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 0.46 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.658 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 0.27 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' B' ' 4' ' ' LEU . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 0.15 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.52 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 0.24 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.633 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 0.17 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 0.69 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.21 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.587 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 3.65 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 2.92 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 0.88 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.52 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.978 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 0.34 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 2.49 109.493 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.46 112.594 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.978 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.08 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.69 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 0.94 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.554 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 0.12 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 0.23 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 1.63 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 0.36 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.668 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 1.45 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.34 112.669 175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 0.58 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 315' ' ' VAL . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 0.47 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.668 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 0.22 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.61 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 0.22 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.17 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 0.16 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.44 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 2.82 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 0.67 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.59 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 2.56 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.599 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.18 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.705 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.58 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.653 ' HA ' HG23 ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 0.92 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.11 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.725 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 0.1 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.653 HG23 ' HA ' ' A' ' 306' ' ' SER . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 0.13 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 0.13 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 0.13 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 315' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.23 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 312' ' ' VAL . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.49 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.587 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.56 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 0.27 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.49 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.652 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 0.65 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.57 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.16 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.72 112.521 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 1.64 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 328' ' ' THR . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.07 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.36 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 326' ' ' ARG . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 3.98 110.786 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 0.34 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.708 HG21 HD22 ' A' ' 324' ' ' LEU . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 0.34 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 0.71 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.701 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.3 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 0.33 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.49 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 2.41 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.848 ' HB3' HD11 ' A' ' 281' ' ' LEU . 45.7 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.878 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 2.45 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.602 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.07 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.658 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 0.17 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 0.29 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.781 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.54 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.507 ' HB3' HG13 ' B' ' 5' ' ' VAL . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.34 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo . . . . . 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.5 120.077 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 85.4 Cg_exo . . . . . 0 N--CA 1.476 0.473 0 N-CA-C 112.773 0.259 . . . . 0.48 112.773 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.554 HD12 HG21 ' A' ' 259' ' ' VAL . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.26 109.964 -172.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.01 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 0.34 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 13.0 p . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.05 111.575 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.334 -0.617 . . . . 0.47 109.334 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.439 ' CG ' HH21 ' A' ' 336' ' ' ARG . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.717 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 0.46 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.574 HD11 ' CE ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 0.27 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.753 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 0.15 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.52 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 0.24 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 0.17 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.588 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 0.69 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.21 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 3.65 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' B' ' 7' ' ' SER . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 2.92 110.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 0.88 113.582 169.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.52 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.956 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 0.34 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 273' ' ' ARG . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 2.49 108.97 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.46 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.956 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.08 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.795 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.69 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 0.94 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 0.12 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.961 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 0.23 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 1.63 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 0.36 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 1.45 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.561 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.34 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 0.58 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 0.47 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 0.22 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.61 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 0.22 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.17 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 0.16 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.44 109.202 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 2.82 109.384 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 0.67 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.59 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 2.56 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.18 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.787 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.688 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 0.92 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.11 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.632 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 0.1 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.688 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 0.13 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 0.13 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 0.13 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.23 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.544 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.49 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.56 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 0.27 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.49 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.539 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 0.65 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.45 ' HD2' HD11 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.57 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.665 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.16 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.72 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 1.64 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.704 HD22 HG21 ' A' ' 328' ' ' THR . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.07 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.36 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.561 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 3.98 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 0.34 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.704 HG21 HD22 ' A' ' 324' ' ' LEU . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 0.34 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.455 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 0.71 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.3 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 0.33 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.665 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.49 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 2.41 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.961 ' HB3' HD11 ' A' ' 281' ' ' LEU . 7.2 mt-30 -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.727 ' H ' HD13 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 2.45 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.57 ' CD ' HD13 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.07 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 0.17 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 0.29 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.34 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 276' ' ' MET . 31.6 Cg_exo . . . . . 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.5 118.122 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.231 0.136 0 N-CA-C 111.054 -0.402 . . . . 0.48 111.054 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 259' ' ' VAL . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.26 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.01 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.728 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 0.34 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.05 110.639 -175.827 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.47 110.128 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.755 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.429 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 0.46 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 0.27 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.728 HG13 HD13 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 0.15 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.52 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 0.24 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 0.17 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.57 ' OG ' HD11 ' B' ' 6' ' ' ILE . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 0.69 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.21 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.514 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.7 OUTLIER -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.588 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 3.65 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 2.92 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 0.88 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.52 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 0.34 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 2.49 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.46 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.603 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.08 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.69 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 0.94 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.513 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 0.12 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 0.23 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 1.63 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.495 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 0.36 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 1.45 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.34 113.591 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.508 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 0.58 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 315' ' ' VAL . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 0.47 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 0.22 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.61 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 0.22 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.17 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 0.16 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.44 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 2.82 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 0.67 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.425 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.59 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 2.56 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.18 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.519 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.58 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.721 ' HA ' HG23 ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 0.92 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.11 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 0.1 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 0.13 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 0.13 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.662 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 0.13 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 0.23 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.49 112.273 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.56 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 0.27 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.49 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 258' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 0.65 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.57 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.422 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.661 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.16 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.72 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 1.64 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.07 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.36 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 3.98 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 0.34 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.752 HG21 HD22 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 0.34 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 0.71 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.3 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 0.33 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.661 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.49 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.464 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 2.41 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.841 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.828 ' HB3' HD11 ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 2.45 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.487 ' HG2' HD13 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.07 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.53 HD12 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 0.17 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.534 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 0.29 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.54 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.703 ' HB3' HG13 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.34 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo . . . . . 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.5 119.075 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.823 -0.491 . . . . 0.48 110.823 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.761 HD23 HG21 ' A' ' 259' ' ' VAL . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.26 110.539 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.01 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.05 110.946 -175.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.804 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 121.384 0.611 . . . . 0.47 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.503 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 0.46 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 0.27 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.763 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 0.15 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.52 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 0.24 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.614 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 0.17 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.577 ' HB3' HD11 ' B' ' 6' ' ' ILE . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 0.69 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.21 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.489 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.8 OUTLIER -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.541 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 3.65 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 2.92 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 0.88 113.253 168.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.806 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 0.34 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 2.49 108.373 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.46 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.825 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.08 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 339' ' ' ILE . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.69 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.485 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 0.94 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.518 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 0.12 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 0.23 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.8 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 1.63 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 0.36 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.665 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 1.45 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.34 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 0.58 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.567 HD12 HG22 ' A' ' 315' ' ' VAL . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 0.47 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.665 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 0.22 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.69 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.61 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 0.22 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.17 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 0.16 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.44 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 2.82 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 0.67 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.59 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.488 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 2.56 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.18 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.504 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.58 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.685 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 0.92 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.11 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.642 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 0.1 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.685 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 0.13 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 0.13 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 0.13 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.8 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 0.23 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 312' ' ' VAL . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.49 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.56 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.567 HG22 HD12 ' A' ' 290' ' ' ILE . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 0.27 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.49 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 258' ' ' ILE . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 0.65 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.57 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.726 ' SD ' HG22 ' A' ' 318' ' ' ILE . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.16 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.72 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 1.64 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 328' ' ' THR . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.07 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.36 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 3.98 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 0.34 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.766 HG21 HD22 ' A' ' 324' ' ' LEU . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 0.34 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 0.71 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.698 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.3 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 0.33 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.804 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.49 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 2.41 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.877 ' HB3' HD11 ' A' ' 281' ' ' LEU . 9.9 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.595 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 2.45 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.564 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.07 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 0.17 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.56 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.697 ' HA ' HG23 ' B' ' 6' ' ' ILE . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.54 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.34 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.825 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo . . . . . 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.5 118.396 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 111.307 -0.305 . . . . 0.48 111.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 259' ' ' VAL . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.26 111.256 -168.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.01 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.729 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 0.34 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.05 111.886 -173.886 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.779 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 120.52 0.2 . . . . 0.47 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.648 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 0.27 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.725 HG13 HD13 ' B' ' 6' ' ' ILE 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 0.15 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.52 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 0.24 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 0.17 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 0.69 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.21 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.438 ' HG2' HG12 ' A' ' 315' ' ' VAL . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.637 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 3.65 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 2.92 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 0.88 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.52 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 1.001 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 0.34 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 2.49 109.266 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.46 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' MET . . . . . 1.001 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.08 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.749 ' HB3' ' HG3' ' A' ' 341' ' ' LYS . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.69 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 0.94 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.595 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 0.12 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 0.23 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.707 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 1.63 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.742 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 0.36 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.641 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 1.45 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.34 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 0.58 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 0.47 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.641 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 0.22 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.742 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.61 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.6 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 0.22 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.17 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 0.16 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.44 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 2.82 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG11 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.67 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.59 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 2.56 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.18 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.607 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.58 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 0.92 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.11 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 0.1 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 0.13 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 0.13 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 0.13 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.707 HG11 HD11 ' A' ' 282' ' ' ILE . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 0.23 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.49 112.433 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.56 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 0.27 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.49 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 0.65 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.57 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.596 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.16 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.72 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 1.64 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.846 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.07 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.36 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.417 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 3.98 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.34 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.695 ' HB ' HD13 ' A' ' 324' ' ' LEU . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 0.34 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.743 ' HB2' HD11 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 0.71 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.3 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 0.33 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.49 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 2.41 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.809 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.672 ' O ' HG12 ' A' ' 282' ' ' ILE . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 2.45 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.07 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 0.17 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.511 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 0.29 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.729 ' HA ' HG23 ' B' ' 6' ' ' ILE . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.54 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.749 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.34 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.5 118.097 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.857 -0.094 . . . . 0.48 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 259' ' ' VAL . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.26 110.292 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.685 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.01 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 263' ' ' SER . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 0.34 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.05 110.937 -178.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.644 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 119.666 -0.207 . . . . 0.47 111.555 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 0.46 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 0.27 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.634 HG13 HD12 ' B' ' 6' ' ' ILE 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 0.15 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.52 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 0.24 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.568 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 0.17 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.923 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.21 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.651 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 3.65 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 2.92 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 0.88 113.149 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.52 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.826 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 0.34 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 2.49 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.46 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.826 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.08 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.69 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 0.94 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 0.12 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.869 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 0.23 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 1.63 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 0.36 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.559 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 1.45 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.34 112.839 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 0.58 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 0.47 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.559 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 0.22 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.61 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 0.22 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.17 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 0.16 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.44 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 2.82 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 0.67 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.59 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.596 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 2.56 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.596 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.18 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 278' ' ' VAL . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.58 109.485 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 0.92 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.11 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 0.1 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 0.13 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 0.13 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 0.13 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 0.23 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.49 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.56 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 0.27 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.417 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.49 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.755 HD13 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 0.65 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.57 114.666 -163.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.557 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.16 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.72 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 1.64 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 328' ' ' THR . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.07 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.36 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 3.98 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 0.34 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.72 HG21 HD22 ' A' ' 324' ' ' LEU . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 0.34 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 0.71 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.3 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 0.33 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.49 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 2.41 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.869 ' HB3' HD11 ' A' ' 281' ' ' LEU . 10.7 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.706 ' HB3' HD11 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 2.45 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.07 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 0.17 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.613 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 0.29 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.54 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.685 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.34 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.804 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo . . . . . 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.5 116.957 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.015 0.34 . . . . 0.48 111.845 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.627 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.26 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' A' ' 341' ' ' LYS . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 263' ' ' SER . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 0.34 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.05 110.454 -173.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 109.466 -0.568 . . . . 0.47 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.565 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.747 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.697 HG13 HD13 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 0.27 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.7 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 0.15 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.52 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 0.24 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 0.17 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.774 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 0.69 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 260' ' ' ASN . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.21 106.57 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.594 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.591 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 3.65 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 2.92 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.88 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.52 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 1.013 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 0.34 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 2.49 109.102 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.46 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' MET . . . . . 1.013 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.08 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.796 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.69 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 0.94 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 0.12 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 0.23 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 1.63 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 0.36 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 1.45 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.34 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.67 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 0.58 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 315' ' ' VAL . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 0.47 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 0.22 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.61 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 0.22 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.17 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.702 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 0.16 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.44 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 2.82 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 0.67 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.59 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 2.56 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.18 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.889 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' HG23 ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 0.92 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.11 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 0.1 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 306' ' ' SER . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 0.13 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 0.13 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 0.13 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 0.23 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.482 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.49 112.961 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.594 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.56 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 0.27 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.49 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 258' ' ' ILE . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 0.65 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.57 118.885 -175.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.16 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.72 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 1.64 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 328' ' ' THR . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.07 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.36 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 3.98 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 0.34 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.697 HG21 HD22 ' A' ' 324' ' ' LEU . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 0.34 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 0.71 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.3 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 0.33 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.49 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 2.41 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 281' ' ' LEU . 15.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.653 ' H ' HD13 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 2.45 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.412 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.07 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 0.17 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.548 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 0.29 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.54 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.34 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo . . . . . 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.5 117.259 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 110.443 -0.637 . . . . 0.48 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 259' ' ' VAL . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.26 111.11 -169.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.01 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 0.34 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 2.4 p . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.05 112.814 -169.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 7.0 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 115.568 1.692 . . . . 0.47 115.568 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.741 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 0.46 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.844 HG13 HD13 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 0.27 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.638 HG13 HD13 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 0.15 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.52 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 0.24 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.542 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 0.17 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.514 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 0.69 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.21 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.488 ' HG2' HG12 ' A' ' 315' ' ' VAL . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.487 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 3.65 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 2.92 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 0.88 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.52 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.999 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 0.34 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 2.49 108.856 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.46 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.999 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.08 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.738 ' HB3' ' CG ' ' A' ' 341' ' ' LYS . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.69 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 0.94 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.569 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 0.12 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.953 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 0.23 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 1.63 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.706 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 318' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 0.36 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 1.45 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.446 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.34 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.529 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 0.58 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.597 HD12 HG22 ' A' ' 315' ' ' VAL . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 0.47 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 0.22 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.706 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.61 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 0.22 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.17 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 0.16 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.569 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.44 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 2.82 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 0.67 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.59 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 2.56 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.18 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.768 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.58 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.746 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.662 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 0.92 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.11 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 0.1 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 0.13 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 0.13 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 0.13 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.701 HG11 HD11 ' A' ' 282' ' ' ILE . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 0.23 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.49 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.56 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 0.27 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.49 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.844 HD13 HG13 ' A' ' 258' ' ' ILE . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 0.65 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.423 ' HD2' HD11 ' A' ' 261' ' ' LEU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.57 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.666 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.16 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.72 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.407 ' HG3' ' CA ' ' A' ' 320' ' ' GLU . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 1.64 108.671 -178.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.07 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.36 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.446 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 3.98 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 0.34 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.745 HG21 HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 0.34 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 0.71 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.3 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 0.33 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.666 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.49 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 2.41 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.953 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.9 mt-30 -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.553 ' HG2' HG21 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 2.45 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.07 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 0.17 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 0.29 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 277' ' ' SER . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.54 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.738 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.34 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo . . . . . 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.5 118.937 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 N-CA-C 110.452 -0.634 . . . . 0.48 110.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.611 ' HB3' HG21 ' A' ' 259' ' ' VAL . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.26 111.289 -168.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.01 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 0.34 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.05 111.541 -173.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 111.953 0.353 . . . . 0.47 111.953 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 0.46 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG12 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 0.27 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.688 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 0.15 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 45.6 t-20 -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.52 107.249 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 0.24 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.642 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 0.17 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 0.69 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.21 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.594 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.653 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 3.65 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 2.92 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 0.88 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.52 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.34 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 2.49 108.848 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.46 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.671 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.08 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.69 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 305' ' ' ASP . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 0.94 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 0.12 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.946 HD11 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 0.23 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 1.63 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.521 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 0.36 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.608 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 1.45 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.34 112.752 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.638 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 0.58 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 0.47 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.608 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 0.22 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.61 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 0.22 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.17 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.642 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 0.16 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.44 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 2.82 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.435 ' HB3' HG11 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.67 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.59 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 2.56 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.18 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.404 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.58 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.642 ' HB2' HG21 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 0.92 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.11 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 0.1 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 0.13 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 0.13 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 0.13 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 282' ' ' ILE . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 0.23 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.49 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.56 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 0.27 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.49 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.592 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 0.65 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.57 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.638 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.16 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 1.64 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.07 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.36 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 3.98 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 0.34 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 0.34 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 0.71 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.652 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.3 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 0.33 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.49 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 2.41 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.946 ' HB3' HD11 ' A' ' 281' ' ' LEU . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 2.45 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.474 ' CD ' HD13 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.07 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.514 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 0.29 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.814 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.54 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.595 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.34 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo . . . . . 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.5 118.492 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 111.022 -0.415 . . . . 0.48 111.022 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 259' ' ' VAL . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.26 111.023 -167.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.01 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 259' ' ' VAL . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 0.34 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.05 110.769 -177.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 110.298 -0.26 . . . . 0.47 110.298 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 0.46 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.618 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 0.27 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.748 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 0.15 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 50.8 t-20 -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.52 106.959 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 0.24 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.64 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 0.17 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.551 ' CB ' HD11 ' B' ' 6' ' ' ILE . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 0.69 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.21 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.53 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 3.65 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 2.92 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 0.88 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.52 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.34 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 2.49 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.46 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.681 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.08 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.745 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.69 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 0.94 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 0.12 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.804 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 0.23 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 1.63 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.546 ' CG ' HG12 ' A' ' 290' ' ' ILE . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 0.36 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 1.45 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.34 113.697 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.508 ' H ' HD13 ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 0.58 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 0.47 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.61 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 0.22 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.17 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 0.16 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.44 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 2.82 109.445 174.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 0.67 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.59 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 2.56 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.18 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.426 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.58 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.697 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 0.92 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.11 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 0.1 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 306' ' ' SER . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 0.13 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 0.13 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 0.13 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 315' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 0.23 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.49 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.53 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.56 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 0.27 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.49 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 0.65 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.663 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.57 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.652 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.16 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.72 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 1.64 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.07 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.36 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 3.98 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 0.34 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 0.34 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.524 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 0.71 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.3 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 0.33 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.652 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.49 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 2.41 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.804 ' HB3' HD11 ' A' ' 281' ' ' LEU . 10.2 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.782 ' HA ' HH11 ' A' ' 336' ' ' ARG . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 2.45 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.774 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.07 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 0.17 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.577 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 0.29 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 277' ' ' SER . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.54 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.34 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo . . . . . 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.5 117.308 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo . . . . . 0 C--O 1.231 0.159 0 N-CA-C 111.498 -0.231 . . . . 0.48 111.498 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.26 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.01 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 0.34 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 341' ' ' LYS . 3.2 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.05 111.381 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.645 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.6 mp . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 120.858 0.361 . . . . 0.47 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.511 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.706 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 0.46 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 0.27 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.672 HG21 HD23 ' B' ' 4' ' ' LEU 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 0.15 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.52 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 0.24 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 0.17 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.548 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 0.69 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.21 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 3.65 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 2.92 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 0.88 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.52 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.987 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 0.34 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 2.49 109.327 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.46 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.987 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.08 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.69 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 0.94 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 0.12 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.872 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 0.23 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 1.63 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 0.36 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.649 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 1.45 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.34 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.639 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 0.58 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 0.47 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.649 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.61 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 0.22 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.17 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 0.16 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.44 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 2.82 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.67 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.59 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 2.56 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.18 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.58 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.69 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 0.92 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.11 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 0.1 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.69 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 0.13 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 0.13 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.625 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 0.13 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 0.23 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.49 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.56 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 0.27 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.49 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 321' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 0.65 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.57 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.439 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.16 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.72 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 1.64 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.847 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.07 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.36 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 3.98 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 0.34 112.415 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.734 ' HB ' HD13 ' A' ' 324' ' ' LEU . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 0.34 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 0.71 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.715 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.3 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 0.33 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.645 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.49 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 2.41 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.872 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.3 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.728 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 2.45 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.07 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 0.17 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 0.29 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.789 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.54 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.34 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo . . . . . 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.5 119.17 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 CA--C 1.528 0.198 0 CA-C-O 120.792 0.247 . . . . 0.48 111.855 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.779 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.26 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 341' ' ' LYS . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.01 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.05 111.356 -176.632 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.681 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.6 OUTLIER . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 108.36 -0.978 . . . . 0.47 108.36 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.573 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 0.46 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 0.27 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' B' ' 4' ' ' LEU 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 0.15 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.52 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 0.24 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 0.17 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.758 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 0.69 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.21 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.571 ' OE1' HG12 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.617 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 3.65 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 2.92 110.572 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.482 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 0.88 113.71 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.52 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.925 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 0.34 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 2.49 110.46 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.46 112.21 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.925 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.08 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.69 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 0.94 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 297' ' ' ARG . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 282' ' ' ILE . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 0.12 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 0.23 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.771 HD11 HG11 ' A' ' 312' ' ' VAL . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 1.63 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.717 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 0.36 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 1.45 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.34 112.437 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 0.58 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 315' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 0.47 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.721 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 0.22 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.717 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.61 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 0.22 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.17 110.257 175.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 0.16 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.44 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 2.82 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 0.67 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.59 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 2.56 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.18 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.593 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.58 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.691 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.668 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 0.92 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.11 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 0.1 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.668 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 0.13 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 0.13 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 0.13 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.771 HG11 HD11 ' A' ' 282' ' ' ILE . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 0.23 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.49 112.901 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.56 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 0.27 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.49 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 258' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 0.65 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 318' ' ' ILE . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.57 116.142 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.16 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.72 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 1.64 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.07 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.36 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 3.98 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 0.34 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.706 HG21 HD22 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 0.34 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 0.71 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.678 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.3 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 0.33 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 2.41 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.979 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 2.45 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.07 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 0.29 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.54 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.566 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.34 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo . . . . . 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.5 117.444 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.464 ' HG3' ' HE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo . . . . . 0 C--O 1.23 0.118 0 N-CA-C 110.65 -0.558 . . . . 0.48 110.65 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 259' ' ' VAL . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.26 110.83 -173.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.01 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.739 HD13 HG13 ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 0.34 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.05 110.952 -176.452 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.47 108.75 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.687 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 0.46 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.998 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 0.27 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.739 HG13 HD13 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 0.15 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 50.2 t-20 -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.52 107.004 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 0.24 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.643 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 0.17 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.547 ' CB ' HD11 ' B' ' 6' ' ' ILE . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 0.69 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.21 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.602 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.644 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 3.65 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 2.92 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 0.88 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.52 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 1.002 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 0.34 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 275' ' ' GLY . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 2.49 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.46 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' MET . . . . . 1.002 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.08 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.793 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.69 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 0.94 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.551 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.659 HG12 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 0.12 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 0.23 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 1.63 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.527 ' CG ' HG12 ' A' ' 290' ' ' ILE . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 0.36 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.683 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 1.45 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.34 112.974 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.594 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 0.58 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 315' ' ' VAL . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 0.47 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.683 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 0.22 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.61 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 0.22 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.17 110.695 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 0.16 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.44 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 2.82 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 0.67 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.59 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 2.56 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.18 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.644 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.58 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.695 ' HA ' HG23 ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 0.92 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.11 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.626 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 0.1 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.695 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 0.13 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 0.13 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 0.13 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 0.23 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.49 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.56 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 0.27 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.49 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.998 HD13 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 0.65 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.57 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.402 ' OE2' HD11 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.633 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.16 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.72 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 1.64 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 328' ' ' THR . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.07 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.36 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 3.98 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 0.34 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 324' ' ' LEU . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 0.34 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 0.71 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.682 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.688 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.3 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 0.33 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.633 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.49 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.682 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 2.41 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.792 ' HB3' HD11 ' A' ' 281' ' ' LEU . 3.6 mt-30 -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.761 ' HB3' HD11 ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 2.45 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.464 ' HE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.07 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 0.17 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 0.29 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.54 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.569 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.34 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.5 117.914 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.519 -0.274 0 CA-C-O 120.917 0.299 . . . . 0.48 112.087 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.26 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.47 ' N ' HD13 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.01 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 0.34 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.05 110.813 -176.847 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 8.3 mt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 114.463 1.283 . . . . 0.47 114.463 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 336' ' ' ARG . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 0.46 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 318' ' ' ILE . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 0.27 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.689 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 0.15 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.52 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 0.24 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 0.17 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' HD11 ' B' ' 6' ' ' ILE . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 0.69 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.21 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 3.65 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 2.92 110.738 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 0.88 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.52 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.984 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.34 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.2 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.46 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.984 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.08 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.69 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 0.94 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.525 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 0.23 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.755 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 318' ' ' ILE . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 0.36 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.628 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 1.45 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.34 112.598 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.525 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 0.58 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 0.47 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.628 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 0.22 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.671 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.61 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 0.22 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.17 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.44 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 2.82 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 0.67 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.59 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 2.56 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.18 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.738 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.58 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.715 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 0.92 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.11 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.61 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 0.1 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.715 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 0.13 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 0.13 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 0.13 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 0.23 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.49 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.56 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 0.27 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.49 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 0.65 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.57 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.16 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.72 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 1.64 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 328' ' ' THR . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.07 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.36 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 3.98 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 0.34 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.77 HG21 HD22 ' A' ' 324' ' ' LEU . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 0.34 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 0.71 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.707 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.3 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.707 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 0.33 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.577 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.49 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.531 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 2.41 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.832 ' HB3' HD11 ' A' ' 281' ' ' LEU . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.755 ' H ' HD13 ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 2.45 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.07 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 0.17 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.551 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 0.29 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.54 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.621 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.34 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo . . . . . 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.5 118.032 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.517 -0.358 0 CA-C-O 120.634 0.181 . . . . 0.48 112.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.669 ' HB2' HG21 ' A' ' 259' ' ' VAL . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.26 111.374 -172.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.01 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.687 HD13 HG13 ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 0.34 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.882 -177.045 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 110.065 -0.346 . . . . 0.47 110.065 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.735 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 0.46 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 0.27 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.687 HG13 HD13 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 0.15 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.52 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 0.24 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.542 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 0.69 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.21 106.274 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.547 ' CG ' HG12 ' A' ' 315' ' ' VAL . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.645 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 3.65 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 2.92 109.716 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 0.88 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.52 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.878 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 0.34 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 2.49 107.527 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 342' ' ' PRO . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.46 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.878 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.08 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.69 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 0.94 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 0.12 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 0.23 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.747 HD11 HG11 ' A' ' 312' ' ' VAL . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 1.63 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.482 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 0.36 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 1.45 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.693 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.34 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 0.58 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.502 HD12 HG22 ' A' ' 315' ' ' VAL . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 0.47 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 0.22 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.61 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 0.22 109.655 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.17 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 0.16 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.44 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 2.82 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 0.67 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.59 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 2.56 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.18 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.594 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.58 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.675 ' HA ' HG21 ' A' ' 278' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 0.92 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.11 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.668 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 0.1 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 306' ' ' SER . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 0.13 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 0.13 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 0.13 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 282' ' ' ILE . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 0.23 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.542 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.49 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.56 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 0.27 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.49 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 0.65 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.57 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.651 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.16 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.72 112.801 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 1.64 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.07 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.36 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 3.98 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 0.34 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 0.34 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 0.71 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.689 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.3 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 0.33 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.651 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.49 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 2.41 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.797 ' HB3' HD11 ' A' ' 281' ' ' LEU . 5.3 mt-30 -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.87 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 2.45 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.542 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.07 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 0.17 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.508 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 0.29 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.54 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.34 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.1 Cg_exo . . . . . 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.5 117.546 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.459 0.108 . . . . 0.48 111.883 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 259' ' ' VAL . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.26 110.72 -172.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.01 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.656 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 0.34 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.05 111.33 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.8 mp . . . . . 0 C--O 1.221 -0.425 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 0.46 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.644 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 0.27 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.655 HG13 HD13 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 0.15 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 45.2 t-20 -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.52 107.251 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 0.24 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.637 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 0.17 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.523 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 0.69 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.21 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.575 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 3.65 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 2.92 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 0.88 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.52 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.43 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 0.34 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.559 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.46 111.523 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.641 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.08 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.818 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.69 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 0.94 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 0.23 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 1.63 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 0.36 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 1.45 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.676 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.34 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.443 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.543 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 0.58 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 313' ' ' ARG . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 0.47 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.65 ' CG2' HD12 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 0.22 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.61 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.17 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 0.16 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.44 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ARG . . . . . 0.432 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 2.82 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 0.67 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.59 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.494 ' CB ' ' HE1' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.794 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 2.56 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.18 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.58 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.794 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 0.92 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.11 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.719 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 0.1 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 0.13 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 0.13 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 0.13 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.741 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 0.23 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.49 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.56 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 0.27 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.49 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 0.65 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.57 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.608 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.16 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.72 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 1.64 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.845 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.07 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.36 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 3.98 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 0.34 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.706 ' HB ' HD13 ' A' ' 324' ' ' LEU . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 0.34 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 0.71 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.712 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.3 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 0.33 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.49 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 2.41 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.879 ' HB3' HD11 ' A' ' 281' ' ' LEU . 16.4 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.815 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 2.45 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.582 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.07 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.648 HD12 HG21 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 0.17 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.561 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.29 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.818 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.54 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.581 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.34 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo . . . . . 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.5 117.275 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.725 0.219 . . . . 0.48 111.676 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 259' ' ' VAL . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.26 111.136 -171.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.01 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.736 HG23 ' HA ' ' A' ' 340' ' ' PHE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 0.34 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.803 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.903 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.47 -0.196 . . . . 0.47 110.47 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 0.46 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.729 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 0.27 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.607 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 0.15 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.52 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 0.24 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 0.17 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.468 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 0.69 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.21 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.683 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.593 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 3.65 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 342' ' ' PRO . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 2.92 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 0.88 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.52 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 0.34 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 2.49 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 342' ' ' PRO . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.46 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.775 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.08 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.8 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.69 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 0.94 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.472 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 0.12 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 0.23 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.73 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 1.63 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 0.36 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.698 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 1.45 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.34 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.515 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 0.58 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 0.47 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 0.22 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.61 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 0.22 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.17 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 0.16 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.44 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 2.82 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.456 ' HB3' HG11 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.59 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 2.56 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.18 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.58 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.707 ' HA ' HG23 ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 0.92 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.11 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 0.1 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 306' ' ' SER . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 0.13 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 0.13 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 0.13 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.73 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 0.23 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 312' ' ' VAL . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.49 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.683 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.56 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 0.27 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.49 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 0.65 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.57 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.406 ' OE2' HD11 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.16 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.72 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 1.64 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.673 HD22 HG21 ' A' ' 328' ' ' THR . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.07 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.36 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 3.98 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 0.34 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.673 HG21 HD22 ' A' ' 324' ' ' LEU . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 0.34 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 0.71 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.3 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 0.33 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.903 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.49 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.495 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 2.41 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.63 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 2.45 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.07 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 0.17 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 0.29 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.54 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.634 ' HB3' HG13 ' B' ' 5' ' ' VAL . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.34 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.5 116.056 -167.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--O 1.234 0.311 0 N-CA-C 111.412 -0.265 . . . . 0.48 111.412 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 259' ' ' VAL . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.26 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 341' ' ' LYS . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.01 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 0.34 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.05 111.08 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.862 0.363 . . . . 0.47 110.249 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.778 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 0.46 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.641 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 0.27 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.794 HG21 HD23 ' B' ' 4' ' ' LEU . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 0.15 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.52 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 0.24 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.66 ' CG1' HD13 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.826 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 0.69 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.21 105.797 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 3.65 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 2.92 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 0.88 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.52 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 0.34 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 275' ' ' GLY . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 2.49 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.46 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.08 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.69 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 0.94 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.631 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 0.12 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 0.23 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 312' ' ' VAL . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 1.63 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 0.36 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 1.45 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.34 113.014 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.635 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 0.58 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 0.47 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.564 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 0.22 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.61 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 0.22 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.17 111.224 175.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 0.16 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.631 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.44 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 2.82 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 0.67 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.731 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.59 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.415 ' HB2' ' HE1' ' A' ' 276' ' ' MET . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.732 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 2.56 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.18 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.732 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.639 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 0.92 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.11 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.609 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 0.1 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.639 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 0.13 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 0.13 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 0.13 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 282' ' ' ILE . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 0.23 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.49 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.56 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 290' ' ' ILE . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 0.27 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.646 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.49 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.641 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 0.65 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.57 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.443 ' OE2' HD11 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.635 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.16 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.72 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 1.64 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 328' ' ' THR . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.07 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.36 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 3.98 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 0.34 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.753 HG21 HD22 ' A' ' 324' ' ' LEU . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 0.34 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 0.71 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.3 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 0.33 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.49 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.498 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 2.41 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.782 ' HB3' HD11 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 2.45 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.07 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 258' ' ' ILE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 0.17 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 0.29 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.772 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.54 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.34 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.5 115.198 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 337' ' ' ARG . 84.4 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 N-CA-C 112.716 0.237 . . . . 0.48 112.716 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.26 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.01 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.752 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 0.34 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.05 112.08 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.784 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.804 0.335 . . . . 0.47 110.285 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 0.46 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.613 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 0.27 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.698 HG21 HD23 ' B' ' 4' ' ' LEU 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 0.15 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.52 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 0.24 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 0.17 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.516 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.69 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.21 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.604 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 3.65 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 2.92 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 0.88 113.34 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.52 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.911 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 0.34 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 2.49 108.688 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.46 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.911 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.08 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.762 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.69 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 305' ' ' ASP . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 0.94 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 0.12 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 0.23 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 1.63 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 0.36 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 1.45 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.34 113.777 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.498 ' H ' HD22 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.616 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 0.58 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.47 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 0.22 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.61 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 0.22 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.17 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.44 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 2.82 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.67 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.59 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 2.56 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.18 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 301' ' ' ASP . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.58 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 0.92 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.11 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 0.1 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 0.13 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 0.13 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 0.13 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 0.23 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.49 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.604 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.56 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 0.27 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.49 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 0.65 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.57 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.616 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.16 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.72 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 1.64 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.07 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.36 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 3.98 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 0.34 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.678 HG21 HD22 ' A' ' 324' ' ' LEU . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.34 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 0.71 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.691 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.3 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 0.33 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.504 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.49 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.699 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 2.41 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.952 ' HB3' HD11 ' A' ' 281' ' ' LEU . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.754 ' H ' HD13 ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 2.45 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.563 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.07 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 258' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 0.17 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.503 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 0.29 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.54 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.34 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.2 Cg_exo . . . . . 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.5 118.35 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 N-CA-C 111.592 -0.195 . . . . 0.48 111.592 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.67 HD23 HG21 ' A' ' 259' ' ' VAL . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.26 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.01 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.769 HD13 HG13 ' A' ' 259' ' ' VAL . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 0.34 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.121 -177.908 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.4 mp . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 109.5 -0.555 . . . . 0.47 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ASP . . . . . 0.63 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 0.46 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 0.27 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.769 HG13 HD13 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 0.15 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.52 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 0.24 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.674 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 0.17 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.544 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.69 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.21 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.644 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.533 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 3.65 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 2.92 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 0.88 113.09 167.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.52 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.923 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 0.34 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 2.49 109.872 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.46 112.794 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.08 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.69 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 0.94 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.584 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 0.12 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 0.23 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.71 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 1.63 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.549 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 0.36 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 1.45 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.34 113.548 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.695 ' O ' HD12 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 0.58 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 0.47 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 0.22 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.61 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 0.22 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.17 111.294 175.1 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 0.16 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.584 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.44 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 2.82 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 0.67 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.59 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 2.56 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.592 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.18 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.519 ' CE1' HG23 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.58 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 0.92 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.11 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.614 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 0.1 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 0.13 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 0.13 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 0.13 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 0.23 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.49 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.56 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 0.27 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.49 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 319' ' ' PRO . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 0.65 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.57 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.641 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.16 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.72 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 1.64 108.472 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.07 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.36 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 3.98 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 0.34 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 0.34 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.422 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 0.71 109.632 173.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' SER . . . . . 0.721 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.3 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.721 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 0.33 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.641 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.49 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 2.41 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 18.1 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.71 ' H ' HD13 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 2.45 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ARG . . . . . 0.569 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.07 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 0.17 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ILE . . . . . 0.571 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 0.29 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.54 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.34 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 341' ' ' LYS . 24.4 Cg_exo . . . . . 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.5 118.309 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.7 -0.482 . . . . 1.84 109.7 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -95.95 124.46 52.06 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.975 -0.379 . . . . 1.1 109.975 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo -49.77 120.99 6.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.736 2.291 . . . . 0.48 111.871 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.709 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.26 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.548 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.01 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.676 HD13 HG13 ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 0.34 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.57 ' HB2' ' OE1' ' A' ' 343' ' ' GLU . 4.0 m -110.16 -7.43 14.89 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.05 109.872 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.637 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 4.7 t -100.38 156.45 17.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.716 -1.129 . . . . 2.56 110.696 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.29 -127.28 1.06 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.336 -1.105 . . . . 1.85 110.336 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' B' ' 12' ' ' ARG . 18.7 p-10 -53.97 147.94 11.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.796 0.331 . . . . 3.21 110.825 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.81 58.77 4.46 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.622 1.677 . . . . 5.81 110.055 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' B' ' 10' ' ' ASN . 1.2 ppt_? -77.24 -166.32 0.71 Allowed 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 111.173 -2.74 . . . . 5.3 111.456 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.571 -0.728 . . . . 7.77 109.872 172.865 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.62 ' HA ' ' O ' ' A' ' 228' ' ' LEU . 23.5 p80 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.246 0.546 . . . . 40.22 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.61 176.2 10.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.001 -0.545 . . . . 40.04 111.316 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 66.78 -78.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.648 0.779 . . . . 39.27 111.841 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -147.0 19.32 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.069 0.461 . . . . 37.29 110.656 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 224' ' ' HIS . 62.3 tp -139.65 88.5 2.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.871 -0.604 . . . . 36.13 110.218 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.29 -61.19 1.97 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.658 0.742 . . . . 34.41 110.893 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.535 ' HG3' ' H ' ' A' ' 232' ' ' LEU . 12.1 pt-20 -168.53 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.438 -1.255 . . . . 32.45 108.896 -168.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.23 -30.44 62.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.842 -0.799 . . . . 30.94 108.842 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 230' ' ' GLU . 16.5 tp -78.44 55.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 30.21 109.889 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 25.3 t -142.44 106.64 4.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.652 . . . . 27.83 109.746 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.98 56.7 4.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.364 0.602 . . . . 27.14 110.454 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -74.17 -65.99 0.78 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.286 -0.87 . . . . 25.54 109.978 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 237' ' ' GLU . 12.2 p -146.49 -153.36 0.48 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.66 -1.237 . . . . 23.93 107.66 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.429 ' H ' ' HB ' ' A' ' 236' ' ' THR . 1.3 mp0 -84.14 84.98 7.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.944 -0.761 . . . . 24.03 108.944 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -125.91 97.99 5.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 22.83 110.673 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -78.8 69.52 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.399 0.619 . . . . 21.0 110.21 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -82.85 57.53 3.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.562 -0.745 . . . . 19.72 111.455 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.64 64.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.838 -0.619 . . . . 17.66 110.806 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.5 tp -105.12 90.11 3.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.797 -0.638 . . . . 16.08 110.129 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.6 178.54 7.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.049 -0.523 . . . . 14.08 110.782 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.3 -175.82 2.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 13.03 111.559 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -52.87 145.4 12.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.681 0.993 . . . . 12.06 113.681 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 247' ' ' GLY . 11.1 p -107.4 172.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.838 -1.074 . . . . 9.73 109.866 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.542 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -100.01 117.94 6.03 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.28 -0.873 . . . . 7.65 111.919 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.8 p -96.08 -73.81 0.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.977 0.418 . . . . 6.51 110.597 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -59.4 2.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.523 0.678 . . . . 4.79 111.11 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 7.9 m -149.09 -147.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 114.249 -1.341 . . . . 2.23 111.174 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.658 HG22 HD22 ' A' ' 332' ' ' LEU . 4.8 p 53.66 73.87 0.35 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.465 1.126 . . . . 1.43 108.943 -168.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -61.88 -139.48 0.01 OUTLIER Glycine 0 C--N 1.319 -0.401 0 CA-C-N 113.648 -1.615 . . . . 1.61 113.49 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.892 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 8.5 p -82.44 16.88 1.9 Allowed 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 123.251 1.5 . . . . 1.62 111.219 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.677 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -85.96 -55.29 4.02 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.574 -3.012 . . . . 0.47 112.205 -167.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.612 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.892 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 0.46 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.658 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 0.27 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' B' ' 4' ' ' LEU . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 0.15 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.52 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 0.24 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.633 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 0.17 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 0.69 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.21 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.587 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.637 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 3.65 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 2.92 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 0.88 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.52 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.978 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 0.34 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.606 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 2.49 109.493 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.46 112.594 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.978 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.08 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.69 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 0.94 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.554 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 0.12 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 0.23 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 1.63 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 0.36 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.668 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 1.45 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.34 112.669 175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 0.58 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 315' ' ' VAL . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 0.47 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.668 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 0.22 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.61 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 0.22 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.17 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 0.16 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.44 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 2.82 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 0.67 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.59 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 2.56 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.599 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.18 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.705 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.58 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.653 ' HA ' HG23 ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 0.92 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.11 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.725 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 0.1 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.653 HG23 ' HA ' ' A' ' 306' ' ' SER . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 0.13 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 0.13 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 0.13 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 315' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.23 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 312' ' ' VAL . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.49 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.587 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.56 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 0.27 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.49 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.652 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 0.65 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.57 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.16 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.72 112.521 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 1.64 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 328' ' ' THR . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.07 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.36 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 326' ' ' ARG . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 3.98 110.786 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 0.34 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.708 HG21 HD22 ' A' ' 324' ' ' LEU . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 0.34 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 0.71 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.701 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.3 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 0.33 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.49 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 2.41 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.848 ' HB3' HD11 ' A' ' 281' ' ' LEU . 45.7 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.878 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 2.45 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.602 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.07 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.658 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 0.17 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 0.29 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.781 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.54 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.507 ' HB3' HG13 ' B' ' 5' ' ' VAL . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.34 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo -28.94 169.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.5 120.077 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' B' ' 7' ' ' SER . 11.0 pt-20 -152.61 129.24 10.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.805 -2.452 . . . . 2.54 107.719 174.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 59.85 64.06 1.36 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.677 0.621 . . . . 2.26 112.677 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.2 OUTLIER -80.32 -175.1 4.93 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 1.22 111.153 171.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.2 m -72.35 -32.39 66.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.971 0.891 . . . . 1.77 111.015 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.606 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 113.805 -1.543 . . . . 2.89 112.17 -163.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.187 0.042 . . . . 1.84 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t70 70.45 105.71 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 123.836 0.71 . . . . 1.1 110.968 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 85.4 Cg_exo -43.71 128.68 6.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.55 2.833 . . . . 0.48 112.773 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.554 HD12 HG21 ' A' ' 259' ' ' VAL . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.26 109.964 -172.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.01 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 0.34 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 13.0 p -114.7 -6.79 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.05 111.575 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.67 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.8 t -94.79 153.62 17.66 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 2.56 110.37 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.79 103.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.763 -0.935 . . . . 1.85 110.763 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' B' ' 12' ' ' ARG . 58.9 t30 -128.13 170.08 13.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.704 -0.48 . . . . 3.21 109.704 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.16 47.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.863 1.316 . . . . 5.81 111.272 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' B' ' 10' ' ' ASN . 34.5 ptt180 -110.11 159.27 17.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 112.758 -2.019 . . . . 5.3 109.774 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.76 -0.638 . . . . 7.77 110.206 177.642 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.749 0.309 . . . . 40.22 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.71 86.48 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.964 0.411 . . . . 40.04 109.976 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HD3' ' OE1' ' A' ' 230' ' ' GLU . 0.0 OUTLIER -134.67 61.17 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.918 0.389 . . . . 39.27 110.583 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.12 -25.85 66.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 37.29 110.723 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.38 -9.98 59.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 36.13 111.274 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 44.84 71.87 0.24 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.851 0.719 . . . . 34.41 112.627 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 226' ' ' ARG . 7.9 pt-20 -75.34 107.62 7.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.376 0.608 . . . . 32.45 110.14 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.62 -45.03 12.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 30.94 110.132 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.1 mt 59.27 74.45 0.44 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.241 0.544 . . . . 30.21 111.45 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.0 p -103.22 29.9 5.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.807 0.813 . . . . 27.83 109.274 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -83.35 6.98 17.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.877 -1.056 . . . . 27.14 111.161 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 2.1 m -69.23 162.03 27.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.343 -0.614 . . . . 25.54 109.343 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 5.3 p -146.33 129.95 16.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.418 . . . . 23.93 109.888 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.29 126.13 35.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.714 0.769 . . . . 24.03 109.303 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -152.04 94.94 2.01 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.395 -1.275 . . . . 22.83 109.318 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -131.52 -63.49 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.505 -0.77 . . . . 21.0 110.137 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 54.97 51.73 13.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.445 0.64 . . . . 19.72 110.412 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 148.74 42.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.156 -0.929 . . . . 17.66 111.362 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.68 133.89 39.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.618 -0.719 . . . . 16.08 109.569 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.462 ' HB2' ' OD2' ' A' ' 330' ' ' ASP . . . -78.36 164.55 24.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.389 0.614 . . . . 14.08 111.429 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.0 158.81 20.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.253 -0.885 . . . . 13.03 110.855 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -94.82 146.24 24.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.326 -0.852 . . . . 12.06 111.735 -173.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 247' ' ' GLY . 9.9 p -104.96 -179.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.056 -0.72 . . . . 9.73 109.056 173.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.734 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -75.53 121.75 6.51 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 115.747 -0.661 . . . . 7.65 112.379 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.1 p 50.73 79.2 0.09 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.981 0.912 . . . . 6.51 111.638 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.558 ' HB2' HG23 ' A' ' 328' ' ' THR . 0.2 OUTLIER -127.2 -93.62 0.47 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.901 -0.591 . . . . 4.79 112.266 -177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.472 ' H ' ' CG ' ' A' ' 249' ' ' GLU . 18.1 m 56.79 -179.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 115.919 1.822 . . . . 2.23 115.919 164.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.509 ' HB ' ' OD1' ' A' ' 255' ' ' ASP . 22.6 p -71.85 102.9 2.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.004 -1.907 . . . . 1.43 111.527 -172.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.412 ' CA ' HD12 ' A' ' 254' ' ' LEU . . . -91.44 60.12 2.94 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.785 -1.098 . . . . 1.61 113.516 -173.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.668 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 60.09 12.93 3.47 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.401 1.096 . . . . 1.62 110.289 -177.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER -81.43 -32.49 32.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.535 -1.666 . . . . 0.47 109.334 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.509 ' OD1' ' HB ' ' A' ' 251' ' ' THR . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.717 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 0.46 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.574 HD11 ' CE ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 0.27 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.753 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 0.15 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.52 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 0.24 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 0.17 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.588 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 0.69 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.21 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' B' ' 8' ' ' SER . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 3.65 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' B' ' 8' ' ' SER . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 2.92 110.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 0.88 113.582 169.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.52 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.956 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 0.34 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.608 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 2.49 108.97 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.46 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.956 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.08 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.795 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.69 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 0.94 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 0.12 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.961 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 0.23 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 1.63 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 0.36 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 1.45 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.561 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.34 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 0.58 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 0.47 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 0.22 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.61 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 0.22 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.17 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 0.16 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.44 109.202 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 2.82 109.384 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 0.67 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.59 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 2.56 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.18 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.787 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.688 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 0.92 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.11 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.632 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 0.1 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.688 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 0.13 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 0.13 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 0.13 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.23 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.544 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.49 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.56 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 0.27 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.49 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.539 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 0.65 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.45 ' HD2' HD11 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.57 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.665 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.16 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.72 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 1.64 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.704 HD22 HG21 ' A' ' 328' ' ' THR . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.07 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.36 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.561 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 3.98 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 0.34 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.704 HG21 HD22 ' A' ' 324' ' ' LEU . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 0.34 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.455 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 0.71 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.3 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 0.33 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.665 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.49 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 2.41 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.961 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.727 ' H ' HD13 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 2.45 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.57 ' CD ' HD13 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.07 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 0.17 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 0.29 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.34 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.638 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 31.6 Cg_exo -28.2 155.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.5 118.122 176.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -156.34 113.82 3.22 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.492 -2.14 . . . . 2.54 107.475 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 28.5 t70 60.59 75.86 0.39 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.533 0.682 . . . . 2.26 111.359 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.638 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -80.63 -73.39 0.37 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.765 0.793 . . . . 1.22 111.703 175.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.1 t 177.77 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.811 -1.54 . . . . 1.77 108.969 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.608 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 CA-C-N 112.322 -2.217 . . . . 2.89 112.328 -167.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.314 -0.624 . . . . 1.84 109.314 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.81 128.42 63.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 123.719 0.637 . . . . 1.1 111.18 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo -56.23 119.28 6.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.66 2.24 . . . . 0.48 111.054 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 259' ' ' VAL . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.26 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.01 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.728 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 0.34 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -107.12 -16.73 14.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.05 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.599 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 16.1 t -68.86 -174.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.994 -1.003 . . . . 2.56 110.015 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.6 91.92 0.41 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 109.981 -1.248 . . . . 1.85 109.981 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.93 141.17 56.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.435 1.112 . . . . 3.21 113.265 -165.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -168.7 23.05 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.904 -1.953 . . . . 5.81 107.47 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -137.24 38.88 2.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.055 -1.884 . . . . 5.3 110.678 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.534 -0.757 . . . . 7.77 110.035 178.774 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.45 ' HB3' ' CD ' ' A' ' 230' ' ' GLU . 12.2 t-80 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.378 -0.23 . . . . 40.22 110.378 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.1 mmt -95.0 -46.58 6.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.314 0.578 . . . . 40.04 109.552 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -152.54 -37.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.256 -0.883 . . . . 39.27 110.451 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.06 165.72 11.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 37.29 111.132 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.73 145.94 30.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.704 -0.851 . . . . 36.13 108.704 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 58.61 52.06 7.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.304 0.573 . . . . 34.41 110.047 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.45 ' CD ' ' HB3' ' A' ' 224' ' ' HIS . 57.9 mt-10 -62.79 121.84 14.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.064 -0.971 . . . . 32.45 111.277 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.49 130.59 43.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.477 -0.783 . . . . 30.94 110.251 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 233' ' ' SER . 2.9 pp -81.41 -18.67 44.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 30.21 111.845 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 232' ' ' LEU . 8.7 t -108.16 133.69 52.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.9 -0.778 . . . . 27.83 108.9 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 75.31 5.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.814 0.34 . . . . 27.14 110.923 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.5 p 55.45 -172.68 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.282 1.033 . . . . 25.54 112.598 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 7.0 m -98.22 -51.49 3.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.268 0.556 . . . . 23.93 110.34 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.53 161.42 22.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.088 -0.96 . . . . 24.03 109.984 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER 66.13 97.88 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.699 0.624 . . . . 22.83 110.531 -178.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 75.25 175.67 0.23 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.062 -0.972 . . . . 21.0 110.307 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 57.76 50.8 10.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.024 -0.534 . . . . 19.72 111.046 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.41 -56.88 13.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.563 . . . . 17.66 109.996 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.63 97.03 8.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.109 -1.071 . . . . 16.08 108.109 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -101.13 142.04 33.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.049 -0.523 . . . . 14.08 111.089 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.26 -172.5 2.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 13.03 109.705 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.92 134.64 48.61 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.461 0.648 . . . . 12.06 111.439 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 247' ' ' GLY . 8.7 p -106.34 172.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 9.73 110.679 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -126.59 41.54 1.61 Allowed Glycine 0 C--N 1.309 -0.923 0 CA-C-N 114.573 -1.194 . . . . 7.65 111.946 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -172.51 82.45 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.374 -0.602 . . . . 6.51 109.374 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.476 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.6 pm0 -83.59 -135.68 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.222 0.534 . . . . 4.79 111.417 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 m -158.96 -169.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.285 -0.871 . . . . 2.23 110.128 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 16.3 p -105.32 2.4 28.84 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 113.201 0.815 . . . . 1.43 113.201 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 44.33 37.66 4.76 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 124.413 1.071 . . . . 1.61 115.396 170.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.763 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.2 OUTLIER 58.7 14.74 3.31 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 118.327 1.063 . . . . 1.62 112.353 -176.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -84.96 -38.54 19.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.47 110.128 -177.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.755 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.429 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 0.46 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 0.27 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.728 HG13 HD13 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 0.15 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.52 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 0.24 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 0.17 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.599 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 0.69 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.21 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.514 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.7 OUTLIER -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.588 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 3.65 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 2.92 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 0.88 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.52 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 0.34 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 2.49 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.46 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.603 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.08 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.69 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 0.94 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.513 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 0.12 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 0.23 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 1.63 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.495 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 0.36 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 1.45 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.34 113.591 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.508 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 0.58 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 315' ' ' VAL . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 0.47 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 0.22 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.61 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 0.22 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.17 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 0.16 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.44 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 2.82 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 0.67 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.425 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.59 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 2.56 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.18 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.519 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.58 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.721 ' HA ' HG23 ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 0.92 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.11 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 0.1 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 0.13 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 0.13 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.662 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 0.13 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 0.23 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.49 112.273 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.56 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 0.27 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.49 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 258' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 0.65 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.57 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.422 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.661 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.16 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.72 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 1.64 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.07 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.36 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 3.98 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 0.34 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.752 HG21 HD22 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 0.34 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 0.71 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.3 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 0.33 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.661 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.49 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.464 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 2.41 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.841 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.828 ' HB3' HD11 ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 2.45 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.487 ' HG2' HD13 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.07 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.53 HD12 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 0.17 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.534 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 0.29 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.54 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.703 ' HB3' HG13 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.34 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo -31.72 171.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.5 119.075 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -151.6 128.73 11.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 111.862 -2.426 . . . . 2.54 108.707 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 52.3 73.23 0.35 Allowed 'General case' 0 C--N 1.321 -0.671 0 O-C-N 124.206 0.941 . . . . 2.26 113.43 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.4 mm? -79.11 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.958 0.885 . . . . 1.22 110.431 170.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -169.52 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.991 -1.459 . . . . 1.77 108.208 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.305 -1.35 0 CA-C-N 112.954 -1.93 . . . . 2.89 110.174 -177.492 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.033 0.012 . . . . 1.84 111.033 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.75 125.75 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 O-C-N 123.657 0.598 . . . . 1.1 110.945 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.32 117.53 4.3 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 121.867 1.711 . . . . 0.48 110.823 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.761 HD23 HG21 ' A' ' 259' ' ' VAL . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.26 110.539 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.01 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p -108.94 -29.28 8.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.05 110.946 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.647 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 m -70.36 148.68 48.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.948 -1.023 . . . . 2.56 110.746 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.62 108.81 0.35 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.917 -1.273 . . . . 1.85 109.917 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -141.97 164.31 30.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.944 0.402 . . . . 3.21 110.33 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.6 1.5 4.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.579 -0.737 . . . . 5.81 110.849 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -57.07 173.32 0.23 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.567 -1.197 . . . . 5.3 111.999 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.789 . . . . 7.77 110.323 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.923 0.392 . . . . 40.22 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.7 ptp -163.3 35.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 40.04 109.544 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -126.38 120.9 31.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.512 -0.767 . . . . 39.27 110.685 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 55.06 50.25 15.78 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.579 0.55 . . . . 37.29 111.679 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.09 56.28 3.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.835 0.826 . . . . 36.13 109.941 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -113.35 98.22 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.052 -0.976 . . . . 34.41 109.376 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.64 113.51 6.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 32.45 111.543 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.86 76.38 1.62 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.751 -0.659 . . . . 30.94 110.057 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.87 65.4 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.492 . . . . 30.21 109.702 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 m -104.06 -70.91 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.234 -0.439 . . . . 27.83 110.719 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 52.71 1.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.284 0.564 . . . . 27.14 110.077 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.678 ' HB ' ' OE1' ' A' ' 237' ' ' GLU . 7.5 p -81.35 -47.54 13.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.092 -0.958 . . . . 25.54 110.984 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 m 68.88 86.66 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.1 -0.5 . . . . 23.93 111.152 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.678 ' OE1' ' HB ' ' A' ' 235' ' ' THR . 5.3 mp0 -99.89 -22.33 15.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.046 0.927 . . . . 24.03 109.725 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.49 93.54 8.8 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.409 -1.269 . . . . 22.83 110.696 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -66.04 -49.95 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.662 -0.699 . . . . 21.0 109.961 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 56.75 66.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 19.72 111.274 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.72 -15.28 28.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.234 0.54 . . . . 17.66 110.743 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.66 100.3 6.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.882 -0.784 . . . . 16.08 108.882 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -144.03 135.24 25.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.999 -0.546 . . . . 14.08 111.191 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.47 -173.6 4.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.834 -0.621 . . . . 13.03 110.126 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 249' ' ' GLU . 4.2 pt-20 -54.81 122.82 11.59 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.523 0.678 . . . . 12.06 110.929 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.2 p -88.35 155.71 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.003 0.906 . . . . 9.73 112.642 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 70.85 -114.01 5.07 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.136 -1.393 . . . . 7.65 111.26 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -123.68 -11.66 7.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.643 0.258 . . . . 6.51 111.391 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.722 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.8 pm0 -141.11 -113.81 0.13 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.13 -0.693 . . . . 4.79 109.13 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.3 m -155.09 -179.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.11 0.481 . . . . 2.23 111.291 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.3 p -111.3 9.04 21.63 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.149 -0.932 . . . . 1.43 112.856 -170.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.31 -122.2 20.3 Favored Glycine 0 C--N 1.315 -0.631 0 O-C-N 123.853 0.721 . . . . 1.61 111.864 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.861 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.0 m -119.01 16.15 13.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.191 0.996 . . . . 1.62 109.278 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.804 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp -79.68 -44.31 21.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.219 -1.809 . . . . 0.47 109.913 -164.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.503 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 0.46 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 0.27 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.763 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 0.15 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.52 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 0.24 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.614 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 0.17 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.577 ' HB3' HD11 ' B' ' 6' ' ' ILE . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 0.69 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.21 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.489 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.8 OUTLIER -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.647 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 3.65 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 2.92 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 0.88 113.253 168.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.806 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 0.34 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.688 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 2.49 108.373 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.46 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.825 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.08 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 339' ' ' ILE . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.69 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.485 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 0.94 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.518 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 0.12 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 0.23 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.8 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 1.63 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 0.36 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.665 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 1.45 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.34 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 0.58 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.567 HD12 HG22 ' A' ' 315' ' ' VAL . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 0.47 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.665 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 0.22 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.69 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.61 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 0.22 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.17 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 0.16 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.44 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 2.82 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 0.67 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.59 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.488 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 2.56 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.18 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.504 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.58 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.685 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 0.92 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.11 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.642 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 0.1 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.685 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 0.13 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 0.13 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 0.13 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.8 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 0.23 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 312' ' ' VAL . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.49 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.56 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.567 HG22 HD12 ' A' ' 290' ' ' ILE . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 0.27 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.49 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 258' ' ' ILE . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 0.65 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.57 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.726 ' SD ' HG22 ' A' ' 318' ' ' ILE . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.16 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.72 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 1.64 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 328' ' ' THR . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.07 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.36 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 3.98 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 0.34 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.766 HG21 HD22 ' A' ' 324' ' ' LEU . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 0.34 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 0.71 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.698 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.3 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 0.33 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.804 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.49 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 2.41 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.877 ' HB3' HD11 ' A' ' 281' ' ' LEU . 9.9 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.595 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 2.45 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.564 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.07 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 0.17 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.56 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.697 ' HA ' HG23 ' B' ' 6' ' ' ILE . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.54 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.34 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.825 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo -28.18 150.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.5 118.396 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -155.53 110.07 2.92 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.215 -2.266 . . . . 2.54 106.862 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.81 71.66 0.57 Allowed 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.903 0.752 . . . . 2.26 111.641 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.5 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -78.35 -164.71 0.58 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.898 -0.592 . . . . 1.22 109.767 171.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.5 m -66.99 -30.91 71.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.982 0.896 . . . . 1.77 110.752 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.688 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 113.832 -1.531 . . . . 2.89 111.978 -162.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.576 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.443 -0.577 . . . . 1.84 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -111.34 115.97 51.52 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.952 -0.388 . . . . 1.1 109.952 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.79 119.69 6.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.987 2.458 . . . . 0.48 111.307 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 259' ' ' VAL . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.26 111.256 -168.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.01 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.729 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 0.34 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 4.6 p -104.57 -19.48 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.05 111.886 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 8.8 t -70.12 -174.36 0.79 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.507 -0.769 . . . . 2.56 109.806 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.6 85.35 0.32 Allowed Glycine 0 CA--C 1.503 -0.686 0 N-CA-C 111.12 -0.792 . . . . 1.85 111.12 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.77 168.0 27.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.78 -0.71 . . . . 3.21 110.299 -170.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.1 -18.89 60.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 5.81 111.874 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -73.42 49.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.987 -0.551 . . . . 5.3 112.062 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.778 -0.629 . . . . 7.77 111.113 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.798 0.332 . . . . 40.22 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 61.4 ttp -81.56 118.46 22.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.205 -0.452 . . . . 40.04 109.91 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -101.95 124.64 47.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 39.27 110.322 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.86 137.11 57.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.584 . . . . 37.29 111.001 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.2 -54.95 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.918 -0.771 . . . . 36.13 108.918 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -156.83 -59.6 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.551 -0.75 . . . . 34.41 109.506 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.42 107.81 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 32.45 112.639 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.65 80.34 7.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.263 -0.88 . . . . 30.94 109.479 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.23 -48.95 77.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 30.21 110.948 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' A' ' 240' ' ' GLN . 37.7 m -109.97 57.78 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.64 -0.709 . . . . 27.83 111.093 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.07 -30.77 65.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 27.14 109.558 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 236' ' ' THR . 0.2 OUTLIER 59.58 -157.56 0.33 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.066 -0.97 . . . . 25.54 110.98 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 235' ' ' THR . 2.6 m 65.1 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.549 0.74 . . . . 23.93 110.86 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.91 -6.05 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.138 0.494 . . . . 24.03 110.856 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.86 30.15 1.24 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.785 -0.643 . . . . 22.83 110.874 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 60.07 -142.82 0.55 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.101 -0.5 . . . . 21.0 110.829 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 7.3 tp60 67.38 67.46 0.39 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.663 0.602 . . . . 19.72 110.215 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.94 167.64 0.23 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.882 -1.054 . . . . 17.66 112.069 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 54.8 tp -68.48 125.55 26.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 16.08 110.597 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -77.14 126.67 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 14.08 110.702 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.72 -178.58 5.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.428 -0.582 . . . . 13.03 109.428 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -73.03 114.54 11.3 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.268 0.556 . . . . 12.06 110.841 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.7 p -77.38 155.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.158 -0.928 . . . . 9.73 110.962 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 80.64 -55.9 4.72 Favored Glycine 0 C--N 1.309 -0.955 0 CA-C-N 114.679 -1.146 . . . . 7.65 111.586 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.1 p -90.64 55.8 3.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.646 0.736 . . . . 6.51 109.358 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.515 ' HB2' HG22 ' A' ' 250' ' ' VAL . 1.8 pt-20 -99.04 -88.17 0.34 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.226 -0.897 . . . . 4.79 112.696 -173.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.745 ' HB ' HD11 ' A' ' 332' ' ' LEU . 3.2 m -139.4 -160.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.346 -0.843 . . . . 2.23 112.956 -166.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.601 ' H ' HD13 ' A' ' 332' ' ' LEU . 1.8 t 43.85 70.74 0.29 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-O 123.005 1.383 . . . . 1.43 109.973 -171.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -63.18 -137.61 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 111.826 -2.443 . . . . 1.61 114.812 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.885 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 6.4 p -74.25 6.04 3.94 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 122.924 1.345 . . . . 1.62 111.591 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.779 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp -81.76 -45.82 15.09 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 110.901 -2.863 . . . . 0.47 111.413 -167.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.648 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.885 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 0.27 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.725 HG13 HD13 ' B' ' 6' ' ' ILE 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 0.15 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.52 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 0.24 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 0.17 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 0.69 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.21 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.438 ' HG2' HG12 ' A' ' 315' ' ' VAL . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.637 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 3.65 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 2.92 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 0.88 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.52 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 1.001 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 0.34 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.653 ' HA ' ' CD2' ' A' ' 347' ' ' LEU . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 2.49 109.266 175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.46 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' MET . . . . . 1.001 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.08 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.749 ' HB3' ' HG3' ' A' ' 341' ' ' LYS . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.69 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 0.94 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.595 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 0.12 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 0.23 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.707 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 1.63 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.742 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 0.36 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.641 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 1.45 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.34 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 0.58 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 0.47 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.641 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 0.22 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.742 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.61 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.6 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 0.22 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.17 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 0.16 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.44 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 2.82 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG11 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.67 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.59 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 2.56 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.18 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.607 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.58 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 0.92 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.11 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 0.1 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 0.13 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 0.13 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 0.13 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.707 HG11 HD11 ' A' ' 282' ' ' ILE . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 0.23 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.49 112.433 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.56 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 0.27 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.49 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 0.65 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.57 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.596 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.16 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.72 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 1.64 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.846 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.07 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.36 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.417 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 3.98 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.34 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.695 ' HB ' HD13 ' A' ' 324' ' ' LEU . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 0.34 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.743 ' HB2' HD11 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 0.71 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.3 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.745 HD11 ' HB ' ' A' ' 250' ' ' VAL . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 0.33 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.49 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 2.41 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.809 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.672 ' O ' HG12 ' A' ' 282' ' ' ILE . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 2.45 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.07 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 0.17 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.511 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 0.29 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.729 ' HA ' HG23 ' B' ' 6' ' ' ILE . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.54 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.749 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.34 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo -32.19 166.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.5 118.097 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 18.1 mm-40 -152.93 126.13 8.58 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.855 -1.975 . . . . 2.54 108.174 174.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 53.32 76.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.05 0.844 . . . . 2.26 112.969 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.4 OUTLIER -83.53 -83.4 0.14 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.159 0.981 . . . . 1.22 110.216 169.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 347' ' ' LEU . 5.0 t -179.47 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.236 -1.802 . . . . 1.77 108.569 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.653 ' CD2' ' HA ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 111.982 -2.372 . . . . 2.89 111.952 -169.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.564 0.221 . . . . 1.84 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 69.57 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.937 -0.574 . . . . 1.1 111.139 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo -49.11 123.55 10.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.48 111.857 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 259' ' ' VAL . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.26 110.292 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.685 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.01 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 263' ' ' SER . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 0.34 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -109.04 -12.6 14.83 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.05 110.937 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.475 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.8 t -73.11 -174.44 1.55 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.199 -0.909 . . . . 2.56 109.757 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.53 90.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.382 -0.913 . . . . 1.85 112.273 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.93 166.96 31.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.781 -0.822 . . . . 3.21 108.781 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -44.86 -60.23 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.679 0.612 . . . . 5.81 111.379 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 44.3 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.62 1.341 . . . . 5.3 114.62 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.92 -1.036 . . . . 7.77 110.225 178.358 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.643 0.259 . . . . 40.22 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.6 mmm -132.94 -69.47 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.357 -0.383 . . . . 40.04 110.767 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 60.09 99.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.87 0.731 . . . . 39.27 111.409 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.6 73.09 5.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 37.29 110.041 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 228' ' ' LEU . 2.4 pt? -77.74 53.27 1.1 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.521 0.676 . . . . 36.13 111.434 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.72 3.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.744 -0.662 . . . . 34.41 109.952 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.21 108.33 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.613 0.721 . . . . 32.45 110.535 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 231' ' ' LEU . 2.5 pt? -92.8 -8.01 44.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.485 -0.78 . . . . 30.94 110.23 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.0 123.36 47.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 30.21 109.87 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.6 p -70.27 -34.95 73.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.095 -0.502 . . . . 27.83 109.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 34.7 t70 48.43 71.47 0.35 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 124.114 0.884 . . . . 27.14 111.399 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m 72.93 -34.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.778 -0.646 . . . . 25.54 112.304 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 25.8 m -75.37 81.74 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.051 0.453 . . . . 23.93 110.157 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -112.42 -15.79 13.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.166 -0.47 . . . . 24.03 111.284 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 0.2 OUTLIER -64.36 106.13 1.06 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.267 -0.879 . . . . 22.83 110.387 177.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 240' ' ' GLN . 5.1 tp-100 -82.72 169.46 16.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.693 -0.685 . . . . 21.0 109.8 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 239' ' ' GLN . 47.4 mt-30 74.29 129.99 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.746 0.654 . . . . 19.72 111.301 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.58 138.6 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.674 -0.694 . . . . 17.66 111.273 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.22 143.92 31.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 16.08 110.212 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -76.22 159.47 30.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 14.08 110.545 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.05 -164.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.25 0.969 . . . . 13.03 112.642 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 245' ' ' GLU . 2.1 mp0 -51.82 136.68 27.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.791 -0.64 . . . . 12.06 111.774 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.5 p -81.59 156.76 4.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.702 0.763 . . . . 9.73 111.462 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 89.22 -102.67 2.91 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.397 -1.274 . . . . 7.65 111.44 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m 49.13 49.58 19.35 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.945 0.403 . . . . 6.51 111.951 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.518 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 2.3 pt-20 -89.84 -99.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.014 0.911 . . . . 4.79 111.802 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.518 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 14.7 m -141.44 174.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.796 -1.547 . . . . 2.23 111.8 -170.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.449 ' HB ' ' OH ' ' A' ' 333' ' ' TYR . 5.0 p -109.3 19.25 19.61 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.78 -1.555 . . . . 1.43 111.889 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.439 ' HA3' HD12 ' A' ' 254' ' ' LEU . . . 47.84 -124.01 9.8 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.837 -1.074 . . . . 1.61 112.155 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.723 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 4.2 m -120.12 22.64 11.34 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 123.11 1.433 . . . . 1.62 108.62 168.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.644 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER -80.72 -38.44 28.79 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.2 -2.273 . . . . 0.47 111.555 -165.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 0.46 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 0.27 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.634 HG13 HD12 ' B' ' 6' ' ' ILE 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 0.15 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.52 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 0.24 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.568 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 0.17 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.923 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.21 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.651 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 3.65 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 2.92 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 0.88 113.149 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.52 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.826 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 0.34 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.568 ' HD2' HD23 ' A' ' 347' ' ' LEU . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 2.49 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' LEU . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.46 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.826 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.08 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.69 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 0.94 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 0.12 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.869 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 0.23 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 1.63 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 0.36 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.559 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 1.45 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.34 112.839 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 0.58 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 0.47 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.559 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 0.22 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.61 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 0.22 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.17 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 0.16 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.44 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 2.82 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 0.67 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.59 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.596 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 2.56 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.596 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.18 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 278' ' ' VAL . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.58 109.485 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 0.92 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.11 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 0.1 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 0.13 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 0.13 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 0.13 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 0.23 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.49 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.56 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 0.27 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.417 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.49 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.755 HD13 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 0.65 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.57 114.666 -163.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.557 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.16 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.72 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 1.64 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 328' ' ' THR . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.07 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.36 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 3.98 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 0.34 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.72 HG21 HD22 ' A' ' 324' ' ' LEU . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 0.34 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 0.71 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.3 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 0.33 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.49 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 2.41 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.869 ' HB3' HD11 ' A' ' 281' ' ' LEU . 10.7 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.706 ' HB3' HD11 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 2.45 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.07 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 0.17 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.613 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 0.29 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.54 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.685 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.34 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.804 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo -47.3 171.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.5 116.957 -177.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -151.88 112.53 4.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 112.596 -2.093 . . . . 2.54 107.862 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.57 83.57 0.16 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.578 -1.192 . . . . 2.26 113.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.1 mm? -88.42 -166.17 1.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.905 -0.776 . . . . 1.22 108.905 161.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 347' ' ' LEU . 1.9 t -69.33 -43.48 73.6 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.541 1.163 . . . . 1.77 109.534 169.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.636 HD22 ' H ' ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 CA-C-N 112.893 -1.958 . . . . 2.89 112.361 -166.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.847 -0.427 . . . . 1.84 109.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -42.85 115.65 1.77 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.331 1.019 . . . . 1.1 112.277 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo -47.53 119.35 3.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.346 2.697 . . . . 0.48 111.845 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.627 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.26 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' A' ' 341' ' ' LYS . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 263' ' ' SER . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 0.34 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -68.49 -70.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.05 110.454 -173.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.721 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 20.3 m -158.66 165.29 34.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.939 -0.476 . . . . 2.56 111.303 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.53 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -86.65 147.0 21.01 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.246 -0.888 . . . . 1.85 111.585 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -77.12 122.29 24.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.782 0.801 . . . . 3.21 110.657 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -175.41 25.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.678 -1.601 . . . . 5.81 107.471 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -93.82 161.16 14.43 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.115 -1.857 . . . . 5.3 111.727 -167.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.382 -0.827 . . . . 7.77 109.825 177.68 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.561 -0.163 . . . . 40.22 110.561 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 53.2 ttm 56.95 62.52 2.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.185 0.517 . . . . 40.04 111.122 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -145.85 26.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.032 -0.531 . . . . 39.27 110.404 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 68.44 -65.08 0.28 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 37.29 110.651 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.46 137.76 32.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.185 -0.672 . . . . 36.13 109.185 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -139.92 -63.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.775 -0.193 . . . . 34.41 110.616 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.99 106.68 0.04 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.946 0.778 . . . . 32.45 110.868 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.8 tt -132.41 82.99 2.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.738 -0.664 . . . . 30.94 109.544 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.9 tp -149.67 60.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.961 -0.563 . . . . 30.21 109.856 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -63.85 -59.14 4.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.761 -0.654 . . . . 27.83 110.568 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -151.52 -70.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 27.14 110.98 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 p 53.64 122.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.485 1.114 . . . . 25.54 113.419 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.1 m -98.62 84.43 3.15 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.715 . . . . 23.93 109.508 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.88 -16.63 14.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.809 0.814 . . . . 24.03 111.063 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.96 118.65 18.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.344 -1.298 . . . . 22.83 110.454 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 58.95 68.72 0.79 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.841 0.713 . . . . 21.0 111.05 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -67.9 140.37 56.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.949 -0.569 . . . . 19.72 111.254 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.9 118.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.067 0.854 . . . . 17.66 111.74 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.61 118.79 21.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.619 -0.718 . . . . 16.08 110.326 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -80.56 133.0 35.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.648 -0.705 . . . . 14.08 111.197 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.83 -172.37 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 13.03 110.694 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.92 150.4 28.85 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.958 0.725 . . . . 12.06 112.958 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.659 HG23 HG21 ' A' ' 250' ' ' VAL . 14.4 p -104.28 168.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.223 -0.899 . . . . 9.73 110.719 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.505 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 123.19 -67.98 0.48 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.534 -0.757 . . . . 7.65 113.697 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.6 m -62.73 -65.39 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.077 0.465 . . . . 6.51 112.067 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 250' ' ' VAL . 1.4 pt-20 -109.35 -94.65 0.41 Allowed 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 112.792 0.664 . . . . 4.79 112.792 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.659 HG21 HG23 ' A' ' 246' ' ' VAL . 8.2 m 48.53 -171.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 125.152 1.532 . . . . 2.23 114.864 171.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.9 p -65.26 114.32 4.65 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.313 -1.312 . . . . 1.43 110.172 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -76.93 -137.86 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.033 -0.985 . . . . 1.61 110.806 172.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.843 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.6 m -84.32 20.56 1.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.029 0.918 . . . . 1.62 110.291 171.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp -82.9 -40.3 20.37 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 113.507 -1.679 . . . . 0.47 109.466 -168.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.565 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.697 HG13 HD13 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 0.27 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.7 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 0.15 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.52 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 0.24 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 0.17 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.774 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 0.69 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 260' ' ' ASN . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.21 106.57 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.594 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.721 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 3.65 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 2.92 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.88 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.52 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 1.013 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 0.34 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.699 ' HA ' HD23 ' A' ' 347' ' ' LEU . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 2.49 109.102 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.46 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' MET . . . . . 1.013 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.08 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.796 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.69 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 0.94 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 0.12 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 0.23 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 1.63 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 0.36 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 1.45 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.34 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.67 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 0.58 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 315' ' ' VAL . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 0.47 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 0.22 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.61 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 0.22 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.17 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.702 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 0.16 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.44 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 2.82 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 0.67 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.59 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 2.56 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.18 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.889 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' HG23 ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 0.92 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.11 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 0.1 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 306' ' ' SER . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 0.13 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 0.13 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 0.13 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 0.23 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.482 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.49 112.961 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.594 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.56 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 0.27 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.49 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 258' ' ' ILE . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 0.65 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.57 118.885 -175.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.16 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.72 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 1.64 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 328' ' ' THR . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.07 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.36 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 3.98 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 0.34 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.697 HG21 HD22 ' A' ' 324' ' ' LEU . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 0.34 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 0.71 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.3 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 0.33 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.49 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 2.41 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 281' ' ' LEU . 15.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.653 ' H ' HD13 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 2.45 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.412 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.07 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 0.17 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.548 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 0.29 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.54 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.34 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo -38.26 170.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.5 117.259 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -152.19 119.8 6.07 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 112.78 -2.009 . . . . 2.54 107.847 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.6 t70 58.28 71.48 0.58 Allowed 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.734 0.646 . . . . 2.26 112.587 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.8 OUTLIER -79.62 -79.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.144 1.449 . . . . 1.22 108.716 167.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.694 ' HB3' HD13 ' A' ' 347' ' ' LEU . 0.4 OUTLIER -177.3 -44.53 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 111.739 -2.482 . . . . 1.77 106.492 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.796 0 CA-C-N 111.539 -2.573 . . . . 2.89 111.736 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.217 -0.66 . . . . 1.84 109.217 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -113.16 116.09 47.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 121.055 -0.258 . . . . 1.1 110.443 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo -55.67 117.56 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.276 1.984 . . . . 0.48 110.443 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 259' ' ' VAL . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.26 111.11 -169.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.01 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 0.34 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 2.4 p -91.86 -12.44 33.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.05 112.814 -169.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 263' ' ' SER . 42.7 m -132.67 167.19 20.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.085 0.469 . . . . 2.56 111.641 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.12 79.57 0.18 Allowed Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.927 -1.269 . . . . 1.85 109.927 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -160.69 168.9 23.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.785 -0.82 . . . . 3.21 108.785 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -79.34 49.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.008 1.385 . . . . 5.81 110.916 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 8' ' ' SER . 19.9 ptt180 -78.35 -170.29 1.97 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 112.5 -2.136 . . . . 5.3 110.77 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.002 -0.523 . . . . 7.77 110.261 175.861 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.769 -0.456 . . . . 40.22 109.769 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 94.0 mmm -140.71 49.33 1.7 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 40.04 111.008 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 63.42 33.38 13.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.012 -0.54 . . . . 39.27 111.813 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.16 20.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 37.29 110.138 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.99 142.09 56.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.547 -0.751 . . . . 36.13 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -56.77 3.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.68 . . . . 34.41 110.342 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.93 106.29 17.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.923 0.868 . . . . 32.45 111.333 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.42 -28.56 7.17 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.791 -1.095 . . . . 30.94 109.829 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.41 -74.34 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.434 -0.803 . . . . 30.21 111.341 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -82.25 165.77 20.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 27.83 110.636 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -123.23 33.25 5.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 27.14 110.749 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.2 m 59.07 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.664 -0.698 . . . . 25.54 111.298 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.2 m 54.08 52.19 13.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.666 0.746 . . . . 23.93 110.818 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -92.93 -10.31 36.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.479 -0.782 . . . . 24.03 110.905 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 27.2 mmt180 -105.1 43.81 1.08 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.049 -0.978 . . . . 22.83 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -137.5 72.4 1.42 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.263 -0.643 . . . . 21.0 109.263 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -71.28 66.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.754 -0.657 . . . . 19.72 111.332 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.84 -44.5 0.35 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 17.66 109.915 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 63.1 tp -91.5 112.92 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 16.08 109.607 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -63.4 142.38 58.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.049 0.452 . . . . 14.08 111.179 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.68 176.34 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 13.03 110.951 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 140.2 56.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.572 0.701 . . . . 12.06 111.947 -174.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 247' ' ' GLY . 9.9 p -119.14 178.64 2.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.237 -0.892 . . . . 9.73 109.975 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -62.67 125.11 34.53 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.59 -1.004 . . . . 7.65 110.59 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m -66.49 84.5 0.1 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.221 0.452 . . . . 6.51 112.221 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.566 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 1.7 pt-20 -98.39 -80.04 0.46 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.322 0.582 . . . . 4.79 110.555 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.566 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 5.9 m -149.04 -142.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.649 -1.159 . . . . 2.23 110.309 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 30.4 p 50.61 70.02 0.57 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.911 0.862 . . . . 1.43 110.395 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.65 -151.96 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.3 -1.318 . . . . 1.61 112.593 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -51.74 68.79 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.915 -0.756 . . . . 1.62 109.547 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 7.0 mt 16.61 -70.48 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.502 1.921 . . . . 0.47 115.568 157.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.611 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.741 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 0.46 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.844 HG13 HD13 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 0.27 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.638 HG13 HD13 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 0.15 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.52 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 0.24 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.542 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 0.17 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 0.69 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.21 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.488 ' HG2' HG12 ' A' ' 315' ' ' VAL . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.487 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 3.65 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 2.92 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 0.88 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.52 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.999 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 0.34 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.589 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 2.49 108.856 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.46 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.999 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.08 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.738 ' HB3' ' CG ' ' A' ' 341' ' ' LYS . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.69 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 0.94 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.569 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 0.12 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.953 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 0.23 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 1.63 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.706 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 318' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 0.36 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 1.45 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.446 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.34 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.529 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 0.58 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.597 HD12 HG22 ' A' ' 315' ' ' VAL . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 0.47 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 0.22 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.706 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.61 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 0.22 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.17 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 0.16 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.569 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.44 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 2.82 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 0.67 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.59 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 2.56 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.18 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.768 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.58 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.746 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.662 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 0.92 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.11 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 0.1 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 0.13 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 0.13 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 0.13 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.701 HG11 HD11 ' A' ' 282' ' ' ILE . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 0.23 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.49 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.56 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 0.27 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.49 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.844 HD13 HG13 ' A' ' 258' ' ' ILE . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 0.65 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.423 ' HD2' HD11 ' A' ' 261' ' ' LEU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.57 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.666 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.16 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.72 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.407 ' HG3' ' CA ' ' A' ' 320' ' ' GLU . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 1.64 108.671 -178.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.07 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.36 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.446 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 3.98 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 0.34 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.745 HG21 HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 0.34 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 0.71 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.3 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 0.33 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.666 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.49 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 2.41 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.953 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.9 mt-30 -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.553 ' HG2' HG21 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 2.45 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.07 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 0.17 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 0.29 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 277' ' ' SER . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.54 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.738 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.34 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo -28.62 165.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.5 118.937 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 13.5 pt-20 -146.37 125.62 13.02 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.669 -2.06 . . . . 2.54 108.852 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.5 t70 48.73 76.67 0.11 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.655 0.983 . . . . 2.26 113.655 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.6 mm? -85.29 -166.58 1.55 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 -28.19 69.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.943 0.878 . . . . 1.77 112.073 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.589 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.355 -1.293 . . . . 2.89 111.841 -161.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.031 -0.729 . . . . 1.84 109.031 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.87 113.69 16.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 121.244 -0.182 . . . . 1.1 110.593 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.12 117.99 3.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.346 2.031 . . . . 0.48 110.452 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.611 ' HB3' HG21 ' A' ' 259' ' ' VAL . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.26 111.289 -168.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.01 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 0.34 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p -67.26 -65.29 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.05 111.541 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.778 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 69.7 m -156.32 177.62 11.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.224 -0.658 . . . . 2.56 109.224 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -72.09 -150.42 1.03 Allowed Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 119.975 -1.107 . . . . 1.85 111.159 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -73.34 163.46 28.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -41.55 -57.43 2.25 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.132 0.895 . . . . 5.81 112.864 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 48.81 -161.15 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.736 0.779 . . . . 5.3 112.264 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 7.77 109.937 176.528 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.242 0.544 . . . . 40.22 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 23.2 ttt -105.83 -51.69 2.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.077 -0.51 . . . . 40.04 109.667 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -167.69 149.37 5.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.657 -0.868 . . . . 39.27 108.657 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -77.03 80.3 3.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.074 0.464 . . . . 37.29 111.277 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.78 71.47 4.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.965 -0.561 . . . . 36.13 109.808 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 232' ' ' LEU . . . -69.81 86.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 34.41 111.243 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.61 105.77 5.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.544 . . . . 32.45 111.079 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 32.2 tp 47.1 48.79 15.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.595 0.712 . . . . 30.94 110.516 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.404 ' HB3' ' HB1' ' A' ' 229' ' ' ALA . 0.7 OUTLIER -132.0 80.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 30.21 109.76 -174.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 31.9 m -91.17 82.16 5.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.84 -0.618 . . . . 27.83 109.773 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 37.3 t70 65.18 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.142 0.902 . . . . 27.14 110.799 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 73.2 p 55.07 123.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.028 1.122 . . . . 25.54 114.028 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.5 m -86.55 -25.01 25.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.506 -0.77 . . . . 23.93 111.131 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -166.08 107.79 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.432 1.11 . . . . 24.03 108.632 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.709 ' N ' ' HD3' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -105.91 -22.02 13.01 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.22 -1.809 . . . . 22.83 110.494 -167.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 74.5 -101.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.954 -1.021 . . . . 21.0 111.695 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 53.92 -169.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.199 0.312 . . . . 19.72 110.982 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.84 -38.22 62.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 17.66 109.763 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.87 76.65 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.297 -0.865 . . . . 16.08 109.477 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -74.34 164.06 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.347 -0.842 . . . . 14.08 111.494 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.24 -9.7 54.4 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 123.817 1.77 . . . . 13.03 110.059 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.5 146.56 53.83 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 110.173 -3.194 . . . . 12.06 110.082 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.445 HG22 ' OG ' ' A' ' 331' ' ' SER . 0.8 OUTLIER -128.78 177.34 6.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.267 0.556 . . . . 9.73 110.196 -177.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 331' ' ' SER . . . 126.29 -50.45 0.88 Allowed Glycine 0 C--N 1.309 -0.927 0 CA-C-N 115.277 -0.874 . . . . 7.65 113.502 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.2 p -101.04 67.96 1.22 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.492 0.552 . . . . 6.51 112.492 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 250' ' ' VAL . 2.0 tp10 -102.18 -75.05 0.61 Allowed 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.202 0.525 . . . . 4.79 110.099 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.622 ' C ' HG22 ' A' ' 251' ' ' THR . 28.9 m -149.65 -161.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.961 -1.018 . . . . 2.23 111.674 -175.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 250' ' ' VAL . 0.1 OUTLIER 175.44 86.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.165 -1.791 . . . . 1.43 106.165 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -54.75 -147.51 0.01 OUTLIER Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.395 -1.275 . . . . 1.61 113.253 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.873 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 23.7 m -75.99 20.33 0.19 Allowed 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.577 -0.955 . . . . 1.62 111.737 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -88.09 -44.27 11.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.584 -1.644 . . . . 0.47 111.953 -163.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.873 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 0.46 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG12 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 0.27 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.688 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 0.15 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 45.6 t-20 -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.52 107.249 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 0.24 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.642 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 0.17 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.535 ' CA ' ' HA2' ' B' ' 9' ' ' GLY . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 0.69 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.21 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.594 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.778 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 3.65 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 2.92 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 0.88 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.52 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.34 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.601 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 2.49 108.848 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.46 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.671 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.08 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.69 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 305' ' ' ASP . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 0.94 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 0.12 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.946 HD11 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 0.23 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 1.63 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.521 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 0.36 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.608 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 1.45 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.34 112.752 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.638 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 0.58 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 0.47 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.608 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 0.22 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.61 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 0.22 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.17 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.642 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 0.16 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.44 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 2.82 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.435 ' HB3' HG11 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.67 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.59 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 2.56 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.18 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.404 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.58 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.642 ' HB2' HG21 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 0.92 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.11 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 0.1 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 0.13 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 0.13 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 0.13 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 282' ' ' ILE . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 0.23 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.49 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.56 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 0.27 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.49 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.592 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 0.65 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.57 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.704 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.16 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 1.64 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.07 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.36 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 3.98 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 0.34 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 0.34 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 0.71 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.652 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.3 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 0.33 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.704 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.49 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 2.41 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.946 ' HB3' HD11 ' A' ' 281' ' ' LEU . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 2.45 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.474 ' CD ' HD13 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.07 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.514 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 0.29 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.814 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.54 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.595 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.34 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo -32.27 165.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.5 118.492 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -150.63 109.53 3.88 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.282 -2.236 . . . . 2.54 107.632 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.02 88.18 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.699 1.0 . . . . 2.26 113.699 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 347' ' ' LEU . 1.5 mm? -89.19 -166.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 1.22 110.052 166.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 4.8 t -59.58 -37.61 78.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.079 0.942 . . . . 1.77 111.138 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.601 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 113.957 -1.474 . . . . 2.89 112.105 -164.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.805 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.18 -0.674 . . . . 1.84 109.18 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -123.05 108.03 32.66 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.998 -0.281 . . . . 1.1 110.659 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo -50.42 118.44 4.04 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.363 2.042 . . . . 0.48 111.022 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 259' ' ' VAL . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.26 111.023 -167.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.01 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 259' ' ' VAL . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 0.34 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p -94.43 -21.19 19.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.05 110.769 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 8.3 t -69.56 -174.61 0.72 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.32 -0.855 . . . . 2.56 110.413 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 263' ' ' SER . . . 122.48 106.82 1.89 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.196 -0.526 . . . . 1.85 111.828 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' B' ' 12' ' ' ARG . 53.4 t30 -160.7 168.28 25.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.631 -0.877 . . . . 3.21 108.631 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -77.33 45.07 0.45 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.465 1.126 . . . . 5.81 111.109 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' B' ' 10' ' ' ASN . 99.2 mtt180 -57.58 149.73 20.73 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.158 -1.837 . . . . 5.3 110.867 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.327 -0.844 . . . . 7.77 109.834 179.017 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.374 -0.232 . . . . 40.22 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 81.3 mtp 69.48 -77.87 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 124.065 0.853 . . . . 40.04 111.507 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -162.6 118.11 1.86 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.331 -0.395 . . . . 39.27 110.53 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.76 6.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.435 -0.58 . . . . 37.29 109.435 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.45 -95.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.264 -0.174 . . . . 36.13 110.958 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 65.6 -48.2 0.39 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.767 0.827 . . . . 34.41 112.582 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 319' ' ' PRO . 11.0 pt-20 -63.06 114.55 3.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.539 0.685 . . . . 32.45 110.835 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.15 154.3 41.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.862 -1.063 . . . . 30.94 110.896 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.32 60.18 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.461 0.648 . . . . 30.21 111.956 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.5 p -77.55 73.0 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.071 -0.513 . . . . 27.83 110.734 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.26 -20.77 63.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.193 -0.458 . . . . 27.14 111.153 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.7 m -58.01 -32.18 67.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.751 -0.463 . . . . 25.54 109.751 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 323' ' ' GLN . 11.6 m 72.8 -61.42 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 23.93 112.475 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 64.58 116.31 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.422 1.106 . . . . 24.03 111.525 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -132.65 -35.08 1.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.233 -1.349 . . . . 22.83 109.722 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -86.14 158.57 19.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.357 -0.838 . . . . 21.0 109.565 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 58.69 55.05 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.138 0.494 . . . . 19.72 110.822 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.07 -12.8 56.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 17.66 111.473 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 246' ' ' VAL . 3.5 tm? -75.6 -45.55 36.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.914 -0.772 . . . . 16.08 108.914 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 63.8 137.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.397 0.888 . . . . 14.08 113.397 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.16 -166.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.266 1.026 . . . . 13.03 113.015 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.27 151.37 5.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 12.06 112.119 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 242' ' ' LEU . 5.3 p -78.89 153.44 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.654 0.74 . . . . 9.73 111.926 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 143.7 -52.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.236 -1.347 . . . . 7.65 111.936 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.5 m -102.94 96.55 6.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.901 0.381 . . . . 6.51 110.32 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -50.19 134.12 22.81 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.175 0.988 . . . . 4.79 111.783 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.9 m 36.4 -134.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 112.08 -2.327 . . . . 2.23 114.641 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 332' ' ' LEU . 30.5 p 51.58 74.64 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.251 1.024 . . . . 1.43 109.955 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.12 57.16 0.25 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.617 -1.629 . . . . 1.61 114.692 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.676 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.3 OUTLIER 57.16 18.43 4.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.269 1.033 . . . . 1.62 111.083 -177.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.2 OUTLIER -82.22 -37.83 25.44 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.633 -1.621 . . . . 0.47 110.298 -172.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.458 ' OD1' ' HB1' ' B' ' 1' ' ' ALA . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 253' ' ' SER . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 0.46 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.618 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 0.27 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.748 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 0.15 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 50.8 t-20 -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.52 106.959 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 0.24 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.64 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 0.17 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.552 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 0.69 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.21 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.53 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 3.65 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 2.92 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 0.88 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.52 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.34 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.625 ' HD2' HD23 ' A' ' 347' ' ' LEU . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 2.49 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.46 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.681 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.08 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.745 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.69 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 0.94 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 0.12 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.804 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 0.23 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 1.63 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.546 ' CG ' HG12 ' A' ' 290' ' ' ILE . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 0.36 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 1.45 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.34 113.697 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.508 ' H ' HD13 ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 0.58 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 0.47 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.61 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 0.22 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.17 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 0.16 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.44 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 2.82 109.445 174.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 0.67 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.59 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 2.56 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.18 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.426 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.58 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.697 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 0.92 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.11 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 0.1 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 306' ' ' SER . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 0.13 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 0.13 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 0.13 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 315' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 0.23 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.49 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.53 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.56 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 0.27 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.49 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 0.65 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.663 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.57 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.6 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.16 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.72 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 1.64 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.07 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.36 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 3.98 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 0.34 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 0.34 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.524 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 0.71 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.3 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 0.33 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.49 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 2.41 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.804 ' HB3' HD11 ' A' ' 281' ' ' LEU . 10.2 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.805 ' CZ ' ' HB3' ' B' ' 1' ' ' ALA . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 2.45 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.774 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.07 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 0.17 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.577 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 0.29 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 277' ' ' SER . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.54 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.34 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo -35.77 170.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.5 117.308 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -146.34 118.05 8.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.92 -1.945 . . . . 2.54 108.963 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.15 81.74 0.08 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 114.335 1.235 . . . . 2.26 114.335 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.8 mm? -85.85 -167.92 2.03 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.103 -1.443 . . . . 1.22 107.103 160.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.61 ' HB2' HD13 ' A' ' 347' ' ' LEU . 1.9 m -73.16 -38.76 66.09 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.833 1.301 . . . . 1.77 108.84 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.625 HD23 ' HD2' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 112.73 -2.032 . . . . 2.89 111.147 -169.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.47 0.176 . . . . 1.84 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.6 t70 63.13 107.4 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.723 0.639 . . . . 1.1 111.982 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo -51.12 119.81 5.89 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.663 2.242 . . . . 0.48 111.498 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.26 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.01 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 0.34 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 3.2 p -100.09 4.07 44.36 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.05 111.381 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.599 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 6.3 t -126.17 153.03 45.2 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.417 -0.81 . . . . 2.56 110.256 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.84 -129.73 3.21 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.418 -1.473 . . . . 1.85 109.418 165.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -53.78 138.4 35.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.25 0.525 . . . . 3.21 109.789 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.5 -15.15 58.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.449 -0.796 . . . . 5.81 110.894 -172.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 12' ' ' ARG . 40.2 mtt-85 55.09 -160.19 0.18 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.042 -0.981 . . . . 5.3 112.1 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.199 -0.905 . . . . 7.77 110.284 177.914 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.572 0.225 . . . . 40.22 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -159.83 128.91 5.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.276 -0.268 . . . . 40.04 110.276 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 79.04 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.624 -0.262 . . . . 39.27 111.21 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.8 23.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.021 -0.536 . . . . 37.29 112.146 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 20.2 tp -140.06 14.01 2.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.079 0.466 . . . . 36.13 110.213 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 63.71 173.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.211 -0.904 . . . . 34.41 112.745 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -159.01 140.85 13.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.102 -0.954 . . . . 32.45 108.619 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.1 tp 52.26 67.97 0.89 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.517 0.675 . . . . 30.94 110.262 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? -126.37 37.42 4.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 30.21 110.42 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -58.49 -47.44 84.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.629 -0.714 . . . . 27.83 110.365 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.29 54.53 8.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.032 0.92 . . . . 27.14 109.369 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 327' ' ' ALA . 0.2 OUTLIER -74.76 155.25 37.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.983 -1.008 . . . . 25.54 110.681 -174.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 15.1 m 70.84 -42.79 0.54 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.383 0.673 . . . . 23.93 112.019 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.04 -7.72 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 24.03 111.219 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? -51.13 121.03 5.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.438 -0.801 . . . . 22.83 110.979 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.73 -53.16 5.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 21.0 111.24 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -91.97 29.6 1.57 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.171 0.51 . . . . 19.72 112.07 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -163.03 125.42 2.63 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.638 -0.71 . . . . 17.66 110.794 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.1 tp -107.94 -25.77 11.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 16.08 109.816 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.77 128.46 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.28 -0.873 . . . . 14.08 112.235 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.15 -174.18 3.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.124 -0.944 . . . . 13.03 110.41 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.28 129.71 41.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.094 0.473 . . . . 12.06 110.459 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 247' ' ' GLY . 14.4 p -76.63 167.95 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.409 0.623 . . . . 9.73 110.522 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 109.86 -120.97 5.86 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.079 -0.964 . . . . 7.65 111.718 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -86.03 70.79 10.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.343 0.592 . . . . 6.51 110.399 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -92.46 -104.75 0.12 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.738 -0.665 . . . . 4.79 111.128 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.4 m 47.38 -178.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 115.624 1.713 . . . . 2.23 115.624 168.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 8.4 p -83.33 -2.64 56.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.154 -1.385 . . . . 1.43 110.604 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 55.62 -126.01 38.37 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.13 -0.941 . . . . 1.61 112.274 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.786 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -114.08 16.86 18.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.224 1.011 . . . . 1.62 109.259 171.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.661 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 4.6 mp -83.94 -40.12 18.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.208 -1.814 . . . . 0.47 110.242 -165.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.511 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 0.46 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 0.27 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.672 HG21 HD23 ' B' ' 4' ' ' LEU 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 0.15 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.52 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 0.24 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 0.17 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.583 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 0.69 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.21 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.599 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 3.65 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 2.92 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 0.88 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.52 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.987 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 0.34 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.647 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 2.49 109.327 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.46 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.987 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.08 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.69 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 0.94 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 0.12 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.872 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 0.23 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 1.63 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 0.36 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.649 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 1.45 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.34 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.639 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 0.58 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 0.47 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.649 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.61 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 0.22 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.17 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 0.16 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.44 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 2.82 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.67 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.59 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 2.56 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.18 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.58 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.69 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 0.92 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.11 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 0.1 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.69 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 0.13 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 0.13 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.625 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 0.13 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 0.23 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.49 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.56 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 0.27 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.49 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 321' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 0.65 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.57 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.439 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.16 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.72 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 1.64 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.847 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.07 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.36 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 3.98 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 235' ' ' THR . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 0.34 112.415 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.734 ' HB ' HD13 ' A' ' 324' ' ' LEU . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 0.34 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 0.71 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.715 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.3 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 0.33 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.661 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.49 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 2.41 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.872 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.3 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.728 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 2.45 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.07 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 0.17 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 0.29 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.789 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.54 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.34 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo -28.51 166.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.5 119.17 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 10.1 pt-20 -150.03 125.89 10.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.298 -2.228 . . . . 2.54 108.185 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.2 t70 53.53 76.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.097 0.777 . . . . 2.26 113.097 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.4 mm? -87.47 -168.5 2.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.16 -0.473 . . . . 1.22 110.047 167.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.5 t -62.41 -32.15 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.96 0.886 . . . . 1.77 111.349 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.647 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.063 -1.426 . . . . 2.89 112.276 -161.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.985 -0.376 . . . . 1.84 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 3' ' ' PRO . 30.1 t70 -65.22 130.35 94.74 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.273 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 2' ' ' ASP . 48.7 Cg_exo -54.32 127.96 28.02 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.813 2.342 . . . . 0.48 111.855 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.779 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.26 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 341' ' ' LYS . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.01 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -63.81 -70.12 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.05 111.356 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.741 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 95.8 p -159.87 163.45 34.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.425 0.631 . . . . 2.56 112.152 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.571 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -89.98 118.95 5.4 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 114.818 -1.083 . . . . 1.85 111.527 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.97 167.68 24.12 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.131 -1.063 . . . . 3.21 108.131 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.26 3.45 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.584 0.707 . . . . 5.81 110.311 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -47.98 135.84 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.763 -1.108 . . . . 5.3 110.833 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.546 -0.74 . . . . 7.77 110.94 -178.391 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 119.676 -0.202 . . . . 40.22 110.737 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.7 ptm 43.83 43.93 5.42 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.767 0.667 . . . . 40.04 111.025 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.68 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.052 -0.976 . . . . 39.27 111.255 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -119.06 97.29 5.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.357 -0.383 . . . . 37.29 110.967 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.11 -27.21 68.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 36.13 109.678 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.85 152.05 48.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.157 -0.929 . . . . 34.41 109.258 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -158.27 109.24 2.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.888 0.375 . . . . 32.45 111.178 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.546 ' HG ' ' H ' ' A' ' 232' ' ' LEU . 19.2 tp 59.24 172.11 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.58 -0.736 . . . . 30.94 112.399 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.546 ' H ' ' HG ' ' A' ' 231' ' ' LEU . 2.5 tt 58.07 76.6 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.926 -0.768 . . . . 30.21 108.926 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 m 57.61 55.1 5.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.681 -0.691 . . . . 27.83 109.772 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.59 -48.68 69.02 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.103 -0.953 . . . . 27.14 111.145 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.12 127.68 17.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.626 -0.716 . . . . 25.54 110.99 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.7 m -161.69 -62.33 0.05 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.366 -0.834 . . . . 23.93 109.517 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -103.34 -40.44 6.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.623 0.725 . . . . 24.03 110.305 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.53 88.26 6.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.62 -1.173 . . . . 22.83 110.084 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.71 -42.71 4.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 21.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -67.54 143.69 56.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.762 -0.654 . . . . 19.72 110.944 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 72.38 -14.98 0.51 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.831 0.707 . . . . 17.66 112.257 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 62.3 tp -103.06 -69.29 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.433 . . . . 16.08 110.422 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.92 174.97 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.814 -0.63 . . . . 14.08 110.746 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.7 -164.1 0.8 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.135 -0.484 . . . . 13.03 110.838 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -50.33 155.19 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.476 -0.784 . . . . 12.06 112.185 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 247' ' ' GLY . 12.2 p -64.38 160.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.751 0.786 . . . . 9.73 111.183 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.49 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 101.76 22.34 10.31 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.704 -1.135 . . . . 7.65 111.504 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -84.96 88.62 7.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 6.51 109.774 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 249' ' ' GLU . 0.0 OUTLIER -64.58 -61.52 2.16 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.142 0.972 . . . . 4.79 111.819 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 332' ' ' LEU . 14.9 m -147.53 -144.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 113.694 -1.594 . . . . 2.23 110.724 -165.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.0 p 68.72 -23.04 0.14 Allowed 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 124.226 1.01 . . . . 1.43 112.549 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.22 21.96 41.79 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-O 119.43 -0.65 . . . . 1.61 114.669 168.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.6 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 67.08 15.96 10.2 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.153 0.978 . . . . 1.62 110.515 -176.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.687 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 0.6 OUTLIER -80.58 -31.34 36.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.774 -1.557 . . . . 0.47 108.36 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.573 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 0.46 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 0.27 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' B' ' 4' ' ' LEU 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 0.15 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.52 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 0.24 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 0.17 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.758 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 0.69 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.21 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.571 ' OE1' HG12 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.741 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 3.65 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 2.92 110.572 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.482 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 0.88 113.71 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.52 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.925 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 0.34 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.479 ' CD ' ' HA ' ' A' ' 347' ' ' LEU . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 2.49 110.46 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.46 112.21 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.925 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.08 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.69 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 0.94 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 297' ' ' ARG . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 282' ' ' ILE . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 0.12 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 0.23 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.771 HD11 HG11 ' A' ' 312' ' ' VAL . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 1.63 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.717 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 0.36 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 1.45 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.34 112.437 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 0.58 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 315' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 0.47 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.721 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 0.22 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.717 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.61 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 0.22 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.17 110.257 175.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 0.16 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.44 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 2.82 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 0.67 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.59 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 2.56 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.18 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.593 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.58 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.691 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.668 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 0.92 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.11 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 0.1 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.668 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 0.13 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 0.13 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 0.13 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.771 HG11 HD11 ' A' ' 282' ' ' ILE . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 0.23 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.49 112.901 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.56 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 0.27 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.49 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 258' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 0.65 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 318' ' ' ILE . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.57 116.142 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.16 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.72 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 1.64 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.07 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.36 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 3.98 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 0.34 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.706 HG21 HD22 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 0.34 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 0.71 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.678 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.3 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 0.33 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.687 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 2.41 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.979 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 2.45 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.07 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 0.29 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.54 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.566 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.34 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo -34.94 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.5 117.444 177.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -143.26 105.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.148 -1.842 . . . . 2.54 107.558 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.9 90.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.825 -1.08 . . . . 2.26 113.407 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 342' ' ' PRO . 2.8 mm? -90.06 -95.1 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.403 1.097 . . . . 1.22 108.316 166.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 5.1 t -177.11 -47.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 104.567 -2.383 . . . . 1.77 104.567 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.605 HD13 ' OXT' ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 CA-C-N 110.577 -3.011 . . . . 2.89 107.002 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.077 -0.342 . . . . 1.84 110.077 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.09 128.37 90.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.202 -0.454 . . . . 1.1 111.402 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.464 ' HG3' ' HE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo -50.34 119.26 4.81 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.905 2.403 . . . . 0.48 110.65 176.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 259' ' ' VAL . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.26 110.83 -173.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.01 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.739 HD13 HG13 ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 0.34 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 10.8 p -103.45 -14.29 16.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.05 110.952 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.558 ' HB2' ' CB ' ' A' ' 263' ' ' SER . 18.0 m -71.53 -174.81 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.322 -0.854 . . . . 2.56 110.259 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.74 87.42 0.14 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.556 -0.83 . . . . 1.85 112.165 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.3 151.55 39.53 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.825 . . . . 3.21 108.774 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.37 9.32 4.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.397 0.617 . . . . 5.81 111.362 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -56.43 152.85 10.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.263 -0.881 . . . . 5.3 110.584 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.172 -0.467 . . . . 7.77 111.28 -177.296 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.769 -0.456 . . . . 40.22 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.5 mmt 54.8 53.36 10.6 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.929 -0.578 . . . . 40.04 110.039 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 66.83 -67.04 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.113 -0.948 . . . . 39.27 110.681 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -163.24 127.58 2.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.751 -0.659 . . . . 37.29 109.435 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.46 -42.84 82.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 36.13 109.742 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -84.39 98.91 10.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.841 -0.618 . . . . 34.41 109.982 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.48 119.23 24.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.582 -0.735 . . . . 32.45 110.777 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.7 143.59 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.981 -0.554 . . . . 30.94 109.692 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? -128.78 146.74 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.657 -0.497 . . . . 30.21 109.657 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 m -141.26 65.59 1.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.083 0.468 . . . . 27.83 110.01 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -81.01 33.84 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.555 0.693 . . . . 27.14 110.986 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 t -86.2 -170.84 3.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.36 -0.837 . . . . 25.54 110.151 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 m -83.46 70.41 10.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.879 -1.055 . . . . 23.93 110.412 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.1 23.34 2.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.01 0.91 . . . . 24.03 109.746 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -77.67 -51.5 10.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.398 -0.819 . . . . 22.83 109.607 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.35 -65.19 0.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.595 -0.73 . . . . 21.0 109.722 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 54.56 54.63 9.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.834 -0.621 . . . . 19.72 110.173 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -167.52 126.07 1.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.298 -0.865 . . . . 17.66 110.428 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.6 tp -80.98 64.97 5.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.515 0.674 . . . . 16.08 109.763 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -145.38 147.47 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.449 -0.796 . . . . 14.08 110.416 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.33 -176.94 4.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.714 -0.476 . . . . 13.03 109.714 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 245' ' ' GLU . 7.0 pt-20 -68.83 130.33 42.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.121 0.486 . . . . 12.06 111.248 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.688 HG22 ' H ' ' A' ' 247' ' ' GLY . 7.1 p -112.68 174.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.739 -0.664 . . . . 9.73 110.556 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 246' ' ' VAL . . . 115.45 142.04 7.56 Favored Glycine 0 C--N 1.31 -0.902 0 CA-C-N 114.999 -1.0 . . . . 7.65 111.835 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.1 p -67.56 -53.52 27.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.485 0.66 . . . . 6.51 110.597 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.74 -89.37 0.13 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.476 -0.784 . . . . 4.79 110.988 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 332' ' ' LEU . 9.2 m -143.74 -149.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.045 -0.979 . . . . 2.23 111.086 -170.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.3 p 73.09 -23.44 0.21 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.002 0.921 . . . . 1.43 112.975 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.36 27.22 24.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 115.907 1.123 . . . . 1.61 115.907 166.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 66.37 13.76 9.37 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.319 1.059 . . . . 1.62 111.325 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -82.84 -33.69 27.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.199 -1.364 . . . . 0.47 108.75 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.687 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 0.46 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.998 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 0.27 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.739 HG13 HD13 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 0.15 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 50.2 t-20 -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.52 107.004 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 0.24 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.643 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 0.17 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' B' ' 8' ' ' SER . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 0.69 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.21 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.602 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.644 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 3.65 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 2.92 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 0.88 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.52 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 1.002 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 0.34 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.438 ' O ' HD23 ' A' ' 345' ' ' LEU . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 2.49 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.808 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.46 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' MET . . . . . 1.002 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.08 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.793 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.69 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 0.94 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.551 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.659 HG12 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 0.12 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 0.23 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 1.63 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.527 ' CG ' HG12 ' A' ' 290' ' ' ILE . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 0.36 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.683 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 1.45 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.34 112.974 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.594 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 0.58 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 315' ' ' VAL . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 0.47 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.683 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 0.22 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.61 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 0.22 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.17 110.695 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 0.16 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.44 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 2.82 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 0.67 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.59 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 2.56 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.18 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.644 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.58 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.695 ' HA ' HG23 ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 0.92 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.11 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.626 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 0.1 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.695 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 0.13 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 0.13 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 0.13 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 0.23 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.49 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.56 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 0.27 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.49 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.998 HD13 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 0.65 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.57 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.402 ' OE2' HD11 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.633 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.16 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.72 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 1.64 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 328' ' ' THR . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.07 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.36 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 3.98 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 0.34 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 324' ' ' LEU . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 0.34 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 0.71 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.682 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.688 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.3 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 0.33 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.633 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.49 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.682 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 2.41 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.792 ' HB3' HD11 ' A' ' 281' ' ' LEU . 3.6 mt-30 -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.761 ' HB3' HD11 ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 2.45 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.464 ' HE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.07 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 0.17 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 0.29 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.54 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.569 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.34 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo -33.85 172.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.5 117.914 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 9.3 pt-20 -138.13 122.34 18.1 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 112.551 -2.113 . . . . 2.54 108.506 174.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.808 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 4.5 p-10 39.71 83.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.125 1.528 . . . . 2.26 115.125 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.3 mm? -84.23 -174.91 5.54 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.543 -0.54 . . . . 1.22 109.543 164.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.7 t -75.16 -30.67 60.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.018 0.913 . . . . 1.77 109.664 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.495 ' C ' HD22 ' A' ' 274' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.192 -1.367 . . . . 2.89 110.975 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' HD22 ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.451 ' C ' HH22 ' A' ' 336' ' ' ARG . 29.8 t70 -132.9 111.92 13.42 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.986 -0.375 . . . . 1.1 109.986 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.84 119.18 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.805 3.003 . . . . 0.48 112.087 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.26 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.47 ' N ' HD13 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.01 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 0.34 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -93.24 -22.61 18.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.05 110.813 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.434 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 11.2 t -66.33 -176.18 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.223 -0.899 . . . . 2.56 109.625 174.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.534 ' HA3' ' CE3' ' A' ' 266' ' ' TRP . . . 122.42 86.52 0.82 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.11 -1.043 . . . . 1.85 112.288 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -159.49 155.88 27.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.172 0.511 . . . . 3.21 110.219 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.9 -19.37 65.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.795 -1.093 . . . . 5.81 111.584 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 47.31 98.05 0.01 OUTLIER 'General case' 0 C--O 1.237 0.397 0 N-CA-C 114.455 1.279 . . . . 5.3 114.455 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.559 -1.2 . . . . 7.77 110.405 -179.785 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.374 -0.602 . . . . 40.22 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.0 mmt -120.14 26.45 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.538 . . . . 40.04 111.727 -171.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -85.73 -19.83 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 39.27 110.572 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.95 60.49 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.674 0.749 . . . . 37.29 109.898 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.36 132.66 34.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.05 -0.977 . . . . 36.13 109.371 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.73 -63.84 1.36 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.483 -0.326 . . . . 34.41 110.932 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 68.61 116.96 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.945 0.778 . . . . 32.45 110.179 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.75 74.62 7.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.561 -0.745 . . . . 30.94 111.838 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.62 97.69 9.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 30.21 109.606 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 m -44.16 -64.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.004 -0.998 . . . . 27.83 113.197 -170.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -132.82 -77.71 0.49 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.876 -0.33 . . . . 27.14 110.969 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.6 m -71.84 -65.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.773 -0.455 . . . . 25.54 109.773 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.3 m -154.56 -70.68 0.13 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.719 -0.474 . . . . 23.93 109.719 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 50.14 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.511 1.624 . . . . 24.03 112.536 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -112.59 45.99 1.25 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.395 -2.184 . . . . 22.83 108.703 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -73.92 -49.81 23.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.014 -0.994 . . . . 21.0 110.112 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 249' ' ' GLU . 54.9 tt0 -71.18 97.76 1.58 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.282 -0.417 . . . . 19.72 110.724 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -94.47 124.29 38.41 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.163 -0.471 . . . . 17.66 110.172 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 55.0 tp -83.55 99.16 9.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.958 0.409 . . . . 16.08 110.446 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -137.49 174.04 11.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 14.08 110.636 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 43.73 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.348 1.03 . . . . 13.03 112.448 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.08 160.57 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.723 -0.671 . . . . 12.06 111.96 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 247' ' ' GLY . 12.5 p -61.57 160.59 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.51 0.672 . . . . 9.73 110.717 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 82.66 62.91 1.81 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 114.79 -1.095 . . . . 7.65 111.583 -173.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.8 t -126.0 82.36 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.165 0.507 . . . . 6.51 110.558 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.744 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.5 pm0 -110.16 -112.35 0.32 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.019 -0.537 . . . . 4.79 110.582 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.448 ' H ' ' CG ' ' A' ' 249' ' ' GLU . 3.4 m -149.77 -171.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.92 0.867 . . . . 2.23 112.31 -170.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' B' ' 1' ' ' ALA . 1.5 p -135.43 86.97 2.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.588 -1.642 . . . . 1.43 107.327 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.15 -158.78 0.01 OUTLIER Glycine 0 C--N 1.317 -0.486 0 CA-C-N 113.183 -1.826 . . . . 1.61 113.478 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.472 ' C ' ' HG ' ' A' ' 257' ' ' LEU . 32.6 p -45.52 -60.4 2.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.54 -0.911 . . . . 1.62 108.54 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 8.3 mt 11.76 -68.9 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.179 -1.828 . . . . 0.47 114.463 156.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 336' ' ' ARG . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 0.46 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 318' ' ' ILE . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 0.27 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.689 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 0.15 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.52 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 0.24 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 0.17 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' HD11 ' B' ' 6' ' ' ILE . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 0.69 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.21 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 3.65 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 2.92 110.738 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 0.88 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.52 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.984 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.34 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.555 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.2 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.46 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.984 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.08 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.69 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 0.94 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.525 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 0.23 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.755 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 318' ' ' ILE . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 0.36 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.628 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 1.45 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.34 112.598 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.525 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 0.58 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 0.47 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.628 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 0.22 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.671 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.61 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 0.22 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.17 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.44 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 2.82 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 0.67 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.59 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 2.56 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.18 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.738 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.58 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.715 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 0.92 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.11 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.61 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 0.1 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.715 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 0.13 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 0.13 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 0.13 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 0.23 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.49 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.56 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 0.27 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.49 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 0.65 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.57 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.16 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.72 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 1.64 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 328' ' ' THR . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.07 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.36 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 3.98 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 0.34 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.77 HG21 HD22 ' A' ' 324' ' ' LEU . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 0.34 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 0.71 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.707 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.3 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.707 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 0.33 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.577 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.49 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.531 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 2.41 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.832 ' HB3' HD11 ' A' ' 281' ' ' LEU . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.755 ' H ' HD13 ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 2.45 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.07 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 0.17 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.551 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 0.29 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.54 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.621 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.34 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo -35.84 177.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.5 118.032 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -155.41 122.9 5.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.73 -2.486 . . . . 2.54 107.138 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 60.71 77.35 0.33 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.04 0.837 . . . . 2.26 112.641 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.3 mm? -83.42 -167.67 1.79 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 1.22 110.001 167.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 32.5 t -61.31 -53.76 52.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.989 0.899 . . . . 1.77 111.818 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.555 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 113.527 -1.669 . . . . 2.89 111.455 -165.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.459 ' HB1' ' OG1' ' A' ' 251' ' ' THR . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.929 -0.397 . . . . 1.84 109.929 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -174.08 102.19 0.29 Allowed Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.441 -0.948 . . . . 1.1 108.441 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.79 118.33 2.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.708 2.272 . . . . 0.48 112.032 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.669 ' HB2' HG21 ' A' ' 259' ' ' VAL . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.26 111.374 -172.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.01 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.687 HD13 HG13 ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 0.34 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p -102.89 -13.35 16.98 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.882 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.6 t -76.03 -173.06 2.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.026 -0.988 . . . . 2.56 109.778 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.06 80.83 0.11 Allowed Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.759 -0.936 . . . . 1.85 110.759 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.402 ' HB3' ' HG2' ' B' ' 12' ' ' ARG . 58.9 t30 -145.35 157.28 44.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.699 -0.482 . . . . 3.21 109.699 -173.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.94 2.16 15.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.329 0.585 . . . . 5.81 110.882 -176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.402 ' HG2' ' HB3' ' B' ' 10' ' ' ASN . 22.0 ptt180 -57.38 145.58 32.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.128 -0.942 . . . . 5.3 111.161 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.595 -0.717 . . . . 7.77 110.027 176.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.846 0.355 . . . . 40.22 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.44 -41.08 9.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.023 0.439 . . . . 40.04 110.504 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -81.92 -51.29 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 39.27 110.248 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -104.73 118.46 36.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 37.29 109.515 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.95 136.91 41.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.498 -0.319 . . . . 36.13 111.495 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 56.96 -173.55 0.07 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.169 0.918 . . . . 34.41 112.563 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -77.8 -161.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.101 -0.954 . . . . 32.45 108.967 168.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.37 -66.63 0.9 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.844 -0.799 . . . . 30.94 108.844 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 96.4 mt 50.23 52.16 15.29 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.662 0.601 . . . . 30.21 111.951 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.9 t -128.44 89.91 2.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.941 -0.572 . . . . 27.83 109.788 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.7 94.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.218 0.532 . . . . 27.14 110.014 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m -91.8 -15.83 27.68 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 25.54 110.591 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 238' ' ' ARG . 19.8 m -67.01 -40.24 87.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.601 . . . . 23.93 111.701 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 64.22 9.05 4.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.437 0.695 . . . . 24.03 111.977 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 241' ' ' ALA . 16.6 tpt180 -116.45 82.27 1.76 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.616 -0.512 . . . . 22.83 109.616 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -71.82 -68.41 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.113 -0.494 . . . . 21.0 110.104 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -159.02 103.04 1.66 Allowed 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.7 -0.682 . . . . 19.72 110.726 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 238' ' ' ARG . . . -117.79 -9.01 10.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 17.66 110.283 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.95 130.22 42.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.469 -0.787 . . . . 16.08 110.35 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -103.9 163.46 12.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.3 -0.409 . . . . 14.08 111.115 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.32 170.01 10.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.844 -0.616 . . . . 13.03 110.332 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.71 138.57 42.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.973 -0.558 . . . . 12.06 111.273 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 247' ' ' GLY . 8.2 p -104.27 175.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 9.73 110.0 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 246' ' ' VAL . . . 116.29 -2.52 20.58 Favored Glycine 0 C--N 1.311 -0.847 0 CA-C-N 115.46 -0.791 . . . . 7.65 111.885 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t 60.21 48.98 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.355 0.598 . . . . 6.51 111.115 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 250' ' ' VAL . 3.9 mm-40 -87.62 -102.53 0.08 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.843 0.83 . . . . 4.79 112.413 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 249' ' ' GLU . 1.0 OUTLIER -151.25 -157.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.163 -1.38 . . . . 2.23 110.074 -166.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.555 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 1.1 t 42.85 67.08 0.67 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.728 1.251 . . . . 1.43 110.233 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -59.59 -154.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 112.432 -2.167 . . . . 1.61 113.225 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.799 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.7 m -73.18 24.07 0.06 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.944 0.878 . . . . 1.62 111.658 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp -83.12 -45.88 13.43 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.704 -1.589 . . . . 0.47 110.065 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 0.46 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 0.27 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.687 HG13 HD13 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 0.15 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.52 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 0.24 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 0.69 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.21 106.274 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.547 ' CG ' HG12 ' A' ' 315' ' ' VAL . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.645 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 3.65 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 2.92 109.716 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 0.88 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.52 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.878 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 0.34 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 347' ' ' LEU . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 2.49 107.527 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 342' ' ' PRO . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.46 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.878 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.08 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.69 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 0.94 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 0.12 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 0.23 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.747 HD11 HG11 ' A' ' 312' ' ' VAL . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 1.63 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.482 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 0.36 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 1.45 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.693 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.34 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 0.58 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.502 HD12 HG22 ' A' ' 315' ' ' VAL . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 0.47 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 0.22 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.61 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 0.22 109.655 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.17 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 0.16 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.44 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 2.82 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 0.67 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.59 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 2.56 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.18 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.594 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.58 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.675 ' HA ' HG21 ' A' ' 278' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 0.92 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.11 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.668 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 0.1 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 306' ' ' SER . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 0.13 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 0.13 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 0.13 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 282' ' ' ILE . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 0.23 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.542 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.49 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.56 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 0.27 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.49 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 0.65 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.57 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.651 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.16 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.72 112.801 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 1.64 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.07 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.36 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 3.98 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 0.34 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 0.34 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 0.71 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.689 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.3 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 0.33 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.651 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.49 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 2.41 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.797 ' HB3' HD11 ' A' ' 281' ' ' LEU . 5.3 mt-30 -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.87 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 2.45 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.542 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.07 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 0.17 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.508 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 0.29 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.54 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.34 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 32.1 Cg_exo -27.46 160.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.5 117.546 172.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -145.41 104.7 3.95 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 112.549 -2.114 . . . . 2.54 106.936 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.62 89.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.938 0.774 . . . . 2.26 112.444 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.3 OUTLIER -82.53 -178.95 7.26 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.733 169.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.3 t -71.67 -35.22 70.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.392 1.092 . . . . 1.77 109.075 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 273' ' ' ARG . 6.6 mp . . . . . 0 C--N 1.305 -1.366 0 CA-C-N 113.272 -1.785 . . . . 2.89 110.689 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.44 -0.578 . . . . 1.84 109.44 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -95.13 119.58 65.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.174 -0.306 . . . . 1.1 110.174 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.68 128.63 26.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.126 2.55 . . . . 0.48 111.883 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 259' ' ' VAL . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.26 110.72 -172.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.01 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.656 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 0.34 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p -67.85 -59.68 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.05 111.33 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.652 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 75.1 m -153.52 -176.76 5.96 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.143 -0.348 . . . . 2.56 110.682 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.491 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -79.22 -138.05 1.52 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.635 -0.793 . . . . 1.85 112.549 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.45 158.51 29.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.312 -0.255 . . . . 3.21 110.312 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.37 -52.38 37.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.625 0.578 . . . . 5.81 111.417 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 52.02 108.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.397 1.258 . . . . 5.3 114.397 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.282 -1.327 . . . . 7.77 109.694 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.786 0.327 . . . . 40.22 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 98.0 mmm -120.0 91.42 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 40.04 110.249 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -130.6 -62.16 0.93 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 39.27 110.128 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.572 -0.74 . . . . 37.29 111.797 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tt -115.32 -50.57 2.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.771 -0.826 . . . . 36.13 108.771 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.7 -23.92 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.45 -0.795 . . . . 34.41 110.611 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 232' ' ' LEU . 1.5 pm0 -69.09 107.96 3.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.021 -0.536 . . . . 32.45 110.966 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 231' ' ' LEU . 1.6 tm? 65.32 -9.68 0.21 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.811 0.845 . . . . 30.94 112.127 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 230' ' ' GLU . 39.0 tp -79.61 62.23 3.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.71 0.767 . . . . 30.21 110.538 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.3 t -159.43 -76.36 0.07 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.143 -0.935 . . . . 27.83 109.044 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.7 t70 51.38 52.52 14.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.81 0.814 . . . . 27.14 110.008 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.1 p -122.47 159.01 28.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.111 -0.949 . . . . 25.54 110.688 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.7 m 61.14 86.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.582 0.552 . . . . 23.93 111.548 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -69.13 -26.42 64.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.797 0.808 . . . . 24.03 110.521 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.667 ' HD3' ' O ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -59.2 -38.09 79.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.159 -1.382 . . . . 22.83 109.751 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -129.36 67.64 1.43 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 21.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -77.22 89.66 3.68 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.58 -0.736 . . . . 19.72 110.185 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 63.29 -94.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 17.66 111.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' LEU . 1.6 tm? -123.56 8.34 8.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.623 0.725 . . . . 16.08 109.727 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.36 127.77 33.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.491 -0.777 . . . . 14.08 112.374 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.9 p30 43.65 -164.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.636 1.21 . . . . 13.03 114.049 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.448 ' HG3' HH22 ' A' ' 238' ' ' ARG . 5.6 pt-20 -49.71 128.06 17.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.825 -1.08 . . . . 12.06 111.76 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 247' ' ' GLY . 14.9 p -86.89 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.765 . . . . 9.73 110.766 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.508 ' N ' HG22 ' A' ' 246' ' ' VAL . . . -124.26 42.44 1.56 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.992 -1.003 . . . . 7.65 112.365 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.7 p -88.17 80.49 7.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.776 0.322 . . . . 6.51 110.865 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 250' ' ' VAL . 41.0 mm-40 -65.88 -77.25 0.07 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.22 1.01 . . . . 4.79 111.783 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 251' ' ' THR . 5.1 m -153.36 -162.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.969 -1.923 . . . . 2.23 110.562 -165.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 250' ' ' VAL . 4.7 p 68.54 -4.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.38 1.072 . . . . 1.43 112.598 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 46.61 -111.27 0.66 Allowed Glycine 0 C--N 1.32 -0.306 0 C-N-CA 121.09 -0.576 . . . . 1.61 112.418 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.668 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.8 m -135.18 24.08 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 123.033 1.397 . . . . 1.62 108.856 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.8 mp -83.71 -42.82 16.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 112.362 -2.199 . . . . 0.47 111.899 -166.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 0.46 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.644 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 0.27 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.655 HG13 HD13 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 0.15 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 45.2 t-20 -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.52 107.251 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 0.24 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.637 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 0.17 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.523 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 0.69 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.21 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.575 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.652 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 3.65 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 2.92 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 0.88 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.52 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 0.34 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.485 ' NH1' ' HB3' ' A' ' 347' ' ' LEU . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.559 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.46 111.523 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.641 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.08 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.818 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.69 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 0.94 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 0.23 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 1.63 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 0.36 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 1.45 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.676 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.34 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.443 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.543 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 0.58 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 313' ' ' ARG . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 0.47 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.65 ' CG2' HD12 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 0.22 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.61 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.17 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 0.16 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.44 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.432 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 2.82 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 0.67 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.59 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.494 ' CB ' ' HE1' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.794 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 2.56 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.18 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.58 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.794 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 0.92 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.11 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.719 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 0.1 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 0.13 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 0.13 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 0.13 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.741 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 0.23 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.49 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.56 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 0.27 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.49 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 0.65 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.57 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.608 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.16 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.72 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 1.64 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.845 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.07 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.36 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 3.98 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 0.34 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.706 ' HB ' HD13 ' A' ' 324' ' ' LEU . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 0.34 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 0.71 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.712 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.3 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 0.33 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.49 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 2.41 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.879 ' HB3' HD11 ' A' ' 281' ' ' LEU . 16.4 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.815 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 2.45 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.582 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.07 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.648 HD12 HG21 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 0.17 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.561 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.29 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.818 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.54 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.581 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.34 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo -36.01 172.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.5 117.275 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -144.57 106.9 4.36 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.086 -1.87 . . . . 2.54 108.551 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 52.62 84.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.194 -0.912 . . . . 2.26 112.226 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.4 OUTLIER -71.99 177.38 4.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.323 0.582 . . . . 1.22 111.889 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.9 t -64.67 -40.88 96.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 123.017 1.389 . . . . 1.77 108.676 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.485 ' HB3' ' NH1' ' A' ' 273' ' ' ARG . 8.5 mp . . . . . 0 C--N 1.304 -1.397 0 CA-C-N 112.105 -2.316 . . . . 2.89 110.767 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.069 -0.345 . . . . 1.84 110.069 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.07 121.13 59.91 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.116 -0.493 . . . . 1.1 110.893 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo -57.2 121.6 10.34 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.681 2.254 . . . . 0.48 111.676 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 259' ' ' VAL . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.26 111.136 -171.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.01 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.736 HG23 ' HA ' ' A' ' 340' ' ' PHE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 0.34 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p -60.87 -67.19 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.803 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.66 ' HB3' ' NH2' ' A' ' 268' ' ' ARG . 68.1 p -155.44 -178.0 6.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.556 -0.293 . . . . 2.56 110.952 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.456 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -83.67 -174.06 50.13 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.047 -0.596 . . . . 1.85 112.402 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' B' ' 11' ' ' ASP . 64.5 t30 -124.5 170.03 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.953 -0.758 . . . . 3.21 108.953 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' B' ' 10' ' ' ASN . 27.7 t70 72.39 -3.84 2.2 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-O 122.268 1.033 . . . . 5.81 110.245 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' B' ' 10' ' ' ASN . 47.6 mtm105 -54.85 140.43 36.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.728 -1.578 . . . . 5.3 111.735 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.514 -0.755 . . . . 7.77 110.009 178.205 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 28.8 p80 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.376 -0.231 . . . . 40.22 110.376 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 61.98 20.94 11.96 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.502 0.501 . . . . 40.04 112.123 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -130.13 70.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 39.27 110.834 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.91 150.9 40.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.887 -0.597 . . . . 37.29 110.035 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.87 -14.96 61.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 36.13 110.861 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 60.03 -162.74 0.25 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.656 0.597 . . . . 34.41 112.062 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.31 -155.29 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.236 -0.893 . . . . 32.45 110.189 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt -96.12 97.97 9.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.245 -0.889 . . . . 30.94 109.864 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.28 -25.91 60.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 30.21 110.417 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.7 t -92.66 -12.66 30.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.379 -0.601 . . . . 27.83 109.379 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 34.3 t70 63.9 -82.05 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.829 -1.078 . . . . 27.14 112.091 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 p -129.05 129.94 45.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.182 0.515 . . . . 25.54 111.468 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 p -107.22 -72.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.689 -0.687 . . . . 23.93 110.807 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.43 -176.12 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.539 -0.3 . . . . 24.03 111.446 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? 43.76 58.82 3.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.165 0.986 . . . . 22.83 112.944 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -155.35 133.49 11.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.726 -0.67 . . . . 21.0 109.687 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.53 90.39 0.16 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.918 -0.583 . . . . 19.72 111.052 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -117.52 -57.21 2.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 17.66 110.006 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -86.94 116.7 25.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.709 -0.678 . . . . 16.08 109.329 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -133.27 -170.54 2.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.925 -0.58 . . . . 14.08 110.146 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.08 166.16 2.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.518 0.675 . . . . 13.03 111.221 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 245' ' ' GLU . 1.0 OUTLIER -68.25 132.69 47.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.047 -0.979 . . . . 12.06 111.51 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 247' ' ' GLY . 7.2 p -107.08 177.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.077 -0.965 . . . . 9.73 109.423 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.676 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -74.94 65.42 2.23 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.66 -0.7 . . . . 7.65 112.037 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 p -108.65 105.56 15.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.84 0.352 . . . . 6.51 110.79 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.64 -61.14 2.37 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.862 0.839 . . . . 4.79 111.194 172.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 332' ' ' LEU . 4.0 m -150.27 -163.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 113.899 -1.501 . . . . 2.23 111.294 -168.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.721 ' HB ' ' OD2' ' A' ' 255' ' ' ASP . 20.4 p 50.91 73.98 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.472 1.13 . . . . 1.43 109.079 -168.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -60.38 -147.47 0.01 OUTLIER Glycine 0 C--N 1.313 -0.725 0 CA-C-N 113.273 -1.785 . . . . 1.61 113.071 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.804 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.3 m -73.86 15.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.771 0.796 . . . . 1.62 111.102 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.903 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp -84.86 -43.32 14.24 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.183 -1.371 . . . . 0.47 110.47 -168.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.721 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.804 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 0.46 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.729 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 0.27 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.607 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 0.15 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.52 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 0.24 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 0.17 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 0.69 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.21 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.683 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.593 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 3.65 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.66 ' NH2' ' HB3' ' B' ' 8' ' ' SER . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 2.92 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 0.88 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.52 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 0.34 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 2.49 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 342' ' ' PRO . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.46 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.775 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.08 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.8 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.69 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 0.94 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.472 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 0.12 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 0.23 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.73 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 1.63 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 0.36 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.698 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 1.45 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.34 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.515 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 0.58 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 0.47 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 0.22 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.61 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 0.22 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.17 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 0.16 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.44 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 2.82 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.456 ' HB3' HG11 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.59 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 2.56 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.18 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.58 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.707 ' HA ' HG23 ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 0.92 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.11 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 0.1 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 306' ' ' SER . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 0.13 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 0.13 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 0.13 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.73 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 0.23 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 312' ' ' VAL . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.49 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.683 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.56 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 0.27 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.49 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 0.65 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.57 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.406 ' OE2' HD11 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.16 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.72 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 1.64 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.673 HD22 HG21 ' A' ' 328' ' ' THR . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.07 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.36 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 3.98 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 0.34 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.673 HG21 HD22 ' A' ' 324' ' ' LEU . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 0.34 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 0.71 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.3 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 250' ' ' VAL . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 0.33 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.903 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.49 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.495 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 2.41 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.63 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 2.45 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.07 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 0.17 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 0.29 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.54 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.634 ' HB3' HG13 ' B' ' 5' ' ' VAL . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.34 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo -72.97 -179.01 3.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.5 116.056 -167.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -151.71 105.39 3.13 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.51 -2.132 . . . . 2.54 107.761 165.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.6 t70 65.33 84.09 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.158 -0.928 . . . . 2.26 112.05 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.1 OUTLIER -78.46 -165.84 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 1.22 109.785 168.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.3 t -69.93 -44.07 70.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.282 1.039 . . . . 1.77 108.83 172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.304 -1.375 0 CA-C-N 113.399 -1.728 . . . . 2.89 110.835 -176.171 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.45 0.167 . . . . 1.84 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 61.89 107.77 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 124.067 0.854 . . . . 1.1 111.18 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.11 118.95 5.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.47 2.113 . . . . 0.48 111.412 -175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 259' ' ' VAL . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.26 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 341' ' ' LYS . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.01 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 0.34 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p -70.8 -68.61 0.42 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.05 111.08 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.611 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 65.4 p -149.35 -177.59 5.93 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.481 -0.488 . . . . 2.56 111.264 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -85.49 -123.1 1.26 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.547 -0.751 . . . . 1.85 113.367 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' B' ' 12' ' ' ARG . 64.6 t30 -64.28 168.45 5.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.692 -0.754 . . . . 3.21 111.635 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.96 8.58 0.69 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.998 -1.001 . . . . 5.81 111.873 -175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' B' ' 10' ' ' ASN . 68.2 mtt180 59.67 -163.11 0.24 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.858 -1.065 . . . . 5.3 112.182 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.441 -0.79 . . . . 7.77 109.518 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.841 0.353 . . . . 40.22 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -117.0 -32.46 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 40.04 110.707 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 74.11 -49.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.658 0.783 . . . . 39.27 111.361 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -118.59 69.4 0.8 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.093 0.473 . . . . 37.29 111.031 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.87 44.22 2.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.305 -0.628 . . . . 36.13 109.305 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 34.41 110.703 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.24 117.35 25.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.171 -0.468 . . . . 32.45 109.898 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.52 68.85 10.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 30.94 111.193 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp 61.64 -170.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.444 0.64 . . . . 30.21 111.922 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.4 t -104.11 149.08 25.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 27.83 109.18 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.85 -34.39 73.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.224 0.535 . . . . 27.14 109.592 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.8 p -144.22 130.16 19.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.11 -0.95 . . . . 25.54 109.868 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.4 p -101.6 -37.33 8.42 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.285 0.564 . . . . 23.93 110.876 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.39 97.36 9.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.441 -0.799 . . . . 24.03 109.867 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.5 mmp_? -126.85 138.51 53.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.021 -0.536 . . . . 22.83 111.038 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.64 -0.22 57.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.668 -0.696 . . . . 21.0 110.694 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 63.31 44.37 5.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.037 -0.983 . . . . 19.72 110.811 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.84 -150.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 17.66 111.331 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.4 106.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.353 0.597 . . . . 16.08 110.828 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -105.36 159.97 15.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 14.08 109.899 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.41 164.13 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 13.03 110.486 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.49 55.73 3.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.386 1.088 . . . . 12.06 112.197 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.09 -4.04 9.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 124.752 2.215 . . . . 9.73 108.505 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 169.46 56.97 0.03 OUTLIER Glycine 0 C--N 1.266 -3.309 0 CA-C-N 108.641 -3.891 . . . . 7.65 110.373 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 p -57.61 -64.56 0.86 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 6.51 110.944 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.421 ' C ' HG22 ' A' ' 250' ' ' VAL . 4.6 pt-20 -128.25 -111.3 0.28 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.642 -0.708 . . . . 4.79 110.249 171.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.421 HG22 ' C ' ' A' ' 249' ' ' GLU . 7.3 m 50.31 172.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 115.544 1.683 . . . . 2.23 115.544 167.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.56 93.46 5.62 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.411 -1.722 . . . . 1.43 108.102 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -72.3 -139.4 0.29 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 113.575 -1.648 . . . . 1.61 113.112 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.874 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -71.18 9.81 0.68 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.447 0.642 . . . . 1.62 110.946 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp -79.56 -45.89 18.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.517 -1.219 . . . . 0.47 110.249 -166.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 253' ' ' SER . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 0.46 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.641 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 0.27 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.794 HG21 HD23 ' B' ' 4' ' ' LEU . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 0.15 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.52 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 0.24 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.66 ' CG1' HD13 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.826 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 0.69 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.21 105.797 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 3.65 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 2.92 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 0.88 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.52 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 0.34 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 347' ' ' LEU . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 2.49 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.46 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.08 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.69 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 0.94 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.631 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 0.12 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 0.23 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 312' ' ' VAL . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 1.63 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 0.36 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 1.45 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.34 113.014 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.635 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 0.58 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 0.47 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.564 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 0.22 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.61 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 0.22 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.17 111.224 175.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 0.16 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.631 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.44 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 2.82 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 0.67 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.731 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.59 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.415 ' HB2' ' HE1' ' A' ' 276' ' ' MET . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.732 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 2.56 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.18 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.732 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.639 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 0.92 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.11 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.609 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 0.1 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.639 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 0.13 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 0.13 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 0.13 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 282' ' ' ILE . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 0.23 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.49 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.56 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 290' ' ' ILE . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 0.27 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.646 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.49 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.641 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 0.65 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.57 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.443 ' OE2' HD11 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.635 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.16 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.72 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 1.64 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 328' ' ' THR . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.07 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.36 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 3.98 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 0.34 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.753 HG21 HD22 ' A' ' 324' ' ' LEU . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 0.34 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 0.71 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.3 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 0.33 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.49 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.498 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 2.41 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.782 ' HB3' HD11 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 2.45 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.07 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 258' ' ' ILE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 0.17 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 0.29 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.772 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.54 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.34 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo -45.47 178.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.5 115.198 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -139.88 107.33 5.56 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.716 -1.583 . . . . 2.54 108.373 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 33.7 t70 54.44 86.63 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.17 -0.923 . . . . 2.26 113.155 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.6 mm? -79.55 -169.05 1.76 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.342 -0.614 . . . . 1.22 109.342 166.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.675 ' HB3' HD13 ' A' ' 347' ' ' LEU . 1.0 OUTLIER -68.93 -45.99 69.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 123.119 1.438 . . . . 1.77 108.078 168.353 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.85 0 CA-C-N 112.013 -2.358 . . . . 2.89 111.195 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.677 0.275 . . . . 1.84 111.329 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.51 90.13 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.339 -0.846 . . . . 1.1 111.555 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 337' ' ' ARG . 84.4 Cg_exo -43.73 128.4 6.75 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.859 3.04 . . . . 0.48 112.716 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.26 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.01 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.752 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 0.34 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p -98.29 -19.93 17.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.05 112.08 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 263' ' ' SER . 8.7 m -110.62 162.04 15.13 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.119 -0.491 . . . . 2.56 111.117 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.59 -124.62 2.17 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.359 -1.096 . . . . 1.85 110.359 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -60.5 149.49 34.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.322 0.561 . . . . 3.21 110.117 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.26 -12.64 59.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.591 -0.731 . . . . 5.81 111.013 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 49.55 -157.74 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.529 -0.76 . . . . 5.3 112.181 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.901 0 CA-C-O 118.43 -0.795 . . . . 7.77 110.02 174.078 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.749 -0.463 . . . . 40.22 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.2 mtp 64.99 93.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.878 -0.601 . . . . 40.04 111.568 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -90.97 64.06 5.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 39.27 109.595 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -141.56 82.08 1.8 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.656 . . . . 37.29 110.158 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 29.4 tp -77.83 -29.06 50.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 36.13 110.052 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -120.49 97.59 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.879 -0.6 . . . . 34.41 110.869 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 230' ' ' GLU . 0.9 OUTLIER -84.39 126.28 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.243 0.544 . . . . 32.45 109.913 176.312 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.57 -36.15 73.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.608 . . . . 30.94 111.082 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.46 71.09 9.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.1 0.476 . . . . 30.21 110.684 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.1 p -149.57 25.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.592 0.71 . . . . 27.83 110.147 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.82 20.43 4.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.384 -0.825 . . . . 27.14 110.603 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.5 p -83.33 129.79 35.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.564 -0.744 . . . . 25.54 110.317 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 16.0 p -128.82 99.02 5.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.002 0.429 . . . . 23.93 111.567 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.56 87.68 4.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.287 0.565 . . . . 24.03 109.752 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 4.8 mmp_? -124.44 29.63 6.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.616 -0.72 . . . . 22.83 111.043 -173.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.54 129.61 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.843 0.354 . . . . 21.0 110.325 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -138.7 151.53 47.23 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.777 -0.647 . . . . 19.72 110.178 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -111.88 124.03 51.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.4 -0.364 . . . . 17.66 110.816 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.85 -58.73 2.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.117 -0.697 . . . . 16.08 109.117 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 59.01 124.25 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.952 0.882 . . . . 14.08 113.181 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -81.25 163.27 23.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.318 -0.855 . . . . 13.03 111.231 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.49 161.32 17.87 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.979 -1.01 . . . . 12.06 111.2 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 247' ' ' GLY . 9.4 p -65.48 159.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 9.73 111.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 80.08 58.78 2.72 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.054 -0.976 . . . . 7.65 110.942 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.4 p -56.52 -58.92 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 6.51 111.289 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.492 ' HB2' HG22 ' A' ' 250' ' ' VAL . 1.4 pt-20 -106.16 -85.67 0.49 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.308 0.575 . . . . 4.79 112.127 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 332' ' ' LEU . 5.6 m -146.38 -157.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.986 -1.006 . . . . 2.23 111.697 -169.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.523 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 18.4 p 60.15 64.08 1.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.369 1.081 . . . . 1.43 110.032 -172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' CA ' HD12 ' A' ' 254' ' ' LEU . . . -68.26 66.53 0.37 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 113.745 -1.57 . . . . 1.61 115.329 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.743 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 64.4 m 57.8 10.55 1.12 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.579 1.18 . . . . 1.62 112.593 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.784 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER -84.23 -37.93 21.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 113.306 -1.77 . . . . 0.47 110.285 -171.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 0.46 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.613 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 0.27 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.698 HG21 HD23 ' B' ' 4' ' ' LEU 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 0.15 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.52 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 0.24 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 0.17 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.69 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.21 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.604 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 3.65 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 2.92 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 0.88 113.34 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.52 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.911 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 0.34 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.596 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 2.49 108.688 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.46 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.911 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.08 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.762 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.69 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 305' ' ' ASP . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 0.94 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 0.12 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 0.23 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 1.63 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 0.36 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 1.45 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.34 113.777 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.498 ' H ' HD22 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.616 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 0.58 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.47 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 0.22 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.61 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 0.22 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.17 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.44 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 2.82 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.67 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.59 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 2.56 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.18 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 301' ' ' ASP . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.58 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 0.92 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.11 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 0.1 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 0.13 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 0.13 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 0.13 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 0.23 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.49 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.604 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.56 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 0.27 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.49 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 0.65 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.57 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.616 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.16 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.72 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 1.64 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.07 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.36 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 3.98 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 0.34 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.678 HG21 HD22 ' A' ' 324' ' ' LEU . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.34 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 0.71 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.691 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.3 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.692 HD11 ' HB ' ' A' ' 250' ' ' VAL . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 0.33 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.523 ' OH ' ' HA ' ' A' ' 251' ' ' THR . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.49 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.699 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 2.41 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.952 ' HB3' HD11 ' A' ' 281' ' ' LEU . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.754 ' H ' HD13 ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 2.45 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.563 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.07 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 258' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 0.17 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.503 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 0.29 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.54 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.34 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.574 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 32.2 Cg_exo -28.51 161.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.5 118.35 176.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -153.57 118.0 4.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.746 -2.024 . . . . 2.54 108.074 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.02 68.73 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.341 -0.845 . . . . 2.26 113.221 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -80.17 -166.7 1.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.858 0.361 . . . . 1.22 110.442 168.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -57.23 -32.14 66.23 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.986 0.898 . . . . 1.77 111.51 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.596 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 CA-C-N 114.365 -1.289 . . . . 2.89 111.783 -163.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.451 -0.574 . . . . 1.84 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.08 126.47 87.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 123.306 0.379 . . . . 1.1 110.855 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo -52.76 119.98 6.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.718 2.279 . . . . 0.48 111.592 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.67 HD23 HG21 ' A' ' 259' ' ' VAL . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.26 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.01 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.769 HD13 HG13 ' A' ' 259' ' ' VAL . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 0.34 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 57.6 p -105.67 -13.59 15.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.121 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.609 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 t -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.648 -1.16 . . . . 2.56 109.844 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.23 109.96 0.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 1.85 111.397 173.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -155.1 160.81 41.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.312 -0.625 . . . . 3.21 109.312 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -49.17 -61.96 1.79 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.344 0.403 . . . . 5.81 110.9 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 53.82 174.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.419 0.896 . . . . 5.3 113.419 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.638 -0.71 . . . . 7.77 109.461 177.019 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.998 0.428 . . . . 40.22 110.445 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.1 mmt -111.58 25.56 11.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.128 0.49 . . . . 40.04 110.78 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -105.57 -28.71 10.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.549 -0.751 . . . . 39.27 110.139 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 48.05 58.31 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.86 0.725 . . . . 37.29 111.14 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.81 76.27 10.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 36.13 110.992 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.64 -78.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.573 -0.74 . . . . 34.41 109.767 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.08 100.0 4.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.679 -0.692 . . . . 32.45 109.49 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.97 87.77 4.78 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.792 -1.095 . . . . 30.94 109.929 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 79.8 mt -82.92 48.47 1.36 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.443 -0.798 . . . . 30.21 110.951 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 33.9 m -98.27 10.25 41.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.385 0.612 . . . . 27.83 110.207 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.63 77.94 5.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 27.14 110.536 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.9 m -98.16 -70.75 0.71 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.411 -0.813 . . . . 25.54 110.118 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 2.9 m 56.38 56.93 5.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.387 0.613 . . . . 23.93 110.953 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.47 -12.02 3.51 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.571 -0.741 . . . . 24.03 112.214 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 3.4 mmp_? -70.89 133.98 46.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.149 -0.478 . . . . 22.83 110.744 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -97.68 -165.82 1.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.516 -0.311 . . . . 21.0 110.421 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 67.67 72.24 0.33 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.86 0.725 . . . . 19.72 111.776 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -92.32 -152.23 0.3 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.895 -0.593 . . . . 17.66 110.593 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 242' ' ' LEU . 3.5 tm? -71.63 113.1 8.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.133 0.492 . . . . 16.08 109.863 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.31 145.11 24.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.025 -0.534 . . . . 14.08 110.701 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -69.28 160.0 32.04 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.423 0.63 . . . . 13.03 110.073 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.04 139.95 40.2 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.066 -0.97 . . . . 12.06 112.11 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 247' ' ' GLY . 10.0 p -109.52 168.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.939 -1.028 . . . . 9.73 109.691 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -96.21 112.18 4.38 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 114.557 -1.201 . . . . 7.65 111.572 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -40.9 99.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 6.51 110.635 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -94.29 127.46 40.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.927 -0.579 . . . . 4.79 111.274 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 252' ' ' GLY . 19.8 m 34.81 -146.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 112.893 -1.958 . . . . 2.23 114.623 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.423 ' HB ' ' OH ' ' A' ' 333' ' ' TYR . 1.3 p 65.43 -16.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.606 1.162 . . . . 1.43 112.336 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.13 -121.8 26.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.528 -0.368 . . . . 1.61 112.484 176.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.748 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.3 m -125.31 23.76 7.52 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.01 1.385 . . . . 1.62 108.38 169.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.4 mp -87.11 -35.13 18.84 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 112.392 -2.185 . . . . 0.47 109.5 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASP . . . . . 0.63 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 0.46 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 0.27 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.769 HG13 HD13 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 0.15 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.52 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 0.24 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.674 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 0.17 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.544 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.69 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.21 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.644 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.609 ' HE3' ' O ' ' B' ' 8' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 3.65 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 2.92 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 0.88 113.09 167.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.52 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.923 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 0.34 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 2.49 109.872 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.46 112.794 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.08 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.69 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 0.94 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.584 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 0.12 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 0.23 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.71 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 1.63 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.549 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 0.36 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 1.45 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.34 113.548 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.695 ' O ' HD12 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 0.58 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 0.47 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 0.22 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.61 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 0.22 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.17 111.294 175.1 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 0.16 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.584 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.44 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 2.82 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 0.67 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.59 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 2.56 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.592 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.18 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.519 ' CE1' HG23 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.58 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 0.92 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.11 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.614 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 0.1 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 0.13 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 0.13 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 0.13 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 0.23 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.49 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.56 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 0.27 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.49 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 319' ' ' PRO . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 0.65 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.57 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.641 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.16 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.72 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 1.64 108.472 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.07 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.36 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 3.98 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 0.34 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 0.34 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.422 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 0.71 109.632 173.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' SER . . . . . 0.721 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.3 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.721 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 0.33 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.641 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.49 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 2.41 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 18.1 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.71 ' H ' HD13 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 2.45 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ARG . . . . . 0.569 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.07 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 0.17 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ILE . . . . . 0.571 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 0.29 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.54 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.34 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 341' ' ' LYS . 24.4 Cg_exo -29.22 163.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.5 118.309 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 11.1 mm-40 -159.24 126.44 4.75 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.027 -2.351 . . . . 2.54 107.434 172.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.59 60.07 0.38 Allowed 'General case' 0 C--N 1.316 -0.866 0 O-C-N 124.282 0.988 . . . . 2.26 112.464 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 342' ' ' PRO . 1.8 mm? -80.97 -172.08 3.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -74.46 -30.64 61.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.119 0.961 . . . . 1.77 109.931 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.131 -1.395 . . . . 2.89 110.965 -171.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo . . . . . 0 C--O 1.232 0.22 0 CA-C-O 120.734 0.222 . . . . 0.48 111.871 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.709 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.26 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.548 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.01 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.676 HD13 HG13 ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 0.34 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 342' ' ' PRO . 4.0 m . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.05 109.872 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.677 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 112.205 0.446 . . . . 0.47 112.205 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 0.46 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.658 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 0.27 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' B' ' 4' ' ' LEU . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 0.15 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.52 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 0.24 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.633 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 0.17 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 0.69 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.21 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.587 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 3.65 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 2.92 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 0.88 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.52 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.978 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 0.34 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 2.49 109.493 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.46 112.594 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.978 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.08 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.69 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 0.94 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.554 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 0.12 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 0.23 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 1.63 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 0.36 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.668 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 1.45 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.34 112.669 175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 0.58 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 315' ' ' VAL . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 0.47 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.668 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 0.22 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.61 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 0.22 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.17 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 0.16 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.44 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 2.82 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 0.67 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.59 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 2.56 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.599 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.18 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.705 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.58 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.653 ' HA ' HG23 ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 0.92 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.11 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.725 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 0.1 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.653 HG23 ' HA ' ' A' ' 306' ' ' SER . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 0.13 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 0.13 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 0.13 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 315' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.23 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 312' ' ' VAL . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.49 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.587 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.56 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 0.27 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.49 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.652 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 0.65 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.57 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.16 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.72 112.521 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 1.64 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 328' ' ' THR . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.07 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.36 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 326' ' ' ARG . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 3.98 110.786 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 0.34 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.708 HG21 HD22 ' A' ' 324' ' ' LEU . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 0.34 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 0.71 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.701 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.3 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 0.33 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.49 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 2.41 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.848 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.6 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.878 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 2.45 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.602 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.07 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.658 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 0.17 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 0.29 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.781 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.54 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.507 ' HB3' HG13 ' B' ' 5' ' ' VAL . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.34 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo . . . . . 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.5 120.077 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 85.4 Cg_exo . . . . . 0 N--CA 1.476 0.473 0 N-CA-C 112.773 0.259 . . . . 0.48 112.773 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.554 HD12 HG21 ' A' ' 259' ' ' VAL . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.26 109.964 -172.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.01 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 0.34 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 13.0 p . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.05 111.575 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.334 -0.617 . . . . 0.47 109.334 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.439 ' CG ' HH21 ' A' ' 336' ' ' ARG . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.717 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 0.46 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.574 HD11 ' CE ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 0.27 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.753 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 0.15 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.52 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 0.24 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 0.17 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.588 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 0.69 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.21 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 3.65 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' B' ' 7' ' ' SER . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 2.92 110.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 0.88 113.582 169.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.52 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.956 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 0.34 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 273' ' ' ARG . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 2.49 108.97 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.46 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.956 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.08 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.795 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.69 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 0.94 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 0.12 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.961 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 0.23 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 1.63 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 0.36 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 1.45 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.561 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.34 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 0.58 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 0.47 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 0.22 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.61 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 0.22 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.17 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 0.16 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.44 109.202 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 2.82 109.384 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 0.67 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.59 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 2.56 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.18 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.787 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.688 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 0.92 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.11 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.632 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 0.1 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.688 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 0.13 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 0.13 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 0.13 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.23 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.544 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.49 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.56 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 0.27 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.49 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.539 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 0.65 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.45 ' HD2' HD11 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.57 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.665 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.16 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.72 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 1.64 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.704 HD22 HG21 ' A' ' 328' ' ' THR . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.07 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.36 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.561 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 3.98 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 0.34 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.704 HG21 HD22 ' A' ' 324' ' ' LEU . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 0.34 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.455 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 0.71 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.3 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 0.33 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.665 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.49 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 2.41 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.961 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.727 ' H ' HD13 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 2.45 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.57 ' CD ' HD13 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.07 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 0.17 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 0.29 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.34 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 276' ' ' MET . 31.6 Cg_exo . . . . . 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.5 118.122 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.231 0.136 0 N-CA-C 111.054 -0.402 . . . . 0.48 111.054 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 259' ' ' VAL . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.26 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.01 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.728 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 0.34 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.05 110.639 -175.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.47 110.128 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.755 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.429 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 0.46 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 0.27 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.728 HG13 HD13 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 0.15 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.52 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 0.24 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 0.17 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.57 ' OG ' HD11 ' B' ' 6' ' ' ILE . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 0.69 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.21 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.683 HE21 HG12 ' A' ' 315' ' ' VAL . 2.3 mp0 -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.588 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 3.65 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 2.92 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 0.88 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.52 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 0.34 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 2.49 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.46 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.603 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.08 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.69 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 0.94 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.513 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 0.12 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 0.23 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 1.63 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.495 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 0.36 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 1.45 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.34 113.591 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.508 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 0.58 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 315' ' ' VAL . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 0.47 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 0.22 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.61 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 0.22 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.17 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 0.16 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.44 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 2.82 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 0.67 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.425 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.59 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 2.56 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.18 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.519 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.58 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.721 ' HA ' HG23 ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 0.92 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.11 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 0.1 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 0.13 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 0.13 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.662 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 0.13 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 0.23 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.49 112.273 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.56 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.683 HG12 HE21 ' A' ' 265' ' ' GLN . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 0.27 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.49 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 258' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 0.65 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.57 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.422 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.661 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.16 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.72 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 1.64 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.07 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.36 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 3.98 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 0.34 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.752 HG21 HD22 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 0.34 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 0.71 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.3 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 0.33 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.661 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.49 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.464 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 2.41 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.841 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.828 ' HB3' HD11 ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 2.45 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.487 ' HG2' HD13 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.07 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.53 HD12 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 0.17 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.534 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 0.29 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.54 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.703 ' HB3' HG13 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.34 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo . . . . . 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.5 119.075 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.823 -0.491 . . . . 0.48 110.823 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.761 HD23 HG21 ' A' ' 259' ' ' VAL . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.26 110.539 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.01 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.05 110.946 -175.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.804 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 121.384 0.611 . . . . 0.47 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.503 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 0.46 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 0.27 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.763 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 0.15 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.52 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 0.24 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.614 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 0.17 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.577 ' HB3' HD11 ' B' ' 6' ' ' ILE . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 0.69 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.21 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.647 HE21 HG12 ' A' ' 315' ' ' VAL . 2.3 mp0 -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.541 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 3.65 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 2.92 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 0.88 113.253 168.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.806 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 0.34 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 2.49 108.373 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.46 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.825 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.08 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 339' ' ' ILE . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.69 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.485 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 0.94 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.518 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 0.12 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 0.23 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.8 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 1.63 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 0.36 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.665 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 1.45 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.34 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 0.58 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.567 HD12 HG22 ' A' ' 315' ' ' VAL . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 0.47 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.665 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 0.22 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.69 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.61 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 0.22 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.17 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 0.16 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.44 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 2.82 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 0.67 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.59 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.488 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 2.56 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.18 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.504 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.58 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.685 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 0.92 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.11 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.642 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 0.1 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.685 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 0.13 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 0.13 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 0.13 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.8 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 0.23 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 312' ' ' VAL . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.49 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.56 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.647 HG12 HE21 ' A' ' 265' ' ' GLN . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 0.27 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.49 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 258' ' ' ILE . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 0.65 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.57 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.726 ' SD ' HG22 ' A' ' 318' ' ' ILE . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.16 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.72 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 1.64 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 328' ' ' THR . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.07 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.36 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 3.98 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 0.34 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.766 HG21 HD22 ' A' ' 324' ' ' LEU . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 0.34 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 0.71 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.698 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.3 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 0.33 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.804 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.49 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 2.41 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.877 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.595 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 2.45 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.564 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.07 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 0.17 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.56 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.697 ' HA ' HG23 ' B' ' 6' ' ' ILE . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.54 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.34 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.825 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo . . . . . 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.5 118.396 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 111.307 -0.305 . . . . 0.48 111.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 259' ' ' VAL . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.26 111.256 -168.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.01 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.729 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 0.34 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.05 111.886 -173.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.779 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 120.52 0.2 . . . . 0.47 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.648 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 0.27 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.725 HG13 HD13 ' B' ' 6' ' ' ILE 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 0.15 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.52 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 0.24 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 0.17 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 0.69 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.21 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.438 ' HG2' HG12 ' A' ' 315' ' ' VAL . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.637 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 3.65 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 2.92 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 0.88 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.52 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 1.001 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 0.34 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 2.49 109.266 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.46 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 1.001 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.08 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.749 ' HB3' ' HG3' ' A' ' 341' ' ' LYS . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.69 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 0.94 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.595 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 0.12 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 0.23 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.707 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 1.63 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.742 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 0.36 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.641 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 1.45 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.34 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 0.58 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 0.47 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.641 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 0.22 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.742 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.61 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.6 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 0.22 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.17 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 0.16 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.44 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 2.82 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG11 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.67 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.59 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 2.56 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.18 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.607 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.58 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 0.92 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.11 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 0.1 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 0.13 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 0.13 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 0.13 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.707 HG11 HD11 ' A' ' 282' ' ' ILE . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 0.23 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.49 112.433 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.56 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 0.27 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.49 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 0.65 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.57 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.596 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.16 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.72 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 1.64 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.846 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.07 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.36 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.417 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 3.98 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.34 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.695 ' HB ' HD13 ' A' ' 324' ' ' LEU . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 0.34 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.743 ' HB2' HD11 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 0.71 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.3 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 0.33 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.49 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 2.41 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.809 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.672 ' O ' HG12 ' A' ' 282' ' ' ILE . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 2.45 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.07 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 0.17 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.511 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 0.29 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.729 ' HA ' HG23 ' B' ' 6' ' ' ILE . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.54 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.749 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.34 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.5 118.097 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.857 -0.094 . . . . 0.48 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 259' ' ' VAL . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.26 110.292 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.685 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.01 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 263' ' ' SER . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 0.34 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.05 110.937 -178.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.644 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 119.666 -0.207 . . . . 0.47 111.555 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 0.46 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 0.27 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.634 HG13 HD12 ' B' ' 6' ' ' ILE 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 0.15 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.52 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 0.24 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.568 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 0.17 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.923 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.21 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.651 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 3.65 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 2.92 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 0.88 113.149 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.52 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.826 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 0.34 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 2.49 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.46 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.826 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.08 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.69 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 0.94 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 0.12 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.869 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 0.23 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 1.63 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 0.36 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.559 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 1.45 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.34 112.839 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 0.58 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 0.47 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.559 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 0.22 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.61 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 0.22 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.17 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 0.16 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.44 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 2.82 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 0.67 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.59 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.596 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 2.56 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.596 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.18 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 278' ' ' VAL . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.58 109.485 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 0.92 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.11 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 0.1 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 0.13 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 0.13 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 0.13 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 0.23 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.49 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.56 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 0.27 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.417 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.49 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.755 HD13 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 0.65 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.57 114.666 -163.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.557 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.16 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.72 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 1.64 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 328' ' ' THR . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.07 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.36 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 3.98 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 0.34 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.72 HG21 HD22 ' A' ' 324' ' ' LEU . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 0.34 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 0.71 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.3 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 0.33 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.49 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 2.41 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.869 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.6 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.706 ' HB3' HD11 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 2.45 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.07 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 0.17 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.613 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 0.29 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.54 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.685 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.34 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.804 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo . . . . . 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.5 116.957 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.015 0.34 . . . . 0.48 111.845 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.627 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.26 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' A' ' 341' ' ' LYS . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 263' ' ' SER . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 0.34 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.05 110.454 -173.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 109.466 -0.568 . . . . 0.47 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.565 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.747 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.697 HG13 HD13 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 0.27 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.7 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 0.15 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.52 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 0.24 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 0.17 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.774 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 0.69 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 260' ' ' ASN . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.21 106.57 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.594 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.591 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 3.65 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 2.92 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.88 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.52 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 1.013 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 0.34 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 2.49 109.102 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.46 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 1.013 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.08 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.796 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.69 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 0.94 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 0.12 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 0.23 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 1.63 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 0.36 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 1.45 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.34 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.67 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 0.58 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 315' ' ' VAL . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 0.47 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 0.22 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.61 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 0.22 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.17 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.702 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 0.16 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.44 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 2.82 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 0.67 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.59 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 2.56 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.18 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.889 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' HG23 ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 0.92 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.11 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 0.1 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 306' ' ' SER . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 0.13 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 0.13 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 0.13 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 0.23 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.482 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.49 112.961 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.594 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.56 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 0.27 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.49 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 258' ' ' ILE . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 0.65 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.57 118.885 -175.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.16 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.72 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 1.64 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 328' ' ' THR . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.07 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.36 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 3.98 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 0.34 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.697 HG21 HD22 ' A' ' 324' ' ' LEU . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 0.34 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 0.71 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.3 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 0.33 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.49 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 2.41 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.653 ' H ' HD13 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 2.45 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.412 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.07 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 0.17 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.548 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 0.29 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.54 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.34 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo . . . . . 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.5 117.259 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 110.443 -0.637 . . . . 0.48 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 259' ' ' VAL . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.26 111.11 -169.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.01 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 0.34 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 2.4 p . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.05 112.814 -169.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 7.0 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 115.568 1.692 . . . . 0.47 115.568 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.741 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 0.46 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.844 HG13 HD13 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 0.27 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.638 HG13 HD13 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 0.15 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.52 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 0.24 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.542 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 0.17 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.514 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 0.69 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.21 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.488 ' HG2' HG12 ' A' ' 315' ' ' VAL . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.487 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 3.65 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 2.92 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 0.88 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.52 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.999 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 0.34 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 2.49 108.856 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.46 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.999 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.08 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.738 ' HB3' ' CG ' ' A' ' 341' ' ' LYS . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.69 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 0.94 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.569 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 0.12 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.953 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 0.23 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 1.63 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.706 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 318' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 0.36 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 1.45 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.446 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.34 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.529 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 0.58 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.597 HD12 HG22 ' A' ' 315' ' ' VAL . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 0.47 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 0.22 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.706 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.61 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 0.22 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.17 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 0.16 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.569 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.44 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 2.82 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 0.67 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.59 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 2.56 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.18 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.768 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.58 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.746 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.662 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 0.92 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.11 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 0.1 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 0.13 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 0.13 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 0.13 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.701 HG11 HD11 ' A' ' 282' ' ' ILE . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 0.23 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.49 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.56 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 0.27 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.49 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.844 HD13 HG13 ' A' ' 258' ' ' ILE . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 0.65 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.423 ' HD2' HD11 ' A' ' 261' ' ' LEU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.57 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.666 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.16 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.72 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.407 ' HG3' ' CA ' ' A' ' 320' ' ' GLU . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 1.64 108.671 -178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.07 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.36 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.446 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 3.98 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 0.34 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.745 HG21 HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 0.34 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 0.71 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.3 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 0.33 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.666 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.49 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 2.41 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.953 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.2 OUTLIER -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.553 ' HG2' HG21 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 2.45 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.07 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 0.17 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 0.29 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 277' ' ' SER . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.54 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.738 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.34 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo . . . . . 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.5 118.937 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 N-CA-C 110.452 -0.634 . . . . 0.48 110.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.611 ' HB3' HG21 ' A' ' 259' ' ' VAL . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.26 111.289 -168.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.01 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 0.34 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.05 111.541 -173.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 111.953 0.353 . . . . 0.47 111.953 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 0.46 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG12 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 0.27 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.688 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 0.15 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.517 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.52 107.249 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 0.24 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.642 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 0.17 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 0.69 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.21 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.594 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.653 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 3.65 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 2.92 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 0.88 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.52 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.34 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 2.49 108.848 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.46 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.671 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.08 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.69 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 305' ' ' ASP . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 0.94 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 0.12 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.946 HD11 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 0.23 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 1.63 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.521 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 0.36 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.608 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 1.45 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.34 112.752 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.638 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 0.58 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 0.47 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.608 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 0.22 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.61 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 0.22 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.17 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.642 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 0.16 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.44 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 2.82 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.435 ' HB3' HG11 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.67 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.59 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 2.56 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.18 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.404 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.58 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.642 ' HB2' HG21 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 0.92 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.11 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 0.1 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 0.13 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 0.13 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 0.13 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 282' ' ' ILE . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 0.23 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.49 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.56 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 0.27 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.49 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.592 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 0.65 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.57 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.638 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.16 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 1.64 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.07 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.36 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 3.98 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 0.34 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 0.34 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 0.71 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.652 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.3 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 0.33 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.49 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 2.41 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.946 ' HB3' HD11 ' A' ' 281' ' ' LEU . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 2.45 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.474 ' CD ' HD13 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.07 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.514 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 0.29 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.814 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.54 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.595 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.34 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo . . . . . 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.5 118.492 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--O 1.234 0.304 0 N-CA-C 111.022 -0.415 . . . . 0.48 111.022 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 259' ' ' VAL . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.26 111.023 -167.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.01 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 259' ' ' VAL . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 0.34 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.05 110.769 -177.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 110.298 -0.26 . . . . 0.47 110.298 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 0.46 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.618 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 0.27 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.748 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 0.15 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.52 106.959 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 0.24 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.64 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 0.17 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.551 ' CB ' HD11 ' B' ' 6' ' ' ILE . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 0.69 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.21 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.53 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 3.65 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 2.92 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 0.88 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.52 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.34 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 275' ' ' GLY . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 2.49 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.46 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.681 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.08 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.745 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.69 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 0.94 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 0.12 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.804 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 0.23 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 1.63 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.546 ' CG ' HG12 ' A' ' 290' ' ' ILE . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 0.36 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 1.45 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.34 113.697 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.508 ' H ' HD13 ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 0.58 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 0.47 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.61 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 0.22 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.17 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 0.16 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.44 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 2.82 109.445 174.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 0.67 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.59 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 2.56 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.18 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.426 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.58 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.697 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 0.92 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.11 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 0.1 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 306' ' ' SER . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 0.13 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 0.13 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 0.13 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 315' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 0.23 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.49 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.53 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.56 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 0.27 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.49 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 0.65 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.663 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.57 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.652 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.16 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.72 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 1.64 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.07 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.36 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 3.98 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 0.34 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 0.34 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.524 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 0.71 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.3 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 0.33 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.652 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.49 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 2.41 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.804 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.782 ' HA ' HH11 ' A' ' 336' ' ' ARG . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 2.45 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.774 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.07 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 0.17 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.577 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 0.29 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 277' ' ' SER . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.54 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.34 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo . . . . . 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.5 117.308 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo . . . . . 0 C--O 1.231 0.159 0 N-CA-C 111.498 -0.231 . . . . 0.48 111.498 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.26 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.01 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 0.34 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 341' ' ' LYS . 3.2 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.05 111.381 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.645 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.6 mp . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 120.858 0.361 . . . . 0.47 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.511 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.706 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 0.46 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 0.27 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.672 HG21 HD23 ' B' ' 4' ' ' LEU 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 0.15 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.52 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 0.24 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 0.17 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.548 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 0.69 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.21 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 3.65 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 2.92 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 0.88 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.52 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.987 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 0.34 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 2.49 109.327 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.46 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.987 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.08 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.69 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 0.94 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 0.12 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.872 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 0.23 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 1.63 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 0.36 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.649 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 1.45 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.34 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.639 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 0.58 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 0.47 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.649 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.61 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 0.22 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.17 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 0.16 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.44 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 2.82 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.67 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.59 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 2.56 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.18 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.58 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.69 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 0.92 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.11 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 0.1 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.69 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 0.13 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 0.13 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.625 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 0.13 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 0.23 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.49 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.56 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 0.27 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.49 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 321' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 0.65 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.57 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.439 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.16 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.72 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 1.64 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.847 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.07 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.36 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 3.98 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 0.34 112.415 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.734 ' HB ' HD13 ' A' ' 324' ' ' LEU . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 0.34 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 0.71 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.715 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.3 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 0.33 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.645 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.49 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 2.41 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.872 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.7 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.728 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 2.45 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.07 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 0.17 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 0.29 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.789 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.54 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.34 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo . . . . . 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.5 119.17 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 CA--C 1.528 0.198 0 CA-C-O 120.792 0.247 . . . . 0.48 111.855 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.779 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.26 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 341' ' ' LYS . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.01 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.05 111.356 -176.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.681 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.6 OUTLIER . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 108.36 -0.978 . . . . 0.47 108.36 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.573 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 0.46 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 0.27 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' B' ' 4' ' ' LEU 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 0.15 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.52 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 0.24 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 0.17 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.758 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 0.69 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.21 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.571 ' OE1' HG12 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.617 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 3.65 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 2.92 110.572 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.482 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 0.88 113.71 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.52 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.925 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 0.34 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 2.49 110.46 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 274' ' ' ASN . 1.0 OUTLIER -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.46 112.21 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.925 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.08 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.69 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 0.94 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 297' ' ' ARG . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 282' ' ' ILE . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 0.12 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 0.23 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.771 HD11 HG11 ' A' ' 312' ' ' VAL . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 1.63 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.717 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 0.36 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 1.45 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.34 112.437 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 0.58 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 315' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 0.47 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.721 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 0.22 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.717 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.61 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 0.22 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.17 110.257 175.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 0.16 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.44 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 2.82 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 0.67 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.59 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 2.56 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.18 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.593 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.58 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.691 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.668 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 0.92 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.11 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 0.1 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.668 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 0.13 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 0.13 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 0.13 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.771 HG11 HD11 ' A' ' 282' ' ' ILE . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 0.23 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.49 112.901 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.56 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 0.27 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.49 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 258' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 0.65 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 318' ' ' ILE . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.57 116.142 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.16 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.72 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 1.64 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.07 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.36 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 3.98 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 0.34 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.706 HG21 HD22 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 0.34 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 0.71 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.678 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.3 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 0.33 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 2.41 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.979 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 2.45 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.07 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 0.29 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.54 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.566 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.34 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo . . . . . 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.5 117.444 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.464 ' HG3' ' HE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo . . . . . 0 C--O 1.23 0.118 0 N-CA-C 110.65 -0.558 . . . . 0.48 110.65 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 259' ' ' VAL . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.26 110.83 -173.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.01 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.739 HD13 HG13 ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 0.34 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.05 110.952 -176.452 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.75 -0.833 . . . . 0.47 108.75 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.687 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 0.46 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.998 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 0.27 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.739 HG13 HD13 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 0.15 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.533 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.52 107.004 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 0.24 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.643 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 0.17 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.547 ' CB ' HD11 ' B' ' 6' ' ' ILE . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 0.69 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.21 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.602 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.644 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 3.65 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 2.92 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 0.88 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.52 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 1.002 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 0.34 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 275' ' ' GLY . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 2.49 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.46 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 1.002 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.08 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.793 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.69 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 0.94 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.551 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.659 HG12 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 0.12 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 0.23 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 1.63 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.527 ' CG ' HG12 ' A' ' 290' ' ' ILE . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 0.36 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.683 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 1.45 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.34 112.974 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.594 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 0.58 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 315' ' ' VAL . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 0.47 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.683 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 0.22 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.61 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 0.22 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.17 110.695 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 0.16 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.44 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 2.82 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 0.67 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.59 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 2.56 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.18 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.644 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.58 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.695 ' HA ' HG23 ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 0.92 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.11 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.626 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 0.1 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.695 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 0.13 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 0.13 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 0.13 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 0.23 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.49 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.56 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 0.27 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.49 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.998 HD13 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 0.65 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.57 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.402 ' OE2' HD11 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.633 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.16 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.72 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 1.64 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 328' ' ' THR . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.07 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.36 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 3.98 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 0.34 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 324' ' ' LEU . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 0.34 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 0.71 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.682 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.688 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.3 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 0.33 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.633 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.49 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.682 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 2.41 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.792 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.3 OUTLIER -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.761 ' HB3' HD11 ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 2.45 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.464 ' HE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.07 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 0.17 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 0.29 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.54 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.569 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.34 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.5 117.914 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.519 -0.274 0 CA-C-O 120.917 0.299 . . . . 0.48 112.087 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.26 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.47 ' N ' HD13 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.01 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 0.34 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.05 110.813 -176.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 8.3 mt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 114.463 1.283 . . . . 0.47 114.463 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 336' ' ' ARG . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 0.46 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 318' ' ' ILE . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 0.27 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.689 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 0.15 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.52 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 0.24 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 0.17 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' HD11 ' B' ' 6' ' ' ILE . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 0.69 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.21 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 3.65 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 2.92 110.738 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 0.88 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.52 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.984 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.34 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.2 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.46 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.984 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.08 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.69 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 0.94 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.525 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 0.23 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.755 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 318' ' ' ILE . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 0.36 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.628 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 1.45 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.34 112.598 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.525 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 0.58 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 0.47 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.628 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 0.22 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.671 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.61 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 0.22 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.17 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.44 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 2.82 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 0.67 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.59 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 2.56 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.18 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.738 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.58 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.715 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 0.92 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.11 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.61 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 0.1 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.715 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 0.13 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 0.13 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 0.13 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 0.23 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.49 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.56 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 0.27 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.49 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 0.65 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.57 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.16 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.72 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 1.64 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 328' ' ' THR . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.07 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.36 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 3.98 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 0.34 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.77 HG21 HD22 ' A' ' 324' ' ' LEU . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 0.34 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 0.71 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.707 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.3 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.707 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 0.33 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.577 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.49 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.531 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 2.41 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.832 ' HB3' HD11 ' A' ' 281' ' ' LEU . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.755 ' H ' HD13 ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 2.45 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.07 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 0.17 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.551 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 0.29 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.54 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.621 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.34 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo . . . . . 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.5 118.032 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.517 -0.358 0 CA-C-O 120.634 0.181 . . . . 0.48 112.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.669 ' HB2' HG21 ' A' ' 259' ' ' VAL . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.26 111.374 -172.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.01 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.687 HD13 HG13 ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 0.34 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.882 -177.045 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 110.065 -0.346 . . . . 0.47 110.065 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.735 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 0.46 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 0.27 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.687 HG13 HD13 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 0.15 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.52 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 0.24 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.542 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 0.69 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.21 106.274 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.547 ' CG ' HG12 ' A' ' 315' ' ' VAL . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.645 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 3.65 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 2.92 109.716 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 0.88 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.52 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.878 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 0.34 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 2.49 107.527 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 342' ' ' PRO . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.46 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.878 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.08 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.69 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 0.94 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 0.12 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 0.23 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.747 HD11 HG11 ' A' ' 312' ' ' VAL . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 1.63 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.482 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 0.36 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 1.45 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.693 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.34 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 0.58 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.502 HD12 HG22 ' A' ' 315' ' ' VAL . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 0.47 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 0.22 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.61 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 0.22 109.655 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.17 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 0.16 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.44 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 2.82 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 0.67 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.59 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 2.56 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.18 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.594 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.58 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.675 ' HA ' HG21 ' A' ' 278' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 0.92 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.11 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.668 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 0.1 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 306' ' ' SER . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 0.13 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 0.13 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 0.13 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 282' ' ' ILE . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 0.23 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.542 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.49 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.56 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 0.27 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.49 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 0.65 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.57 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.651 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.16 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.72 112.801 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 1.64 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.07 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.36 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 3.98 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 0.34 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 0.34 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 0.71 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.689 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.3 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 0.33 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.651 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.49 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 2.41 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.797 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.7 OUTLIER -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.87 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 2.45 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.542 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.07 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 0.17 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.508 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 0.29 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.54 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.34 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.1 Cg_exo . . . . . 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.5 117.546 172.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.459 0.108 . . . . 0.48 111.883 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 259' ' ' VAL . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.26 110.72 -172.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.01 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.656 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 0.34 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.05 111.33 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.8 mp . . . . . 0 C--O 1.221 -0.425 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 0.46 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.644 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 0.27 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.655 HG13 HD13 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 0.15 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.52 107.251 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 0.24 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.637 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 0.17 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.523 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 0.69 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.21 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.575 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 3.65 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 2.92 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 0.88 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.52 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.43 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 0.34 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.559 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 274' ' ' ASN . 0.9 OUTLIER -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.46 111.523 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.641 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.08 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.818 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.69 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 0.94 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 0.23 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 1.63 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 0.36 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 1.45 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.676 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.34 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.443 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.543 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 0.58 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 313' ' ' ARG . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 0.47 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.65 ' CG2' HD12 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 0.22 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.61 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.17 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 0.16 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.44 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . 0.432 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 2.82 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 0.67 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.59 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.494 ' CB ' ' HE1' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.794 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 2.56 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.18 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.58 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.794 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 0.92 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.11 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.719 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 0.1 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 0.13 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 0.13 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 0.13 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.741 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 0.23 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.49 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.56 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 0.27 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.49 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 0.65 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.57 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.608 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.16 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.72 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 1.64 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.845 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.07 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.36 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 3.98 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 0.34 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.706 ' HB ' HD13 ' A' ' 324' ' ' LEU . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 0.34 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 0.71 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.712 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.3 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 0.33 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.49 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 2.41 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.879 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.6 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.815 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 2.45 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.582 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.07 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.648 HD12 HG21 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 0.17 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.561 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.29 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.818 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.54 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.581 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.34 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo . . . . . 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.5 117.275 177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.725 0.219 . . . . 0.48 111.676 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 259' ' ' VAL . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.26 111.136 -171.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.01 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.736 HG23 ' HA ' ' A' ' 340' ' ' PHE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 0.34 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.803 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.903 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.47 -0.196 . . . . 0.47 110.47 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 0.46 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.729 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 0.27 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.607 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 0.15 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.52 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 0.24 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 0.17 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.468 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 0.69 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.21 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.683 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.593 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 3.65 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 342' ' ' PRO . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 2.92 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 0.88 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.52 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 0.34 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 2.49 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 342' ' ' PRO . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.46 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.775 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.08 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.8 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.69 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 0.94 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.472 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 0.12 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 0.23 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.73 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 1.63 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 0.36 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.698 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 1.45 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.34 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.515 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 0.58 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 0.47 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 0.22 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.61 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 0.22 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.17 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 0.16 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.44 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 2.82 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.456 ' HB3' HG11 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.59 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 2.56 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.18 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.58 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.707 ' HA ' HG23 ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 0.92 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.11 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 0.1 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 306' ' ' SER . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 0.13 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 0.13 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 0.13 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.73 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 0.23 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 312' ' ' VAL . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.49 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.683 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.56 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 0.27 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.49 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 0.65 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.57 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.406 ' OE2' HD11 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.16 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.72 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 1.64 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.673 HD22 HG21 ' A' ' 328' ' ' THR . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.07 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.36 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 3.98 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 0.34 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.673 HG21 HD22 ' A' ' 324' ' ' LEU . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 0.34 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 0.71 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.3 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 0.33 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.903 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.49 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.495 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 2.41 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.63 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 2.45 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.07 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 0.17 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 0.29 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.54 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.634 ' HB3' HG13 ' B' ' 5' ' ' VAL . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.34 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.5 116.056 -167.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--O 1.234 0.311 0 N-CA-C 111.412 -0.265 . . . . 0.48 111.412 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 259' ' ' VAL . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.26 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 341' ' ' LYS . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.01 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 0.34 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.05 111.08 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 120.862 0.363 . . . . 0.47 110.249 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.778 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 0.46 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.641 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 0.27 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.794 HG21 HD23 ' B' ' 4' ' ' LEU . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 0.15 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.52 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 0.24 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.66 ' CG1' HD13 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.826 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 0.69 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 264' ' ' GLN . 0.0 OUTLIER -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.21 105.797 178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 3.65 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 2.92 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 0.88 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.52 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 0.34 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 275' ' ' GLY . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 2.49 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.46 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.08 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.69 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 0.94 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.631 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 0.12 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 0.23 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 312' ' ' VAL . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 1.63 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 0.36 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 1.45 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.34 113.014 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.635 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 0.58 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 0.47 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.564 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 0.22 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.61 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 0.22 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.17 111.224 175.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 0.16 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.631 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.44 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 2.82 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 0.67 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.731 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.59 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.415 ' HB2' ' HE1' ' A' ' 276' ' ' MET . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.732 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 2.56 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.18 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.732 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.639 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 0.92 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.11 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.609 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 0.1 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.639 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 0.13 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 0.13 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 0.13 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 282' ' ' ILE . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 0.23 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.49 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.56 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 290' ' ' ILE . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 0.27 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.646 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.49 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.641 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 0.65 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.57 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.443 ' OE2' HD11 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.635 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.16 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.72 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 1.64 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 328' ' ' THR . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.07 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.36 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 3.98 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 0.34 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.753 HG21 HD22 ' A' ' 324' ' ' LEU . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 0.34 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 0.71 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.3 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 0.33 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.49 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.498 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 2.41 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.782 ' HB3' HD11 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 2.45 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.07 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 258' ' ' ILE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 0.17 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 0.29 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.772 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.54 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.34 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo . . . . . 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.5 115.198 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 337' ' ' ARG . 84.4 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 N-CA-C 112.716 0.237 . . . . 0.48 112.716 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.26 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.01 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.752 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 0.34 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.05 112.08 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.784 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 120.804 0.335 . . . . 0.47 110.285 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 0.46 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.613 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 0.27 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.698 HG21 HD23 ' B' ' 4' ' ' LEU 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 0.15 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.52 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 0.24 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 0.17 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.516 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.69 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.21 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.604 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 3.65 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 2.92 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 0.88 113.34 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.52 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.911 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 0.34 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 2.49 108.688 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.46 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.911 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.08 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.762 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.69 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 305' ' ' ASP . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 0.94 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 0.12 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 0.23 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 1.63 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 0.36 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 1.45 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.34 113.777 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.498 ' H ' HD22 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.616 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 0.58 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.47 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 0.22 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.61 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 0.22 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.17 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.44 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 2.82 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.67 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.59 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 2.56 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.18 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 301' ' ' ASP . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.58 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 0.92 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.11 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 0.1 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 0.13 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 0.13 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 0.13 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 0.23 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.49 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.604 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.56 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 0.27 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.49 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 0.65 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.57 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.616 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.16 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.72 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 1.64 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.07 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.36 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 3.98 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 0.34 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.678 HG21 HD22 ' A' ' 324' ' ' LEU . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.34 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 0.71 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.691 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.3 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 0.33 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.504 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.49 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.699 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 2.41 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.952 ' HB3' HD11 ' A' ' 281' ' ' LEU . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.754 ' H ' HD13 ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 2.45 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.563 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.07 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 258' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 0.17 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.503 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 0.29 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.54 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.34 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 276' ' ' MET . 32.2 Cg_exo . . . . . 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.5 118.35 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 N-CA-C 111.592 -0.195 . . . . 0.48 111.592 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.67 HD23 HG21 ' A' ' 259' ' ' VAL . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.26 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.01 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.769 HD13 HG13 ' A' ' 259' ' ' VAL . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 0.34 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.121 -177.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.4 mp . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 109.5 -0.555 . . . . 0.47 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ASP . . . . . 0.63 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.629 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 0.46 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 0.27 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.769 HG13 HD13 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 0.15 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.52 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 0.24 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.674 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 0.17 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.544 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.69 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.21 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.644 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.533 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 3.65 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 2.92 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 0.88 113.09 167.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.52 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.923 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 0.34 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 2.49 109.872 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.46 112.794 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.08 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.69 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 0.94 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.584 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 0.12 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 0.23 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.71 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 1.63 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.549 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 0.36 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 1.45 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.34 113.548 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.695 ' O ' HD12 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 0.58 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 0.47 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 0.22 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.61 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 0.22 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.17 111.294 175.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 0.16 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.584 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.44 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 2.82 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 0.67 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.59 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 2.56 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.592 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.18 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.519 ' CE1' HG23 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.58 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 0.92 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.11 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.614 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 0.1 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 0.13 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 0.13 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 0.13 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 0.23 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.49 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.56 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 0.27 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.49 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 319' ' ' PRO . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 0.65 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.57 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.641 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.16 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.72 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 1.64 108.472 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.07 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.36 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 3.98 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 0.34 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 0.34 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.422 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 0.71 109.632 173.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . 0.721 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.3 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.721 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 0.33 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.641 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.49 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 2.41 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 3.0 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.71 ' H ' HD13 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 2.45 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ARG . . . . . 0.569 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.07 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 0.17 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ILE . . . . . 0.571 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 0.29 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.54 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.34 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 341' ' ' LYS . 24.4 Cg_exo . . . . . 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.5 118.309 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.7 -0.482 . . . . 1.84 109.7 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -95.95 124.46 52.06 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.975 -0.379 . . . . 1.1 109.975 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 64.3 Cg_exo -49.77 120.99 6.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.736 2.291 . . . . 0.48 111.871 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.709 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.2 tm? -94.64 136.61 34.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.98 -0.748 . . . . 1.26 108.98 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.548 ' N ' HD13 ' B' ' 4' ' ' LEU . 59.1 t -77.01 102.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.297 0.57 . . . . 1.01 111.399 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.676 HD13 HG13 ' A' ' 259' ' ' VAL . 5.8 tp -92.85 116.38 33.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.586 0.707 . . . . 0.34 109.2 174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.57 ' HB2' ' OE1' ' A' ' 343' ' ' GLU . 4.0 m -110.16 -7.43 14.89 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.381 0.61 . . . . 1.05 109.872 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.637 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 4.7 t -100.38 156.45 17.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.716 -1.129 . . . . 2.56 110.696 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.29 -127.28 1.06 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.336 -1.105 . . . . 1.85 110.336 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' B' ' 12' ' ' ARG . 18.7 p-10 -53.97 147.94 11.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.796 0.331 . . . . 3.21 110.825 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.81 58.77 4.46 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.622 1.677 . . . . 5.81 110.055 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' B' ' 10' ' ' ASN . 1.2 ppt_? -77.24 -166.32 0.71 Allowed 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 111.173 -2.74 . . . . 5.3 111.456 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.571 -0.728 . . . . 7.77 109.872 172.865 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.62 ' HA ' ' O ' ' A' ' 228' ' ' LEU . 23.5 p80 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.246 0.546 . . . . 40.22 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.61 176.2 10.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.001 -0.545 . . . . 40.04 111.316 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 66.78 -78.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.648 0.779 . . . . 39.27 111.841 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -147.0 19.32 1.25 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.069 0.461 . . . . 37.29 110.656 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 224' ' ' HIS . 62.3 tp -139.65 88.5 2.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.871 -0.604 . . . . 36.13 110.218 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.29 -61.19 1.97 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.658 0.742 . . . . 34.41 110.893 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.535 ' HG3' ' H ' ' A' ' 232' ' ' LEU . 12.1 pt-20 -168.53 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.438 -1.255 . . . . 32.45 108.896 -168.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.23 -30.44 62.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.842 -0.799 . . . . 30.94 108.842 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 230' ' ' GLU . 16.5 tp -78.44 55.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 30.21 109.889 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 25.3 t -142.44 106.64 4.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.652 . . . . 27.83 109.746 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.98 56.7 4.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.364 0.602 . . . . 27.14 110.454 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -74.17 -65.99 0.78 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.286 -0.87 . . . . 25.54 109.978 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 237' ' ' GLU . 12.2 p -146.49 -153.36 0.48 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.66 -1.237 . . . . 23.93 107.66 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.429 ' H ' ' HB ' ' A' ' 236' ' ' THR . 1.3 mp0 -84.14 84.98 7.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.944 -0.761 . . . . 24.03 108.944 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -125.91 97.99 5.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 22.83 110.673 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -78.8 69.52 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.399 0.619 . . . . 21.0 110.21 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -82.85 57.53 3.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.562 -0.745 . . . . 19.72 111.455 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.64 64.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.838 -0.619 . . . . 17.66 110.806 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.5 tp -105.12 90.11 3.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.797 -0.638 . . . . 16.08 110.129 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -84.6 178.54 7.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.049 -0.523 . . . . 14.08 110.782 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.3 -175.82 2.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 13.03 111.559 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -52.87 145.4 12.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.681 0.993 . . . . 12.06 113.681 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 247' ' ' GLY . 11.1 p -107.4 172.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.838 -1.074 . . . . 9.73 109.866 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.542 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -100.01 117.94 6.03 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.28 -0.873 . . . . 7.65 111.919 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.8 p -96.08 -73.81 0.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.977 0.418 . . . . 6.51 110.597 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -59.4 2.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.523 0.678 . . . . 4.79 111.11 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 7.9 m -149.09 -147.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 114.249 -1.341 . . . . 2.23 111.174 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.658 HG22 HD22 ' A' ' 332' ' ' LEU . 4.8 p 53.66 73.87 0.35 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.465 1.126 . . . . 1.43 108.943 -168.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -61.88 -139.48 0.01 OUTLIER Glycine 0 C--N 1.319 -0.401 0 CA-C-N 113.648 -1.615 . . . . 1.61 113.49 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.892 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 8.5 p -82.44 16.88 1.9 Allowed 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 123.251 1.5 . . . . 1.62 111.219 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.677 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -85.96 -55.29 4.02 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.574 -3.012 . . . . 0.47 112.205 -167.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.612 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 2.0 m-20 -51.48 -42.77 61.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.154 0.502 . . . . 2.08 110.359 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.58 -32.35 73.03 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.092 -0.958 . . . . 0.89 111.684 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.892 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.8 mt -62.82 -53.01 60.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.437 0.636 . . . . 0.46 111.575 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.658 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.8 OUTLIER -48.16 -47.23 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.36 -1.291 . . . . 0.27 110.167 175.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' B' ' 4' ' ' LEU . 4.4 t -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.718 -2.037 . . . . 0.15 111.328 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -59.66 -50.22 74.72 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 124.049 1.88 . . . . 0.52 107.64 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -62.84 -45.36 92.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 109.889 -3.323 . . . . 0.24 112.422 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.633 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.02 -36.19 72.71 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.985 -0.552 . . . . 0.17 111.535 -172.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 1.3 p -78.81 -24.4 44.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.719 0.295 . . . . 0.69 111.162 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -67.07 -33.84 76.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 106.111 -1.811 . . . . 1.21 106.111 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.587 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -89.72 -20.09 24.01 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.053 -2.34 . . . . 1.53 114.304 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.637 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.5 t90 -85.13 167.02 16.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.765 1.269 . . . . 0.21 110.587 -172.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.8 mtm180 -156.2 109.41 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 112.045 -2.343 . . . . 3.65 110.774 -169.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -68.99 145.55 96.7 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 121.342 0.592 . . . . 2.92 110.689 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 304' ' ' PHE . 50.2 Cg_endo -95.44 150.16 1.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.451 3.434 . . . . 0.57 111.718 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -52.86 -14.49 3.55 Favored 'Trans proline' 0 C--N 1.331 -0.389 0 C-N-CA 123.966 3.111 . . . . 0.88 113.236 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.5 p -89.76 -23.24 21.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.518 0.562 . . . . 0.52 112.518 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.978 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.08 138.85 58.04 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-O 121.393 0.616 . . . . 0.34 112.554 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.606 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 21.5 mmt180 -110.06 170.7 7.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 2.49 109.493 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.43 32.68 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.479 0.918 . . . . 1.62 113.479 -167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 166.4 34.58 0.02 OUTLIER Glycine 0 C--N 1.301 -1.41 0 CA-C-N 115.471 -0.786 . . . . 0.46 112.594 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.978 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 5.4 ptm -88.52 152.94 21.53 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.109 -1.811 . . . . 1.08 106.109 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.781 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 5.7 p -154.42 152.45 30.18 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 118.462 -1.295 . . . . 0.69 114.201 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.6 t -127.64 131.91 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-N 113.864 -1.516 . . . . 0.94 108.969 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.554 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.4 tt0 -95.37 122.94 38.6 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.104 -1.443 . . . . 1.39 107.104 165.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 38.2 t -117.7 117.91 56.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.981 -0.554 . . . . 0.12 110.476 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 335' ' ' GLN . 6.5 tp -90.03 119.41 30.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.957 0.885 . . . . 0.23 110.113 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 1.9 mt -104.18 166.6 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.516 0 CA-C-N 113.725 -1.579 . . . . 1.63 110.774 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.9 mt-10 -140.15 133.98 30.58 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 113.078 -1.874 . . . . 0.3 108.841 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 290' ' ' ILE . 16.6 mtp -146.24 159.83 42.8 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 123.249 1.499 . . . . 0.36 112.623 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.668 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -93.6 160.59 32.57 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 111.072 -2.786 . . . . 1.45 108.84 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -59.74 4.25 0.17 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.049 2.5 . . . . 0.34 112.669 175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 285' ' ' LEU . 15.0 t70 -101.74 -17.05 16.44 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.656 -0.868 . . . . 0.55 108.656 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.74 -9.72 68.57 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.558 -1.201 . . . . 0.16 110.789 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.0 OUTLIER -58.46 117.26 4.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.96 0.886 . . . . 0.58 110.149 174.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 315' ' ' VAL . 4.6 mt -66.59 114.56 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.72 -1.582 . . . . 0.47 110.605 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.668 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.9 p -94.89 -28.2 15.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.338 -1.301 . . . . 0.22 110.015 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.9 t30 -151.56 170.05 20.61 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.61 110.084 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' NE ' ' A' ' 313' ' ' ARG . . . -173.8 125.64 0.37 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.423 -1.262 . . . . 0.22 109.369 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.01 169.17 18.25 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.198 0.999 . . . . 0.17 110.319 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -77.31 115.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 CA-C-N 113.168 -1.833 . . . . 0.16 108.09 168.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 3.3 p -86.26 -32.01 21.34 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.734 -1.575 . . . . 0.44 109.485 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -152.05 108.89 3.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.968 -1.015 . . . . 2.82 108.676 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -77.7 149.49 34.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.497 0.555 . . . . 0.67 112.497 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 277' ' ' SER . 59.4 p -82.09 -7.69 59.63 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.365 -0.834 . . . . 0.59 109.826 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.3 27.26 44.75 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -172.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 3.3 t70 -146.32 92.63 2.2 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.57 107.374 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 62.4 mttt -54.92 -43.38 98.83 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.503 0.557 . . . . 2.56 112.503 -172.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.599 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 2.3 Cg_endo -51.12 -51.43 11.21 Favored 'Trans proline' 0 CA--C 1.501 -1.166 0 C-N-CA 121.896 1.731 . . . . 0.18 111.654 170.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.705 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 62.0 t80 -62.03 -54.45 41.39 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.498 0.666 . . . . 0.58 109.66 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.4 m-20 -50.98 -57.81 7.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.407 -1.269 . . . . 2.31 111.325 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.653 ' HA ' HG23 ' A' ' 309' ' ' VAL . 4.3 t -70.07 -38.22 75.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 114.176 1.176 . . . . 0.92 114.176 -175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.0 p -51.79 -31.61 27.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.39 1.091 . . . . 0.11 109.505 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.725 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.83 -30.33 24.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.882 -1.963 . . . . 0.1 110.809 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.653 HG23 ' HA ' ' A' ' 306' ' ' SER . 50.0 t -62.94 -40.67 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 123.41 1.576 . . . . 0.13 108.426 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -12.25 59.94 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.272 -1.331 . . . . 0.13 110.766 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.93 -44.45 40.09 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.272 -1.381 . . . . 0.13 107.272 170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 315' ' ' VAL . 29.0 m -70.78 -53.65 21.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.23 112.047 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.552 ' HG2' HG23 ' A' ' 312' ' ' VAL . 14.9 mmt180 -57.51 -34.32 68.97 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.172 -0.922 . . . . 0.49 112.344 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.587 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.0 t30 -70.26 -25.77 63.51 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.93 -0.308 . . . . 0.56 111.523 -174.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.09 -44.29 65.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.75 1.262 . . . . 0.27 109.036 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.98 -19.67 0.11 Allowed Glycine 0 C--N 1.307 -1.063 0 CA-C-N 112.226 -2.261 . . . . 0.7 117.91 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -161.47 125.08 3.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 117.694 0.747 . . . . 3.49 109.946 177.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.652 HG12 HG13 ' A' ' 258' ' ' ILE . 2.9 mp -102.81 139.52 20.23 Favored Pre-proline 0 N--CA 1.437 -1.113 0 CA-C-N 116.637 -0.256 . . . . 0.65 111.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 318' ' ' ILE . 42.5 Cg_endo -54.58 -71.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 125.012 3.808 . . . . 0.57 117.35 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 34.1 mt-10 -73.2 1.11 9.95 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 1.9 114.721 -162.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 321' ' ' MET . 5.8 mmm -62.22 -25.34 67.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.736 -0.602 . . . . 1.16 110.768 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 54.3 mt-30 -82.48 1.7 36.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.72 112.521 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 2.2 mt-30 -100.44 -10.64 20.92 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.26 1.029 . . . . 1.64 109.341 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 328' ' ' THR . 71.1 mt -91.14 164.79 23.76 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.49 -1.686 . . . . 1.07 113.029 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.7 Cg_exo -60.93 134.71 54.91 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 C-N-CA 124.396 3.397 . . . . 0.36 108.49 160.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 326' ' ' ARG . 13.7 mmt85 -52.05 -38.78 58.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.525 0.678 . . . . 3.98 110.786 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.54 74.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.549 -1.205 . . . . 0.34 112.11 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.708 HG21 HD22 ' A' ' 324' ' ' LEU . 54.7 m -82.23 -37.98 25.17 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 122.145 0.974 . . . . 0.34 108.672 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -60.87 -48.37 82.1 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.089 -1.414 . . . . 0.71 109.548 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 19.5 t70 -56.13 -34.07 65.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.625 0.77 . . . . 0.83 111.159 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.701 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.24 -49.32 57.35 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.762 1.268 . . . . 0.3 108.983 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 12.2 mt -102.98 -59.26 1.74 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.103 -1.862 . . . . 0.33 115.058 -166.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 77.6 m-85 -107.58 -5.89 17.27 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.664 -0.698 . . . . 0.49 112.036 -161.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.08 -49.37 63.67 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.693 0.759 . . . . 2.41 109.885 171.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.848 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.6 mt-30 -123.26 118.65 28.08 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.017 -1.105 . . . . 0.45 108.017 165.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.878 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -109.18 141.38 41.5 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 118.663 -1.215 . . . . 2.45 108.167 -173.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.602 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 4.7 mmt180 -113.58 114.65 26.77 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 109.168 -0.678 . . . . 1.07 109.168 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.658 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.0 mt -109.43 124.66 66.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.309 -0.859 . . . . 0.17 110.279 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -99.02 111.59 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.65 -0.87 . . . . 0.29 108.65 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.781 ' O ' ' HA ' ' A' ' 277' ' ' SER . 75.1 m-85 -90.57 104.06 16.69 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.33 -0.989 . . . . 0.54 108.33 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.507 ' HB3' HG13 ' B' ' 5' ' ' VAL . 70.1 tttt -137.25 88.95 16.77 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 109.481 -0.562 . . . . 1.34 109.481 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 276' ' ' MET . 42.7 Cg_exo -28.94 169.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 1 C-N-CA 127.655 5.57 . . . . 0.5 120.077 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' B' ' 7' ' ' SER . 11.0 pt-20 -152.61 129.24 10.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 111.805 -2.452 . . . . 2.54 107.719 174.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 59.85 64.06 1.36 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.677 0.621 . . . . 2.26 112.677 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.2 OUTLIER -80.32 -175.1 4.93 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 1.22 111.153 171.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.2 m -72.35 -32.39 66.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.971 0.891 . . . . 1.77 111.015 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.606 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 113.805 -1.543 . . . . 2.89 112.17 -163.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.187 0.042 . . . . 1.84 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.8 t70 70.45 105.71 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 123.836 0.71 . . . . 1.1 110.968 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 85.4 Cg_exo -43.71 128.68 6.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.55 2.833 . . . . 0.48 112.773 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.554 HD12 HG21 ' A' ' 259' ' ' VAL . 0.3 OUTLIER -103.73 129.4 51.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 1.26 109.964 -172.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.7 p -74.58 114.81 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.594 0.711 . . . . 1.01 111.899 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.753 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -112.79 120.41 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.342 -0.844 . . . . 0.34 109.577 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 13.0 p -114.7 -6.79 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.218 0.532 . . . . 1.05 111.575 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.67 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.8 t -94.79 153.62 17.66 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 2.56 110.37 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.79 103.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.763 -0.935 . . . . 1.85 110.763 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' B' ' 12' ' ' ARG . 58.9 t30 -128.13 170.08 13.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.704 -0.48 . . . . 3.21 109.704 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.16 47.6 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.863 1.316 . . . . 5.81 111.272 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' B' ' 10' ' ' ASN . 34.5 ptt180 -110.11 159.27 17.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 112.758 -2.019 . . . . 5.3 109.774 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.76 -0.638 . . . . 7.77 110.206 177.642 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.749 0.309 . . . . 40.22 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.71 86.48 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.964 0.411 . . . . 40.04 109.976 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HD3' ' OE1' ' A' ' 230' ' ' GLU . 0.0 OUTLIER -134.67 61.17 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.918 0.389 . . . . 39.27 110.583 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.12 -25.85 66.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 37.29 110.723 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.38 -9.98 59.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 36.13 111.274 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 44.84 71.87 0.24 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.851 0.719 . . . . 34.41 112.627 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 226' ' ' ARG . 7.9 pt-20 -75.34 107.62 7.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.376 0.608 . . . . 32.45 110.14 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.62 -45.03 12.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 30.94 110.132 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.1 mt 59.27 74.45 0.44 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.241 0.544 . . . . 30.21 111.45 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.0 p -103.22 29.9 5.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.807 0.813 . . . . 27.83 109.274 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -83.35 6.98 17.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.877 -1.056 . . . . 27.14 111.161 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 2.1 m -69.23 162.03 27.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.343 -0.614 . . . . 25.54 109.343 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 5.3 p -146.33 129.95 16.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.979 0.418 . . . . 23.93 109.888 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.29 126.13 35.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.714 0.769 . . . . 24.03 109.303 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -152.04 94.94 2.01 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.395 -1.275 . . . . 22.83 109.318 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -131.52 -63.49 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.505 -0.77 . . . . 21.0 110.137 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 54.97 51.73 13.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.445 0.64 . . . . 19.72 110.412 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.84 148.74 42.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.156 -0.929 . . . . 17.66 111.362 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.68 133.89 39.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.618 -0.719 . . . . 16.08 109.569 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.462 ' HB2' ' OD2' ' A' ' 330' ' ' ASP . . . -78.36 164.55 24.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.389 0.614 . . . . 14.08 111.429 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.0 158.81 20.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.253 -0.885 . . . . 13.03 110.855 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -94.82 146.24 24.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.326 -0.852 . . . . 12.06 111.735 -173.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 247' ' ' GLY . 9.9 p -104.96 -179.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.056 -0.72 . . . . 9.73 109.056 173.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.734 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -75.53 121.75 6.51 Favored Glycine 0 C--N 1.308 -0.978 0 CA-C-N 115.747 -0.661 . . . . 7.65 112.379 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.1 p 50.73 79.2 0.09 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.981 0.912 . . . . 6.51 111.638 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.558 ' HB2' HG23 ' A' ' 328' ' ' THR . 0.2 OUTLIER -127.2 -93.62 0.47 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.901 -0.591 . . . . 4.79 112.266 -177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.472 ' H ' ' CG ' ' A' ' 249' ' ' GLU . 18.1 m 56.79 -179.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 115.919 1.822 . . . . 2.23 115.919 164.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.509 ' HB ' ' OD1' ' A' ' 255' ' ' ASP . 22.6 p -71.85 102.9 2.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.004 -1.907 . . . . 1.43 111.527 -172.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.412 ' CA ' HD12 ' A' ' 254' ' ' LEU . . . -91.44 60.12 2.94 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.785 -1.098 . . . . 1.61 113.516 -173.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.668 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 60.09 12.93 3.47 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.401 1.096 . . . . 1.62 110.289 -177.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER -81.43 -32.49 32.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.535 -1.666 . . . . 0.47 109.334 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.509 ' OD1' ' HB ' ' A' ' 251' ' ' THR . 2.1 m-20 -50.71 -53.13 33.94 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.468 -0.787 . . . . 2.08 110.836 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.2 t70 -65.02 -31.26 72.4 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 114.049 -1.432 . . . . 0.89 110.213 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.717 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.8 mt -64.55 -53.13 52.71 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.239 -0.891 . . . . 0.46 112.101 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.574 HD11 ' CE ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.72 -44.45 14.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 123.03 1.395 . . . . 0.27 110.695 173.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.753 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.1 t -70.49 -35.86 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 112.389 -2.187 . . . . 0.15 111.485 178.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.5 t30 -60.41 -50.07 75.05 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 123.831 1.777 . . . . 0.52 107.35 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 63.1 mt -60.54 -50.08 74.98 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 110.054 -3.248 . . . . 0.24 112.224 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -60.15 -37.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.895 0 CA-C-N 116.216 -0.447 . . . . 0.17 112.038 -171.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.588 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.5 p -81.64 -15.22 55.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.989 0.366 . . . . 0.69 111.989 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -71.24 -33.37 69.78 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.905 -1.887 . . . . 1.21 105.905 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.588 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.8 mp0 -90.25 -20.08 23.39 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 112.039 -2.346 . . . . 1.53 114.406 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' B' ' 8' ' ' SER . 13.8 t90 -86.35 170.63 11.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.335 1.064 . . . . 0.21 110.61 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 87.9 mtm180 -153.7 110.29 3.36 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.281 -2.236 . . . . 3.65 110.019 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' B' ' 8' ' ' SER . 34.3 mtm180 -77.71 135.69 63.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.795 0.331 . . . . 2.92 110.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 38.4 Cg_endo -89.6 147.55 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.072 2.514 . . . . 0.57 111.797 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.3 Cg_endo -52.87 -7.86 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.03 3.154 . . . . 0.88 113.582 169.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 53.3 p -95.35 -15.38 23.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.52 111.481 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.956 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.55 145.07 54.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.11 0.481 . . . . 0.34 111.439 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.608 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 42.9 mmt-85 -124.4 168.58 12.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.97 -0.752 . . . . 2.49 108.97 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.06 53.77 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.001 1.111 . . . . 1.62 114.001 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.32 24.42 0.03 OUTLIER Glycine 0 C--N 1.287 -2.145 0 CA-C-N 113.884 -1.507 . . . . 0.46 113.518 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.956 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.2 ptm -81.95 149.47 28.17 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.959 -1.867 . . . . 1.08 105.959 167.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.795 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 23.8 p -159.34 153.54 23.69 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.878 -1.129 . . . . 0.69 113.209 -171.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -126.91 126.65 68.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.648 -1.614 . . . . 0.94 109.871 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.33 114.19 26.22 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.356 -1.35 . . . . 1.39 107.356 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 282' ' ' ILE . 43.0 t -116.19 122.29 69.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.45 -0.795 . . . . 0.12 110.414 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.961 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.0 tp -95.61 107.89 20.12 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.546 -0.752 . . . . 0.23 109.964 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.74 160.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 107.499 -1.297 . . . . 1.63 107.499 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 18.0 mt-10 -128.89 144.84 51.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.063 -0.717 . . . . 0.3 109.063 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 4.5 mtp -149.56 160.38 43.53 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 123.34 1.543 . . . . 0.36 113.559 -169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.635 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.2 mt -92.23 165.0 20.95 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 110.986 -2.824 . . . . 1.45 109.768 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.561 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 77.9 Cg_exo -58.73 -3.68 1.57 Allowed 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.554 2.836 . . . . 0.34 112.471 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 3.4 t70 -99.7 -15.06 18.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.043 -0.98 . . . . 0.55 108.789 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.577 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 93.92 -11.69 70.48 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 114.581 -1.19 . . . . 0.16 110.426 -171.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -52.64 120.08 5.27 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.968 0.889 . . . . 0.58 109.979 175.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 316' ' ' GLY . 3.1 mm -66.95 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 113.799 -1.546 . . . . 0.47 110.084 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.635 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.0 p -98.08 -27.36 14.24 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.345 -0.843 . . . . 0.22 110.544 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.0 t30 -154.82 172.85 17.31 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.098 0.475 . . . . 0.61 110.953 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.96 132.42 0.25 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.014 -0.994 . . . . 0.22 110.737 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.81 170.91 14.83 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.291 1.043 . . . . 0.17 109.944 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -80.91 117.53 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-N 113.005 -1.907 . . . . 0.16 108.385 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 -36.18 20.67 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.003 -1.453 . . . . 0.44 109.202 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 33.4 mmt180 -148.03 107.82 4.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.916 -1.038 . . . . 2.82 109.384 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -76.59 149.28 36.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.676 -0.693 . . . . 0.67 112.008 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 277' ' ' SER . 79.7 p -82.68 -7.05 59.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.993 0.901 . . . . 0.59 109.779 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.16 61.62 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.396 -1.275 . . . . 0.57 111.033 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -104.68 96.25 6.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.585 0.707 . . . . 1.57 109.276 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 58.6 mttt -58.37 -40.01 79.61 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 114.322 -1.308 . . . . 2.56 112.224 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.5 Cg_endo -49.23 -52.91 7.87 Favored 'Trans proline' 0 CA--C 1.505 -0.961 0 C-N-CA 122.313 2.008 . . . . 0.18 111.398 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.787 ' CE2' ' HG3' ' A' ' 276' ' ' MET . 71.9 t80 -60.19 -49.27 78.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.634 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 58.3 m-20 -56.19 -59.99 4.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.896 -1.047 . . . . 2.31 111.108 178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.688 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -68.96 -35.57 76.91 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 114.095 1.146 . . . . 0.92 114.095 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -53.66 -29.47 38.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.213 1.006 . . . . 0.11 109.354 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.632 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.8 -29.95 20.6 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.157 -1.838 . . . . 0.1 111.076 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.688 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 51.8 t -62.96 -40.05 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.452 1.596 . . . . 0.13 108.589 169.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.11 -13.82 60.51 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 114.226 -1.352 . . . . 0.13 110.759 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.27 -43.15 52.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.058 -1.46 . . . . 0.13 107.058 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 315' ' ' VAL . 23.8 m -73.1 -49.02 41.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.23 112.603 -175.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.544 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 15.1 mmt180 -57.13 -39.73 75.74 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.515 -0.766 . . . . 0.49 112.424 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.588 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 54.3 t30 -69.57 -24.5 63.7 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.087 0.403 . . . . 0.56 112.087 -171.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.2 m -66.65 -41.45 88.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.667 1.223 . . . . 0.27 109.28 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.52 -21.38 0.24 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 112.286 -2.234 . . . . 0.7 116.377 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -162.13 133.08 5.06 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 122.631 0.373 . . . . 3.49 110.564 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.539 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.44 126.09 37.07 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-O 121.446 0.641 . . . . 0.65 110.213 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.45 ' HD2' HD11 ' A' ' 261' ' ' LEU . 61.4 Cg_endo -60.25 -47.96 13.19 Favored 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.807 3.671 . . . . 0.57 116.189 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.09 4.73 25.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.502 1.297 . . . . 1.9 114.502 -165.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.665 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.7 mmt -65.77 -26.05 67.54 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.169 0.509 . . . . 1.16 111.86 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -77.43 3.45 13.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.469 -0.787 . . . . 0.72 111.821 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -95.97 -49.21 5.38 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.476 -1.305 . . . . 1.64 107.476 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.704 HD22 HG21 ' A' ' 328' ' ' THR . 80.9 mt -56.2 155.65 12.36 Favored Pre-proline 0 N--CA 1.417 -2.117 0 CA-C-N 113.907 -1.497 . . . . 1.07 115.029 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.4 Cg_exo -58.37 137.86 82.7 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 124.28 3.32 . . . . 0.36 109.179 163.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.561 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 48.1 tpt85 -50.61 -35.7 31.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.483 0.659 . . . . 3.98 111.151 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.96 -30.82 62.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.537 -1.211 . . . . 0.34 111.798 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.704 HG21 HD22 ' A' ' 324' ' ' LEU . 51.9 m -80.23 -37.02 33.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.446 1.117 . . . . 0.34 108.201 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.455 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 11.4 t80 -59.85 -53.69 54.91 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 113.521 -1.672 . . . . 0.71 109.41 171.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 1.9 t70 -56.48 -27.37 56.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.966 0.906 . . . . 0.83 110.499 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -72.85 -52.92 12.89 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.497 1.141 . . . . 0.3 109.32 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -100.44 -61.16 1.4 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.618 -1.628 . . . . 0.33 114.289 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.665 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.7 m-85 -104.9 -4.76 21.77 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.877 -0.601 . . . . 0.49 111.817 -163.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 1.2 tmt_? -43.42 -59.49 2.11 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 122.888 1.328 . . . . 2.41 108.716 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.961 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -121.4 109.73 15.23 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 112.458 -2.156 . . . . 0.45 107.043 163.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.727 ' H ' HD13 ' A' ' 282' ' ' ILE . 5.2 tpt180 -103.12 114.39 28.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.13 -1.433 . . . . 2.45 107.13 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.57 ' CD ' HD13 ' A' ' 281' ' ' LEU . 9.8 mmt180 -81.05 110.73 16.86 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 118.485 -1.286 . . . . 1.07 110.573 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 258' ' ' ILE . 10.3 mt -97.92 121.7 48.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 113.273 -1.785 . . . . 0.17 108.598 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -100.76 112.14 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.381 -0.97 . . . . 0.29 108.381 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 277' ' ' SER . 91.5 m-85 -87.73 101.03 13.28 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 18.4 ttmt -136.35 95.5 13.02 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 116.207 -0.451 . . . . 1.34 110.663 -171.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.638 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 31.6 Cg_exo -28.2 155.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 1 C-N-CA 126.592 4.861 . . . . 0.5 118.122 176.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -156.34 113.82 3.22 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 112.492 -2.14 . . . . 2.54 107.475 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 28.5 t70 60.59 75.86 0.39 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.533 0.682 . . . . 2.26 111.359 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.638 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -80.63 -73.39 0.37 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.765 0.793 . . . . 1.22 111.703 175.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.1 t 177.77 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.811 -1.54 . . . . 1.77 108.969 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.608 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.511 0 CA-C-N 112.322 -2.217 . . . . 2.89 112.328 -167.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.314 -0.624 . . . . 1.84 109.314 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -54.81 128.42 63.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 123.719 0.637 . . . . 1.1 111.18 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 31.2 Cg_exo -56.23 119.28 6.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.66 2.24 . . . . 0.48 111.054 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 259' ' ' VAL . 65.1 tp -94.79 139.57 31.09 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.503 -0.479 . . . . 1.26 110.928 -170.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.4 t -69.63 103.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.376 -0.829 . . . . 1.01 110.876 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.728 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -95.25 112.05 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 108.617 -0.883 . . . . 0.34 108.617 172.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -107.12 -16.73 14.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.378 0.609 . . . . 1.05 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.599 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 16.1 t -68.86 -174.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.994 -1.003 . . . . 2.56 110.015 177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.6 91.92 0.41 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 109.981 -1.248 . . . . 1.85 109.981 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -59.93 141.17 56.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.435 1.112 . . . . 3.21 113.265 -165.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -168.7 23.05 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.904 -1.953 . . . . 5.81 107.47 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -137.24 38.88 2.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.055 -1.884 . . . . 5.3 110.678 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.534 -0.757 . . . . 7.77 110.035 178.774 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.45 ' HB3' ' CD ' ' A' ' 230' ' ' GLU . 12.2 t-80 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.378 -0.23 . . . . 40.22 110.378 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.1 mmt -95.0 -46.58 6.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.314 0.578 . . . . 40.04 109.552 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -152.54 -37.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.256 -0.883 . . . . 39.27 110.451 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.06 165.72 11.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 37.29 111.132 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.73 145.94 30.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.704 -0.851 . . . . 36.13 108.704 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 58.61 52.06 7.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.304 0.573 . . . . 34.41 110.047 -172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.45 ' CD ' ' HB3' ' A' ' 224' ' ' HIS . 57.9 mt-10 -62.79 121.84 14.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.064 -0.971 . . . . 32.45 111.277 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.49 130.59 43.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.477 -0.783 . . . . 30.94 110.251 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 233' ' ' SER . 2.9 pp -81.41 -18.67 44.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.845 0.313 . . . . 30.21 111.845 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 232' ' ' LEU . 8.7 t -108.16 133.69 52.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.9 -0.778 . . . . 27.83 108.9 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 75.31 5.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.814 0.34 . . . . 27.14 110.923 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.5 p 55.45 -172.68 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.282 1.033 . . . . 25.54 112.598 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 7.0 m -98.22 -51.49 3.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.268 0.556 . . . . 23.93 110.34 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.53 161.42 22.34 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.088 -0.96 . . . . 24.03 109.984 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER 66.13 97.88 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.699 0.624 . . . . 22.83 110.531 -178.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 75.25 175.67 0.23 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.062 -0.972 . . . . 21.0 110.307 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 57.76 50.8 10.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.024 -0.534 . . . . 19.72 111.046 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.41 -56.88 13.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.563 . . . . 17.66 109.996 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.63 97.03 8.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.109 -1.071 . . . . 16.08 108.109 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -101.13 142.04 33.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.049 -0.523 . . . . 14.08 111.089 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.26 -172.5 2.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 13.03 109.705 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.92 134.64 48.61 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.461 0.648 . . . . 12.06 111.439 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 247' ' ' GLY . 8.7 p -106.34 172.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 9.73 110.679 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -126.59 41.54 1.61 Allowed Glycine 0 C--N 1.309 -0.923 0 CA-C-N 114.573 -1.194 . . . . 7.65 111.946 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -172.51 82.45 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.374 -0.602 . . . . 6.51 109.374 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.476 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.6 pm0 -83.59 -135.68 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.222 0.534 . . . . 4.79 111.417 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.1 m -158.96 -169.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.285 -0.871 . . . . 2.23 110.128 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 16.3 p -105.32 2.4 28.84 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 113.201 0.815 . . . . 1.43 113.201 -172.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 44.33 37.66 4.76 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 124.413 1.071 . . . . 1.61 115.396 170.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.763 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.2 OUTLIER 58.7 14.74 3.31 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 118.327 1.063 . . . . 1.62 112.353 -176.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -84.96 -38.54 19.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.47 110.128 -177.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.755 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.6 p-10 -58.88 -43.81 90.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.118 0.961 . . . . 2.08 109.667 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.429 ' HA ' ' CD2' ' B' ' 4' ' ' LEU . 5.8 t70 -61.71 -36.44 80.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.975 -1.92 . . . . 0.89 110.976 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.0 mt -62.17 -54.58 39.05 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.442 -0.799 . . . . 0.46 112.068 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.71 -47.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.664 1.221 . . . . 0.27 110.271 175.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.728 HG13 HD13 ' B' ' 6' ' ' ILE 0.254 4.9 t -64.79 -39.61 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 113.059 -1.882 . . . . 0.15 111.275 177.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -57.73 -51.58 68.96 Favored 'General case' 0 CA--C 1.486 -1.516 0 CA-C-O 123.912 1.815 . . . . 0.52 107.589 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 78.8 mt -61.36 -43.87 98.13 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 109.934 -3.303 . . . . 0.24 112.506 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -64.15 -39.96 87.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-N 115.844 -0.616 . . . . 0.17 112.101 -171.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.599 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.2 p -80.41 -17.17 52.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.822 0.344 . . . . 0.69 111.805 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.58 -35.22 75.15 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 105.859 -1.904 . . . . 1.21 105.859 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.683 HE21 HG12 ' A' ' 315' ' ' VAL . 2.3 mp0 -88.56 -17.2 30.7 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 112.096 -2.32 . . . . 1.53 114.25 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.588 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.1 t90 -89.59 171.88 9.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.603 1.192 . . . . 0.21 109.935 -173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.454 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 23.4 ttt180 -152.15 123.14 7.55 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.309 -2.223 . . . . 3.65 109.311 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 12.0 ptp180 -81.22 147.65 61.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 119.05 -1.06 . . . . 2.92 109.742 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 87.7 Cg_endo -101.61 -179.45 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 124.912 3.741 . . . . 0.57 111.768 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.73 -7.83 7.27 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.686 2.924 . . . . 0.88 110.658 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.7 p -84.23 -32.91 24.23 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.999 -1.455 . . . . 0.52 111.299 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 269' ' ' PRO . . . -58.83 139.64 56.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.375 0.607 . . . . 0.34 112.479 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 273' ' ' ARG . 10.7 mmt180 -113.63 170.88 7.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.124 -0.944 . . . . 2.49 109.391 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -74.35 56.01 0.63 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.278 1.037 . . . . 1.62 112.932 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.01 34.79 0.08 OUTLIER Glycine 0 C--N 1.283 -2.377 0 CA-C-N 113.426 -1.716 . . . . 0.46 112.349 171.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.603 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 13.7 mtp -81.33 146.92 30.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.528 -1.656 . . . . 1.08 106.528 170.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.4 p -150.17 146.92 27.16 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.399 -1.32 . . . . 0.69 113.544 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -123.33 125.98 72.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 113.643 -1.617 . . . . 0.94 108.734 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.513 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 12.1 tt0 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.129 -1.434 . . . . 1.39 107.129 168.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 282' ' ' ILE . 54.0 t -118.27 117.77 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.668 -0.696 . . . . 0.12 110.276 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.1 tp -92.66 103.01 15.43 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.784 -1.098 . . . . 0.23 109.181 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.66 156.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.711 0 N-CA-C 107.206 -1.405 . . . . 1.63 107.206 177.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.7 mt-10 -121.41 139.2 53.77 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 108.918 -0.771 . . . . 0.3 108.918 -172.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.495 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 9.7 mtp -146.67 161.99 39.4 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 123.043 1.402 . . . . 0.36 112.109 -173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -110.79 168.48 7.52 Favored Pre-proline 0 C--N 1.292 -1.929 0 CA-C-N 111.167 -2.742 . . . . 1.45 110.183 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.47 -5.2 0.25 Allowed 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 124.07 3.18 . . . . 0.34 113.591 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 285' ' ' LEU . 4.8 t70 -97.79 -12.59 22.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.716 0.769 . . . . 0.55 109.715 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.508 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 88.98 -13.11 63.99 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.607 -1.179 . . . . 0.16 112.467 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 98.7 m -55.1 125.98 22.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.423 1.106 . . . . 0.58 110.563 170.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 315' ' ' VAL . 5.1 mt -73.45 112.87 10.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.229 -1.805 . . . . 0.47 109.821 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 42.9 p -98.24 -19.99 17.51 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.663 -1.153 . . . . 0.22 110.37 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.0 t30 -151.61 171.42 17.65 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 110.142 -0.318 . . . . 0.61 110.142 172.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.59 132.66 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.45 -0.796 . . . . 0.22 111.215 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.56 169.46 17.53 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 122.456 1.122 . . . . 0.17 110.732 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -81.62 117.56 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.741 -2.027 . . . . 0.16 107.843 167.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.6 p -89.68 -30.17 18.27 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.772 -1.558 . . . . 0.44 109.211 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -154.12 111.94 3.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.021 -0.991 . . . . 2.82 109.272 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 10.3 p -79.2 150.22 31.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.315 -0.857 . . . . 0.67 111.618 -173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.425 ' OG ' ' HD1' ' A' ' 304' ' ' PHE . 0.9 OUTLIER -81.44 -5.03 57.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.582 0.706 . . . . 0.59 109.401 172.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.49 24.83 52.86 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.127 -1.189 . . . . 0.57 110.127 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 14.1 t70 -141.29 94.8 2.74 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.53 -0.915 . . . . 1.57 108.53 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 61.4 mttt -56.04 -45.01 99.96 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 114.844 -1.071 . . . . 2.56 112.279 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.4 Cg_endo -49.82 -52.12 9.51 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 121.896 1.73 . . . . 0.18 111.3 169.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.519 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 25.5 t80 -58.32 -54.5 46.34 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.014 0.912 . . . . 0.58 109.368 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 70.1 m-20 -56.3 -58.13 9.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.701 -1.591 . . . . 2.31 111.109 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.721 ' HA ' HG23 ' A' ' 309' ' ' VAL . 70.6 m -69.8 -35.08 74.54 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 114.629 1.344 . . . . 0.92 114.629 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.0 p -54.17 -29.92 47.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.27 1.033 . . . . 0.11 109.298 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.94 -29.49 25.08 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.425 -1.716 . . . . 0.1 110.633 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.721 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.6 t -64.06 -39.34 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 CA-C-O 123.309 1.528 . . . . 0.13 108.767 170.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.3 -15.01 60.54 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.449 -1.251 . . . . 0.13 110.769 175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.662 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.01 -42.39 57.52 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.927 -1.508 . . . . 0.13 106.927 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.4 m -70.54 -54.6 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 CA-C-N 116.04 -0.527 . . . . 0.23 111.62 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.1 mmt180 -56.71 -36.59 69.86 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.345 -0.843 . . . . 0.49 112.273 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 56.3 t30 -69.84 -25.09 63.58 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 111.668 0.247 . . . . 0.56 111.668 -173.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.683 HG12 HE21 ' A' ' 265' ' ' GLN . 1.9 m -72.82 -46.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 122.275 1.036 . . . . 0.27 108.607 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.51 -21.33 0.02 OUTLIER Glycine 0 C--O 1.211 -1.327 0 CA-C-N 111.832 -2.44 . . . . 0.7 117.804 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.0 OUTLIER -143.74 114.84 7.87 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 117.701 0.751 . . . . 3.49 110.626 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 258' ' ' ILE . 3.1 mp -102.09 134.5 20.03 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 121.251 0.548 . . . . 0.65 110.448 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.3 Cg_endo -74.76 -53.72 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.744 2.963 . . . . 0.57 116.019 -164.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.422 ' OE2' HD11 ' A' ' 257' ' ' LEU . 43.2 mt-10 -80.57 5.5 15.2 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.491 0.923 . . . . 1.9 113.491 -168.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.661 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 16.0 mmm -65.61 -25.35 67.35 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.716 -0.615 . . . . 1.16 111.22 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -82.1 3.48 26.78 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.72 111.898 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -93.27 -48.55 6.39 Favored 'General case' 0 N--CA 1.404 -2.725 0 N-CA-C 107.806 -1.183 . . . . 1.64 107.806 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 328' ' ' THR . 87.5 mt -54.77 154.39 9.49 Favored Pre-proline 0 N--CA 1.418 -2.063 0 N-CA-C 115.468 1.655 . . . . 1.07 115.468 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 61.2 Cg_exo -58.37 138.95 88.62 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 124.569 3.513 . . . . 0.36 109.698 163.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -44.93 40.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.813 0.816 . . . . 3.98 110.014 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.26 77.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.098 -1.41 . . . . 0.34 112.422 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.752 HG21 HD22 ' A' ' 324' ' ' LEU . 50.3 m -78.06 -40.7 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.393 1.092 . . . . 0.34 108.574 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 10.7 t80 -56.09 -49.34 74.11 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.436 -1.711 . . . . 0.71 109.667 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 34.9 t70 -54.64 -38.71 67.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.653 -0.703 . . . . 0.83 111.46 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -63.5 -49.9 71.75 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.336 -1.302 . . . . 0.3 108.454 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 7.5 mt -103.0 -58.78 1.81 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.42 -2.173 . . . . 0.33 115.128 -165.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.661 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.6 m-85 -109.47 -5.4 15.78 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.283 -0.871 . . . . 0.49 112.306 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.464 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.83 -41.4 64.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.595 0.712 . . . . 2.41 109.219 171.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.841 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.3 mt-30 -132.3 110.71 10.79 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.094 -1.447 . . . . 0.45 107.094 161.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.828 ' HB3' HD11 ' A' ' 282' ' ' ILE . 21.2 tpt180 -103.63 115.38 30.39 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.606 -1.257 . . . . 2.45 107.606 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.487 ' HG2' HD13 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -81.73 116.23 21.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 118.54 -1.264 . . . . 1.07 111.811 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.53 HD12 HG21 ' A' ' 282' ' ' ILE . 9.4 mt -101.36 123.49 54.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 113.154 -1.839 . . . . 0.17 108.937 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.534 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -103.08 110.42 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 N-CA-C 109.208 -0.664 . . . . 0.29 109.208 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.5 m-85 -88.32 101.44 13.87 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.331 -0.618 . . . . 0.54 109.331 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.703 ' HB3' HG13 ' B' ' 5' ' ' VAL . 61.8 tttt -135.97 89.37 20.74 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 116.352 -0.386 . . . . 1.34 110.07 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 276' ' ' MET . 24.4 Cg_exo -31.72 171.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 1 C-N-CA 127.168 5.245 . . . . 0.5 119.075 179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -151.6 128.73 11.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 111.862 -2.426 . . . . 2.54 108.707 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 52.3 73.23 0.35 Allowed 'General case' 0 C--N 1.321 -0.671 0 O-C-N 124.206 0.941 . . . . 2.26 113.43 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.4 mm? -79.11 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.958 0.885 . . . . 1.22 110.431 170.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -169.52 -44.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.991 -1.459 . . . . 1.77 108.208 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.305 -1.35 0 CA-C-N 112.954 -1.93 . . . . 2.89 110.174 -177.492 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.033 0.012 . . . . 1.84 111.033 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.75 125.75 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 O-C-N 123.657 0.598 . . . . 1.1 110.945 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.32 117.53 4.3 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 121.867 1.711 . . . . 0.48 110.823 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.761 HD23 HG21 ' A' ' 259' ' ' VAL . 45.4 tp -101.32 140.84 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.909 -0.316 . . . . 1.26 110.539 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 341' ' ' LYS . 78.2 t -72.39 112.6 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.01 110.941 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 259' ' ' VAL . 5.4 tp -109.46 120.34 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.687 -0.688 . . . . 0.34 109.703 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 15.5 p -108.94 -29.28 8.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.573 0.702 . . . . 1.05 110.946 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.647 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 m -70.36 148.68 48.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.948 -1.023 . . . . 2.56 110.746 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.62 108.81 0.35 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.917 -1.273 . . . . 1.85 109.917 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -141.97 164.31 30.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.944 0.402 . . . . 3.21 110.33 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.6 1.5 4.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.579 -0.737 . . . . 5.81 110.849 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -57.07 173.32 0.23 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.567 -1.197 . . . . 5.3 111.999 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.789 . . . . 7.77 110.323 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.923 0.392 . . . . 40.22 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.7 ptp -163.3 35.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 40.04 109.544 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -126.38 120.9 31.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.512 -0.767 . . . . 39.27 110.685 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 55.06 50.25 15.78 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.579 0.55 . . . . 37.29 111.679 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.5 tp -84.09 56.28 3.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.835 0.826 . . . . 36.13 109.941 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -113.35 98.22 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.052 -0.976 . . . . 34.41 109.376 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.64 113.51 6.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 32.45 111.543 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.86 76.38 1.62 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.751 -0.659 . . . . 30.94 110.057 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.87 65.4 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.492 . . . . 30.21 109.702 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 m -104.06 -70.91 0.75 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.234 -0.439 . . . . 27.83 110.719 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 52.71 1.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.284 0.564 . . . . 27.14 110.077 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.678 ' HB ' ' OE1' ' A' ' 237' ' ' GLU . 7.5 p -81.35 -47.54 13.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.092 -0.958 . . . . 25.54 110.984 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.3 m 68.88 86.66 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.1 -0.5 . . . . 23.93 111.152 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.678 ' OE1' ' HB ' ' A' ' 235' ' ' THR . 5.3 mp0 -99.89 -22.33 15.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.046 0.927 . . . . 24.03 109.725 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.49 93.54 8.8 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.409 -1.269 . . . . 22.83 110.696 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -66.04 -49.95 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.662 -0.699 . . . . 21.0 109.961 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 56.75 66.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 19.72 111.274 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.72 -15.28 28.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.234 0.54 . . . . 17.66 110.743 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.66 100.3 6.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.882 -0.784 . . . . 16.08 108.882 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -144.03 135.24 25.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.999 -0.546 . . . . 14.08 111.191 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.47 -173.6 4.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.834 -0.621 . . . . 13.03 110.126 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 249' ' ' GLU . 4.2 pt-20 -54.81 122.82 11.59 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.523 0.678 . . . . 12.06 110.929 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.2 p -88.35 155.71 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 122.003 0.906 . . . . 9.73 112.642 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 70.85 -114.01 5.07 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.136 -1.393 . . . . 7.65 111.26 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.5 t -123.68 -11.66 7.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.643 0.258 . . . . 6.51 111.391 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.722 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.8 pm0 -141.11 -113.81 0.13 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.13 -0.693 . . . . 4.79 109.13 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.3 m -155.09 -179.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.11 0.481 . . . . 2.23 111.291 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.3 p -111.3 9.04 21.63 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.149 -0.932 . . . . 1.43 112.856 -170.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.31 -122.2 20.3 Favored Glycine 0 C--N 1.315 -0.631 0 O-C-N 123.853 0.721 . . . . 1.61 111.864 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.861 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.0 m -119.01 16.15 13.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.191 0.996 . . . . 1.62 109.278 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.804 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 2.7 mp -79.68 -44.31 21.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.219 -1.809 . . . . 0.47 109.913 -164.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.503 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 10.2 p-10 -53.97 -48.61 70.16 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.851 -1.068 . . . . 2.08 111.071 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.64 -32.46 73.8 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.153 -1.385 . . . . 0.89 111.054 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 253' ' ' SER . 7.9 mt -61.49 -53.33 57.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.178 0.514 . . . . 0.46 111.888 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.63 -46.3 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 122.771 1.272 . . . . 0.27 110.572 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.763 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.0 t -68.23 -35.71 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.612 -2.085 . . . . 0.15 110.911 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.0 t30 -61.02 -50.78 71.95 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 123.949 1.833 . . . . 0.52 107.546 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 77.3 mt -61.93 -47.42 84.99 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 110.178 -3.192 . . . . 0.24 112.524 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.614 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -61.01 -36.67 73.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 CA-C-N 116.053 -0.521 . . . . 0.17 111.554 -171.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.577 ' HB3' HD11 ' B' ' 6' ' ' ILE . 2.6 p -81.31 -17.29 49.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.098 0.407 . . . . 0.69 112.098 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -73.52 -35.14 65.53 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.198 -1.779 . . . . 1.21 106.198 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.647 HE21 HG12 ' A' ' 315' ' ' VAL . 2.3 mp0 -86.1 -19.21 30.53 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 112.304 -2.225 . . . . 1.53 114.005 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.647 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.7 t90 -87.62 168.17 13.26 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.91 1.338 . . . . 0.21 110.528 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 40.9 ttp180 -156.11 103.42 2.2 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 111.584 -2.553 . . . . 3.65 109.899 -173.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 17.8 ptt180 -81.52 147.39 59.52 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.314 -0.554 . . . . 2.92 109.846 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 64.3 Cg_endo -96.74 151.99 1.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 124.413 3.408 . . . . 0.57 112.949 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.2 Cg_endo -52.4 -16.42 5.1 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 124.155 3.237 . . . . 0.88 113.253 168.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.0 p -81.63 -28.38 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.568 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.806 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -62.71 139.71 58.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.977 -0.556 . . . . 0.34 111.043 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.688 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 19.9 mmt180 -132.41 168.36 18.29 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.373 -0.973 . . . . 2.49 108.373 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.07 137.81 12.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.517 0.51 . . . . 1.62 110.414 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 54.13 26.05 34.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 117.799 1.88 . . . . 0.46 117.799 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.825 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 0.0 OUTLIER -81.74 151.62 27.39 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.416 -1.698 . . . . 1.08 106.416 159.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 339' ' ' ILE . 33.1 t -169.89 157.8 6.94 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 122.706 1.241 . . . . 0.69 112.479 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.485 ' HB ' ' OD1' ' A' ' 305' ' ' ASP . 2.3 p -134.57 127.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.36 -2.2 . . . . 0.94 108.918 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.518 ' HG3' HG12 ' A' ' 339' ' ' ILE . 7.6 tt0 -90.68 122.26 33.3 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.065 -1.087 . . . . 1.39 108.065 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 282' ' ' ILE . 83.0 t -117.17 117.97 57.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.232 -0.895 . . . . 0.12 110.673 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.4 tp -89.58 117.78 28.73 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.726 -0.67 . . . . 0.23 109.818 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.8 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.66 167.61 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-O 121.483 0.658 . . . . 1.63 110.022 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.2 mt-10 -139.77 140.17 36.63 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.393 -1.73 . . . . 0.3 109.037 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 17.1 mtp -150.94 160.84 43.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 123.335 1.541 . . . . 0.36 113.543 -169.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.665 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.3 mt -88.92 160.31 43.89 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 110.692 -2.958 . . . . 1.45 108.962 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -57.29 -3.2 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.479 2.786 . . . . 0.34 112.847 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -95.58 -19.98 19.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.668 0.747 . . . . 0.55 109.091 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.654 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 95.92 -2.44 64.07 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 114.1 -1.409 . . . . 0.16 110.271 -172.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.1 OUTLIER -62.08 120.14 10.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.816 0.817 . . . . 0.58 109.876 172.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.567 HD12 HG22 ' A' ' 315' ' ' VAL . 2.6 mt -67.53 117.36 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-N 114.297 -1.319 . . . . 0.47 110.934 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.665 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 51.2 p -99.84 -25.76 14.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.486 -1.233 . . . . 0.22 110.572 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.69 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.1 t30 -153.05 170.9 19.33 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.987 0.422 . . . . 0.61 110.065 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -173.25 126.97 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.747 -1.115 . . . . 0.22 109.452 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 169.01 18.56 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.466 1.127 . . . . 0.17 111.01 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.647 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -77.32 115.06 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 112.947 -1.933 . . . . 0.16 108.474 166.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -87.33 -33.13 19.3 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 113.36 -1.746 . . . . 0.44 109.022 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -151.58 117.98 5.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.78 -1.1 . . . . 2.82 108.969 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.5 p -84.37 150.92 25.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.183 0.438 . . . . 0.67 112.183 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 277' ' ' SER . 60.6 p -82.81 -11.36 58.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.679 0.752 . . . . 0.59 109.929 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 97.29 -14.65 63.32 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 114.498 -1.228 . . . . 0.57 111.23 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.488 ' CG ' ' HG2' ' A' ' 303' ' ' PRO . 30.4 t70 -107.25 97.32 7.1 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.095 -1.076 . . . . 1.57 108.095 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 59.5 mttt -57.82 -42.37 95.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 114.779 -1.1 . . . . 2.56 111.926 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.0 OUTLIER -49.69 -49.91 14.59 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.003 1.802 . . . . 0.18 111.619 167.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.504 ' HE1' ' HA ' ' A' ' 277' ' ' SER . 66.6 t80 -59.06 -51.82 68.39 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.132 -0.692 . . . . 0.58 109.132 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.647 ' HB3' HG21 ' A' ' 295' ' ' VAL . 65.5 m-20 -54.16 -60.62 3.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.392 -1.276 . . . . 2.31 111.182 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.685 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 5.2 t -67.8 -36.12 79.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.182 -0.917 . . . . 0.92 113.454 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.9 p -54.67 -30.01 54.27 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.487 1.137 . . . . 0.11 109.361 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.642 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.01 -29.64 23.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.17 -1.832 . . . . 0.1 110.46 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.685 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 58.0 t -62.94 -39.84 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 CA-C-O 123.576 1.655 . . . . 0.13 108.865 169.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.54 -13.98 60.38 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 113.845 -1.525 . . . . 0.13 110.787 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.97 -43.25 55.09 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.09 -1.448 . . . . 0.13 107.09 171.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.8 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -71.31 -53.79 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-O 121.615 0.722 . . . . 0.23 111.688 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 312' ' ' VAL . 8.3 mmt180 -58.03 -34.64 70.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.223 -0.898 . . . . 0.49 112.632 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 57.0 t30 -68.0 -26.07 65.73 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.536 0.207 . . . . 0.56 111.328 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.647 HG12 HE21 ' A' ' 265' ' ' GLN . 1.3 m -69.94 -44.84 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.538 1.161 . . . . 0.27 109.148 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 64.62 -27.62 0.1 Allowed Glycine 0 C--N 1.307 -1.07 0 CA-C-N 112.238 -2.256 . . . . 0.7 117.534 172.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -146.62 122.35 10.54 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.251 0.548 . . . . 3.49 110.148 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.813 HD13 HG13 ' A' ' 258' ' ' ILE . 93.9 mt -104.97 137.62 19.26 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.509 0.671 . . . . 0.65 111.071 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.2 Cg_endo -70.91 -57.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.03 3.154 . . . . 0.57 116.603 -162.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -82.38 5.57 19.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.272 1.582 . . . . 1.9 115.272 -162.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.726 ' SD ' HG22 ' A' ' 318' ' ' ILE . 0.0 OUTLIER -59.39 -23.67 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.706 0.684 . . . . 1.16 111.884 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -84.3 5.54 26.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.861 -0.609 . . . . 0.72 112.559 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -96.33 -48.3 5.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.757 -1.572 . . . . 1.64 106.757 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 328' ' ' THR . 82.3 mt -55.17 155.67 8.64 Favored Pre-proline 0 N--CA 1.413 -2.275 0 CA-C-N 113.642 -1.617 . . . . 1.07 114.796 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.3 Cg_exo -60.11 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.435 3.423 . . . . 0.36 109.28 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -52.33 -43.01 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.457 0.646 . . . . 3.98 110.28 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.23 70.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.613 -1.176 . . . . 0.34 112.342 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.766 HG21 HD22 ' A' ' 324' ' ' LEU . 53.5 m -84.19 -38.36 20.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.188 0.994 . . . . 0.34 109.261 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -45.63 90.73 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.051 -1.431 . . . . 0.71 109.293 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 18.5 t70 -56.8 -32.52 65.77 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.993 0.902 . . . . 0.83 111.018 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.698 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.53 -47.67 59.3 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.138 -1.392 . . . . 0.3 109.193 -177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 7.3 mt -104.85 -60.28 1.63 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.259 -1.792 . . . . 0.33 115.669 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.804 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 75.1 m-85 -107.13 -4.36 18.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.265 -0.425 . . . . 0.49 111.951 -162.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -53.56 -52.47 59.61 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.236 -0.653 . . . . 2.41 109.236 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.877 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -119.05 113.13 20.46 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.849 -1.069 . . . . 0.45 108.442 163.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.595 ' O ' HG12 ' A' ' 282' ' ' ILE . 22.6 tpt180 -104.35 109.96 22.01 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.106 -0.701 . . . . 2.45 109.106 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.564 ' CD ' HD13 ' A' ' 281' ' ' LEU . 6.1 mmt180 -84.28 119.97 25.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.944 0.878 . . . . 1.07 112.56 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 258' ' ' ILE . 6.3 mt -115.87 123.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.796 -1.547 . . . . 0.17 109.717 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.56 HG23 ' OG ' ' A' ' 277' ' ' SER . 0.6 OUTLIER -102.26 111.12 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.697 ' HA ' HG23 ' B' ' 6' ' ' ILE . 49.8 m-85 -88.69 100.31 13.02 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.235 -1.024 . . . . 0.54 108.235 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 23.9 ttmt -136.22 106.72 9.44 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 116.401 -0.363 . . . . 1.34 110.173 -170.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.825 ' HD2' ' O ' ' A' ' 276' ' ' MET . 93.7 Cg_exo -28.18 150.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 126.495 4.797 . . . . 0.5 118.396 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -155.53 110.07 2.92 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.215 -2.266 . . . . 2.54 106.862 169.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.81 71.66 0.57 Allowed 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.903 0.752 . . . . 2.26 111.641 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.5 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.1 OUTLIER -78.35 -164.71 0.58 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.898 -0.592 . . . . 1.22 109.767 171.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.5 m -66.99 -30.91 71.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.982 0.896 . . . . 1.77 110.752 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.688 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 113.832 -1.531 . . . . 2.89 111.978 -162.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.576 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.443 -0.577 . . . . 1.84 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -111.34 115.97 51.52 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.952 -0.388 . . . . 1.1 109.952 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.79 119.69 6.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.987 2.458 . . . . 0.48 111.307 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 259' ' ' VAL . 54.1 tp -98.32 141.85 30.69 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.529 -0.468 . . . . 1.26 111.256 -168.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.5 106.95 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.34 -0.846 . . . . 1.01 110.797 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.729 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.5 tp -99.15 111.99 30.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.536 -0.756 . . . . 0.34 109.217 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 4.6 p -104.57 -19.48 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.636 -0.711 . . . . 1.05 111.886 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 8.8 t -70.12 -174.36 0.79 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.507 -0.769 . . . . 2.56 109.806 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.6 85.35 0.32 Allowed Glycine 0 CA--C 1.503 -0.686 0 N-CA-C 111.12 -0.792 . . . . 1.85 111.12 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.77 168.0 27.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.78 -0.71 . . . . 3.21 110.299 -170.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.1 -18.89 60.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.537 -0.756 . . . . 5.81 111.874 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -73.42 49.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.987 -0.551 . . . . 5.3 112.062 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.778 -0.629 . . . . 7.77 111.113 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.798 0.332 . . . . 40.22 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 61.4 ttp -81.56 118.46 22.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.205 -0.452 . . . . 40.04 109.91 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -101.95 124.64 47.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 39.27 110.322 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -64.86 137.11 57.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.584 . . . . 37.29 111.001 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.2 -54.95 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.918 -0.771 . . . . 36.13 108.918 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -156.83 -59.6 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.551 -0.75 . . . . 34.41 109.506 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.42 107.81 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.136 -0.938 . . . . 32.45 112.639 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.65 80.34 7.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.263 -0.88 . . . . 30.94 109.479 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.23 -48.95 77.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 30.21 110.948 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' A' ' 240' ' ' GLN . 37.7 m -109.97 57.78 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.64 -0.709 . . . . 27.83 111.093 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.07 -30.77 65.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 27.14 109.558 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 236' ' ' THR . 0.2 OUTLIER 59.58 -157.56 0.33 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.066 -0.97 . . . . 25.54 110.98 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 235' ' ' THR . 2.6 m 65.1 -85.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.549 0.74 . . . . 23.93 110.86 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.91 -6.05 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.138 0.494 . . . . 24.03 110.856 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.86 30.15 1.24 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.785 -0.643 . . . . 22.83 110.874 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 60.07 -142.82 0.55 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.101 -0.5 . . . . 21.0 110.829 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 7.3 tp60 67.38 67.46 0.39 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.663 0.602 . . . . 19.72 110.215 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.94 167.64 0.23 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.882 -1.054 . . . . 17.66 112.069 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 54.8 tp -68.48 125.55 26.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 16.08 110.597 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -77.14 126.67 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 14.08 110.702 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.72 -178.58 5.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.428 -0.582 . . . . 13.03 109.428 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -73.03 114.54 11.3 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.268 0.556 . . . . 12.06 110.841 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.7 p -77.38 155.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.158 -0.928 . . . . 9.73 110.962 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 80.64 -55.9 4.72 Favored Glycine 0 C--N 1.309 -0.955 0 CA-C-N 114.679 -1.146 . . . . 7.65 111.586 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.1 p -90.64 55.8 3.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.646 0.736 . . . . 6.51 109.358 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.515 ' HB2' HG22 ' A' ' 250' ' ' VAL . 1.8 pt-20 -99.04 -88.17 0.34 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.226 -0.897 . . . . 4.79 112.696 -173.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.745 ' HB ' HD11 ' A' ' 332' ' ' LEU . 3.2 m -139.4 -160.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.346 -0.843 . . . . 2.23 112.956 -166.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.601 ' H ' HD13 ' A' ' 332' ' ' LEU . 1.8 t 43.85 70.74 0.29 Allowed 'General case' 0 C--N 1.349 0.569 0 CA-C-O 123.005 1.383 . . . . 1.43 109.973 -171.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -63.18 -137.61 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 111.826 -2.443 . . . . 1.61 114.812 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.885 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 6.4 p -74.25 6.04 3.94 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 122.924 1.345 . . . . 1.62 111.591 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.779 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 3.7 mp -81.76 -45.82 15.09 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 110.901 -2.863 . . . . 0.47 111.413 -167.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.648 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -60.68 -45.33 94.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.772 0.796 . . . . 2.08 110.538 -176.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.0 t70 -60.75 -34.47 74.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.576 -1.647 . . . . 0.89 110.804 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.885 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.6 mt -60.98 -53.73 53.68 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.535 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -48.33 -48.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 122.607 1.194 . . . . 0.27 110.656 175.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.725 HG13 HD13 ' B' ' 6' ' ' ILE 0.263 8.8 t -64.56 -38.02 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-N 112.786 -2.006 . . . . 0.15 111.337 176.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 10.0 t30 -60.87 -51.38 69.56 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 124.059 1.885 . . . . 0.52 107.87 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.4 mt -62.24 -44.53 96.34 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 109.878 -3.328 . . . . 0.24 112.593 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 1.2 p -60.74 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.006 -0.543 . . . . 0.17 111.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 266' ' ' TRP . 3.5 m -84.54 -9.18 58.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.334 0.494 . . . . 0.69 112.334 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.79 -20.63 59.71 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 105.741 -1.948 . . . . 1.21 105.741 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.438 ' HG2' HG12 ' A' ' 315' ' ' VAL . 10.6 mm-40 -107.87 -16.82 14.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.068 -2.333 . . . . 1.53 112.578 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.637 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -86.34 169.89 12.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.555 1.169 . . . . 0.21 110.233 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -154.04 110.13 3.26 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 112.333 -2.212 . . . . 3.65 110.066 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 0.1 OUTLIER -72.25 147.11 90.25 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.367 0.603 . . . . 2.92 110.65 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 57.3 Cg_endo -97.87 172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 124.183 3.256 . . . . 0.57 111.721 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.23 -7.63 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.703 2.936 . . . . 0.88 110.365 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.2 p -83.76 -26.04 29.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.84 -1.527 . . . . 0.52 110.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 1.001 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.96 142.82 58.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.297 0.57 . . . . 0.34 112.116 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.653 ' HA ' ' CD2' ' A' ' 347' ' ' LEU . 36.5 mmt180 -116.78 170.06 8.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.642 -0.708 . . . . 2.49 109.266 175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -75.63 56.78 0.92 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.401 1.096 . . . . 1.62 113.352 -167.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 141.87 35.58 0.1 OUTLIER Glycine 0 C--N 1.28 -2.54 0 CA-C-N 113.166 -1.834 . . . . 0.46 112.009 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 1.001 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 4.5 ptm -84.34 152.5 24.06 Favored 'General case' 0 N--CA 1.405 -2.685 0 N-CA-C 105.22 -2.141 . . . . 1.08 105.22 166.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.749 ' HB3' ' HG3' ' A' ' 341' ' ' LYS . 86.8 p -154.24 158.85 40.86 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.047 -1.461 . . . . 0.69 113.66 -171.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.2 t -129.77 124.47 59.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 112.879 -1.964 . . . . 0.94 108.922 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.0 120.65 27.62 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.265 -1.754 . . . . 1.39 106.265 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.595 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.8 t -120.78 116.65 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.614 -0.721 . . . . 0.12 110.27 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.809 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.5 tp -89.19 115.93 27.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.01 -0.995 . . . . 0.23 110.316 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.707 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.04 168.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-N 115.165 -0.925 . . . . 1.63 109.004 176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.742 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 16.1 mt-10 -138.45 141.53 39.49 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 113.455 -1.702 . . . . 0.3 108.359 172.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 13.2 mtp -150.47 163.56 38.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 123.24 1.495 . . . . 0.36 113.03 -169.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.641 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.4 mt -93.5 160.26 33.36 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 110.877 -2.874 . . . . 1.45 109.492 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -60.81 -0.94 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 123.09 2.527 . . . . 0.34 112.348 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 285' ' ' LEU . 1.1 t70 -92.86 -25.44 18.1 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.234 -0.894 . . . . 0.55 108.821 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.69 -9.18 56.9 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 113.818 -1.537 . . . . 0.16 111.404 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 88.3 m -57.33 122.48 12.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.01 0.909 . . . . 0.58 109.81 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 5.5 mt -69.4 114.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-N 113.554 -1.657 . . . . 0.47 109.952 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.641 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 64.3 p -98.7 -22.97 15.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.045 -0.98 . . . . 0.22 109.819 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.742 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.2 t-20 -150.51 171.29 17.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.298 0.571 . . . . 0.61 110.546 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.6 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.92 127.52 0.73 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.62 -1.173 . . . . 0.22 109.253 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.26 168.8 18.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.544 1.164 . . . . 0.17 110.974 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.3 t -82.63 115.76 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 CA-C-N 112.87 -1.968 . . . . 0.16 108.564 167.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 281' ' ' LEU . 21.6 p -96.46 -19.82 18.87 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 113.613 -1.631 . . . . 0.44 110.133 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -155.29 103.17 2.33 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.092 -0.707 . . . . 2.82 109.092 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.422 ' HB3' HG11 ' A' ' 295' ' ' VAL . 38.0 p -78.37 150.73 33.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.67 111.802 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.724 ' HB3' ' O ' ' A' ' 277' ' ' SER . 20.2 p -85.29 -5.61 59.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.397 -0.819 . . . . 0.59 109.994 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.27 -13.28 67.07 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.906 -1.043 . . . . 0.57 111.016 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 6.6 t70 -106.07 103.65 13.18 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.62 0.724 . . . . 1.57 109.261 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.623 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 36.3 mmtt -62.55 -46.4 89.21 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 114.33 -1.304 . . . . 2.56 112.445 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.618 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 0.9 OUTLIER -48.29 -48.04 18.07 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 121.804 1.67 . . . . 0.18 110.848 170.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.607 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.8 t80 -60.8 -48.79 80.22 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.775 -0.648 . . . . 0.58 109.393 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.623 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.98 -61.43 2.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.202 -0.908 . . . . 2.31 111.252 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 67.2 m -69.01 -34.55 75.44 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.717 1.377 . . . . 0.92 114.717 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.5 p -53.05 -30.58 36.59 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 122.045 0.926 . . . . 0.11 109.009 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.2 -30.44 18.55 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.887 -1.96 . . . . 0.1 111.085 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 48.0 t -63.15 -40.46 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 CA-C-O 123.527 1.632 . . . . 0.13 108.905 170.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.8 -11.04 59.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 113.948 -1.478 . . . . 0.13 110.453 176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.57 -45.49 37.44 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.073 -1.454 . . . . 0.13 107.073 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.707 HG11 HD11 ' A' ' 282' ' ' ILE . 27.2 m -68.96 -52.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 121.893 0.854 . . . . 0.23 111.77 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.6 mmt180 -58.11 -31.82 67.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.863 -1.062 . . . . 0.49 112.433 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.707 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 3.9 t30 -76.88 -12.53 59.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.828 0.307 . . . . 0.56 111.828 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -83.16 -44.91 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 122.282 1.039 . . . . 0.27 109.023 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 60.13 -25.47 0.04 OUTLIER Glycine 0 C--O 1.216 -0.979 0 N-CA-C 118.711 2.244 . . . . 0.7 118.711 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.7 OUTLIER -141.7 98.46 3.35 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 118.264 1.032 . . . . 3.49 112.128 -178.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -78.05 129.5 75.51 Favored Pre-proline 0 C--N 1.311 -1.101 0 CA-C-N 114.736 -1.12 . . . . 0.65 111.763 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.16 -53.64 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.454 3.436 . . . . 0.57 117.584 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 41.3 mt-10 -83.25 7.7 15.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.527 0.936 . . . . 1.9 113.527 -162.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.596 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -63.92 -19.41 65.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.081 -0.648 . . . . 1.16 110.806 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.9 10.33 26.8 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.127 -0.942 . . . . 0.72 112.419 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -102.7 -52.79 3.0 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 107.515 -1.291 . . . . 1.64 107.515 169.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.846 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -65.55 161.17 54.19 Favored Pre-proline 0 N--CA 1.397 -3.11 0 CA-C-O 122.895 1.331 . . . . 1.07 114.434 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 54.1 Cg_exo -63.09 139.82 75.03 Favored 'Trans proline' 0 N--CA 1.481 0.771 1 C-N-CA 127.279 5.319 . . . . 0.36 115.04 174.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.417 ' NH1' ' HB2' ' A' ' 330' ' ' ASP . 29.3 tpt85 -48.97 -40.36 30.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.628 0.727 . . . . 3.98 110.837 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.1 70.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.34 112.531 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.695 ' HB ' HD13 ' A' ' 324' ' ' LEU . 52.6 m -79.99 -37.12 34.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.375 -0.972 . . . . 0.34 108.375 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.743 ' HB2' HD11 ' A' ' 324' ' ' LEU . 10.1 t80 -61.68 -48.53 80.39 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.854 -1.521 . . . . 0.71 109.277 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 14.9 t70 -54.0 -33.85 58.24 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.212 -0.903 . . . . 0.83 111.236 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.67 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.0 -50.58 27.49 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.735 -1.121 . . . . 0.3 108.713 -176.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.745 HD11 ' HB ' ' A' ' 250' ' ' VAL . 7.1 mt -102.43 -60.86 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.36 -1.746 . . . . 0.33 115.155 -165.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 72.8 m-85 -105.62 -7.13 18.7 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.613 -0.721 . . . . 0.49 111.876 -163.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -49.46 -45.24 46.43 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.858 0.837 . . . . 2.41 108.934 172.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.809 ' HB3' HD11 ' A' ' 281' ' ' LEU . 22.1 mt-30 -127.06 111.21 13.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.996 -1.456 . . . . 0.45 107.49 164.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.672 ' O ' HG12 ' A' ' 282' ' ' ILE . 20.3 tpt180 -105.58 112.31 25.34 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.575 -0.898 . . . . 2.45 108.575 -170.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 1.7 mtt180 -85.69 134.5 33.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 122.83 1.3 . . . . 1.07 113.177 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.2 mt -122.51 122.11 65.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 112.268 -2.242 . . . . 0.17 109.501 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.511 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -101.5 109.01 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.526 -0.916 . . . . 0.29 108.526 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.729 ' HA ' HG23 ' B' ' 6' ' ' ILE . 87.0 m-85 -85.28 99.12 10.92 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.565 -0.902 . . . . 0.54 108.565 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.749 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 2.3 mtpt -130.21 86.91 52.61 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.99 -0.744 . . . . 1.34 108.99 -171.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 276' ' ' MET . 38.8 Cg_exo -32.19 166.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 1 C-N-CA 126.763 4.975 . . . . 0.5 118.097 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 18.1 mm-40 -152.93 126.13 8.58 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.855 -1.975 . . . . 2.54 108.174 174.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 53.32 76.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.05 0.844 . . . . 2.26 112.969 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.4 OUTLIER -83.53 -83.4 0.14 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.159 0.981 . . . . 1.22 110.216 169.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 347' ' ' LEU . 5.0 t -179.47 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.236 -1.802 . . . . 1.77 108.569 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.653 ' CD2' ' HA ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 111.982 -2.372 . . . . 2.89 111.952 -169.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.737 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.564 0.221 . . . . 1.84 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 69.57 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.937 -0.574 . . . . 1.1 111.139 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 76.4 Cg_exo -49.11 123.55 10.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.712 2.275 . . . . 0.48 111.857 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 259' ' ' VAL . 60.1 tp -101.56 138.06 39.05 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.412 -0.515 . . . . 1.26 110.292 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.685 HG23 ' HB3' ' A' ' 341' ' ' LYS . 2.4 p -76.44 122.05 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.146 -0.934 . . . . 1.01 111.206 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 263' ' ' SER . 13.7 tt -110.58 124.6 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.166 0.508 . . . . 0.34 110.587 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -109.04 -12.6 14.83 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.715 -0.675 . . . . 1.05 110.937 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.475 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.8 t -73.11 -174.44 1.55 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.199 -0.909 . . . . 2.56 109.757 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.53 90.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.382 -0.913 . . . . 1.85 112.273 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -156.93 166.96 31.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.781 -0.822 . . . . 3.21 108.781 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -44.86 -60.23 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.679 0.612 . . . . 5.81 111.379 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 44.3 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 114.62 1.341 . . . . 5.3 114.62 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.92 -1.036 . . . . 7.77 110.225 178.358 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.643 0.259 . . . . 40.22 110.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.6 mmm -132.94 -69.47 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.357 -0.383 . . . . 40.04 110.767 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 60.09 99.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.87 0.731 . . . . 39.27 111.409 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.6 73.09 5.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 37.29 110.041 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 228' ' ' LEU . 2.4 pt? -77.74 53.27 1.1 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.521 0.676 . . . . 36.13 111.434 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.72 3.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.744 -0.662 . . . . 34.41 109.952 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.21 108.33 2.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.613 0.721 . . . . 32.45 110.535 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 231' ' ' LEU . 2.5 pt? -92.8 -8.01 44.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.485 -0.78 . . . . 30.94 110.23 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.0 123.36 47.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 30.21 109.87 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 11.6 p -70.27 -34.95 73.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.095 -0.502 . . . . 27.83 109.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 34.7 t70 48.43 71.47 0.35 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 124.114 0.884 . . . . 27.14 111.399 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m 72.93 -34.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.778 -0.646 . . . . 25.54 112.304 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 25.8 m -75.37 81.74 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.051 0.453 . . . . 23.93 110.157 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -112.42 -15.79 13.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.166 -0.47 . . . . 24.03 111.284 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 0.2 OUTLIER -64.36 106.13 1.06 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.267 -0.879 . . . . 22.83 110.387 177.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 240' ' ' GLN . 5.1 tp-100 -82.72 169.46 16.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.693 -0.685 . . . . 21.0 109.8 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 239' ' ' GLN . 47.4 mt-30 74.29 129.99 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.746 0.654 . . . . 19.72 111.301 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.58 138.6 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.674 -0.694 . . . . 17.66 111.273 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.22 143.92 31.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 16.08 110.212 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -76.22 159.47 30.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 14.08 110.545 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.05 -164.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.25 0.969 . . . . 13.03 112.642 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 245' ' ' GLU . 2.1 mp0 -51.82 136.68 27.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.791 -0.64 . . . . 12.06 111.774 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 247' ' ' GLY . 7.5 p -81.59 156.76 4.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.702 0.763 . . . . 9.73 111.462 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 89.22 -102.67 2.91 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.397 -1.274 . . . . 7.65 111.44 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m 49.13 49.58 19.35 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.945 0.403 . . . . 6.51 111.951 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.518 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 2.3 pt-20 -89.84 -99.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.014 0.911 . . . . 4.79 111.802 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.518 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 14.7 m -141.44 174.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.796 -1.547 . . . . 2.23 111.8 -170.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.449 ' HB ' ' OH ' ' A' ' 333' ' ' TYR . 5.0 p -109.3 19.25 19.61 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.78 -1.555 . . . . 1.43 111.889 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.439 ' HA3' HD12 ' A' ' 254' ' ' LEU . . . 47.84 -124.01 9.8 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.837 -1.074 . . . . 1.61 112.155 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.723 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 4.2 m -120.12 22.64 11.34 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 123.11 1.433 . . . . 1.62 108.62 168.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.644 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 0.4 OUTLIER -80.72 -38.44 28.79 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.2 -2.273 . . . . 0.47 111.555 -165.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -47.24 -56.2 7.18 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.32 0.581 . . . . 2.08 111.363 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -66.12 -30.9 71.48 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 114.843 -1.071 . . . . 0.89 110.655 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -63.03 -54.67 34.5 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.654 -0.703 . . . . 0.46 112.316 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.89 -45.83 16.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.762 1.268 . . . . 0.27 110.36 174.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.634 HG13 HD12 ' B' ' 6' ' ' ILE 0.254 4.4 t -68.16 -36.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 CA-C-N 112.855 -1.975 . . . . 0.15 110.691 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.4 t30 -60.01 -49.49 77.47 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 123.819 1.771 . . . . 0.52 107.243 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 53.2 mt -60.01 -49.22 78.53 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.924 -3.307 . . . . 0.24 111.978 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.568 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.48 -35.73 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-N 116.191 -0.458 . . . . 0.17 112.193 -173.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.923 ' HB3' HD11 ' B' ' 6' ' ' ILE . 1.9 p -79.14 -17.76 54.44 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -70.53 -32.03 69.33 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.075 -1.824 . . . . 1.21 106.075 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.651 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -93.51 -15.37 25.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.065 -2.334 . . . . 1.53 114.221 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 13.0 t90 -92.53 171.47 9.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.292 1.044 . . . . 0.21 109.922 -174.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.476 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 51.7 mtp180 -154.36 118.46 4.74 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 112.461 -2.154 . . . . 3.65 109.675 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -72.53 129.88 86.54 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.441 -0.578 . . . . 2.92 109.441 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.3 Cg_endo -89.14 149.21 5.57 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.867 2.378 . . . . 0.57 111.353 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 9.8 Cg_endo -49.15 -16.91 1.13 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.92 3.08 . . . . 0.88 113.149 169.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 29.8 p -87.13 -21.95 25.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.386 -0.37 . . . . 0.52 111.685 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.826 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.46 139.5 57.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.414 0.626 . . . . 0.34 111.549 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.568 ' HD2' HD23 ' A' ' 347' ' ' LEU . 4.3 mmm180 -103.7 170.97 7.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.053 -0.976 . . . . 2.49 109.64 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 347' ' ' LEU . 1.8 t-20 -77.45 43.66 0.4 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.299 1.047 . . . . 1.62 112.344 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 149.74 42.15 0.03 OUTLIER Glycine 0 C--N 1.297 -1.636 0 CA-C-N 113.423 -1.717 . . . . 0.46 111.825 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.826 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 1.3 ptm -82.56 159.03 22.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 106.487 -1.671 . . . . 1.08 106.487 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.8 p -160.46 152.99 20.81 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 120.075 1.307 . . . . 0.69 112.278 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.5 p -138.16 131.08 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.014 -1.448 . . . . 0.94 110.154 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 339' ' ' ILE . 10.5 tt0 -94.65 119.62 33.57 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.103 -1.073 . . . . 1.39 108.103 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 75.0 t -115.16 120.69 65.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.23 -0.895 . . . . 0.12 110.741 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.869 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -93.13 105.68 17.74 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.581 -0.736 . . . . 0.23 109.21 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.44 158.17 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 107.508 -1.293 . . . . 1.63 107.508 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -129.26 146.31 51.19 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.552 -0.536 . . . . 0.3 109.552 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -149.85 161.35 42.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.522 1.63 . . . . 0.36 113.057 -171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.559 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -88.55 163.23 36.76 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 110.772 -2.922 . . . . 1.45 108.752 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -58.23 -2.68 0.97 Allowed 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 123.164 2.576 . . . . 0.34 112.839 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.6 t70 -98.58 -13.76 20.25 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 318' ' ' ILE . . . 93.75 -13.38 67.6 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.261 -1.336 . . . . 0.16 110.732 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.8 m -50.05 117.37 2.29 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.775 0.798 . . . . 0.58 110.358 173.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 315' ' ' VAL . 1.4 mm -68.42 115.22 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 114.123 -1.399 . . . . 0.47 110.214 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.559 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 48.2 p -99.06 -27.12 13.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.046 -0.979 . . . . 0.22 110.7 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.7 t30 -154.79 173.34 16.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.879 0.371 . . . . 0.61 111.094 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.48 140.3 0.8 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.918 -1.037 . . . . 0.22 110.975 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.99 169.59 18.89 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.375 1.083 . . . . 0.17 111.019 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -78.66 116.06 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.687 0 CA-C-N 112.757 -2.019 . . . . 0.16 108.044 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -31.05 16.71 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 113.898 -1.501 . . . . 0.44 109.982 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -149.96 115.57 5.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.964 -1.016 . . . . 2.82 108.871 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.2 p -86.44 146.17 26.53 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.65 0.611 . . . . 0.67 112.65 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 277' ' ' SER . 70.6 p -81.54 -12.91 58.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.842 0.829 . . . . 0.59 109.691 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.27 66.85 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.44 -1.254 . . . . 0.57 110.963 -173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.596 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 27.0 t70 -105.2 101.89 11.41 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.003 -0.74 . . . . 1.57 109.003 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 9.4 mmpt? -56.87 -45.82 99.92 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 114.552 -1.204 . . . . 2.56 112.211 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.596 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.2 Cg_endo -49.94 -51.12 11.49 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.762 1.641 . . . . 0.18 111.363 170.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 278' ' ' VAL . 46.4 t80 -58.55 -54.01 51.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.726 0.774 . . . . 0.58 109.485 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 295' ' ' VAL . 91.8 m-20 -54.05 -60.49 3.27 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.296 -1.32 . . . . 2.31 111.175 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 4.6 t -65.96 -39.5 90.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.911 -1.04 . . . . 0.92 113.625 -175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.3 p -53.4 -31.15 43.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.226 1.013 . . . . 0.11 109.414 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.43 -28.54 23.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.213 -1.812 . . . . 0.1 110.138 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.0 t -62.6 -41.39 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 CA-C-O 123.199 1.476 . . . . 0.13 108.221 169.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.75 -15.41 60.77 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 113.973 -1.467 . . . . 0.13 110.786 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.13 -43.54 57.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.036 -1.468 . . . . 0.13 107.036 172.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.8 m -73.39 -48.24 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.541 0.686 . . . . 0.23 112.744 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 8.6 mmt180 -58.37 -41.08 83.99 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.245 -0.889 . . . . 0.49 112.711 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 9.5 t-20 -67.21 -25.8 66.29 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 111.618 0.229 . . . . 0.56 111.618 -171.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.1 m -64.92 -41.58 92.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.698 1.237 . . . . 0.27 110.022 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.417 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 67.38 -22.85 0.22 Allowed Glycine 0 C--N 1.308 -0.984 0 CA-C-N 112.577 -2.101 . . . . 0.7 116.669 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.45 128.45 3.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.064 0.459 . . . . 3.49 110.696 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.755 HD13 HG13 ' A' ' 258' ' ' ILE . 84.0 mt -102.78 130.57 23.58 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-O 121.286 0.565 . . . . 0.65 111.241 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.4 Cg_endo -72.08 -48.88 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.488 2.792 . . . . 0.57 114.666 -163.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -73.5 2.82 7.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.266 1.58 . . . . 1.9 115.266 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.557 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.2 mmt -67.29 -25.32 65.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.334 0.588 . . . . 1.16 111.905 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -78.07 6.93 6.91 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.491 -0.777 . . . . 0.72 111.781 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -97.29 -50.37 4.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.734 -1.21 . . . . 1.64 107.734 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 328' ' ' THR . 83.4 mt -56.93 155.67 14.91 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 115.633 1.716 . . . . 1.07 115.633 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 65.8 Cg_exo -58.75 141.44 97.82 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.58 3.52 . . . . 0.36 109.605 162.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -51.24 -41.53 60.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.31 0.576 . . . . 3.98 110.27 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.88 70.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.877 -1.056 . . . . 0.34 111.76 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.72 HG21 HD22 ' A' ' 324' ' ' LEU . 66.2 m -81.24 -41.36 22.36 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.574 -0.899 . . . . 0.34 108.574 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -56.3 -49.69 73.57 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.891 -1.504 . . . . 0.71 109.602 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 15.4 t70 -57.58 -31.34 66.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.225 -0.898 . . . . 0.83 111.275 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -72.29 -51.79 19.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.599 -1.182 . . . . 0.3 109.476 -176.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 4.4 mt -100.49 -60.22 1.56 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.264 -1.789 . . . . 0.33 114.049 -165.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 71.8 m-85 -106.04 -5.83 19.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.839 0.681 . . . . 0.49 112.839 -163.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.05 -52.24 52.34 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.986 -0.746 . . . . 2.41 108.986 172.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.869 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.6 mt-30 -118.37 109.68 16.56 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.407 -1.331 . . . . 0.45 107.407 160.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.706 ' HB3' HD11 ' A' ' 282' ' ' ILE . 17.3 tpt180 -102.99 114.2 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.493 -1.299 . . . . 2.45 107.493 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 7.2 mmt180 -80.76 113.2 18.79 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.566 -1.253 . . . . 1.07 111.101 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 16.0 mt -100.95 123.91 54.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.126 -1.852 . . . . 0.17 108.704 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.613 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -98.93 118.09 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 108.068 -1.086 . . . . 0.29 108.068 176.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 277' ' ' SER . 70.2 m-85 -93.85 107.76 19.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.462 -0.94 . . . . 0.54 108.462 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.685 ' HB3' HG23 ' B' ' 5' ' ' VAL . 12.5 ttmt -141.48 110.36 6.29 Favored Pre-proline 0 N--CA 1.434 -1.254 0 CA-C-N 116.194 -0.457 . . . . 1.34 110.599 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.804 ' HD2' ' O ' ' A' ' 276' ' ' MET . 9.5 Cg_endo -47.3 171.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 1 C-N-CA 125.526 4.151 . . . . 0.5 116.957 -177.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -151.88 112.53 4.18 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 112.596 -2.093 . . . . 2.54 107.862 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.57 83.57 0.16 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.578 -1.192 . . . . 2.26 113.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.1 mm? -88.42 -166.17 1.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.905 -0.776 . . . . 1.22 108.905 161.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 347' ' ' LEU . 1.9 t -69.33 -43.48 73.6 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.541 1.163 . . . . 1.77 109.534 169.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.636 HD22 ' H ' ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 CA-C-N 112.893 -1.958 . . . . 2.89 112.361 -166.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.847 -0.427 . . . . 1.84 109.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -42.85 115.65 1.77 Allowed Pre-proline 0 N--CA 1.464 0.233 0 O-C-N 124.331 1.019 . . . . 1.1 112.277 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 73.4 Cg_exo -47.53 119.35 3.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.346 2.697 . . . . 0.48 111.845 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.627 ' HB2' HH22 ' A' ' 336' ' ' ARG . 2.1 tm? -107.87 135.8 48.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 1.26 109.473 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' A' ' 341' ' ' LYS . 97.8 t -74.69 101.41 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.67 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 263' ' ' SER . 7.5 tp -84.64 124.09 39.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.869 -1.16 . . . . 0.34 107.869 170.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -68.49 -70.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.246 -0.434 . . . . 1.05 110.454 -173.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.721 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 20.3 m -158.66 165.29 34.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.939 -0.476 . . . . 2.56 111.303 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.53 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -86.65 147.0 21.01 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.246 -0.888 . . . . 1.85 111.585 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -77.12 122.29 24.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.782 0.801 . . . . 3.21 110.657 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -175.41 25.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.678 -1.601 . . . . 5.81 107.471 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -93.82 161.16 14.43 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.115 -1.857 . . . . 5.3 111.727 -167.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.382 -0.827 . . . . 7.77 109.825 177.68 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.561 -0.163 . . . . 40.22 110.561 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 53.2 ttm 56.95 62.52 2.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.185 0.517 . . . . 40.04 111.122 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -145.85 26.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.032 -0.531 . . . . 39.27 110.404 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 68.44 -65.08 0.28 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 37.29 110.651 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.46 137.76 32.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.185 -0.672 . . . . 36.13 109.185 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -139.92 -63.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.775 -0.193 . . . . 34.41 110.616 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.99 106.68 0.04 OUTLIER 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.946 0.778 . . . . 32.45 110.868 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.8 tt -132.41 82.99 2.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.738 -0.664 . . . . 30.94 109.544 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.9 tp -149.67 60.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.961 -0.563 . . . . 30.21 109.856 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -63.85 -59.14 4.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.761 -0.654 . . . . 27.83 110.568 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -151.52 -70.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 27.14 110.98 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 p 53.64 122.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.485 1.114 . . . . 25.54 113.419 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 11.1 m -98.62 84.43 3.15 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.715 . . . . 23.93 109.508 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.88 -16.63 14.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.809 0.814 . . . . 24.03 111.063 -171.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -74.96 118.65 18.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.344 -1.298 . . . . 22.83 110.454 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 58.95 68.72 0.79 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.841 0.713 . . . . 21.0 111.05 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -67.9 140.37 56.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.949 -0.569 . . . . 19.72 111.254 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 66.9 118.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.067 0.854 . . . . 17.66 111.74 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 57.4 tp -79.61 118.79 21.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.619 -0.718 . . . . 16.08 110.326 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -80.56 133.0 35.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.648 -0.705 . . . . 14.08 111.197 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.83 -172.37 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 13.03 110.694 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.92 150.4 28.85 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.958 0.725 . . . . 12.06 112.958 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.659 HG23 HG21 ' A' ' 250' ' ' VAL . 14.4 p -104.28 168.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.223 -0.899 . . . . 9.73 110.719 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.505 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 123.19 -67.98 0.48 Allowed Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.534 -0.757 . . . . 7.65 113.697 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.6 m -62.73 -65.39 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.077 0.465 . . . . 6.51 112.067 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.41 ' C ' HG22 ' A' ' 250' ' ' VAL . 1.4 pt-20 -109.35 -94.65 0.41 Allowed 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 112.792 0.664 . . . . 4.79 112.792 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.659 HG21 HG23 ' A' ' 246' ' ' VAL . 8.2 m 48.53 -171.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 125.152 1.532 . . . . 2.23 114.864 171.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.9 p -65.26 114.32 4.65 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.313 -1.312 . . . . 1.43 110.172 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -76.93 -137.86 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.033 -0.985 . . . . 1.61 110.806 172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.843 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.6 m -84.32 20.56 1.61 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.029 0.918 . . . . 1.62 110.291 171.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.876 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 4.2 mp -82.9 -40.3 20.37 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 113.507 -1.679 . . . . 0.47 109.466 -168.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.565 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 8.4 p-10 -52.32 -49.51 64.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.475 -0.784 . . . . 2.08 110.842 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.4 t70 -68.94 -32.04 71.36 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.051 -1.431 . . . . 0.89 111.153 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.7 mt -61.66 -53.25 58.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.778 176.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.697 HG13 HD13 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.91 -45.24 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 122.921 1.343 . . . . 0.27 110.35 175.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.7 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 4.6 t -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.514 -2.13 . . . . 0.15 110.86 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.0 t30 -61.58 -49.78 75.27 Favored 'General case' 0 CA--C 1.483 -1.632 0 CA-C-O 123.63 1.681 . . . . 0.52 107.253 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 61.5 mt -62.31 -49.07 77.09 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 110.229 -3.168 . . . . 0.24 112.084 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.63 -38.04 77.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 CA-C-N 116.259 -0.428 . . . . 0.17 111.479 -171.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.774 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.0 p -81.43 -17.83 47.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.248 0.547 . . . . 0.69 111.187 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 260' ' ' ASN . 14.2 mm100 -70.62 -34.53 72.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.57 -1.641 . . . . 1.21 106.57 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.594 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.9 mp0 -88.63 -18.16 28.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.15 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.721 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.1 t90 -87.95 172.09 9.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.982 1.372 . . . . 0.21 110.863 -172.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 66.4 ttt180 -154.08 146.56 24.03 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 111.896 -2.411 . . . . 3.65 108.881 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.72 150.44 37.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.256 -0.978 . . . . 2.92 109.802 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 70.2 Cg_endo -97.11 167.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.452 2.768 . . . . 0.57 111.116 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -77.05 -10.33 17.95 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.88 110.284 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.6 p -85.62 -30.13 23.51 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.567 -1.651 . . . . 0.52 112.238 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 1.013 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -59.16 136.84 58.08 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 112.999 0.74 . . . . 0.34 112.999 -174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.699 ' HA ' HD23 ' A' ' 347' ' ' LEU . 10.3 mmt180 -111.7 171.51 7.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.305 -0.862 . . . . 2.49 109.102 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -71.34 52.12 0.18 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.252 1.204 . . . . 1.62 114.252 -170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 140.6 41.3 0.08 OUTLIER Glycine 0 C--N 1.283 -2.398 0 CA-C-N 114.466 -1.243 . . . . 0.46 111.976 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 1.013 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 7.5 ptm -85.05 149.07 25.82 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.866 -1.902 . . . . 1.08 105.866 168.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.796 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 29.8 p -146.94 151.01 36.31 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 114.172 1.175 . . . . 0.69 114.172 -169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -122.56 129.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.967 -1.924 . . . . 0.94 108.118 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 0.1 OUTLIER -91.72 122.87 34.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.843 -1.169 . . . . 1.39 107.843 164.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.563 HG12 HG22 ' A' ' 282' ' ' ILE . 53.1 t -124.53 116.65 48.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.524 -1.216 . . . . 0.12 111.07 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 335' ' ' GLN . 1.3 tp -93.65 109.84 21.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.786 -1.097 . . . . 0.23 109.203 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 0.1 OUTLIER -103.75 157.8 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.786 -1.19 . . . . 1.63 107.786 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.7 mt-10 -127.1 144.65 50.98 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.859 -0.793 . . . . 0.3 108.859 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 15.6 mtp -148.36 159.5 43.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 123.635 1.683 . . . . 0.36 113.709 -169.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -88.63 160.49 44.37 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 110.576 -3.011 . . . . 1.45 108.583 177.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -59.78 3.26 0.23 Allowed 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.169 2.579 . . . . 0.34 112.563 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -99.95 -15.68 18.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.55 109.144 176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.67 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 90.07 -7.84 80.9 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.255 -1.338 . . . . 0.16 110.976 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 94.9 m -55.72 117.1 3.34 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.516 0.674 . . . . 0.58 109.718 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 315' ' ' VAL . 1.8 mt -68.68 115.2 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-N 114.229 -1.35 . . . . 0.47 109.716 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 67.8 p -99.9 -25.47 14.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.58 -1.191 . . . . 0.22 110.356 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 29.6 t30 -147.15 171.66 15.0 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.894 -0.409 . . . . 0.61 109.894 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -174.73 130.15 0.33 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.039 -0.982 . . . . 0.22 109.955 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.6 169.06 18.35 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.477 1.132 . . . . 0.17 110.706 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.702 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.4 t -77.14 114.02 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 112.911 -1.949 . . . . 0.16 107.954 168.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.0 OUTLIER -86.98 -28.23 22.79 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 113.32 -1.764 . . . . 0.44 109.41 -177.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -154.09 125.82 7.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.52 -1.218 . . . . 2.82 108.333 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.6 p -88.06 149.1 24.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.175 0.512 . . . . 0.67 111.927 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.4 p -82.84 -8.49 59.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.583 -0.735 . . . . 0.59 110.38 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.45 25.31 59.19 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.543 -1.208 . . . . 0.57 110.911 -169.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 23.9 t70 -147.87 91.85 1.99 Allowed 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.623 -1.621 . . . . 1.57 106.623 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 1.9 mppt? -61.77 -37.34 38.94 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 113.8 -1.546 . . . . 2.56 112.793 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.8 Cg_endo -50.76 -51.03 11.98 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 121.897 1.731 . . . . 0.18 111.138 164.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.889 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 47.8 t80 -58.13 -52.67 64.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 295' ' ' VAL . 63.2 m-20 -54.83 -60.97 2.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 2.31 111.401 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' HG23 ' A' ' 309' ' ' VAL . 54.8 m -68.4 -35.73 78.08 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.67 1.359 . . . . 0.92 114.67 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 96.1 p -54.31 -29.65 48.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.202 1.001 . . . . 0.11 109.508 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.42 -30.16 23.79 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.252 -1.795 . . . . 0.1 110.849 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 306' ' ' SER . 55.9 t -61.99 -39.41 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 123.627 1.68 . . . . 0.13 108.85 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.82 -14.29 60.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 113.959 -1.473 . . . . 0.13 110.582 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.666 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.06 -42.78 56.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 0.13 107.14 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 315' ' ' VAL . 28.5 m -70.98 -53.6 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 121.442 0.639 . . . . 0.23 111.686 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.482 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -55.96 -35.58 66.85 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.185 -0.916 . . . . 0.49 112.961 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.594 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 35.7 t30 -73.66 -19.96 60.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.784 -0.366 . . . . 0.56 111.931 -173.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -72.36 -44.79 62.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.258 1.028 . . . . 0.27 109.39 176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 61.81 -23.3 0.06 OUTLIER Glycine 0 C--O 1.218 -0.888 0 CA-C-N 112.427 -2.17 . . . . 0.7 117.938 169.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.6 mpt_? -147.54 111.91 5.24 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.249 0.619 . . . . 3.49 110.293 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 258' ' ' ILE . 94.9 mt -104.45 126.76 30.58 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 113.353 0.871 . . . . 0.65 113.353 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 320' ' ' GLU . 45.9 Cg_exo -39.53 -82.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 1 C-N-CA 126.134 4.556 . . . . 0.57 118.885 -175.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 254' ' ' LEU . 35.3 mt-10 -75.93 5.21 6.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.281 -1.327 . . . . 1.9 113.229 -156.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -59.0 -28.05 66.0 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.292 0.568 . . . . 1.16 111.306 178.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -86.04 7.16 25.7 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.026 -0.988 . . . . 0.72 111.699 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -97.9 -49.24 4.86 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.523 -1.288 . . . . 1.64 107.523 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 328' ' ' THR . 83.0 mt -53.38 158.39 2.82 Favored Pre-proline 0 N--CA 1.416 -2.126 0 N-CA-C 115.328 1.603 . . . . 1.07 115.328 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -60.41 138.64 81.96 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.448 3.432 . . . . 0.36 108.97 161.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -51.84 -42.67 62.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.576 0.703 . . . . 3.98 110.841 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.571 -1.195 . . . . 0.34 112.159 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.697 HG21 HD22 ' A' ' 324' ' ' LEU . 53.4 m -82.58 -37.87 24.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 122.099 0.952 . . . . 0.34 108.933 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.48 -45.17 92.42 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.249 -1.341 . . . . 0.71 109.32 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 334' ' ' ARG . 10.5 t70 -58.33 -29.99 66.36 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.625 0.77 . . . . 0.83 110.901 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.672 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.42 -49.4 42.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.643 1.211 . . . . 0.3 108.796 -177.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.1 mt -103.03 -60.33 1.57 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.156 -1.838 . . . . 0.33 115.337 -167.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.876 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 74.0 m-85 -105.67 -4.08 21.44 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.289 -0.414 . . . . 0.49 111.788 -162.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.44 -51.18 63.5 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.42 0.628 . . . . 2.41 109.342 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.4 mt-30 -125.63 115.88 20.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 106.812 -1.551 . . . . 0.45 106.812 159.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.653 ' H ' HD13 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -106.36 127.46 53.29 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 105.917 -1.883 . . . . 2.45 105.917 -176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.412 ' HB3' ' OE1' ' A' ' 279' ' ' GLU . 7.0 mmt180 -86.25 119.57 26.68 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.495 -1.378 . . . . 1.07 111.93 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 282' ' ' ILE . 15.8 mt -107.82 118.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.858 -1.065 . . . . 0.17 109.833 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.548 ' O ' HG22 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -97.13 118.78 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.775 -0.824 . . . . 0.29 108.775 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 277' ' ' SER . 90.5 m-85 -95.13 105.17 17.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.289 -0.634 . . . . 0.54 109.289 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 15.4 ttpt -141.93 95.89 6.81 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.238 -0.282 . . . . 1.34 110.238 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.669 ' HD2' ' O ' ' A' ' 276' ' ' MET . 16.8 Cg_exo -38.26 170.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 1 C-N-CA 125.533 4.155 . . . . 0.5 117.259 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -152.19 119.8 6.07 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 112.78 -2.009 . . . . 2.54 107.847 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.6 t70 58.28 71.48 0.58 Allowed 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.734 0.646 . . . . 2.26 112.587 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.8 OUTLIER -79.62 -79.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.144 1.449 . . . . 1.22 108.716 167.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.694 ' HB3' HD13 ' A' ' 347' ' ' LEU . 0.4 OUTLIER -177.3 -44.53 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 111.739 -2.482 . . . . 1.77 106.492 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.796 0 CA-C-N 111.539 -2.573 . . . . 2.89 111.736 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.217 -0.66 . . . . 1.84 109.217 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -113.16 116.09 47.18 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 121.055 -0.258 . . . . 1.1 110.443 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 41.0 Cg_exo -55.67 117.56 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.276 1.984 . . . . 0.48 110.443 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 259' ' ' VAL . 45.3 tp -106.33 145.52 31.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.176 -0.466 . . . . 1.26 111.11 -169.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -76.87 104.26 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.994 -1.003 . . . . 1.01 111.178 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.3 tp -95.04 102.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 122.029 0.918 . . . . 0.34 108.552 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 2.4 p -91.86 -12.44 33.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.146 -0.934 . . . . 1.05 112.814 -169.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 263' ' ' SER . 42.7 m -132.67 167.19 20.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.085 0.469 . . . . 2.56 111.641 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.12 79.57 0.18 Allowed Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.927 -1.269 . . . . 1.85 109.927 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -160.69 168.9 23.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.785 -0.82 . . . . 3.21 108.785 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -79.34 49.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.008 1.385 . . . . 5.81 110.916 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 8' ' ' SER . 19.9 ptt180 -78.35 -170.29 1.97 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 112.5 -2.136 . . . . 5.3 110.77 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.002 -0.523 . . . . 7.77 110.261 175.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.769 -0.456 . . . . 40.22 109.769 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 94.0 mmm -140.71 49.33 1.7 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 40.04 111.008 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 63.42 33.38 13.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.012 -0.54 . . . . 39.27 111.813 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.16 20.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 37.29 110.138 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.99 142.09 56.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.547 -0.751 . . . . 36.13 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -56.77 3.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.68 . . . . 34.41 110.342 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.93 106.29 17.69 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.923 0.868 . . . . 32.45 111.333 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.42 -28.56 7.17 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.791 -1.095 . . . . 30.94 109.829 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.41 -74.34 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.434 -0.803 . . . . 30.21 111.341 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -82.25 165.77 20.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 27.83 110.636 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -123.23 33.25 5.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 27.14 110.749 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.2 m 59.07 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.664 -0.698 . . . . 25.54 111.298 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.2 m 54.08 52.19 13.21 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.666 0.746 . . . . 23.93 110.818 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -92.93 -10.31 36.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.479 -0.782 . . . . 24.03 110.905 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 238' ' ' ARG . 27.2 mmt180 -105.1 43.81 1.08 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.049 -0.978 . . . . 22.83 110.984 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -137.5 72.4 1.42 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.263 -0.643 . . . . 21.0 109.263 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -71.28 66.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.754 -0.657 . . . . 19.72 111.332 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.84 -44.5 0.35 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 17.66 109.915 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 63.1 tp -91.5 112.92 25.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 16.08 109.607 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -63.4 142.38 58.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.049 0.452 . . . . 14.08 111.179 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.68 176.34 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 13.03 110.951 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 140.2 56.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.572 0.701 . . . . 12.06 111.947 -174.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 247' ' ' GLY . 9.9 p -119.14 178.64 2.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.237 -0.892 . . . . 9.73 109.975 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -62.67 125.11 34.53 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.59 -1.004 . . . . 7.65 110.59 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.6 m -66.49 84.5 0.1 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.221 0.452 . . . . 6.51 112.221 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.566 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 1.7 pt-20 -98.39 -80.04 0.46 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.322 0.582 . . . . 4.79 110.555 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.566 ' H ' ' HG3' ' A' ' 249' ' ' GLU . 5.9 m -149.04 -142.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.649 -1.159 . . . . 2.23 110.309 -172.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 30.4 p 50.61 70.02 0.57 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.911 0.862 . . . . 1.43 110.395 -173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.65 -151.96 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.3 -1.318 . . . . 1.61 112.593 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -51.74 68.79 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.915 -0.756 . . . . 1.62 109.547 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 7.0 mt 16.61 -70.48 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.502 1.921 . . . . 0.47 115.568 157.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.611 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 3.2 m-20 -49.37 -49.86 42.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.491 0.662 . . . . 2.08 111.352 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.2 t70 -72.48 -30.96 65.0 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 114.34 -1.3 . . . . 0.89 110.607 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.741 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 8.5 mt -62.49 -52.19 64.48 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.761 -0.654 . . . . 0.46 111.764 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.844 HG13 HD13 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.7 -45.23 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.757 1.265 . . . . 0.27 110.427 174.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.638 HG13 HD13 ' B' ' 6' ' ' ILE 0.251 4.8 t -68.15 -36.57 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-N 112.605 -2.089 . . . . 0.15 110.824 178.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.6 t30 -61.08 -49.82 75.77 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 123.839 1.78 . . . . 0.52 107.262 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.2 mt -62.59 -44.88 95.19 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.189 -3.187 . . . . 0.24 112.288 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.542 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.4 OUTLIER -62.58 -36.61 75.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 CA-C-N 115.93 -0.577 . . . . 0.17 111.622 -172.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.5 p -79.59 -20.07 47.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 0.69 111.279 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -73.49 -22.44 60.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.061 -1.829 . . . . 1.21 106.061 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.488 ' HG2' HG12 ' A' ' 315' ' ' VAL . 9.6 mm-40 -104.53 -20.63 13.63 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 111.928 -2.396 . . . . 1.53 111.96 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.487 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 14.7 t90 -84.86 170.22 13.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.547 1.165 . . . . 0.21 110.431 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 98.8 mtt180 -154.03 107.25 2.91 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.048 -2.342 . . . . 3.65 109.487 -171.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 9.9 ptt180 -70.84 147.79 94.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.416 0.627 . . . . 2.92 110.222 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 44.4 Cg_endo -99.39 173.81 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.382 3.388 . . . . 0.57 111.124 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -88.2 -6.08 6.43 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.248 2.632 . . . . 0.88 110.445 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.8 p -83.71 -25.64 30.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.718 -1.583 . . . . 0.52 111.315 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.999 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -63.84 139.41 58.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.584 0.707 . . . . 0.34 112.585 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.589 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 52.1 mmt-85 -117.08 171.2 8.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.615 -1.175 . . . . 2.49 108.856 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -76.75 54.13 0.96 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.708 1.003 . . . . 1.62 113.708 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 145.16 35.28 0.07 OUTLIER Glycine 0 C--N 1.286 -2.2 0 CA-C-N 113.556 -1.657 . . . . 0.46 112.373 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.999 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.9 ptm -83.7 150.48 25.82 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.997 -2.223 . . . . 1.08 104.997 167.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.738 ' HB3' ' CG ' ' A' ' 341' ' ' LYS . 83.1 p -157.5 158.14 35.16 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.211 -1.396 . . . . 0.69 113.899 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -130.65 128.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 112.513 -2.131 . . . . 0.94 108.739 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.569 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 7.0 tt0 -91.23 118.68 30.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.419 -1.697 . . . . 1.39 106.419 165.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 282' ' ' ILE . 71.6 t -117.96 117.36 54.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.357 -0.838 . . . . 0.12 109.899 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.953 HD11 ' HB3' ' A' ' 335' ' ' GLN . 15.8 tp -91.47 117.69 29.92 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.469 -0.787 . . . . 0.23 110.092 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 335' ' ' GLN . 2.4 mm -94.26 167.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.709 -1.132 . . . . 1.63 109.087 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.706 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.9 mt-10 -139.05 135.73 34.52 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.903 -1.499 . . . . 0.3 109.286 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 318' ' ' ILE . 33.3 mtp -145.86 162.28 38.07 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 123.359 1.552 . . . . 0.36 113.905 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.7 OUTLIER -95.08 161.48 28.07 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 110.728 -2.942 . . . . 1.45 109.543 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.446 ' HG3' ' NE ' ' A' ' 326' ' ' ARG . 53.4 Cg_exo -59.93 -0.14 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.062 2.508 . . . . 0.34 112.468 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.529 ' HA ' ' HG2' ' A' ' 322' ' ' GLN . 18.4 t70 -101.75 -14.19 17.43 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.927 0.87 . . . . 0.55 109.055 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 95.4 -6.98 68.62 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.402 -1.272 . . . . 0.16 110.521 -173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -60.34 114.57 2.99 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.224 1.011 . . . . 0.58 110.292 174.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.597 HD12 HG22 ' A' ' 315' ' ' VAL . 4.1 mt -65.98 114.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 CA-C-N 113.684 -1.598 . . . . 0.47 110.135 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.56 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 37.8 p -95.48 -26.8 15.69 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.861 -1.063 . . . . 0.22 109.518 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.706 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.5 t30 -149.43 171.01 17.26 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.968 -0.56 . . . . 0.61 111.022 175.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.56 128.04 0.52 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.366 -1.288 . . . . 0.22 109.622 175.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.66 169.52 17.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.257 1.027 . . . . 0.17 110.733 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.2 t -79.19 117.41 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 113.087 -1.87 . . . . 0.16 108.698 167.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.569 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.7 p -87.95 -33.18 18.54 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.909 -1.496 . . . . 0.44 109.354 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -149.62 110.08 4.22 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.701 -1.136 . . . . 2.82 108.907 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.4 p -81.42 149.51 28.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.181 0.515 . . . . 0.67 112.146 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 277' ' ' SER . 57.4 p -81.14 -13.47 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.436 -0.802 . . . . 0.59 109.712 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.81 -15.87 59.14 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.785 -1.098 . . . . 0.57 110.725 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 17.2 t70 -104.88 96.91 6.87 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.414 -0.958 . . . . 1.57 108.414 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 53.6 mttt -57.25 -42.36 95.71 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 2.56 112.198 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.2 Cg_endo -50.01 -51.94 9.89 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.072 1.848 . . . . 0.18 111.358 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.768 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 56.2 t80 -59.34 -50.32 74.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.176 -0.675 . . . . 0.58 109.176 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.746 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.6 m-20 -55.67 -62.89 1.38 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.789 -1.096 . . . . 2.31 110.996 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.662 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 63.1 m -67.21 -36.13 81.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 114.461 1.282 . . . . 0.92 114.461 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -54.64 -30.67 55.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.485 1.136 . . . . 0.11 108.98 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.714 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.29 -30.6 23.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.014 -1.903 . . . . 0.1 110.919 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.3 t -64.4 -39.83 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-O 123.523 1.63 . . . . 0.13 108.869 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.2 -16.65 60.97 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.195 -1.366 . . . . 0.13 110.166 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 308' ' ' ALA . . . -72.71 -43.53 62.89 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.493 -1.299 . . . . 0.13 107.493 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.701 HG11 HD11 ' A' ' 282' ' ' ILE . 27.3 m -71.18 -51.85 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 115.317 -0.856 . . . . 0.23 111.62 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.74 -32.72 67.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.138 -0.937 . . . . 0.49 112.648 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 15.2 t30 -76.4 -16.46 59.7 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.176 -0.609 . . . . 0.56 111.388 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -74.22 -44.15 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 122.34 1.067 . . . . 0.27 108.517 172.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.8 -23.31 0.06 OUTLIER Glycine 0 C--N 1.311 -0.821 0 CA-C-N 112.442 -2.163 . . . . 0.7 117.637 170.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.6 OUTLIER -155.64 117.22 3.99 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.675 0.75 . . . . 3.49 109.381 -178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.844 HD13 HG13 ' A' ' 258' ' ' ILE . 80.2 mt -103.96 130.88 22.61 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.75 1.019 . . . . 0.65 113.75 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.423 ' HD2' HD11 ' A' ' 261' ' ' LEU . 52.8 Cg_exo -38.59 -85.32 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.27 1 C-N-CA 125.885 4.39 . . . . 0.57 117.653 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 46.0 mt-10 -72.57 5.51 3.0 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.771 -1.104 . . . . 1.9 113.06 -159.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.666 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 10.0 mmm -66.68 -24.91 66.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.627 -0.429 . . . . 1.16 111.363 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 13.1 mt-30 -84.87 4.83 31.44 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.455 0.539 . . . . 0.72 112.455 177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.407 ' HG3' ' CA ' ' A' ' 320' ' ' GLU . 0.3 OUTLIER -99.42 -12.09 20.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 122.037 0.922 . . . . 1.64 108.671 -178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 328' ' ' THR . 73.2 mt -94.07 164.43 20.47 Favored Pre-proline 0 N--CA 1.409 -2.478 0 CA-C-N 113.859 -1.519 . . . . 1.07 113.154 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.8 Cg_exo -60.63 135.6 61.54 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 124.767 3.645 . . . . 0.36 109.291 160.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.446 ' NE ' ' HG3' ' A' ' 286' ' ' PRO . 41.9 tpt85 -51.68 -38.42 54.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.09 0.471 . . . . 3.98 110.844 173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.66 73.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 0.34 111.752 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.745 HG21 HD22 ' A' ' 324' ' ' LEU . 52.3 m -79.73 -38.92 32.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 122.029 0.919 . . . . 0.34 108.865 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.45 -51.26 70.61 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.911 -1.495 . . . . 0.71 109.43 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.693 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.8 t70 -56.08 -31.34 63.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.159 0.984 . . . . 0.83 110.856 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -71.23 -49.78 39.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.563 1.173 . . . . 0.3 109.822 -178.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.822 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 10.6 mt -102.21 -57.11 2.12 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.422 -1.717 . . . . 0.33 115.206 -166.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.666 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 56.4 m-85 -110.05 -5.4 15.42 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.053 -0.521 . . . . 0.49 110.89 -163.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.693 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -43.91 -63.49 0.85 Allowed 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 124.254 1.021 . . . . 2.41 109.154 170.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.953 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.2 OUTLIER -110.88 115.31 29.29 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 113.201 -1.818 . . . . 0.45 107.615 161.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.553 ' HG2' HG21 ' A' ' 258' ' ' ILE . 24.1 tpt180 -99.56 134.01 43.06 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.015 -1.476 . . . . 2.45 107.015 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.8 mmt180 -107.26 117.46 34.13 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 118.881 0.764 . . . . 1.07 109.779 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 258' ' ' ILE . 7.2 mt -117.19 120.38 64.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.683 -0.689 . . . . 0.17 109.756 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 1.0 OUTLIER -98.41 113.55 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 N-CA-C 108.572 -0.899 . . . . 0.29 108.572 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 277' ' ' SER . 64.5 m-85 -89.24 98.16 11.61 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.348 -0.982 . . . . 0.54 108.348 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.738 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 0.3 OUTLIER -128.62 87.3 55.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.914 -0.585 . . . . 1.34 109.577 -172.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 276' ' ' MET . 39.1 Cg_exo -28.62 165.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 127.328 5.352 . . . . 0.5 118.937 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 13.5 pt-20 -146.37 125.62 13.02 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.669 -2.06 . . . . 2.54 108.852 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 26.5 t70 48.73 76.67 0.11 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.655 0.983 . . . . 2.26 113.655 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.6 mm? -85.29 -166.58 1.55 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.4 m -65.43 -28.19 69.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.943 0.878 . . . . 1.77 112.073 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.589 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.355 -1.293 . . . . 2.89 111.841 -161.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.031 -0.729 . . . . 1.84 109.031 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.87 113.69 16.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 121.244 -0.182 . . . . 1.1 110.593 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.12 117.99 3.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.346 2.031 . . . . 0.48 110.452 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.611 ' HB3' HG21 ' A' ' 259' ' ' VAL . 42.6 tp -102.1 139.58 37.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.147 -0.621 . . . . 1.26 111.289 -168.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 341' ' ' LYS . 75.2 t -70.06 104.08 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.979 -1.009 . . . . 1.01 111.0 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 259' ' ' VAL . 5.7 tp -94.59 117.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.91 -1.144 . . . . 0.34 107.91 170.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 4.8 p -67.26 -65.29 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.425 -0.807 . . . . 1.05 111.541 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.778 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 69.7 m -156.32 177.62 11.24 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.224 -0.658 . . . . 2.56 109.224 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -72.09 -150.42 1.03 Allowed Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 119.975 -1.107 . . . . 1.85 111.159 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -73.34 163.46 28.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -41.55 -57.43 2.25 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.132 0.895 . . . . 5.81 112.864 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 48.81 -161.15 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.736 0.779 . . . . 5.3 112.264 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 7.77 109.937 176.528 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.242 0.544 . . . . 40.22 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 23.2 ttt -105.83 -51.69 2.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.077 -0.51 . . . . 40.04 109.667 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -167.69 149.37 5.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.657 -0.868 . . . . 39.27 108.657 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -77.03 80.3 3.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.074 0.464 . . . . 37.29 111.277 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.78 71.47 4.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.965 -0.561 . . . . 36.13 109.808 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 232' ' ' LEU . . . -69.81 86.14 0.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 34.41 111.243 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.61 105.77 5.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.544 . . . . 32.45 111.079 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 32.2 tp 47.1 48.79 15.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.595 0.712 . . . . 30.94 110.516 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.404 ' HB3' ' HB1' ' A' ' 229' ' ' ALA . 0.7 OUTLIER -132.0 80.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 30.21 109.76 -174.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 31.9 m -91.17 82.16 5.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.84 -0.618 . . . . 27.83 109.773 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 37.3 t70 65.18 -80.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.142 0.902 . . . . 27.14 110.799 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 73.2 p 55.07 123.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.028 1.122 . . . . 25.54 114.028 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.5 m -86.55 -25.01 25.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.506 -0.77 . . . . 23.93 111.131 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -166.08 107.79 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 122.432 1.11 . . . . 24.03 108.632 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.709 ' N ' ' HD3' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -105.91 -22.02 13.01 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.22 -1.809 . . . . 22.83 110.494 -167.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 74.5 -101.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.954 -1.021 . . . . 21.0 111.695 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 53.92 -169.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.199 0.312 . . . . 19.72 110.982 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.84 -38.22 62.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 17.66 109.763 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.87 76.65 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.297 -0.865 . . . . 16.08 109.477 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -74.34 164.06 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.347 -0.842 . . . . 14.08 111.494 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.24 -9.7 54.4 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 123.817 1.77 . . . . 13.03 110.059 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.5 146.56 53.83 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 110.173 -3.194 . . . . 12.06 110.082 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.445 HG22 ' OG ' ' A' ' 331' ' ' SER . 0.8 OUTLIER -128.78 177.34 6.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.267 0.556 . . . . 9.73 110.196 -177.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 331' ' ' SER . . . 126.29 -50.45 0.88 Allowed Glycine 0 C--N 1.309 -0.927 0 CA-C-N 115.277 -0.874 . . . . 7.65 113.502 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.2 p -101.04 67.96 1.22 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.492 0.552 . . . . 6.51 112.492 -172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.598 ' HG3' HG22 ' A' ' 250' ' ' VAL . 2.0 tp10 -102.18 -75.05 0.61 Allowed 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.202 0.525 . . . . 4.79 110.099 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.622 ' C ' HG22 ' A' ' 251' ' ' THR . 28.9 m -149.65 -161.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.961 -1.018 . . . . 2.23 111.674 -175.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 250' ' ' VAL . 0.1 OUTLIER 175.44 86.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.165 -1.791 . . . . 1.43 106.165 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -54.75 -147.51 0.01 OUTLIER Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.395 -1.275 . . . . 1.61 113.253 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.873 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 23.7 m -75.99 20.33 0.19 Allowed 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.577 -0.955 . . . . 1.62 111.737 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -88.09 -44.27 11.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.584 -1.644 . . . . 0.47 111.953 -163.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -48.59 -49.88 34.89 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.532 0.682 . . . . 2.08 111.146 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.3 t70 -68.49 -33.42 74.12 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.12 -1.4 . . . . 0.89 111.42 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.873 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.5 mt -60.91 -53.31 58.88 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.272 0.558 . . . . 0.46 112.034 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.592 HG13 HG12 ' A' ' 318' ' ' ILE . 0.8 OUTLIER -49.58 -44.55 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 122.603 1.192 . . . . 0.27 110.794 175.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.688 HG13 HD13 ' B' ' 6' ' ' ILE 0.267 5.2 t -69.35 -35.56 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 112.75 -2.023 . . . . 0.15 111.319 177.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.517 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -62.67 -48.32 79.82 Favored 'General case' 0 CA--C 1.486 -1.497 0 CA-C-O 123.78 1.752 . . . . 0.52 107.249 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.7 mt -62.54 -48.02 81.32 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 110.574 -3.012 . . . . 0.24 111.985 177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.642 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -60.55 -35.27 62.25 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-N 116.137 -0.483 . . . . 0.17 111.718 -171.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.535 ' CA ' ' HA2' ' B' ' 9' ' ' GLY . 1.2 p -80.64 -24.09 39.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.693 0.282 . . . . 0.69 111.315 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -64.71 -34.8 79.15 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 105.897 -1.89 . . . . 1.21 105.897 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.594 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 1.9 mp0 -89.41 -20.2 24.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 111.688 -2.505 . . . . 1.53 114.441 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.778 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.2 t90 -91.43 168.42 11.56 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.827 1.299 . . . . 0.21 110.579 -172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 76.1 ttt180 -153.0 125.0 7.93 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.868 -2.424 . . . . 3.65 110.924 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.435 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 24.9 ptt180 -75.09 141.68 74.84 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.581 0.705 . . . . 2.92 109.801 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.2 Cg_endo -97.53 175.9 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 124.348 3.365 . . . . 0.57 111.512 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.05 -10.14 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.562 2.841 . . . . 0.88 110.026 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 22.7 p -88.0 -20.11 26.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.52 111.821 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -66.49 134.14 51.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.34 111.586 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.601 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.3 mmt180 -116.38 172.21 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 2.49 108.848 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -78.24 41.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.763 1.023 . . . . 1.62 113.763 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 161.93 36.28 0.02 OUTLIER Glycine 0 C--N 1.288 -2.115 0 CA-C-N 114.495 -1.23 . . . . 0.46 112.059 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.671 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 10.8 mtp -86.01 147.65 26.11 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.617 -1.623 . . . . 1.08 106.617 168.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 11.2 p -151.91 152.91 33.17 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 119.11 -1.036 . . . . 0.69 112.59 -173.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 305' ' ' ASP . 2.0 t -129.63 122.9 56.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 113.403 -1.726 . . . . 0.94 109.343 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.1 tt0 -89.27 119.85 30.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.025 -1.472 . . . . 1.39 107.025 169.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 282' ' ' ILE . 57.0 t -122.45 120.07 60.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.68 . . . . 0.12 110.84 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.946 HD11 ' HB3' ' A' ' 335' ' ' GLN . 12.3 tp -91.2 117.51 29.69 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 115.198 -0.91 . . . . 0.23 110.775 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 312' ' ' VAL . 2.3 mm -93.59 169.05 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-N 115.045 -0.979 . . . . 1.63 109.584 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 23.7 mt-10 -140.56 141.51 35.22 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.677 -1.601 . . . . 0.3 108.745 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.521 ' CG ' HG12 ' A' ' 290' ' ' ILE . 14.5 mtp -150.49 160.75 43.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.272 1.511 . . . . 0.36 113.057 -168.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.608 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 1.3 mt -94.56 163.18 23.49 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 111.087 -2.779 . . . . 1.45 109.373 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -60.24 1.26 0.5 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.462 2.775 . . . . 0.34 112.752 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 285' ' ' LEU . 14.2 t70 -101.05 -15.08 17.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.64 -0.874 . . . . 0.55 108.64 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.638 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 94.4 -12.89 68.28 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.61 -1.177 . . . . 0.16 110.227 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.88 116.03 1.96 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.795 0.807 . . . . 0.58 110.174 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -67.68 115.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 113.781 -1.554 . . . . 0.47 110.53 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.608 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 44.6 p -97.74 -26.44 14.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.418 -1.265 . . . . 0.22 110.168 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 17.3 t30 -151.83 169.41 22.33 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.344 0.592 . . . . 0.61 110.354 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -170.95 128.54 0.74 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.515 -1.22 . . . . 0.22 109.475 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.3 169.9 16.98 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 122.33 1.062 . . . . 0.17 110.189 175.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.642 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.2 t -83.67 115.69 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.783 0 CA-C-N 113.207 -1.815 . . . . 0.16 108.886 168.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.7 p -85.71 -28.4 24.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 113.417 -1.72 . . . . 0.44 109.871 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -152.66 112.71 3.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.069 -0.969 . . . . 2.82 108.993 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.435 ' HB3' HG11 ' A' ' 295' ' ' VAL . 5.2 p -92.06 150.16 21.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.67 111.66 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.8 p -81.07 -17.94 48.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.522 -0.763 . . . . 0.59 109.607 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.36 31.22 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.502 -1.226 . . . . 0.57 110.77 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.21 104.06 13.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.364 0.602 . . . . 1.57 110.256 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 47.2 mmtt -61.87 -47.65 91.02 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 114.563 -1.199 . . . . 2.56 112.912 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.3 Cg_endo -48.56 -47.86 19.22 Favored 'Trans proline' 0 CA--C 1.5 -1.187 0 C-N-CA 121.995 1.796 . . . . 0.18 111.003 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.404 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 23.4 t80 -62.55 -47.54 83.41 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-N 114.771 -1.104 . . . . 0.58 108.993 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.642 ' HB2' HG21 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -56.54 -62.29 1.83 Allowed 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.259 -0.882 . . . . 2.31 111.493 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 70.5 m -67.52 -36.21 80.58 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 114.905 1.446 . . . . 0.92 114.905 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 97.0 p -52.84 -30.58 34.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.095 0.95 . . . . 0.11 108.863 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.713 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -86.98 -32.03 20.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.461 -1.7 . . . . 0.1 111.244 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 56.6 t -61.98 -41.48 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 123.475 1.607 . . . . 0.13 108.418 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.06 -12.73 60.39 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 113.831 -1.531 . . . . 0.13 110.388 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.57 -42.87 41.18 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.488 -1.301 . . . . 0.13 107.488 170.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 282' ' ' ILE . 30.7 m -71.73 -53.56 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.732 0.777 . . . . 0.23 111.57 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.4 mmt180 -57.79 -33.88 69.02 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.967 -1.015 . . . . 0.49 112.253 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.594 ' ND2' ' HG3' ' A' ' 265' ' ' GLN . 60.1 t30 -68.73 -28.33 66.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.935 0.398 . . . . 0.56 111.024 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.31 -42.56 74.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.259 1.028 . . . . 0.27 109.1 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 62.49 -13.92 0.08 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.484 -2.144 . . . . 0.7 117.722 167.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -160.19 130.85 5.56 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 117.21 0.505 . . . . 3.49 110.476 175.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.592 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.52 134.93 20.32 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 121.333 0.587 . . . . 0.65 110.37 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.72 -52.5 2.31 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.51 3.473 . . . . 0.57 116.695 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.475 ' HB2' ' CD2' ' A' ' 254' ' ' LEU . 35.9 mt-10 -81.6 6.03 16.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.637 0.977 . . . . 1.9 113.637 -165.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.704 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.1 mmt -65.39 -21.71 66.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.229 -0.588 . . . . 1.16 111.732 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -86.43 11.69 11.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.615 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.41 -51.44 3.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.516 -1.29 . . . . 1.64 107.516 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 85.0 mt -54.69 155.74 7.35 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 115.346 1.61 . . . . 1.07 115.346 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.2 Cg_exo -60.18 140.02 90.12 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.435 3.423 . . . . 0.36 108.689 162.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -55.68 -40.79 72.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.317 0.579 . . . . 3.98 110.819 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.78 71.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.786 -1.097 . . . . 0.34 111.862 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 74.9 m -82.28 -36.95 26.53 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.987 0.898 . . . . 0.34 109.089 -177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.73 -47.1 86.76 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.262 -1.335 . . . . 0.71 109.349 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 10.9 t70 -59.89 -30.72 69.2 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.673 0.749 . . . . 0.83 110.632 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.652 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -68.36 -51.16 47.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 122.751 1.262 . . . . 0.3 108.447 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.7 mt -102.43 -60.48 1.53 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.931 -1.941 . . . . 0.33 114.91 -165.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.704 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 75.1 m-85 -107.12 0.84 23.73 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.523 -0.762 . . . . 0.49 112.206 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 2.5 ptt180 -55.04 -41.3 71.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.233 1.016 . . . . 2.41 108.867 170.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.946 ' HB3' HD11 ' A' ' 281' ' ' LEU . 27.9 mt-30 -132.3 110.63 10.73 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.299 -1.773 . . . . 0.45 107.375 168.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.4 tpt180 -107.05 113.21 26.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.725 -0.843 . . . . 2.45 108.725 -170.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.474 ' CD ' HD13 ' A' ' 281' ' ' LEU . 4.8 mtt180 -85.29 133.21 34.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.943 1.354 . . . . 1.07 113.282 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.514 HD11 ' CG2' ' A' ' 258' ' ' ILE . 8.4 mt -123.82 120.45 59.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.583 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.54 112.16 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.625 -0.88 . . . . 0.29 108.625 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.814 ' O ' ' HA ' ' A' ' 277' ' ' SER . 80.8 m-85 -90.04 100.17 13.04 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.513 -0.921 . . . . 0.54 108.513 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.595 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 15.7 ttmt -136.99 92.65 14.0 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 115.955 -0.566 . . . . 1.34 110.058 -171.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 276' ' ' MET . 37.2 Cg_exo -32.27 165.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.465 4.777 . . . . 0.5 118.492 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -150.63 109.53 3.88 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.282 -2.236 . . . . 2.54 107.632 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.02 88.18 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.699 1.0 . . . . 2.26 113.699 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 347' ' ' LEU . 1.5 mm? -89.19 -166.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 1.22 110.052 166.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 4.8 t -59.58 -37.61 78.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.079 0.942 . . . . 1.77 111.138 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.601 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 113.957 -1.474 . . . . 2.89 112.105 -164.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.805 ' HB3' ' CZ ' ' A' ' 336' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.18 -0.674 . . . . 1.84 109.18 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -123.05 108.03 32.66 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.998 -0.281 . . . . 1.1 110.659 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 54.1 Cg_exo -50.42 118.44 4.04 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.363 2.042 . . . . 0.48 111.022 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 259' ' ' VAL . 17.4 tp -106.42 149.01 27.45 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.121 -0.631 . . . . 1.26 111.023 -167.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.555 HG13 ' HB3' ' A' ' 341' ' ' LYS . 60.8 t -80.36 104.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.398 -0.819 . . . . 1.01 111.027 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 259' ' ' VAL . 7.3 tp -93.54 103.91 15.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.789 0.805 . . . . 0.34 109.698 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.2 p -94.43 -21.19 19.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 1.05 110.769 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 8.3 t -69.56 -174.61 0.72 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.32 -0.855 . . . . 2.56 110.413 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 263' ' ' SER . . . 122.48 106.82 1.89 Allowed Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.196 -0.526 . . . . 1.85 111.828 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' B' ' 12' ' ' ARG . 53.4 t30 -160.7 168.28 25.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.631 -0.877 . . . . 3.21 108.631 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -77.33 45.07 0.45 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.465 1.126 . . . . 5.81 111.109 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' B' ' 10' ' ' ASN . 99.2 mtt180 -57.58 149.73 20.73 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.158 -1.837 . . . . 5.3 110.867 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.327 -0.844 . . . . 7.77 109.834 179.017 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.374 -0.232 . . . . 40.22 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 81.3 mtp 69.48 -77.87 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 124.065 0.853 . . . . 40.04 111.507 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -162.6 118.11 1.86 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.331 -0.395 . . . . 39.27 110.53 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.76 6.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.435 -0.58 . . . . 37.29 109.435 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.45 -95.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.264 -0.174 . . . . 36.13 110.958 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 65.6 -48.2 0.39 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.767 0.827 . . . . 34.41 112.582 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 319' ' ' PRO . 11.0 pt-20 -63.06 114.55 3.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.539 0.685 . . . . 32.45 110.835 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.15 154.3 41.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.862 -1.063 . . . . 30.94 110.896 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.32 60.18 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.461 0.648 . . . . 30.21 111.956 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.5 p -77.55 73.0 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.071 -0.513 . . . . 27.83 110.734 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -69.26 -20.77 63.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.193 -0.458 . . . . 27.14 111.153 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.7 m -58.01 -32.18 67.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.751 -0.463 . . . . 25.54 109.751 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 323' ' ' GLN . 11.6 m 72.8 -61.42 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 23.93 112.475 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 64.58 116.31 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.422 1.106 . . . . 24.03 111.525 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -132.65 -35.08 1.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.233 -1.349 . . . . 22.83 109.722 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -86.14 158.57 19.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.357 -0.838 . . . . 21.0 109.565 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 58.69 55.05 4.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.138 0.494 . . . . 19.72 110.822 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.07 -12.8 56.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 17.66 111.473 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 246' ' ' VAL . 3.5 tm? -75.6 -45.55 36.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.914 -0.772 . . . . 16.08 108.914 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 63.8 137.59 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.397 0.888 . . . . 14.08 113.397 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.0 p30 46.16 -166.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.266 1.026 . . . . 13.03 113.015 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.27 151.37 5.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 12.06 112.119 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 242' ' ' LEU . 5.3 p -78.89 153.44 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.654 0.74 . . . . 9.73 111.926 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 143.7 -52.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.236 -1.347 . . . . 7.65 111.936 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.5 m -102.94 96.55 6.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.901 0.381 . . . . 6.51 110.32 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -50.19 134.12 22.81 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 122.175 0.988 . . . . 4.79 111.783 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.9 m 36.4 -134.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 112.08 -2.327 . . . . 2.23 114.641 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.589 HG22 HD22 ' A' ' 332' ' ' LEU . 30.5 p 51.58 74.64 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.251 1.024 . . . . 1.43 109.955 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.12 57.16 0.25 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 113.617 -1.629 . . . . 1.61 114.692 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.676 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.3 OUTLIER 57.16 18.43 4.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.269 1.033 . . . . 1.62 111.083 -177.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.2 OUTLIER -82.22 -37.83 25.44 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.633 -1.621 . . . . 0.47 110.298 -172.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.458 ' OD1' ' HB1' ' B' ' 1' ' ' ALA . 3.1 m-20 -51.71 -45.16 63.46 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 121.563 0.697 . . . . 2.08 109.836 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 9.8 t70 -63.77 -37.82 88.79 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.749 -1.114 . . . . 0.89 110.483 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 253' ' ' SER . 13.3 mt -61.3 -53.17 60.16 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.163 -0.926 . . . . 0.46 111.99 176.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.618 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.12 -45.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 122.598 1.189 . . . . 0.27 110.615 173.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.748 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 3.5 t -67.67 -38.07 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 112.98 -1.918 . . . . 0.15 111.284 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.13 -49.66 77.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-O 123.709 1.719 . . . . 0.52 106.959 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 83.8 mt -62.05 -49.12 77.24 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 110.455 -3.066 . . . . 0.24 112.779 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.64 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -60.49 -37.98 76.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.053 -0.521 . . . . 0.17 112.369 -171.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.552 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.9 p -80.55 -18.16 49.27 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 111.699 0.259 . . . . 0.69 111.699 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.66 -32.78 70.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.219 -1.771 . . . . 1.21 106.219 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.53 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -88.73 -16.89 31.1 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 112.166 -2.288 . . . . 1.53 114.006 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.5 t90 -88.26 170.78 10.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.264 1.031 . . . . 0.21 109.886 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 41.0 mtp-105 -153.78 112.87 3.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 112.75 -2.023 . . . . 3.65 110.217 -172.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 3.3 ptm180 -69.72 143.04 91.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 2.92 110.289 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 76.3 Cg_endo -98.53 171.47 0.58 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 124.137 3.225 . . . . 0.57 111.645 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.32 -8.67 11.68 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.57 2.847 . . . . 0.88 110.325 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 12.0 p -87.45 -27.89 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.865 -1.516 . . . . 0.52 111.694 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.66 132.01 52.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.34 111.897 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.625 ' HD2' HD23 ' A' ' 347' ' ' LEU . 4.4 mmm180 -106.73 173.88 6.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.853 -1.067 . . . . 2.49 109.916 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.27 36.84 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.988 0.736 . . . . 1.62 112.988 -169.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.15 36.6 0.02 OUTLIER Glycine 0 C--N 1.297 -1.589 0 CA-C-N 115.763 -0.653 . . . . 0.46 112.56 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.681 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 8.8 mtp -81.88 146.98 29.55 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.4 -1.333 . . . . 1.08 107.4 170.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.745 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 18.8 p -152.01 151.26 30.93 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.407 1.098 . . . . 0.69 112.244 -173.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 340' ' ' PHE . 2.3 p -137.11 126.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 113.061 -1.881 . . . . 0.94 109.234 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -88.41 117.8 27.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.325 -1.361 . . . . 1.39 107.325 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 282' ' ' ILE . 53.9 t -116.22 119.58 62.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.818 -0.628 . . . . 0.12 110.397 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.804 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.1 tp -93.03 107.18 19.02 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.012 -0.995 . . . . 0.23 109.515 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.75 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.6 156.12 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 107.905 -1.146 . . . . 1.63 107.905 177.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 16.5 mt-10 -125.52 134.83 51.87 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.118 -0.697 . . . . 0.3 109.118 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.546 ' CG ' HG12 ' A' ' 290' ' ' ILE . 1.8 mtp -145.82 160.09 42.27 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-O 123.272 1.511 . . . . 0.36 111.99 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -106.64 170.02 6.19 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 111.151 -2.75 . . . . 1.45 109.886 -176.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -53.18 -1.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.329 -0.463 0 C-N-CA 124.107 3.205 . . . . 0.34 113.697 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.508 ' H ' HD13 ' A' ' 285' ' ' LEU . 9.0 t70 -107.63 -7.64 16.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.465 0.65 . . . . 0.55 110.381 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 83.35 -13.15 47.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.303 -0.862 . . . . 0.16 112.532 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.9 m -49.73 118.92 3.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 122.275 1.036 . . . . 0.58 109.624 168.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 312' ' ' VAL . 1.1 mt -68.41 118.03 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.367 -1.288 . . . . 0.47 110.145 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.9 p -97.87 -25.72 14.92 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.767 -1.106 . . . . 0.22 110.314 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.9 t30 -152.73 171.42 18.24 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.195 0.521 . . . . 0.61 110.709 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.01 131.69 0.82 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.812 -1.085 . . . . 0.22 110.269 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.63 168.99 18.48 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.453 1.12 . . . . 0.17 111.101 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 305' ' ' ASP . 2.7 t -80.71 116.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.755 0 CA-C-N 112.695 -2.048 . . . . 0.16 108.263 166.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -30.93 17.62 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.585 -1.643 . . . . 0.44 109.876 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 297' ' ' ARG . 30.6 mmt180 -151.13 109.14 3.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.15 -0.932 . . . . 2.82 109.445 174.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 295' ' ' VAL . 2.6 p -83.6 149.35 26.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 0.67 111.642 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 11.0 p -79.09 -18.48 53.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.845 0.831 . . . . 0.59 109.042 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.55 -13.28 39.26 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.467 -1.242 . . . . 0.57 110.669 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 26.0 t70 -100.84 93.31 5.47 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 108.104 -1.073 . . . . 1.57 108.104 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 5.8 mptt -54.66 -43.42 98.27 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 114.511 -1.222 . . . . 2.56 112.197 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.5 Cg_endo -50.44 -49.05 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 C-N-CA 121.757 1.638 . . . . 0.18 111.661 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.426 ' HZ ' ' CD ' ' A' ' 342' ' ' PRO . 45.5 t80 -60.39 -54.83 40.86 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.884 0.85 . . . . 0.58 109.634 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 295' ' ' VAL . 68.9 m-20 -55.47 -54.16 47.27 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.996 -1.456 . . . . 2.31 110.859 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.697 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.9 t -72.11 -36.78 69.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.642 0.979 . . . . 0.92 113.642 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 95.1 p -52.9 -30.16 32.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.447 1.117 . . . . 0.11 109.185 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -85.85 -30.54 22.84 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 112.878 -1.965 . . . . 0.1 110.828 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 306' ' ' SER . 59.7 t -62.96 -40.24 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 CA-C-O 123.676 1.703 . . . . 0.13 108.563 170.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.95 -14.06 60.59 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.02 -1.446 . . . . 0.13 110.903 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.47 -42.64 52.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.928 -1.508 . . . . 0.13 106.928 171.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.694 ' O ' HG22 ' A' ' 315' ' ' VAL . 31.6 m -71.05 -53.15 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.541 0.686 . . . . 0.23 111.682 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.4 mmt180 -55.83 -37.31 68.52 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.343 -0.844 . . . . 0.49 112.555 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.53 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 61.7 t30 -67.71 -26.0 65.94 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.66 0.267 . . . . 0.56 111.526 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.3 m -69.13 -42.96 81.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.426 1.107 . . . . 0.27 109.21 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.45 -17.96 0.09 OUTLIER Glycine 0 C--N 1.311 -0.819 0 CA-C-N 112.281 -2.236 . . . . 0.7 117.004 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.11 129.64 4.49 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 117.056 0.428 . . . . 3.49 111.213 175.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -100.9 122.88 47.37 Favored Pre-proline 0 N--CA 1.433 -1.302 0 CA-C-O 121.256 0.551 . . . . 0.65 110.027 171.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.663 ' HG2' ' OE2' ' A' ' 320' ' ' GLU . 73.7 Cg_endo -62.95 -46.49 10.51 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 123.916 3.077 . . . . 0.57 115.099 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 21.2 mp0 -63.86 -1.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.488 1.662 . . . . 1.9 115.488 -173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.6 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.6 mmt -72.02 -24.3 61.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.217 -0.927 . . . . 1.16 111.783 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.88 5.37 13.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.275 -0.875 . . . . 0.72 112.239 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -100.88 -52.11 3.39 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.875 -1.157 . . . . 1.64 107.875 176.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 82.7 mt -51.94 155.87 2.88 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 115.68 1.733 . . . . 1.07 115.68 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.5 Cg_exo -58.6 136.15 72.16 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 123.935 3.09 . . . . 0.36 108.756 163.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -46.63 39.89 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.94 0.876 . . . . 3.98 110.72 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.08 -33.24 73.02 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.001 -1.454 . . . . 0.34 112.399 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 53.0 m -77.36 -39.99 45.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.306 1.05 . . . . 0.34 108.34 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.524 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 6.8 t80 -58.72 -50.48 73.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.477 -1.692 . . . . 0.71 109.921 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.5 t70 -57.6 -33.77 68.56 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.765 0.793 . . . . 0.83 111.229 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -67.92 -49.3 62.69 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.379 -1.282 . . . . 0.3 108.446 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.7 ' HB3' ' HB2' ' B' ' 1' ' ' ALA . 11.1 mt -101.86 -60.87 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.079 -1.873 . . . . 0.33 114.877 -165.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.621 ' CD2' ' HB2' ' A' ' 332' ' ' LEU . 65.3 m-85 -107.32 -5.0 18.06 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.64 0.607 . . . . 0.49 112.64 -162.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.1 -50.88 60.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.28 0.562 . . . . 2.41 109.843 174.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.804 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.5 mt-30 -121.63 120.61 35.26 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.177 -1.416 . . . . 0.45 107.177 159.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.805 ' CZ ' ' HB3' ' B' ' 1' ' ' ALA . 0.0 OUTLIER -118.4 121.53 40.56 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.034 -1.067 . . . . 2.45 109.314 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.774 ' N ' ' HD3' ' A' ' 336' ' ' ARG . 6.9 mmt180 -82.26 114.11 20.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 122.526 1.155 . . . . 1.07 110.915 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 282' ' ' ILE . 13.4 mt -99.57 122.58 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 113.08 -1.873 . . . . 0.17 108.509 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.577 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -101.06 111.47 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.471 -0.937 . . . . 0.29 108.471 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 277' ' ' SER . 79.9 m-85 -90.1 104.36 16.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.863 -0.792 . . . . 0.54 108.863 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' B' ' 5' ' ' VAL . 13.2 ttmt -139.59 92.19 10.36 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-N 115.986 -0.552 . . . . 1.34 110.296 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.9 Cg_exo -35.77 170.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 1 C-N-CA 126.17 4.58 . . . . 0.5 117.308 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -146.34 118.05 8.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.92 -1.945 . . . . 2.54 108.963 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.15 81.74 0.08 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 114.335 1.235 . . . . 2.26 114.335 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.8 mm? -85.85 -167.92 2.03 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.103 -1.443 . . . . 1.22 107.103 160.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.61 ' HB2' HD13 ' A' ' 347' ' ' LEU . 1.9 m -73.16 -38.76 66.09 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.833 1.301 . . . . 1.77 108.84 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.625 HD23 ' HD2' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 112.73 -2.032 . . . . 2.89 111.147 -169.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.47 0.176 . . . . 1.84 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.6 t70 63.13 107.4 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.723 0.639 . . . . 1.1 111.982 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 50.7 Cg_exo -51.12 119.81 5.89 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.663 2.242 . . . . 0.48 111.498 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -101.41 140.07 36.21 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.658 -0.417 . . . . 1.26 110.366 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 341' ' ' LYS . 54.7 t -70.41 102.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.652 -0.704 . . . . 1.01 111.393 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.2 tp -93.98 102.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.161 -1.051 . . . . 0.34 108.161 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 3.2 p -100.09 4.07 44.36 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.972 -1.013 . . . . 1.05 111.381 -171.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.599 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 6.3 t -126.17 153.03 45.2 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.417 -0.81 . . . . 2.56 110.256 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.84 -129.73 3.21 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.418 -1.473 . . . . 1.85 109.418 165.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -53.78 138.4 35.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.25 0.525 . . . . 3.21 109.789 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.5 -15.15 58.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.449 -0.796 . . . . 5.81 110.894 -172.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 12' ' ' ARG . 40.2 mtt-85 55.09 -160.19 0.18 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.042 -0.981 . . . . 5.3 112.1 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.199 -0.905 . . . . 7.77 110.284 177.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.572 0.225 . . . . 40.22 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -159.83 128.91 5.13 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.276 -0.268 . . . . 40.04 110.276 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.37 79.04 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.624 -0.262 . . . . 39.27 111.21 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.8 23.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.021 -0.536 . . . . 37.29 112.146 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 20.2 tp -140.06 14.01 2.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.079 0.466 . . . . 36.13 110.213 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 63.71 173.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.211 -0.904 . . . . 34.41 112.745 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -159.01 140.85 13.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.102 -0.954 . . . . 32.45 108.619 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.1 tp 52.26 67.97 0.89 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.517 0.675 . . . . 30.94 110.262 -174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? -126.37 37.42 4.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 30.21 110.42 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -58.49 -47.44 84.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.629 -0.714 . . . . 27.83 110.365 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.29 54.53 8.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.032 0.92 . . . . 27.14 109.369 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 327' ' ' ALA . 0.2 OUTLIER -74.76 155.25 37.85 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.983 -1.008 . . . . 25.54 110.681 -174.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 15.1 m 70.84 -42.79 0.54 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.383 0.673 . . . . 23.93 112.019 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.04 -7.72 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 24.03 111.219 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? -51.13 121.03 5.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.438 -0.801 . . . . 22.83 110.979 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.73 -53.16 5.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 21.0 111.24 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -91.97 29.6 1.57 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.171 0.51 . . . . 19.72 112.07 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -163.03 125.42 2.63 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.638 -0.71 . . . . 17.66 110.794 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 65.1 tp -107.94 -25.77 11.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.108 -0.496 . . . . 16.08 109.816 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.77 128.46 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.28 -0.873 . . . . 14.08 112.235 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.15 -174.18 3.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.124 -0.944 . . . . 13.03 110.41 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.28 129.71 41.42 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.094 0.473 . . . . 12.06 110.459 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 247' ' ' GLY . 14.4 p -76.63 167.95 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.409 0.623 . . . . 9.73 110.522 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 109.86 -120.97 5.86 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.079 -0.964 . . . . 7.65 111.718 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.2 t -86.03 70.79 10.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.343 0.592 . . . . 6.51 110.399 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -92.46 -104.75 0.12 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.738 -0.665 . . . . 4.79 111.128 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.4 m 47.38 -178.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 115.624 1.713 . . . . 2.23 115.624 168.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 8.4 p -83.33 -2.64 56.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.154 -1.385 . . . . 1.43 110.604 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 55.62 -126.01 38.37 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.13 -0.941 . . . . 1.61 112.274 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.786 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -114.08 16.86 18.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.224 1.011 . . . . 1.62 109.259 171.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.661 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 4.6 mp -83.94 -40.12 18.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.208 -1.814 . . . . 0.47 110.242 -165.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.511 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 4.4 p-10 -53.62 -46.21 70.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.622 0.725 . . . . 2.08 111.124 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 260' ' ' ASN . 2.1 t70 -69.21 -32.86 72.4 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.731 -1.577 . . . . 0.89 111.035 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -62.5 -51.16 68.55 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-O 121.215 0.531 . . . . 0.46 111.837 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -48.49 -47.24 14.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.839 1.304 . . . . 0.27 110.177 174.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.672 HG21 HD23 ' B' ' 4' ' ' LEU 0.262 6.4 t -67.55 -37.3 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-N 112.376 -2.193 . . . . 0.15 111.175 178.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 7.7 t30 -60.66 -49.12 78.78 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-O 123.837 1.78 . . . . 0.52 107.607 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 70.0 mt -62.84 -45.64 91.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.081 -3.236 . . . . 0.24 112.158 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -62.04 -37.18 77.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 116.221 -0.445 . . . . 0.17 111.83 -171.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.583 ' HB3' ' O ' ' B' ' 8' ' ' SER . 1.8 p -76.86 -23.81 52.66 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.978 0.418 . . . . 0.69 110.964 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -67.48 -30.48 70.18 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.532 -1.655 . . . . 1.21 106.532 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.574 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -94.07 -17.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.213 -2.267 . . . . 1.53 114.481 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.599 ' HE3' ' O ' ' B' ' 8' ' ' SER . 14.3 t90 -90.75 173.63 7.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.954 1.359 . . . . 0.21 110.919 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.492 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 25.0 ttp85 -153.52 120.4 5.68 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.317 -2.22 . . . . 3.65 109.949 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 19.1 mtm180 -79.2 137.07 56.61 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 120.284 -0.566 . . . . 2.92 109.693 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 42.6 Cg_endo -91.13 173.58 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.146 2.564 . . . . 0.57 111.083 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.95 -9.47 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.363 2.709 . . . . 0.88 110.145 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 25.0 p -88.92 -16.93 30.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.733 -1.576 . . . . 0.52 111.26 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.987 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -66.42 141.55 57.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.351 0.596 . . . . 0.34 111.653 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.647 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 69.0 mmt-85 -119.23 171.15 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.484 -0.78 . . . . 2.49 109.327 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -76.93 57.71 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.651 1.215 . . . . 1.62 113.032 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 144.84 33.29 0.08 OUTLIER Glycine 0 C--N 1.284 -2.342 0 CA-C-N 113.027 -1.897 . . . . 0.46 112.576 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.987 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -82.14 146.27 29.68 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.68 -1.97 . . . . 1.08 105.68 166.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 4.7 p -157.1 151.59 25.34 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.018 -1.073 . . . . 0.69 112.926 -169.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.3 t -127.26 127.49 69.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.04 -1.436 . . . . 0.94 109.433 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 297' ' ' ARG . 11.2 tt0 -91.29 113.02 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.343 -1.354 . . . . 1.39 107.343 168.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 282' ' ' ILE . 45.6 t -115.71 119.61 62.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.93 -0.577 . . . . 0.12 110.371 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.872 HD11 ' HB3' ' A' ' 335' ' ' GLN . 3.3 tp -92.49 107.71 19.42 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.069 -0.969 . . . . 0.23 109.669 177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.31 157.96 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.47 -0.937 . . . . 1.63 108.47 177.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.0 mt-10 -125.69 142.07 51.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.513 -0.921 . . . . 0.3 108.513 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.0 mtp -150.21 159.09 44.69 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 123.38 1.562 . . . . 0.36 112.727 -171.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.649 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 3.2 mt -85.53 163.29 45.12 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 110.572 -3.013 . . . . 1.45 109.283 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -59.03 -5.0 2.41 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.023 2.482 . . . . 0.34 112.369 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.22 -16.3 20.45 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.32 -0.855 . . . . 0.55 109.079 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.639 ' CA ' ' HG2' ' A' ' 321' ' ' MET . . . 93.16 -2.84 72.12 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 113.974 -1.466 . . . . 0.16 111.051 -174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.18 125.23 22.76 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.533 0.682 . . . . 0.58 109.875 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 284' ' ' MET . 2.0 mm -68.07 116.13 7.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.499 -1.228 . . . . 0.47 110.979 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.649 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 35.6 p -101.93 -24.9 13.95 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.615 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.0 t-20 -158.78 172.94 17.34 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.106 0.479 . . . . 0.61 111.145 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.54 136.28 0.97 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.05 -0.977 . . . . 0.22 110.647 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.35 169.65 17.26 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 122.38 1.086 . . . . 0.17 110.791 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.59 115.12 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 112.717 -2.038 . . . . 0.16 107.965 168.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -28.88 20.6 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.469 -1.696 . . . . 0.44 109.611 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 279' ' ' GLU . 30.5 mmt180 -150.58 120.32 7.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 114.805 -1.089 . . . . 2.82 109.369 174.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 12.0 p -83.34 148.56 27.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.67 111.845 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 88.6 p -83.47 -7.91 59.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.765 0.793 . . . . 0.59 109.507 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.37 -17.14 59.03 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.777 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.62 101.21 10.68 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.57 109.512 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 42.1 mttt -57.59 -44.43 99.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 114.453 -1.249 . . . . 2.56 112.374 -176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.0 Cg_endo -48.7 -50.21 13.02 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.221 1.947 . . . . 0.18 111.389 171.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 69.3 t80 -62.35 -49.55 75.14 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 123.968 0.793 . . . . 0.58 109.308 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.704 ' HB3' HG21 ' A' ' 295' ' ' VAL . 71.7 m-20 -55.16 -61.82 2.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.011 -0.995 . . . . 2.31 111.098 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.69 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 73.8 m -67.51 -35.54 79.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.531 1.308 . . . . 0.92 114.531 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 90.5 p -53.5 -30.5 41.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.367 1.079 . . . . 0.11 109.046 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -88.17 -29.68 20.35 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.25 -1.795 . . . . 0.1 110.866 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.69 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 47.9 t -63.33 -40.24 88.32 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-O 123.57 1.652 . . . . 0.13 108.468 169.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.31 -14.45 60.9 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 114.052 -1.431 . . . . 0.13 110.703 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.625 ' O ' HG13 ' A' ' 315' ' ' VAL . . . -75.54 -42.37 52.6 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.236 -1.394 . . . . 0.13 107.236 171.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.797 ' O ' HG22 ' A' ' 315' ' ' VAL . 27.0 m -73.08 -47.33 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 121.437 0.636 . . . . 0.23 112.634 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 10.5 mmt180 -58.43 -40.18 81.81 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.491 -0.777 . . . . 0.49 112.445 176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.574 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.2 t30 -69.58 -24.32 63.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.854 0.359 . . . . 0.56 111.967 -171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.4 m -65.72 -41.07 89.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 122.377 1.084 . . . . 0.27 109.775 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 290' ' ' ILE . . . 68.63 -25.68 0.28 Allowed Glycine 0 C--N 1.31 -0.877 0 CA-C-N 112.994 -1.912 . . . . 0.7 116.813 170.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -160.67 125.14 3.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 120.959 0.409 . . . . 3.49 110.92 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 321' ' ' MET . 2.2 mp -102.85 138.63 19.63 Favored Pre-proline 0 N--CA 1.438 -1.074 0 C-N-CA 122.914 0.485 . . . . 0.65 110.0 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -73.03 -53.21 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.65 2.9 . . . . 0.57 116.284 -164.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.439 ' OE2' ' HG ' ' A' ' 254' ' ' LEU . 52.0 mt-10 -78.04 5.26 10.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.612 1.708 . . . . 1.9 115.612 -164.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.695 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -62.42 -24.34 67.35 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.19 0.905 . . . . 1.16 110.629 177.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.77 2.66 41.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.874 -1.057 . . . . 0.72 111.458 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -94.59 -57.89 2.35 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.879 -1.526 . . . . 1.64 106.879 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.847 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.8 OUTLIER -62.23 163.01 15.34 Favored Pre-proline 0 N--CA 1.396 -3.161 0 CA-C-N 113.276 -1.784 . . . . 1.07 114.246 177.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 73.3 Cg_exo -62.39 138.94 74.14 Favored 'Trans proline' 0 N--CA 1.485 0.984 1 C-N-CA 127.298 5.332 . . . . 0.36 115.672 174.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -44.75 -34.68 2.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.582 0.705 . . . . 3.98 111.978 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 235' ' ' THR . . . -84.53 -28.97 26.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.959 -1.019 . . . . 0.34 112.415 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.734 ' HB ' HD13 ' A' ' 324' ' ' LEU . 78.6 m -76.85 -31.28 56.73 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.26 -1.385 . . . . 0.34 107.26 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 324' ' ' LEU . 3.8 t80 -61.96 -51.27 68.79 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.233 -1.803 . . . . 0.71 110.087 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 23.6 t70 -56.04 -36.04 67.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.148 0.975 . . . . 0.83 111.01 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.715 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.85 -49.32 66.07 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.05 -1.432 . . . . 0.3 108.848 -175.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 8.9 mt -104.34 -60.73 1.54 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.109 -1.859 . . . . 0.33 115.02 -167.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.661 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 68.5 m-85 -107.06 -1.02 22.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.259 -0.428 . . . . 0.49 112.062 -162.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.3 OUTLIER -56.53 -57.37 12.64 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.034 -0.728 . . . . 2.41 109.034 167.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.872 ' HB3' HD11 ' A' ' 281' ' ' LEU . 1.7 mt-30 -122.62 114.45 20.63 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.147 -1.057 . . . . 0.45 108.147 162.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.728 ' H ' HD13 ' A' ' 282' ' ' ILE . 10.2 tpt180 -116.02 120.42 39.07 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.459 -0.941 . . . . 2.45 108.459 -172.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' B' ' 3' ' ' PRO . 6.2 mmt180 -84.82 117.32 23.8 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.125 -0.985 . . . . 1.07 111.379 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 282' ' ' ILE . 8.3 mt -101.48 122.45 53.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 113.637 -1.619 . . . . 0.17 108.935 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.5 OUTLIER -101.97 111.02 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.027 -0.731 . . . . 0.29 109.027 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.789 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -87.88 100.65 13.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.786 -0.82 . . . . 0.54 108.786 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.1 ttmt -135.94 88.94 21.66 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 116.377 -0.374 . . . . 1.34 110.537 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 276' ' ' MET . 36.8 Cg_exo -28.51 166.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.721 5.614 . . . . 0.5 119.17 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 10.1 pt-20 -150.03 125.89 10.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.298 -2.228 . . . . 2.54 108.185 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.2 t70 53.53 76.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.097 0.777 . . . . 2.26 113.097 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.4 mm? -87.47 -168.5 2.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.16 -0.473 . . . . 1.22 110.047 167.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.5 t -62.41 -32.15 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.96 0.886 . . . . 1.77 111.349 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.647 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.063 -1.426 . . . . 2.89 112.276 -161.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.985 -0.376 . . . . 1.84 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 3' ' ' PRO . 30.1 t70 -65.22 130.35 94.74 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.273 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 2' ' ' ASP . 48.7 Cg_exo -54.32 127.96 28.02 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.813 2.342 . . . . 0.48 111.855 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.779 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -101.07 138.02 38.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 1.26 109.782 -173.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 341' ' ' LYS . 4.0 p -74.14 108.18 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.608 0.718 . . . . 1.01 112.14 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.0 tp -97.41 119.74 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -63.81 -70.12 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 1.05 111.356 -176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.741 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 95.8 p -159.87 163.45 34.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.425 0.631 . . . . 2.56 112.152 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.571 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -89.98 118.95 5.4 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 114.818 -1.083 . . . . 1.85 111.527 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.97 167.68 24.12 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.131 -1.063 . . . . 3.21 108.131 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.26 3.45 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.584 0.707 . . . . 5.81 110.311 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -47.98 135.84 12.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.763 -1.108 . . . . 5.3 110.833 174.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.546 -0.74 . . . . 7.77 110.94 -178.391 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 119.676 -0.202 . . . . 40.22 110.737 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.7 ptm 43.83 43.93 5.42 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.767 0.667 . . . . 40.04 111.025 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.68 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.052 -0.976 . . . . 39.27 111.255 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -119.06 97.29 5.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.357 -0.383 . . . . 37.29 110.967 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.11 -27.21 68.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 36.13 109.678 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.85 152.05 48.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.157 -0.929 . . . . 34.41 109.258 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -158.27 109.24 2.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.888 0.375 . . . . 32.45 111.178 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.546 ' HG ' ' H ' ' A' ' 232' ' ' LEU . 19.2 tp 59.24 172.11 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.58 -0.736 . . . . 30.94 112.399 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.546 ' H ' ' HG ' ' A' ' 231' ' ' LEU . 2.5 tt 58.07 76.6 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.926 -0.768 . . . . 30.21 108.926 -177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 m 57.61 55.1 5.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.681 -0.691 . . . . 27.83 109.772 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.59 -48.68 69.02 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.103 -0.953 . . . . 27.14 111.145 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.12 127.68 17.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.626 -0.716 . . . . 25.54 110.99 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.7 m -161.69 -62.33 0.05 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.366 -0.834 . . . . 23.93 109.517 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -103.34 -40.44 6.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.623 0.725 . . . . 24.03 110.305 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.53 88.26 6.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.62 -1.173 . . . . 22.83 110.084 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -107.71 -42.71 4.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.05 -0.523 . . . . 21.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -67.54 143.69 56.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.762 -0.654 . . . . 19.72 110.944 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 72.38 -14.98 0.51 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.831 0.707 . . . . 17.66 112.257 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 62.3 tp -103.06 -69.29 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.433 . . . . 16.08 110.422 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -97.92 174.97 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.814 -0.63 . . . . 14.08 110.746 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.7 -164.1 0.8 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.135 -0.484 . . . . 13.03 110.838 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -50.33 155.19 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.476 -0.784 . . . . 12.06 112.185 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 247' ' ' GLY . 12.2 p -64.38 160.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.751 0.786 . . . . 9.73 111.183 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.49 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 101.76 22.34 10.31 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.704 -1.135 . . . . 7.65 111.504 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -84.96 88.62 7.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 6.51 109.774 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 249' ' ' GLU . 0.0 OUTLIER -64.58 -61.52 2.16 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.142 0.972 . . . . 4.79 111.819 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 332' ' ' LEU . 14.9 m -147.53 -144.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 113.694 -1.594 . . . . 2.23 110.724 -165.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.0 p 68.72 -23.04 0.14 Allowed 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 124.226 1.01 . . . . 1.43 112.549 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.22 21.96 41.79 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-O 119.43 -0.65 . . . . 1.61 114.669 168.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.6 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 67.08 15.96 10.2 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.153 0.978 . . . . 1.62 110.515 -176.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.687 ' HB2' ' HH ' ' A' ' 333' ' ' TYR . 0.6 OUTLIER -80.58 -31.34 36.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.774 -1.557 . . . . 0.47 108.36 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.573 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 5.2 p-10 -53.65 -47.66 70.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.752 -1.113 . . . . 2.08 110.412 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 260' ' ' ASN . 8.3 t70 -65.93 -34.25 77.68 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.954 -1.475 . . . . 0.89 110.638 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 12.5 mt -62.5 -54.31 41.79 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 115.531 -0.759 . . . . 0.46 111.972 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.33 -46.18 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 122.567 1.175 . . . . 0.27 110.629 173.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' B' ' 4' ' ' LEU 0.256 3.4 t -66.34 -38.14 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.047 -1.888 . . . . 0.15 111.043 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 8.2 t30 -58.76 -50.19 74.84 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 124.054 1.883 . . . . 0.52 107.138 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 67.4 mt -62.53 -49.3 75.89 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 109.862 -3.335 . . . . 0.24 112.684 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.38 -38.97 77.78 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 N-CA-C 111.869 0.322 . . . . 0.17 111.869 -171.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.758 ' HB3' HD11 ' B' ' 6' ' ' ILE . 93.4 p -81.74 -14.97 55.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.181 0.515 . . . . 0.69 111.27 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.58 -34.02 69.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.302 -1.74 . . . . 1.21 106.302 173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.571 ' OE1' HG12 ' A' ' 315' ' ' VAL . 1.9 mp0 -88.88 -19.27 26.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.427 -2.169 . . . . 1.53 114.635 175.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.741 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 13.7 t90 -87.24 171.74 10.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.398 1.095 . . . . 0.21 110.616 -172.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 50.4 mtp180 -152.5 115.92 4.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.566 -2.106 . . . . 3.65 109.736 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -77.86 141.33 63.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.333 0.587 . . . . 2.92 110.572 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.482 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 41.1 Cg_endo -97.47 151.02 0.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.556 3.504 . . . . 0.57 112.972 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 19.1 Cg_endo -54.27 -8.41 1.07 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.393 3.395 . . . . 0.88 113.71 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.2 p -90.02 -28.42 19.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.416 0.524 . . . . 0.52 112.416 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.925 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -61.06 135.77 57.88 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.296 0.85 . . . . 0.34 113.296 -173.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.479 ' CD ' ' HA ' ' A' ' 347' ' ' LEU . 13.1 mmm180 -110.71 175.25 5.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.619 -1.173 . . . . 2.49 110.46 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 274' ' ' ASN . 1.0 OUTLIER -72.07 35.79 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.549 0.944 . . . . 1.62 113.549 -167.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 153.94 39.99 0.02 OUTLIER Glycine 0 C--N 1.296 -1.659 0 CA-C-N 115.934 -0.576 . . . . 0.46 112.21 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.925 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.8 ptm -87.72 152.14 22.37 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 106.913 -1.514 . . . . 1.08 106.913 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 24.4 p -157.26 156.15 32.0 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 118.775 -1.17 . . . . 0.69 113.317 -171.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -129.07 130.67 68.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.934 -1.484 . . . . 0.94 109.966 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 297' ' ' ARG . 5.4 tt0 -93.63 119.27 32.44 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.649 -1.241 . . . . 1.39 107.649 167.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 282' ' ' ILE . 76.4 t -122.21 120.08 60.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.95 -0.568 . . . . 0.12 110.78 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 335' ' ' GLN . 13.3 tp -90.02 118.39 29.54 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.837 -0.62 . . . . 0.23 110.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.771 HD11 HG11 ' A' ' 312' ' ' VAL . 2.1 mm -93.84 168.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-N 115.137 -0.938 . . . . 1.63 109.157 174.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.717 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 12.9 mt-10 -139.74 139.42 36.49 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 113.933 -1.485 . . . . 0.3 108.904 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 19.9 mtp -149.82 159.69 44.16 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 123.287 1.518 . . . . 0.36 113.246 -168.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -92.9 162.04 29.91 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.827 -2.897 . . . . 1.45 109.803 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -58.1 -3.3 1.12 Allowed 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.649 2.9 . . . . 0.34 112.437 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 285' ' ' LEU . 10.7 t70 -100.63 -15.86 17.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.344 -0.844 . . . . 0.55 108.937 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.486 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 95.62 -6.68 67.86 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.655 -1.157 . . . . 0.16 110.831 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -59.29 119.94 8.34 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.875 0.845 . . . . 0.58 109.953 174.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 315' ' ' VAL . 3.3 mt -66.93 114.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 113.829 -1.532 . . . . 0.47 110.664 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.721 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 43.0 p -95.9 -25.16 16.1 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.969 -1.014 . . . . 0.22 109.731 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.717 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 2.4 t-20 -152.44 172.26 16.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.447 0.641 . . . . 0.61 111.137 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.74 128.21 0.5 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.266 -1.334 . . . . 0.22 109.172 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.1 OUTLIER -139.54 168.04 20.73 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 122.22 1.01 . . . . 0.17 110.257 175.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -78.9 115.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 CA-C-N 113.112 -1.858 . . . . 0.16 108.57 168.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.1 p -86.95 -28.27 22.82 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 113.773 -1.558 . . . . 0.44 109.715 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 279' ' ' GLU . 18.4 tpt180 -153.4 110.96 3.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.851 -1.068 . . . . 2.82 109.324 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.5 p -77.63 148.09 35.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.648 -0.706 . . . . 0.67 111.784 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 277' ' ' SER . 66.3 p -81.84 -11.56 58.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.59 109.469 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.97 -13.18 67.57 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.512 -1.222 . . . . 0.57 110.856 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 9.2 t70 -103.52 94.22 5.36 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.393 -0.966 . . . . 1.57 108.393 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 8.1 mptt -58.43 -42.3 93.88 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.175 -1.375 . . . . 2.56 112.468 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.1 Cg_endo -49.99 -50.79 12.33 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 122.124 1.883 . . . . 0.18 111.372 167.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.593 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 51.5 t80 -59.49 -51.47 69.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.475 0.655 . . . . 0.58 109.321 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.691 ' HB3' HG21 ' A' ' 295' ' ' VAL . 64.5 m-20 -55.54 -62.1 1.91 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.639 -1.164 . . . . 2.31 111.172 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.668 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 61.8 m -67.15 -36.12 81.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.617 1.34 . . . . 0.92 114.617 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.5 p -54.86 -29.31 55.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.29 1.043 . . . . 0.11 109.438 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.692 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -84.0 -31.34 25.53 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.214 -1.812 . . . . 0.1 110.349 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.668 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 53.5 t -63.28 -40.2 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 123.305 1.526 . . . . 0.13 108.822 170.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.39 -14.41 60.46 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.205 -1.362 . . . . 0.13 110.748 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.86 -42.58 57.64 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 107.223 -1.399 . . . . 0.13 107.223 171.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.771 HG11 HD11 ' A' ' 282' ' ' ILE . 31.1 m -71.93 -53.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.607 0.718 . . . . 0.23 111.8 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.0 mmt180 -59.69 -33.53 71.7 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.389 -0.823 . . . . 0.49 112.901 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 51.6 t30 -68.47 -23.57 64.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.781 0.324 . . . . 0.56 111.293 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 312' ' ' VAL . 1.4 m -73.19 -42.87 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.764 1.269 . . . . 0.27 108.614 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 63.65 -19.46 0.09 OUTLIER Glycine 0 C--N 1.31 -0.911 0 CA-C-N 111.903 -2.408 . . . . 0.7 116.395 171.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -161.5 131.15 4.73 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.492 -0.558 . . . . 3.49 109.492 175.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 258' ' ' ILE . 2.8 mp -100.46 134.46 20.66 Favored Pre-proline 0 N--CA 1.434 -1.244 0 CA-C-O 121.454 0.645 . . . . 0.65 110.555 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 318' ' ' ILE . 56.1 Cg_endo -59.32 -56.38 1.35 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.859 3.706 . . . . 0.57 116.142 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 0.5 OUTLIER -69.72 -4.18 18.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.958 1.466 . . . . 1.9 114.958 -167.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 12.7 mmm -66.38 -25.23 66.68 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.604 -0.685 . . . . 1.16 112.46 -175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.98 7.3 13.49 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 112.33 0.493 . . . . 0.72 112.33 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -108.1 -10.08 15.5 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.554 0.692 . . . . 1.64 109.28 -177.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 328' ' ' THR . 61.5 mt -85.56 164.02 41.95 Favored Pre-proline 0 N--CA 1.416 -2.163 0 CA-C-O 122.789 1.28 . . . . 1.07 112.164 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.1 Cg_exo -61.85 133.51 45.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 124.448 3.432 . . . . 0.36 108.556 159.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 326' ' ' ARG . 2.7 tpp180 -51.92 -40.83 61.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.762 0.791 . . . . 3.98 111.254 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.06 -28.86 69.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.717 -1.128 . . . . 0.34 112.324 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.706 HG21 HD22 ' A' ' 324' ' ' LEU . 53.8 m -80.76 -38.12 29.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.069 0.938 . . . . 0.34 108.495 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.96 -50.66 72.9 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.217 -1.356 . . . . 0.71 109.832 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 37.7 t70 -55.87 -38.26 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.991 0.901 . . . . 0.83 110.909 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.678 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.33 -47.56 73.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.449 -1.25 . . . . 0.3 109.12 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.678 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 14.2 mt -104.71 -54.22 2.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 115.904 1.816 . . . . 0.33 115.904 -166.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.687 ' HH ' ' HB2' ' A' ' 254' ' ' LEU . 83.5 m-85 -112.8 -2.62 14.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.907 -163.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.625 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 0.4 OUTLIER -53.31 -39.01 63.68 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.376 1.084 . . . . 2.41 108.432 170.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.979 ' HB3' HD11 ' A' ' 281' ' ' LEU . 11.7 mt-30 -132.18 115.24 15.45 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 112.826 -1.988 . . . . 0.45 107.634 166.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 282' ' ' ILE . 21.3 tpt180 -106.14 112.39 25.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 119.089 -1.044 . . . . 2.45 109.061 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.5 mmt180 -84.33 130.54 34.79 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 123.035 1.398 . . . . 1.07 112.774 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.5 mt -120.57 123.03 69.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.55 -2.114 . . . . 0.17 109.532 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.28 113.38 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 107.827 -1.175 . . . . 0.29 107.827 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.775 ' O ' ' HA ' ' A' ' 277' ' ' SER . 73.0 m-85 -91.47 98.99 12.01 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.08 -1.082 . . . . 0.54 108.08 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.566 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.0 ttmt -135.04 90.6 21.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.977 -0.379 . . . . 1.34 109.977 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 276' ' ' MET . 13.4 Cg_exo -34.94 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 126.193 4.595 . . . . 0.5 117.444 177.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -143.26 105.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.148 -1.842 . . . . 2.54 107.558 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.9 90.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.825 -1.08 . . . . 2.26 113.407 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 342' ' ' PRO . 2.8 mm? -90.06 -95.1 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.403 1.097 . . . . 1.22 108.316 166.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 5.1 t -177.11 -47.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 104.567 -2.383 . . . . 1.77 104.567 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.605 HD13 ' OXT' ' A' ' 347' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 CA-C-N 110.577 -3.011 . . . . 2.89 107.002 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.077 -0.342 . . . . 1.84 110.077 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.09 128.37 90.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.202 -0.454 . . . . 1.1 111.402 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.464 ' HG3' ' HE ' ' A' ' 337' ' ' ARG . 52.5 Cg_exo -50.34 119.26 4.81 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.905 2.403 . . . . 0.48 110.65 176.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 259' ' ' VAL . 38.2 tp -99.45 139.5 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.531 -0.868 . . . . 1.26 110.83 -173.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 341' ' ' LYS . 74.0 t -73.09 108.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.428 -0.806 . . . . 1.01 110.938 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.739 HD13 HG13 ' A' ' 259' ' ' VAL . 6.5 tp -100.98 109.56 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 109.063 -0.717 . . . . 0.34 109.063 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.432 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 10.8 p -103.45 -14.29 16.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.624 -0.716 . . . . 1.05 110.952 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.558 ' HB2' ' CB ' ' A' ' 263' ' ' SER . 18.0 m -71.53 -174.81 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.322 -0.854 . . . . 2.56 110.259 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.74 87.42 0.14 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.556 -0.83 . . . . 1.85 112.165 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.3 151.55 39.53 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.825 . . . . 3.21 108.774 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -79.37 9.32 4.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.397 0.617 . . . . 5.81 111.362 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -56.43 152.85 10.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.263 -0.881 . . . . 5.3 110.584 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.172 -0.467 . . . . 7.77 111.28 -177.296 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.769 -0.456 . . . . 40.22 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.5 mmt 54.8 53.36 10.6 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.929 -0.578 . . . . 40.04 110.039 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 66.83 -67.04 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.113 -0.948 . . . . 39.27 110.681 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -163.24 127.58 2.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.751 -0.659 . . . . 37.29 109.435 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.46 -42.84 82.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 36.13 109.742 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -84.39 98.91 10.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.841 -0.618 . . . . 34.41 109.982 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.48 119.23 24.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.582 -0.735 . . . . 32.45 110.777 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.7 143.59 31.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.981 -0.554 . . . . 30.94 109.692 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.0 pt? -128.78 146.74 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.657 -0.497 . . . . 30.21 109.657 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 m -141.26 65.59 1.38 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.083 0.468 . . . . 27.83 110.01 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -81.01 33.84 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.555 0.693 . . . . 27.14 110.986 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 t -86.2 -170.84 3.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.36 -0.837 . . . . 25.54 110.151 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 m -83.46 70.41 10.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.879 -1.055 . . . . 23.93 110.412 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.1 23.34 2.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.01 0.91 . . . . 24.03 109.746 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -77.67 -51.5 10.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.398 -0.819 . . . . 22.83 109.607 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.35 -65.19 0.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.595 -0.73 . . . . 21.0 109.722 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 54.56 54.63 9.02 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.834 -0.621 . . . . 19.72 110.173 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -167.52 126.07 1.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.298 -0.865 . . . . 17.66 110.428 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.6 tp -80.98 64.97 5.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.515 0.674 . . . . 16.08 109.763 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -145.38 147.47 32.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.449 -0.796 . . . . 14.08 110.416 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.33 -176.94 4.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.714 -0.476 . . . . 13.03 109.714 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 245' ' ' GLU . 7.0 pt-20 -68.83 130.33 42.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.121 0.486 . . . . 12.06 111.248 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.688 HG22 ' H ' ' A' ' 247' ' ' GLY . 7.1 p -112.68 174.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.739 -0.664 . . . . 9.73 110.556 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 246' ' ' VAL . . . 115.45 142.04 7.56 Favored Glycine 0 C--N 1.31 -0.902 0 CA-C-N 114.999 -1.0 . . . . 7.65 111.835 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.1 p -67.56 -53.52 27.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.485 0.66 . . . . 6.51 110.597 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.74 -89.37 0.13 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.476 -0.784 . . . . 4.79 110.988 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 332' ' ' LEU . 9.2 m -143.74 -149.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.045 -0.979 . . . . 2.23 111.086 -170.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 254' ' ' LEU . 3.3 p 73.09 -23.44 0.21 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.002 0.921 . . . . 1.43 112.975 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.36 27.22 24.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 115.907 1.123 . . . . 1.61 115.907 166.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 0.1 OUTLIER 66.37 13.76 9.37 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.319 1.059 . . . . 1.62 111.325 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -82.84 -33.69 27.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.199 -1.364 . . . . 0.47 108.75 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.687 ' HB2' ' NH2' ' A' ' 336' ' ' ARG . 15.3 p-10 -55.63 -46.79 77.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.094 -0.957 . . . . 2.08 110.374 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 260' ' ' ASN . 16.2 t70 -61.33 -37.98 85.23 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.522 -1.672 . . . . 0.89 110.956 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 10.6 mt -60.4 -54.43 45.74 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.191 -0.913 . . . . 0.46 111.863 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.998 HG13 HD13 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.11 -46.72 13.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 122.6 1.191 . . . . 0.27 110.436 175.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.739 HG13 HD13 ' B' ' 6' ' ' ILE 0.26 4.4 t -66.65 -37.75 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 112.753 -2.021 . . . . 0.15 111.232 177.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.533 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -59.79 -49.76 76.47 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 123.796 1.76 . . . . 0.52 107.004 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 68.1 mt -63.63 -49.02 74.9 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 110.372 -3.103 . . . . 0.24 112.65 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.643 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -59.89 -37.31 71.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-N 116.256 -0.429 . . . . 0.17 111.827 -171.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' B' ' 8' ' ' SER . 5.3 p -80.9 -17.89 49.08 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.621 -0.263 . . . . 0.69 111.6 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -71.47 -34.1 69.89 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.347 -1.723 . . . . 1.21 106.347 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.602 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.6 mp0 -87.22 -18.65 29.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.541 -2.118 . . . . 1.53 113.865 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.644 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 12.9 t90 -87.75 172.74 9.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.876 1.322 . . . . 0.21 110.445 -173.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 37.0 ttp180 -154.12 112.11 3.53 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 112.257 -2.247 . . . . 3.65 110.28 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -74.07 133.29 78.66 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.767 -0.457 . . . . 2.92 109.767 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 41.8 Cg_endo -90.58 167.83 4.06 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.607 2.205 . . . . 0.57 110.471 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.96 -9.06 16.8 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.391 2.727 . . . . 0.88 109.444 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 36.1 p -88.24 -15.04 36.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.484 -1.689 . . . . 0.52 111.233 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 1.002 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -67.37 144.38 55.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.176 0.512 . . . . 0.34 110.962 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.438 ' O ' HD23 ' A' ' 345' ' ' LEU . 22.0 mmt180 -110.79 172.84 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.438 -0.801 . . . . 2.49 110.197 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.808 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 6.1 m-80 -71.28 34.83 0.05 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.393 0.886 . . . . 1.62 113.393 -169.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 273' ' ' ARG . . . 155.5 36.45 0.02 OUTLIER Glycine 0 C--N 1.299 -1.518 0 CA-C-N 115.387 -0.824 . . . . 0.46 112.036 175.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 1.002 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.9 ptm -82.82 150.73 26.41 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.487 -1.672 . . . . 1.08 106.487 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.793 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 12.7 p -157.55 153.67 27.32 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.045 -1.062 . . . . 0.69 113.551 -170.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.611 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.09 128.49 68.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.658 -1.61 . . . . 0.94 109.315 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.551 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.1 tt0 -89.72 118.13 29.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.986 -1.487 . . . . 1.39 106.986 167.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.659 HG12 HG22 ' A' ' 282' ' ' ILE . 47.6 t -122.86 117.81 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.19 0.519 . . . . 0.12 111.041 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 335' ' ' GLN . 14.1 tp -95.23 107.65 19.76 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.312 -0.858 . . . . 0.23 110.054 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -106.3 155.12 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.083 -1.08 . . . . 1.63 108.083 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 17.6 mt-10 -121.65 145.15 48.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.633 -0.877 . . . . 0.3 108.633 -168.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.527 ' CG ' HG12 ' A' ' 290' ' ' ILE . 32.6 mtp -148.83 161.3 42.1 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 123.463 1.602 . . . . 0.36 114.284 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.683 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.5 mt -97.33 161.17 26.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 110.553 -3.021 . . . . 1.45 109.974 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.75 1.29 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.566 2.844 . . . . 0.34 112.974 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.594 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 22.1 t70 -102.39 -12.64 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.086 0.946 . . . . 0.55 109.177 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 321' ' ' MET . . . 90.93 -3.29 80.77 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 114.237 -1.347 . . . . 0.16 109.894 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -62.61 117.18 5.9 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.817 0.818 . . . . 0.58 110.275 174.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 315' ' ' VAL . 2.2 mt -68.31 115.32 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 CA-C-N 113.897 -1.501 . . . . 0.47 110.43 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.683 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 46.7 p -95.13 -29.09 14.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.367 -1.288 . . . . 0.22 110.416 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 20.6 t30 -150.07 171.99 15.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.092 -0.504 . . . . 0.61 110.308 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.73 131.75 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.183 -0.917 . . . . 0.22 110.402 174.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.39 168.83 18.94 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 122.541 1.163 . . . . 0.17 110.695 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.08 118.78 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 CA-C-N 112.839 -1.982 . . . . 0.16 108.282 166.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 2.0 p -88.43 -29.15 20.42 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.021 -1.445 . . . . 0.44 109.764 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -153.01 116.81 4.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.966 -1.015 . . . . 2.82 109.38 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 13.3 p -77.24 149.96 35.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.922 -0.581 . . . . 0.67 111.676 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 277' ' ' SER . 74.4 p -83.82 -8.64 59.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.985 0.898 . . . . 0.59 109.385 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.61 -12.1 66.32 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 114.349 -1.296 . . . . 0.57 110.808 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.06 100.04 8.31 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.57 109.616 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 69.2 mttt -54.99 -46.91 99.57 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 114.347 -1.297 . . . . 2.56 112.181 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -48.74 -49.73 14.18 Favored 'Trans proline' 0 CA--C 1.499 -1.265 0 C-N-CA 121.953 1.769 . . . . 0.18 111.258 173.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.644 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 68.6 t80 -62.59 -49.98 73.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.732 -0.667 . . . . 0.58 109.776 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.676 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.3 m-20 -54.98 -60.71 2.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.969 -1.014 . . . . 2.31 111.099 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.695 ' HA ' HG23 ' A' ' 309' ' ' VAL . 71.2 m -68.75 -35.2 76.81 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 114.668 1.358 . . . . 0.92 114.668 -175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -29.85 40.78 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.273 1.035 . . . . 0.11 109.133 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.626 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.86 -30.83 22.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.239 -1.801 . . . . 0.1 110.843 -176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.695 HG23 ' HA ' ' A' ' 306' ' ' SER . 46.5 t -63.2 -41.01 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 CA-C-O 123.525 1.631 . . . . 0.13 108.59 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.04 -14.31 60.98 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 114.267 -1.333 . . . . 0.13 110.593 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.26 -42.77 54.3 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.263 -1.384 . . . . 0.13 107.263 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 309' ' ' VAL . 31.0 m -71.65 -52.53 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.625 0.726 . . . . 0.23 111.745 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.6 mmt180 -57.17 -36.96 71.41 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.859 -1.064 . . . . 0.49 112.416 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.602 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 22.2 t-20 -67.9 -28.03 67.16 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.92 -0.312 . . . . 0.56 111.069 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.2 m -67.15 -43.84 88.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.517 1.151 . . . . 0.27 109.22 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 61.94 -26.79 0.06 OUTLIER Glycine 0 C--N 1.31 -0.866 0 CA-C-N 112.303 -2.226 . . . . 0.7 117.464 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.5 OUTLIER -151.31 120.28 6.67 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.499 0.666 . . . . 3.49 109.588 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.998 HD13 HG13 ' A' ' 258' ' ' ILE . 87.8 mt -103.83 131.35 22.08 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-O 122.069 0.937 . . . . 0.65 112.113 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 318' ' ' ILE . 55.0 Cg_endo -56.7 -58.39 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.663 1 C-N-CA 125.937 4.424 . . . . 0.57 117.507 -171.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.402 ' OE2' HD11 ' A' ' 257' ' ' LEU . 42.0 mt-10 -86.19 3.15 44.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.674 0.99 . . . . 1.9 113.674 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.633 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 11.3 mmm -65.84 -23.17 66.62 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.63 -0.669 . . . . 1.16 111.393 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -80.49 4.87 16.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.553 -0.748 . . . . 0.72 112.381 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -103.9 -14.94 15.81 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.633 0.73 . . . . 1.64 109.198 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 328' ' ' THR . 72.1 mt -86.7 161.03 49.03 Favored Pre-proline 0 N--CA 1.412 -2.345 0 CA-C-O 122.978 1.371 . . . . 1.07 112.572 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.9 Cg_exo -60.04 135.88 65.63 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 124.395 3.397 . . . . 0.36 108.534 160.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -52.59 -41.67 63.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.548 0.69 . . . . 3.98 110.971 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.45 -29.39 70.44 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.758 -1.11 . . . . 0.34 112.443 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 324' ' ' LEU . 52.5 m -81.13 -36.9 29.7 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 122.269 1.033 . . . . 0.34 108.266 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -63.41 -51.66 64.84 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.904 -1.498 . . . . 0.71 109.495 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.682 ' HA ' ' CG ' ' A' ' 334' ' ' ARG . 10.1 t70 -57.16 -28.68 62.99 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.963 0.887 . . . . 0.83 110.666 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.688 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -70.9 -51.86 23.59 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.414 1.102 . . . . 0.3 109.599 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 15.2 mt -102.77 -51.58 3.26 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.682 -1.599 . . . . 0.33 115.278 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.633 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 74.7 m-85 -113.66 -2.86 13.66 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.118 0.485 . . . . 0.49 111.901 -164.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.682 ' CG ' ' HA ' ' A' ' 330' ' ' ASP . 0.8 OUTLIER -46.05 -58.32 3.7 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.771 1.272 . . . . 2.41 108.945 167.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.792 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.3 OUTLIER -120.13 114.92 22.67 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.266 -2.243 . . . . 0.45 107.204 160.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.761 ' HB3' HD11 ' A' ' 282' ' ' ILE . 18.4 tpt180 -108.09 102.89 12.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.629 -1.248 . . . . 2.45 107.629 -173.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.464 ' HE ' ' HG3' ' B' ' 3' ' ' PRO . 14.3 ptt-85 -85.11 129.1 34.86 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 115.894 -2.323 . . . . 1.07 113.609 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 282' ' ' ILE . 9.7 mt -108.36 123.74 64.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 111.14 -2.755 . . . . 0.17 109.084 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -99.22 112.61 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 108.619 -0.882 . . . . 0.29 108.619 178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 277' ' ' SER . 89.8 m-85 -89.88 101.96 14.66 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.782 -0.822 . . . . 0.54 108.782 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.569 ' HE3' ' CB ' ' A' ' 277' ' ' SER . 16.4 ttmt -137.51 90.04 15.24 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 120.855 0.36 . . . . 1.34 110.406 -172.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 276' ' ' MET . 14.2 Cg_exo -33.85 172.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 126.661 4.907 . . . . 0.5 117.914 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' B' ' 7' ' ' SER . 9.3 pt-20 -138.13 122.34 18.1 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 112.551 -2.113 . . . . 2.54 108.506 174.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.808 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 4.5 p-10 39.71 83.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.125 1.528 . . . . 2.26 115.125 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.3 mm? -84.23 -174.91 5.54 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.543 -0.54 . . . . 1.22 109.543 164.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.7 t -75.16 -30.67 60.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.018 0.913 . . . . 1.77 109.664 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.495 ' C ' HD22 ' A' ' 274' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.192 -1.367 . . . . 2.89 110.975 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' HB2' HD22 ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.451 ' C ' HH22 ' A' ' 336' ' ' ARG . 29.8 t70 -132.9 111.92 13.42 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.986 -0.375 . . . . 1.1 109.986 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.84 119.18 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.805 3.003 . . . . 0.48 112.087 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 259' ' ' VAL . 1.3 tm? -97.14 132.85 42.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.407 -0.59 . . . . 1.26 109.407 -166.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.47 ' N ' HD13 ' B' ' 4' ' ' LEU . 48.2 t -74.32 108.89 6.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 1.01 111.096 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD13 HG13 ' A' ' 259' ' ' VAL . 6.6 tp -93.68 105.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.477 0.656 . . . . 0.34 109.402 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -93.24 -22.61 18.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 1.05 110.813 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.434 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 11.2 t -66.33 -176.18 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.223 -0.899 . . . . 2.56 109.625 174.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.534 ' HA3' ' CE3' ' A' ' 266' ' ' TRP . . . 122.42 86.52 0.82 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.11 -1.043 . . . . 1.85 112.288 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -159.49 155.88 27.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.172 0.511 . . . . 3.21 110.219 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.9 -19.37 65.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.795 -1.093 . . . . 5.81 111.584 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 47.31 98.05 0.01 OUTLIER 'General case' 0 C--O 1.237 0.397 0 N-CA-C 114.455 1.279 . . . . 5.3 114.455 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.559 -1.2 . . . . 7.77 110.405 -179.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.374 -0.602 . . . . 40.22 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.0 mmt -120.14 26.45 9.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.538 . . . . 40.04 111.727 -171.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -85.73 -19.83 30.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 39.27 110.572 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.95 60.49 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.674 0.749 . . . . 37.29 109.898 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.2 tp -83.36 132.66 34.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.05 -0.977 . . . . 36.13 109.371 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.73 -63.84 1.36 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.483 -0.326 . . . . 34.41 110.932 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 68.61 116.96 0.03 OUTLIER 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.945 0.778 . . . . 32.45 110.179 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.75 74.62 7.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.561 -0.745 . . . . 30.94 111.838 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.62 97.69 9.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 30.21 109.606 175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 m -44.16 -64.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.004 -0.998 . . . . 27.83 113.197 -170.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -132.82 -77.71 0.49 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.876 -0.33 . . . . 27.14 110.969 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.6 m -71.84 -65.22 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.773 -0.455 . . . . 25.54 109.773 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.3 m -154.56 -70.68 0.13 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.719 -0.474 . . . . 23.93 109.719 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 50.14 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.511 1.624 . . . . 24.03 112.536 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -112.59 45.99 1.25 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.395 -2.184 . . . . 22.83 108.703 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -73.92 -49.81 23.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.014 -0.994 . . . . 21.0 110.112 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 249' ' ' GLU . 54.9 tt0 -71.18 97.76 1.58 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.282 -0.417 . . . . 19.72 110.724 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -94.47 124.29 38.41 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.163 -0.471 . . . . 17.66 110.172 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 55.0 tp -83.55 99.16 9.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.958 0.409 . . . . 16.08 110.446 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -137.49 174.04 11.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.908 -0.587 . . . . 14.08 110.636 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.5 p30 43.73 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.348 1.03 . . . . 13.03 112.448 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.08 160.57 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.723 -0.671 . . . . 12.06 111.96 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 247' ' ' GLY . 12.5 p -61.57 160.59 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.51 0.672 . . . . 9.73 110.717 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 82.66 62.91 1.81 Allowed Glycine 0 C--N 1.31 -0.911 0 CA-C-N 114.79 -1.095 . . . . 7.65 111.583 -173.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.8 t -126.0 82.36 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.165 0.507 . . . . 6.51 110.558 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.744 ' HG3' HG23 ' A' ' 328' ' ' THR . 1.5 pm0 -110.16 -112.35 0.32 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 116.019 -0.537 . . . . 4.79 110.582 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.448 ' H ' ' CG ' ' A' ' 249' ' ' GLU . 3.4 m -149.77 -171.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.92 0.867 . . . . 2.23 112.31 -170.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' B' ' 1' ' ' ALA . 1.5 p -135.43 86.97 2.28 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.588 -1.642 . . . . 1.43 107.327 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.15 -158.78 0.01 OUTLIER Glycine 0 C--N 1.317 -0.486 0 CA-C-N 113.183 -1.826 . . . . 1.61 113.478 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.472 ' C ' ' HG ' ' A' ' 257' ' ' LEU . 32.6 p -45.52 -60.4 2.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.54 -0.911 . . . . 1.62 108.54 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 8.3 mt 11.76 -68.9 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.179 -1.828 . . . . 0.47 114.463 156.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 336' ' ' ARG . 0.6 OUTLIER -56.81 -47.51 80.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.382 -170.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 260' ' ' ASN . 0.2 OUTLIER -83.48 -16.52 45.33 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.642 -0.708 . . . . 0.89 110.571 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 11.3 mt -69.11 -53.04 22.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.047 0.451 . . . . 0.46 111.809 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.526 HG13 HG12 ' A' ' 318' ' ' ILE . 0.7 OUTLIER -49.68 -43.57 18.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 122.874 1.321 . . . . 0.27 110.03 175.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.689 HG13 HD13 ' B' ' 6' ' ' ILE 0.265 6.2 t -70.48 -36.33 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 112.379 -2.191 . . . . 0.15 111.657 176.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 256' ' ' ASP . 7.3 t30 -62.33 -47.91 82.15 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 123.693 1.711 . . . . 0.52 107.218 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 64.1 mt -64.56 -45.5 86.81 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 110.348 -3.114 . . . . 0.24 112.851 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 259' ' ' VAL . 3.4 p -62.08 -40.26 86.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 N-CA-C 112.086 0.402 . . . . 0.17 112.086 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' HD11 ' B' ' 6' ' ' ILE . 61.3 p -81.36 -16.22 52.96 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.177 0.513 . . . . 0.69 111.594 -176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -75.7 -22.07 56.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.078 -1.823 . . . . 1.21 106.078 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 315' ' ' VAL . 5.6 mm-40 -102.92 -12.99 17.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.239 -2.255 . . . . 1.53 111.85 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 12.4 t90 -90.26 169.32 11.21 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.917 1.341 . . . . 0.21 110.785 -174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 78.2 mtm180 -153.98 112.56 3.63 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 111.886 -2.416 . . . . 3.65 109.81 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 18.3 ptp180 -78.11 151.67 78.82 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 2.92 110.738 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 65.1 Cg_endo -101.21 149.1 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 125.013 3.809 . . . . 0.57 112.425 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 14.8 Cg_endo -52.88 -17.86 8.26 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.739 2.959 . . . . 0.88 112.821 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 13.3 p -83.96 -25.78 29.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.52 111.274 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.984 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.64 145.53 48.76 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.34 111.653 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.555 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 82.6 mmt-85 -117.78 171.19 8.21 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.2 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -74.36 55.55 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.628 1.204 . . . . 1.62 113.974 -166.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 135.59 41.84 0.13 Allowed Glycine 0 C--N 1.285 -2.296 0 CA-C-N 112.698 -2.046 . . . . 0.46 111.156 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.984 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 3.7 ptm -84.05 145.86 28.25 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.955 -1.868 . . . . 1.08 105.955 167.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 17.1 p -144.07 153.76 42.52 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.096 1.147 . . . . 0.69 114.096 -167.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.4 t -128.79 125.69 63.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 113.624 -1.625 . . . . 0.94 108.885 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.525 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.6 tt0 -89.6 114.21 25.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.839 -1.541 . . . . 1.39 106.839 167.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 282' ' ' ILE . 58.4 t -116.59 120.51 65.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.126 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.832 HD11 ' HB3' ' A' ' 335' ' ' GLN . 7.0 tp -93.09 101.26 13.57 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.241 -0.89 . . . . 0.23 109.369 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.755 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -97.95 158.88 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 15.3 mt-10 -128.98 138.29 51.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.322 -0.621 . . . . 0.3 109.322 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 318' ' ' ILE . 3.8 mtp -147.66 160.71 42.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 123.291 1.52 . . . . 0.36 112.804 -170.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.628 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 2.1 mt -88.94 165.1 28.63 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 110.854 -2.884 . . . . 1.45 109.827 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.17 -1.95 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.327 2.685 . . . . 0.34 112.598 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 285' ' ' LEU . 16.3 t70 -100.52 -14.16 18.35 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.076 -0.965 . . . . 0.55 109.031 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.525 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 91.55 -8.68 78.53 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 114.485 -1.234 . . . . 0.16 111.037 -172.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -55.73 122.41 11.36 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.863 0.839 . . . . 0.58 110.072 173.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 315' ' ' VAL . 2.0 mm -68.39 114.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.852 -1.522 . . . . 0.47 110.422 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.628 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 34.1 p -99.77 -27.16 13.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.364 -0.835 . . . . 0.22 110.81 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.671 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.3 m-20 -156.39 174.08 15.94 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 116.289 -0.414 . . . . 0.61 111.966 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -172.86 137.48 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.996 -1.002 . . . . 0.22 111.266 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 169.29 17.99 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.351 1.072 . . . . 0.17 110.859 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -84.85 118.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.535 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.586 167.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 4.9 p -88.06 -27.16 22.16 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.994 -1.457 . . . . 0.44 109.531 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -155.86 110.0 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.632 -1.167 . . . . 2.82 109.272 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.0 t -81.16 149.73 28.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.963 0.411 . . . . 0.67 111.072 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 277' ' ' SER . 27.5 p -81.43 -11.01 59.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.964 0.888 . . . . 0.59 109.394 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -17.82 45.55 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.124 -1.398 . . . . 0.57 111.082 -172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 21.1 t70 -103.21 102.82 12.81 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.839 -0.8 . . . . 1.57 108.839 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.679 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 74.5 mttt -64.51 -41.42 58.35 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.741 -1.118 . . . . 2.56 112.821 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.541 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.1 Cg_endo -49.81 -48.57 18.85 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.264 1.309 . . . . 0.18 110.758 167.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.738 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 37.2 t80 -59.99 -47.82 84.25 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.521 0.513 . . . . 0.58 109.629 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.11 -59.63 5.0 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.551 -0.749 . . . . 2.31 111.146 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.715 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 6.9 t -67.61 -37.38 82.45 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.836 -1.075 . . . . 0.92 113.827 -174.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.4 p -52.66 -33.39 46.88 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.298 1.046 . . . . 0.11 108.98 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.61 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.44 -28.23 22.24 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.81 -1.996 . . . . 0.1 110.83 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.715 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 57.6 t -63.05 -41.22 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 CA-C-O 123.549 1.642 . . . . 0.13 108.38 168.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.07 -14.22 60.57 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 113.901 -1.5 . . . . 0.13 110.404 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.26 -44.57 52.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.142 -1.429 . . . . 0.13 107.142 171.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 315' ' ' VAL . 24.5 m -72.73 -47.0 51.91 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.354 -0.839 . . . . 0.23 112.077 -174.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 309' ' ' VAL . 13.8 mmt180 -59.82 -37.02 78.01 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.166 -0.924 . . . . 0.49 112.642 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 11.3 t30 -73.42 -19.31 61.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.429 -0.508 . . . . 0.56 111.74 -170.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 312' ' ' VAL . 4.3 m -67.89 -41.54 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 122.579 1.181 . . . . 0.27 109.055 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 69.05 -27.28 0.31 Allowed Glycine 0 C--N 1.31 -0.871 0 CA-C-N 112.508 -2.133 . . . . 0.7 116.141 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.4 OUTLIER -162.34 132.63 4.73 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 120.815 0.34 . . . . 3.49 110.279 175.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 318' ' ' ILE . 3.2 mp -100.9 136.94 19.67 Favored Pre-proline 0 N--CA 1.431 -1.394 0 CA-C-O 121.119 0.485 . . . . 0.65 109.859 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 318' ' ' ILE . 1.9 Cg_endo -74.7 -52.28 0.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.262 2.641 . . . . 0.57 114.186 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.42 -3.28 10.73 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 115.693 1.738 . . . . 1.9 115.693 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 333' ' ' TYR . 22.5 mmm -63.79 -25.13 68.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.321 -0.862 . . . . 1.16 112.225 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -82.41 8.05 12.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.16 -0.473 . . . . 0.72 111.807 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -13.85 16.51 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 108.372 -0.973 . . . . 1.64 108.372 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 328' ' ' THR . 69.5 mt -91.35 162.63 31.5 Favored Pre-proline 0 N--CA 1.413 -2.278 0 CA-C-N 113.956 -1.475 . . . . 1.07 112.748 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 49.7 Cg_exo -61.21 135.26 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 124.517 3.478 . . . . 0.36 109.146 161.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -51.01 -38.05 48.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.484 0.659 . . . . 3.98 110.995 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.44 -32.45 73.32 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.688 -1.142 . . . . 0.34 111.952 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.77 HG21 HD22 ' A' ' 324' ' ' LEU . 42.8 m -79.8 -40.13 29.29 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.242 1.02 . . . . 0.34 108.812 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 334' ' ' ARG . 8.5 t80 -56.88 -47.35 80.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.669 -1.605 . . . . 0.71 109.368 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 11.1 t70 -61.04 -30.07 70.1 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.832 0.825 . . . . 0.83 110.957 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.707 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.83 -50.5 42.22 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.38 -1.282 . . . . 0.3 109.46 -178.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.707 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.2 mt -102.64 -60.8 1.49 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.999 -1.91 . . . . 0.33 114.852 -166.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.577 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 69.8 m-85 -107.95 -7.37 16.22 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.283 -0.872 . . . . 0.49 111.892 -160.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.531 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -52.07 -44.49 64.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.808 0.813 . . . . 2.41 108.905 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.832 ' HB3' HD11 ' A' ' 281' ' ' LEU . 26.4 mt-30 -129.12 109.66 11.36 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.822 -1.536 . . . . 0.45 107.218 160.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.755 ' H ' HD13 ' A' ' 282' ' ' ILE . 11.0 tpt180 -102.36 120.15 40.01 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.365 -1.346 . . . . 2.45 107.365 -173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.8 mmt180 -82.79 109.12 16.66 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.442 -1.303 . . . . 1.07 110.601 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 282' ' ' ILE . 25.6 mt -96.98 121.77 47.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 113.232 -1.804 . . . . 0.17 108.231 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.551 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.9 OUTLIER -100.35 111.28 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 109.168 -0.678 . . . . 0.29 109.168 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.822 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.6 m-85 -88.54 101.18 13.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.54 109.253 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.621 ' CG ' ' HB3' ' A' ' 277' ' ' SER . 4.7 ttpt -141.13 90.54 9.21 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 109.707 -0.479 . . . . 1.34 109.707 -176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 276' ' ' MET . 17.8 Cg_exo -35.84 177.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 1 C-N-CA 126.026 4.484 . . . . 0.5 118.032 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -155.41 122.9 5.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.73 -2.486 . . . . 2.54 107.138 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 60.71 77.35 0.33 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.04 0.837 . . . . 2.26 112.641 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 345' ' ' LEU . 1.3 mm? -83.42 -167.67 1.79 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 1.22 110.001 167.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 32.5 t -61.31 -53.76 52.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.989 0.899 . . . . 1.77 111.818 171.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.555 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 113.527 -1.669 . . . . 2.89 111.455 -165.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.459 ' HB1' ' OG1' ' A' ' 251' ' ' THR . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.929 -0.397 . . . . 1.84 109.929 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -174.08 102.19 0.29 Allowed Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.441 -0.948 . . . . 1.1 108.441 172.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.79 118.33 2.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.708 2.272 . . . . 0.48 112.032 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.669 ' HB2' HG21 ' A' ' 259' ' ' VAL . 32.0 mt -101.5 146.87 27.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.554 0.692 . . . . 1.26 111.374 -172.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 341' ' ' LYS . 58.5 t -80.24 100.1 4.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.508 -1.224 . . . . 1.01 110.578 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.687 HD13 HG13 ' A' ' 259' ' ' VAL . 6.9 tp -89.58 107.99 18.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.932 0.873 . . . . 0.34 109.473 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.9 p -102.89 -13.35 16.98 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.882 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 263' ' ' SER . 7.6 t -76.03 -173.06 2.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.026 -0.988 . . . . 2.56 109.778 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.06 80.83 0.11 Allowed Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.759 -0.936 . . . . 1.85 110.759 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.402 ' HB3' ' HG2' ' B' ' 12' ' ' ARG . 4.5 t-20 -145.35 157.28 44.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.699 -0.482 . . . . 3.21 109.699 -173.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.94 2.16 15.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.329 0.585 . . . . 5.81 110.882 -176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.402 ' HG2' ' HB3' ' B' ' 10' ' ' ASN . 22.0 ptt180 -57.38 145.58 32.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.128 -0.942 . . . . 5.3 111.161 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.595 -0.717 . . . . 7.77 110.027 176.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.846 0.355 . . . . 40.22 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.44 -41.08 9.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.023 0.439 . . . . 40.04 110.504 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -81.92 -51.29 8.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 39.27 110.248 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -104.73 118.46 36.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 37.29 109.515 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.95 136.91 41.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.498 -0.319 . . . . 36.13 111.495 -174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 56.96 -173.55 0.07 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.169 0.918 . . . . 34.41 112.563 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -77.8 -161.46 0.25 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.101 -0.954 . . . . 32.45 108.967 168.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.37 -66.63 0.9 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.844 -0.799 . . . . 30.94 108.844 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 96.4 mt 50.23 52.16 15.29 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.662 0.601 . . . . 30.21 111.951 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.9 t -128.44 89.91 2.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.941 -0.572 . . . . 27.83 109.788 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.7 94.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.218 0.532 . . . . 27.14 110.014 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.1 m -91.8 -15.83 27.68 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 25.54 110.591 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 238' ' ' ARG . 19.8 m -67.01 -40.24 87.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.879 -0.601 . . . . 23.93 111.701 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 64.22 9.05 4.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.437 0.695 . . . . 24.03 111.977 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 241' ' ' ALA . 16.6 tpt180 -116.45 82.27 1.76 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.616 -0.512 . . . . 22.83 109.616 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -71.82 -68.41 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.113 -0.494 . . . . 21.0 110.104 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -159.02 103.04 1.66 Allowed 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.7 -0.682 . . . . 19.72 110.726 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 238' ' ' ARG . . . -117.79 -9.01 10.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 17.66 110.283 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.95 130.22 42.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.469 -0.787 . . . . 16.08 110.35 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -103.9 163.46 12.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.3 -0.409 . . . . 14.08 111.115 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.32 170.01 10.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.844 -0.616 . . . . 13.03 110.332 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.71 138.57 42.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.973 -0.558 . . . . 12.06 111.273 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 247' ' ' GLY . 8.2 p -104.27 175.53 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 9.73 110.0 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 246' ' ' VAL . . . 116.29 -2.52 20.58 Favored Glycine 0 C--N 1.311 -0.847 0 CA-C-N 115.46 -0.791 . . . . 7.65 111.885 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t 60.21 48.98 7.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.355 0.598 . . . . 6.51 111.115 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.604 ' HB3' HG22 ' A' ' 250' ' ' VAL . 3.9 mm-40 -87.62 -102.53 0.08 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.843 0.83 . . . . 4.79 112.413 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 249' ' ' GLU . 1.0 OUTLIER -151.25 -157.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.163 -1.38 . . . . 2.23 110.074 -166.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.555 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 1.1 t 42.85 67.08 0.67 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.728 1.251 . . . . 1.43 110.233 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -59.59 -154.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 112.432 -2.167 . . . . 1.61 113.225 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.799 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.7 m -73.18 24.07 0.06 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.944 0.878 . . . . 1.62 111.658 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 4.0 mp -83.12 -45.88 13.43 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.704 -1.589 . . . . 0.47 110.065 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.484 ' OD2' ' HD2' ' A' ' 336' ' ' ARG . 6.9 t0 -55.92 -41.71 74.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.779 -0.823 . . . . 2.08 108.779 176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 260' ' ' ASN . 5.8 t70 -63.75 -34.68 78.43 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 114.409 -1.269 . . . . 0.89 110.857 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 253' ' ' SER . 10.4 mt -61.82 -53.81 50.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 115.609 -0.723 . . . . 0.46 111.478 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -48.14 -49.79 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.368 1.08 . . . . 0.27 110.065 175.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.687 HG13 HD13 ' B' ' 6' ' ' ILE 0.25 6.4 t -62.47 -38.18 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 113.226 -1.806 . . . . 0.15 111.521 176.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 9.3 t30 -62.36 -50.72 70.47 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 124.004 1.859 . . . . 0.52 107.664 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 66.3 mt -64.04 -43.23 96.19 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 110.06 -3.245 . . . . 0.24 111.991 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -62.13 -37.34 78.22 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.406 -172.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' B' ' 8' ' ' SER . 3.6 p -81.9 -17.82 45.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.965 0.412 . . . . 0.69 111.348 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -18.34 56.67 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.274 -1.75 . . . . 1.21 106.274 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.547 ' CG ' HG12 ' A' ' 315' ' ' VAL . 14.0 mm-40 -107.47 -19.37 13.59 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 111.911 -2.404 . . . . 1.53 111.524 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.645 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 11.6 t90 -87.65 171.89 10.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 122.535 1.16 . . . . 0.21 109.707 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 73.4 mtm180 -153.37 113.55 3.96 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.499 -2.137 . . . . 3.65 110.856 -173.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -76.81 127.24 84.48 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.168 0.509 . . . . 2.92 109.716 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 54.3 Cg_endo -89.62 173.59 3.66 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.126 2.551 . . . . 0.57 110.87 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.49 -12.21 16.99 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.53 2.82 . . . . 0.88 109.914 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 p -85.05 -23.59 28.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.385 -1.734 . . . . 0.52 111.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.878 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -69.28 139.16 54.34 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.447 0.641 . . . . 0.34 110.833 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 347' ' ' LEU . 11.9 mmt180 -121.77 154.86 36.39 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.527 -1.286 . . . . 2.49 107.527 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 342' ' ' PRO . 1.4 p30 -49.31 131.57 20.16 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.512 0.196 . . . . 1.62 110.5 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 67.19 18.68 69.49 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 116.966 1.546 . . . . 0.46 116.966 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.878 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.0 OUTLIER -82.08 148.13 28.73 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.074 -1.824 . . . . 1.08 106.074 158.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.761 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 13.2 p -160.18 158.23 29.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 119.478 1.035 . . . . 0.69 113.251 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 305' ' ' ASP . 2.1 t -129.18 135.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 113.957 -1.474 . . . . 0.94 108.889 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.82 128.68 44.0 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.661 -1.237 . . . . 1.39 107.661 164.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.2 t -130.43 116.77 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.595 -1.184 . . . . 0.12 111.656 -174.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 335' ' ' GLN . 18.6 tp -90.17 118.34 29.62 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 114.8 -1.091 . . . . 0.23 110.144 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.747 HD11 HG11 ' A' ' 312' ' ' VAL . 3.1 mm -94.72 164.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.688 0 CA-C-N 115.063 -0.972 . . . . 1.63 109.014 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 292' ' ' ASN . 18.0 mt-10 -138.88 131.34 28.68 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.424 -1.716 . . . . 0.3 108.544 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.482 ' CG ' HG12 ' A' ' 290' ' ' ILE . 24.7 mtp -142.23 160.53 40.07 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 123.242 1.496 . . . . 0.36 114.444 -166.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -89.94 164.12 29.62 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 111.014 -2.812 . . . . 1.45 110.872 -172.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.693 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 51.8 Cg_exo -62.46 1.63 0.93 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.057 2.504 . . . . 0.34 111.475 171.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 285' ' ' LEU . 8.7 t70 -106.98 -14.44 14.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.076 -0.966 . . . . 0.55 110.11 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 318' ' ' ILE . . . 95.95 -15.18 63.5 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.589 -1.004 . . . . 0.16 110.589 -171.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 99.0 m -51.34 118.95 3.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.038 0.923 . . . . 0.58 110.583 172.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.502 HD12 HG22 ' A' ' 315' ' ' VAL . 5.2 mt -66.2 111.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.051 -1.432 . . . . 0.47 110.551 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 285' ' ' LEU . 70.3 p -93.54 -28.96 15.75 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.195 -1.366 . . . . 0.22 109.853 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.688 ' CB ' ' HB2' ' A' ' 283' ' ' GLU . 1.1 m-20 -148.04 170.61 17.38 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 116.031 -0.531 . . . . 0.61 110.245 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -174.31 127.67 0.35 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.437 -0.801 . . . . 0.22 109.655 176.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.28 167.11 22.8 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 122.273 1.035 . . . . 0.17 111.429 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.8 t -76.68 114.79 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 CA-C-N 112.984 -1.916 . . . . 0.16 108.671 165.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.3 p -98.09 -15.73 19.86 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 113.239 -1.8 . . . . 0.44 110.27 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -159.01 111.62 2.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.139 -0.937 . . . . 2.82 109.46 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 p -82.89 152.26 25.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.339 0.496 . . . . 0.67 112.339 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 277' ' ' SER . 73.3 p -79.46 -17.02 55.1 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.592 0.71 . . . . 0.59 109.943 176.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 100.15 -8.83 59.3 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.55 93.98 4.51 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.868 0.842 . . . . 1.57 108.742 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 38.7 mttt -60.32 -39.41 67.79 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 114.085 -1.416 . . . . 2.56 113.191 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.5 Cg_endo -50.19 -48.42 19.96 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.006 1.804 . . . . 0.18 111.862 168.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.594 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 76.8 t80 -62.2 -47.79 82.89 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.594 0.711 . . . . 0.58 109.265 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.675 ' HA ' HG21 ' A' ' 278' ' ' VAL . 46.9 m-20 -57.5 -55.47 34.43 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.736 -1.12 . . . . 2.31 111.086 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.671 ' HA ' HG23 ' A' ' 309' ' ' VAL . 1.2 t -71.49 -34.28 70.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.121 -0.945 . . . . 0.92 113.08 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 99.8 p -54.51 -29.4 50.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.211 1.005 . . . . 0.11 109.12 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.668 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.62 -30.61 23.13 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.134 -1.848 . . . . 0.1 110.807 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 306' ' ' SER . 57.3 t -63.9 -38.91 83.61 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-O 123.611 1.672 . . . . 0.13 108.807 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -77.73 -13.94 59.75 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.003 -1.453 . . . . 0.13 110.583 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.23 -44.33 53.56 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.15 -1.426 . . . . 0.13 107.15 171.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 282' ' ' ILE . 31.0 m -69.89 -53.78 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-N 115.371 -0.832 . . . . 0.23 111.391 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.542 ' HG2' HG23 ' A' ' 312' ' ' VAL . 7.7 mmt180 -58.57 -28.61 65.7 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.488 -0.778 . . . . 0.49 113.065 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 14.0 t30 -78.48 -15.55 58.49 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.506 -0.478 . . . . 0.56 111.47 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.7 m -78.66 -45.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.287 1.041 . . . . 0.27 108.662 174.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 58.85 -20.46 0.02 OUTLIER Glycine 0 C--O 1.221 -0.694 0 CA-C-N 112.327 -2.215 . . . . 0.7 118.528 168.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 2.2 mpt_? -151.01 106.43 3.36 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 123.531 0.732 . . . . 3.49 110.089 -175.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.576 ' O ' ' HG2' ' A' ' 321' ' ' MET . 1.9 mp -100.45 130.42 25.76 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.709 0.633 . . . . 0.65 112.709 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 261' ' ' LEU . 51.2 Cg_exo -38.56 -84.43 0.01 OUTLIER 'Trans proline' 0 C--O 1.237 0.429 1 C-N-CA 125.839 4.359 . . . . 0.57 118.204 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 319' ' ' PRO . 30.2 mt-10 -78.23 5.24 10.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 114.398 -1.274 . . . . 1.9 112.844 -158.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.651 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.3 mmm -62.81 -24.44 67.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.23 0.538 . . . . 1.16 111.163 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 23.6 mt-30 -81.8 -3.27 53.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.173 -0.921 . . . . 0.72 112.801 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -85.58 -44.85 12.29 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.951 -1.5 . . . . 1.64 106.951 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 328' ' ' THR . 85.2 mt -53.9 158.08 3.68 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 115.855 1.798 . . . . 1.07 115.855 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.9 Cg_exo -60.24 137.43 74.9 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 124.364 3.376 . . . . 0.36 108.538 159.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -55.05 -38.05 67.51 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.402 0.62 . . . . 3.98 111.25 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.36 71.61 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.819 -1.082 . . . . 0.34 111.838 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.691 HG21 HD22 ' A' ' 324' ' ' LEU . 51.8 m -78.76 -41.19 31.29 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.906 0.86 . . . . 0.34 109.136 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.446 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.6 t80 -56.03 -47.37 77.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.023 -1.444 . . . . 0.71 109.81 172.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 334' ' ' ARG . 22.0 t70 -56.76 -36.79 70.21 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.969 0.89 . . . . 0.83 110.983 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.689 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.54 -47.45 72.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.69 1.234 . . . . 0.3 109.202 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 6.1 mt -102.88 -53.21 2.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.015 -1.902 . . . . 0.33 115.91 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.651 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 95.5 m-85 -111.06 -6.44 14.63 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.571 0.582 . . . . 0.49 112.571 -164.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 330' ' ' ASP . 1.5 ptt180 -50.02 -44.9 51.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.193 0.997 . . . . 2.41 109.67 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.797 ' HB3' HD11 ' A' ' 281' ' ' LEU . 0.7 OUTLIER -123.69 118.65 27.73 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 113.285 -1.78 . . . . 0.45 107.11 164.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.87 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -110.84 133.97 52.91 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.539 -1.282 . . . . 2.45 107.539 -176.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.542 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 5.7 mmt180 -103.97 122.09 44.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.939 0.4 . . . . 1.07 110.164 -171.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 258' ' ' ILE . 10.1 mt -118.6 114.72 45.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.762 -0.654 . . . . 0.17 109.49 -175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.508 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -91.78 112.85 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.772 -1.196 . . . . 0.29 107.772 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 277' ' ' SER . 88.6 m-85 -91.6 95.74 10.08 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.93 -1.137 . . . . 0.54 107.93 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' ' 277' ' ' SER . 53.4 tttt -137.28 98.25 10.29 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 109.557 -0.534 . . . . 1.34 109.557 -170.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.59 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 32.1 Cg_exo -27.46 160.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 1 C-N-CA 126.26 4.64 . . . . 0.5 117.546 172.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -145.41 104.7 3.95 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 112.549 -2.114 . . . . 2.54 106.936 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.62 89.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 O-C-N 123.938 0.774 . . . . 2.26 112.444 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.59 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.3 OUTLIER -82.53 -178.95 7.26 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.733 169.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.3 t -71.67 -35.22 70.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.392 1.092 . . . . 1.77 109.075 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 273' ' ' ARG . 6.6 mp . . . . . 0 C--N 1.305 -1.366 0 CA-C-N 113.272 -1.785 . . . . 2.89 110.689 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 109.44 -0.578 . . . . 1.84 109.44 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -95.13 119.58 65.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.174 -0.306 . . . . 1.1 110.174 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.68 128.63 26.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.126 2.55 . . . . 0.48 111.883 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 259' ' ' VAL . 35.2 tp -104.5 145.85 29.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 120.13 -0.628 . . . . 1.26 110.72 -172.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 341' ' ' LYS . 84.0 t -81.12 106.09 11.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.01 111.186 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.656 HG23 ' HA ' ' A' ' 340' ' ' PHE . 6.2 tp -94.7 113.35 29.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.249 -1.019 . . . . 0.34 108.249 172.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 12.1 p -67.85 -59.68 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 1.05 111.33 -174.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.652 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 75.1 m -153.52 -176.76 5.96 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 122.143 -0.348 . . . . 2.56 110.682 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.491 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -79.22 -138.05 1.52 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.635 -0.793 . . . . 1.85 112.549 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.45 158.51 29.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.312 -0.255 . . . . 3.21 110.312 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.37 -52.38 37.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.625 0.578 . . . . 5.81 111.417 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 52.02 108.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.397 1.258 . . . . 5.3 114.397 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.282 -1.327 . . . . 7.77 109.694 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.786 0.327 . . . . 40.22 110.334 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 98.0 mmm -120.0 91.42 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 40.04 110.249 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -130.6 -62.16 0.93 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 39.27 110.128 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.572 -0.74 . . . . 37.29 111.797 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tt -115.32 -50.57 2.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.771 -0.826 . . . . 36.13 108.771 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -137.7 -23.92 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.45 -0.795 . . . . 34.41 110.611 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 232' ' ' LEU . 1.5 pm0 -69.09 107.96 3.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.021 -0.536 . . . . 32.45 110.966 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 231' ' ' LEU . 1.6 tm? 65.32 -9.68 0.21 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.811 0.845 . . . . 30.94 112.127 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 230' ' ' GLU . 39.0 tp -79.61 62.23 3.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.71 0.767 . . . . 30.21 110.538 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.3 t -159.43 -76.36 0.07 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.143 -0.935 . . . . 27.83 109.044 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.7 t70 51.38 52.52 14.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.81 0.814 . . . . 27.14 110.008 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.1 p -122.47 159.01 28.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.111 -0.949 . . . . 25.54 110.688 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.7 m 61.14 86.15 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.582 0.552 . . . . 23.93 111.548 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -69.13 -26.42 64.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.797 0.808 . . . . 24.03 110.521 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.667 ' HD3' ' O ' ' A' ' 238' ' ' ARG . 0.0 OUTLIER -59.2 -38.09 79.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.159 -1.382 . . . . 22.83 109.751 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.36 67.64 1.43 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.707 -0.679 . . . . 21.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -77.22 89.66 3.68 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.58 -0.736 . . . . 19.72 110.185 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . 63.29 -94.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 17.66 111.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' LEU . 1.6 tm? -123.56 8.34 8.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.623 0.725 . . . . 16.08 109.727 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -58.36 127.77 33.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.491 -0.777 . . . . 14.08 112.374 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.9 p30 43.65 -164.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.636 1.21 . . . . 13.03 114.049 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.448 ' HG3' HH22 ' A' ' 238' ' ' ARG . 5.6 pt-20 -49.71 128.06 17.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.825 -1.08 . . . . 12.06 111.76 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 247' ' ' GLY . 14.9 p -86.89 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.765 . . . . 9.73 110.766 -175.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.508 ' N ' HG22 ' A' ' 246' ' ' VAL . . . -124.26 42.44 1.56 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.992 -1.003 . . . . 7.65 112.365 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.7 p -88.17 80.49 7.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.776 0.322 . . . . 6.51 110.865 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 250' ' ' VAL . 41.0 mm-40 -65.88 -77.25 0.07 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.22 1.01 . . . . 4.79 111.783 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 251' ' ' THR . 5.1 m -153.36 -162.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.969 -1.923 . . . . 2.23 110.562 -165.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 250' ' ' VAL . 4.7 p 68.54 -4.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.38 1.072 . . . . 1.43 112.598 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 46.61 -111.27 0.66 Allowed Glycine 0 C--N 1.32 -0.306 0 C-N-CA 121.09 -0.576 . . . . 1.61 112.418 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.668 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 2.8 m -135.18 24.08 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 123.033 1.397 . . . . 1.62 108.856 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.8 mp -83.71 -42.82 16.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 112.362 -2.199 . . . . 0.47 111.899 -166.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 336' ' ' ARG . 0.6 OUTLIER -49.22 -47.34 46.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.285 0.564 . . . . 2.08 110.86 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 260' ' ' ASN . 19.0 t70 -63.66 -35.19 79.74 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 115.072 -0.967 . . . . 0.89 110.686 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 261' ' ' LEU . 9.5 mt -63.37 -52.4 61.86 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.129 -0.941 . . . . 0.46 111.962 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.644 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.99 -45.65 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 122.742 1.258 . . . . 0.27 110.706 174.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.655 HG13 HD13 ' B' ' 6' ' ' ILE 0.255 4.6 t -68.62 -35.91 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-N 112.84 -1.982 . . . . 0.15 111.218 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 260' ' ' ASN . 0.2 OUTLIER -61.88 -47.49 84.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 123.71 1.719 . . . . 0.52 107.251 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.2 mt -63.9 -49.37 72.95 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 110.602 -2.999 . . . . 0.24 112.337 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.637 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.5 OUTLIER -59.23 -34.62 54.32 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-N 116.313 -0.403 . . . . 0.17 111.532 -171.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.523 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -77.99 -27.83 49.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.54 -0.3 . . . . 0.69 111.325 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -65.84 -30.1 70.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 106.434 -1.691 . . . . 1.21 106.434 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.575 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -91.68 -18.02 24.61 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 112.028 -2.351 . . . . 1.53 114.149 176.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.652 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 11.0 t90 -92.27 172.68 8.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.675 1.226 . . . . 0.21 111.049 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.465 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 82.5 mtp180 -150.61 163.2 39.08 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.399 -2.182 . . . . 3.65 110.267 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.06 130.28 24.65 Favored Pre-proline 0 CA--C 1.518 -0.256 0 CA-C-O 120.82 0.343 . . . . 2.92 110.686 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 45.2 Cg_endo -93.25 147.72 2.4 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.333 2.688 . . . . 0.57 111.102 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 13.0 Cg_endo -51.65 -11.51 0.8 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.01 3.14 . . . . 0.88 113.396 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.3 p -88.46 -25.83 22.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.237 -0.438 . . . . 0.52 111.625 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 345' ' ' LEU . . . -60.73 125.29 23.15 Favored 'General case' 0 N--CA 1.458 -0.029 0 CA-C-O 121.574 0.702 . . . . 0.34 112.33 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.485 ' NH1' ' HB3' ' A' ' 347' ' ' LEU . 10.7 mmt180 -114.26 173.89 6.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.918 -1.037 . . . . 2.49 109.559 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 274' ' ' ASN . 0.9 OUTLIER -74.46 39.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.481 0.919 . . . . 1.62 113.481 -162.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 157.54 37.73 0.02 OUTLIER Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.508 -0.769 . . . . 0.46 111.523 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.641 ' O ' ' HD2' ' A' ' 342' ' ' PRO . 11.4 mtp -82.86 143.65 30.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.037 -1.468 . . . . 1.08 107.037 171.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.818 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 3.8 p -144.69 149.8 36.24 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.243 -0.983 . . . . 0.69 112.43 -171.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.7 t -131.12 129.16 62.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 113.854 -1.521 . . . . 0.94 109.08 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' A' ' 297' ' ' ARG . 12.6 tt0 -95.42 116.89 29.42 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.057 -1.461 . . . . 1.39 107.057 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 282' ' ' ILE . 42.6 t -117.32 119.3 61.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.459 -0.791 . . . . 0.12 110.11 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 335' ' ' GLN . 2.8 tp -91.79 107.39 19.17 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.384 -0.825 . . . . 0.23 108.869 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -101.67 158.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.557 0 N-CA-C 107.438 -1.319 . . . . 1.63 107.438 178.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.5 mt-10 -123.86 137.95 54.57 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.253 -1.388 . . . . 0.3 107.253 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 318' ' ' ILE . 2.3 mtp -142.71 162.54 35.21 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 123.137 1.446 . . . . 0.36 112.817 -171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' CD ' ' A' ' 286' ' ' PRO . 0.2 OUTLIER -88.98 165.26 27.75 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 110.831 -2.895 . . . . 1.45 110.162 -173.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.676 ' CD ' ' HG ' ' A' ' 285' ' ' LEU . 52.3 Cg_exo -60.79 -7.83 8.29 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.448 2.099 . . . . 0.34 110.79 172.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.443 ' HB3' ' OG1' ' A' ' 289' ' ' THR . 2.0 t70 -105.14 -4.01 22.34 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 114.844 -1.071 . . . . 0.55 109.175 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.543 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 87.4 -13.04 61.12 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.072 -0.967 . . . . 0.16 110.732 -177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.0 m -50.03 118.87 3.17 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.806 0.812 . . . . 0.58 110.463 172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 313' ' ' ARG . 1.5 mm -65.13 113.71 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.462 -1.244 . . . . 0.47 110.097 -177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.65 ' CG2' HD12 ' A' ' 285' ' ' LEU . 65.5 p -95.5 -28.24 14.98 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.771 -1.104 . . . . 0.22 110.587 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.3 t30 -158.69 174.31 15.23 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.353 -0.385 . . . . 0.61 111.502 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -173.49 137.43 0.64 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.436 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.89 170.54 15.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 122.201 1.001 . . . . 0.17 110.321 172.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 305' ' ' ASP . 3.0 t -81.91 114.75 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-N 113.435 -1.711 . . . . 0.16 108.516 168.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.08 -31.04 25.54 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.568 -1.651 . . . . 0.44 109.721 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.432 ' HB3' ' CB ' ' A' ' 279' ' ' GLU . 18.6 tpt180 -149.27 117.18 6.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.743 -1.117 . . . . 2.82 109.228 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 63.4 p -92.14 148.21 22.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.177 -0.465 . . . . 0.67 111.125 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.2 p -79.79 -16.06 56.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.73 0.776 . . . . 0.59 109.349 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.92 46.71 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.224 -1.353 . . . . 0.57 110.287 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.494 ' CB ' ' HE1' ' A' ' 276' ' ' MET . 0.8 OUTLIER -103.55 93.06 4.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.664 -0.768 . . . . 1.57 109.365 177.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.794 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 63.6 mttt -62.9 -42.61 78.82 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 114.118 1.155 . . . . 2.56 114.118 -172.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.08 -47.86 18.14 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 121.813 1.675 . . . . 0.18 110.551 171.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' A' ' 276' ' ' MET . 29.8 t80 -62.56 -47.5 83.56 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.447 -1.251 . . . . 0.58 109.654 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.794 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -58.94 -56.81 17.39 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.437 -0.801 . . . . 2.31 111.286 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 59.0 m -71.25 -35.78 71.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.716 1.376 . . . . 0.92 114.716 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 93.7 p -53.48 -29.61 36.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.325 1.059 . . . . 0.11 109.003 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.719 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.97 -29.83 18.2 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.251 -1.795 . . . . 0.1 111.07 -176.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 61.2 t -62.03 -42.17 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-O 123.492 1.615 . . . . 0.13 108.144 168.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -75.89 -11.01 59.89 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.148 -1.387 . . . . 0.13 110.457 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -77.95 -42.72 32.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.282 -1.377 . . . . 0.13 107.282 169.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.741 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.7 m -72.39 -50.45 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-O 121.668 0.747 . . . . 0.23 112.383 -176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 293' ' ' ALA . 12.2 mmt180 -57.1 -38.16 72.97 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.158 -0.928 . . . . 0.49 112.256 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 58.7 t30 -71.18 -23.94 62.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.053 0.39 . . . . 0.56 112.053 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 312' ' ' VAL . 3.4 m -65.88 -40.97 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.544 1.164 . . . . 0.27 109.59 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 69.01 -23.92 0.31 Allowed Glycine 0 C--N 1.306 -1.123 0 CA-C-N 112.558 -2.11 . . . . 0.7 117.023 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.2 OUTLIER -161.99 132.06 4.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 117.164 0.482 . . . . 3.49 111.156 178.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 258' ' ' ILE . 1.7 mp -100.61 139.38 20.56 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 123.414 0.686 . . . . 0.65 110.705 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 318' ' ' ILE . 1.3 Cg_endo -73.6 -50.5 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.266 2.644 . . . . 0.57 115.086 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 323' ' ' GLN . 49.3 mt-10 -80.69 7.34 10.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 114.988 1.477 . . . . 1.9 114.988 -166.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.608 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 14.6 mmt -63.67 -23.05 67.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.111 -0.993 . . . . 1.16 111.566 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -83.88 4.37 29.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.634 -0.712 . . . . 0.72 112.135 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 320' ' ' GLU . 0.0 OUTLIER -103.08 -56.19 2.27 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.453 -1.314 . . . . 1.64 107.453 175.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.845 ' C ' HD12 ' A' ' 324' ' ' LEU . 0.7 OUTLIER -60.5 160.58 17.79 Favored Pre-proline 0 N--CA 1.397 -3.113 0 CA-C-O 123.137 1.446 . . . . 1.07 114.026 178.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 53.5 Cg_exo -63.6 137.19 58.06 Favored 'Trans proline' 0 N--CA 1.483 0.857 1 C-N-CA 127.135 5.223 . . . . 0.36 114.523 174.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -47.55 -39.1 15.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 3.98 111.548 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.33 70.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.525 -1.216 . . . . 0.34 112.418 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.706 ' HB ' HD13 ' A' ' 324' ' ' LEU . 53.0 m -78.51 -34.52 47.29 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.292 1.044 . . . . 0.34 108.232 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 324' ' ' LEU . 4.4 t80 -63.26 -53.1 58.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 113.773 -1.558 . . . . 0.71 109.78 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 21.7 t70 -54.47 -34.78 62.16 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.717 0.77 . . . . 0.83 111.311 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.712 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.48 -50.66 43.25 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.682 -1.145 . . . . 0.3 109.599 -177.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 11.3 mt -103.63 -60.12 1.62 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.29 -1.777 . . . . 0.33 114.868 -166.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.608 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 79.5 m-85 -104.88 -7.21 19.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.754 -0.657 . . . . 0.49 112.397 -162.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 330' ' ' ASP . 0.2 OUTLIER -52.92 -51.99 59.32 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.959 -0.756 . . . . 2.41 108.959 172.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.879 ' HB3' HD11 ' A' ' 281' ' ' LEU . 2.6 mt-30 -126.73 114.84 18.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.493 -1.23 . . . . 0.45 107.983 162.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.815 ' NE ' ' HA ' ' A' ' 336' ' ' ARG . 0.0 OUTLIER -111.56 144.93 40.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.469 -1.678 . . . . 2.45 106.469 -175.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.582 ' H ' ' CZ ' ' A' ' 336' ' ' ARG . 7.0 mmt180 -104.82 115.44 30.31 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 121.444 -0.785 . . . . 1.07 109.155 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.648 HD12 HG21 ' A' ' 282' ' ' ILE . 12.9 mt -101.24 120.12 50.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.132 -0.94 . . . . 0.17 108.856 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.561 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -98.22 112.48 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.29 108.765 -179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.818 ' O ' ' HA ' ' A' ' 277' ' ' SER . 96.9 m-85 -90.51 100.28 13.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.901 -0.778 . . . . 0.54 108.901 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.581 ' HB3' HG13 ' B' ' 5' ' ' VAL . 31.0 tttm -138.0 91.57 13.14 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 116.032 -0.531 . . . . 1.34 109.88 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' B' ' 7' ' ' SER . 17.4 Cg_exo -36.01 172.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.839 4.359 . . . . 0.5 117.275 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -144.57 106.9 4.36 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.086 -1.87 . . . . 2.54 108.551 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 52.62 84.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.194 -0.912 . . . . 2.26 112.226 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.4 OUTLIER -71.99 177.38 4.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.323 0.582 . . . . 1.22 111.889 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.9 t -64.67 -40.88 96.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 123.017 1.389 . . . . 1.77 108.676 166.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.485 ' HB3' ' NH1' ' A' ' 273' ' ' ARG . 8.5 mp . . . . . 0 C--N 1.304 -1.397 0 CA-C-N 112.105 -2.316 . . . . 2.89 110.767 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.069 -0.345 . . . . 1.84 110.069 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.07 121.13 59.91 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.116 -0.493 . . . . 1.1 110.893 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 32.4 Cg_exo -57.2 121.6 10.34 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.681 2.254 . . . . 0.48 111.676 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 259' ' ' VAL . 35.5 tp -106.35 147.31 29.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.759 -0.377 . . . . 1.26 111.136 -171.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 341' ' ' LYS . 91.8 t -79.45 107.19 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.505 -0.77 . . . . 1.01 111.585 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.736 HG23 ' HA ' ' A' ' 340' ' ' PHE . 4.5 tp -94.15 115.88 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.615 -0.884 . . . . 0.34 108.615 171.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 341' ' ' LYS . 2.3 p -60.87 -67.19 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.315 -0.857 . . . . 1.05 111.803 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.66 ' HB3' ' NH2' ' A' ' 268' ' ' ARG . 68.1 p -155.44 -178.0 6.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.556 -0.293 . . . . 2.56 110.952 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.456 ' HA2' ' CA ' ' A' ' 263' ' ' SER . . . -83.67 -174.06 50.13 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.047 -0.596 . . . . 1.85 112.402 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' B' ' 11' ' ' ASP . 2.9 t-20 -124.5 170.03 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.953 -0.758 . . . . 3.21 108.953 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' B' ' 10' ' ' ASN . 27.7 t70 72.39 -3.84 2.2 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-O 122.268 1.033 . . . . 5.81 110.245 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' B' ' 10' ' ' ASN . 47.6 mtm105 -54.85 140.43 36.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.728 -1.578 . . . . 5.3 111.735 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.514 -0.755 . . . . 7.77 110.009 178.205 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.376 -0.231 . . . . 40.22 110.376 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 61.98 20.94 11.96 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.502 0.501 . . . . 40.04 112.123 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -130.13 70.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 39.27 110.834 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.91 150.9 40.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.887 -0.597 . . . . 37.29 110.035 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.87 -14.96 61.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 36.13 110.861 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . 60.03 -162.74 0.25 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.656 0.597 . . . . 34.41 112.062 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.31 -155.29 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.236 -0.893 . . . . 32.45 110.189 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt -96.12 97.97 9.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.245 -0.889 . . . . 30.94 109.864 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.28 -25.91 60.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 30.21 110.417 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.7 t -92.66 -12.66 30.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.379 -0.601 . . . . 27.83 109.379 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 34.3 t70 63.9 -82.05 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.829 -1.078 . . . . 27.14 112.091 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 p -129.05 129.94 45.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.182 0.515 . . . . 25.54 111.468 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 18.3 p -107.22 -72.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.689 -0.687 . . . . 23.93 110.807 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.43 -176.12 2.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.539 -0.3 . . . . 24.03 111.446 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.3 mmp_? 43.76 58.82 3.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.165 0.986 . . . . 22.83 112.944 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -155.35 133.49 11.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.726 -0.67 . . . . 21.0 109.687 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.53 90.39 0.16 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.918 -0.583 . . . . 19.72 111.052 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -117.52 -57.21 2.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 17.66 110.006 175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -86.94 116.7 25.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.709 -0.678 . . . . 16.08 109.329 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -133.27 -170.54 2.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.925 -0.58 . . . . 14.08 110.146 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.08 166.16 2.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.518 0.675 . . . . 13.03 111.221 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 245' ' ' GLU . 1.0 OUTLIER -68.25 132.69 47.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.047 -0.979 . . . . 12.06 111.51 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 247' ' ' GLY . 7.2 p -107.08 177.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.077 -0.965 . . . . 9.73 109.423 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.676 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -74.94 65.42 2.23 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.66 -0.7 . . . . 7.65 112.037 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.1 p -108.65 105.56 15.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.84 0.352 . . . . 6.51 110.79 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.64 -61.14 2.37 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.862 0.839 . . . . 4.79 111.194 172.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 332' ' ' LEU . 4.0 m -150.27 -163.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 113.899 -1.501 . . . . 2.23 111.294 -168.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.721 ' HB ' ' OD2' ' A' ' 255' ' ' ASP . 20.4 p 50.91 73.98 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.472 1.13 . . . . 1.43 109.079 -168.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -60.38 -147.47 0.01 OUTLIER Glycine 0 C--N 1.313 -0.725 0 CA-C-N 113.273 -1.785 . . . . 1.61 113.071 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.804 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.3 m -73.86 15.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.771 0.796 . . . . 1.62 111.102 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.903 ' HB2' ' OH ' ' A' ' 333' ' ' TYR . 3.2 mp -84.86 -43.32 14.24 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.183 -1.371 . . . . 0.47 110.47 -168.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.721 ' OD2' ' HB ' ' A' ' 251' ' ' THR . 1.0 OUTLIER -50.05 -47.71 53.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.508 . . . . 2.08 111.008 -177.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -22.87 56.78 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.953 -1.021 . . . . 0.89 111.186 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.804 ' HG ' ' O ' ' A' ' 253' ' ' SER . 8.8 mt -65.99 -53.16 42.45 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.316 0.579 . . . . 0.46 111.489 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.729 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -48.13 -48.27 12.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 123.072 1.415 . . . . 0.27 110.328 176.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.607 HG13 HD13 ' B' ' 6' ' ' ILE 0.277 5.9 t -66.75 -35.18 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 112.084 -2.325 . . . . 0.15 111.284 178.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.9 t30 -62.25 -49.53 75.36 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 124.047 1.88 . . . . 0.52 107.472 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 59.8 mt -63.26 -45.59 90.8 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 110.024 -3.262 . . . . 0.24 112.035 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.48 -36.33 72.47 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.874 0 CA-C-N 116.239 -0.437 . . . . 0.17 111.479 -172.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.3 OUTLIER -76.0 -29.37 58.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.543 0.211 . . . . 0.69 110.809 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -63.6 -32.21 73.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.427 -1.694 . . . . 1.21 106.427 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.683 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -92.45 -16.15 26.23 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.003 -2.362 . . . . 1.53 114.613 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.593 ' CH2' ' HB3' ' A' ' 340' ' ' PHE . 9.7 t90 -92.3 171.98 8.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.644 1.211 . . . . 0.21 111.218 -173.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 57.2 ttp180 -152.95 168.29 26.31 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.664 -2.062 . . . . 3.65 111.099 -170.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.66 ' NH2' ' HB3' ' B' ' 8' ' ' SER . 21.8 mmt180 -101.32 142.34 24.41 Favored Pre-proline 0 CA--C 1.517 -0.29 0 CA-C-O 121.372 0.606 . . . . 2.92 111.336 171.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 272' ' ' ALA . 47.7 Cg_endo -100.98 148.06 0.34 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 124.661 3.574 . . . . 0.57 111.411 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 11.4 Cg_endo -49.67 -18.01 2.35 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.843 3.029 . . . . 0.88 113.19 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 21.5 p -89.19 -21.26 23.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.248 0.833 . . . . 0.52 113.248 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 269' ' ' PRO . . . -61.24 128.8 38.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.76 0.652 . . . . 0.34 112.76 -174.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 342' ' ' PRO . 12.0 mmt180 -112.43 171.76 7.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.752 -1.113 . . . . 2.49 110.55 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.22 31.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.62 112.861 -161.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 342' ' ' PRO . . . 169.1 34.55 0.02 OUTLIER Glycine 0 C--N 1.305 -1.194 0 CA-C-N 115.103 -0.953 . . . . 0.46 111.637 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.775 ' O ' ' HD3' ' A' ' 342' ' ' PRO . 12.9 mtp -86.01 143.6 28.04 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.952 -1.129 . . . . 1.08 107.952 174.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.8 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 8.6 p -148.31 148.76 30.79 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.768 -1.173 . . . . 0.69 112.341 -169.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.5 t -128.07 123.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 113.543 -1.662 . . . . 0.94 109.509 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.472 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 9.3 tt0 -88.49 116.6 26.83 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 1.39 107.358 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 337' ' ' ARG . 55.8 t -119.5 118.67 58.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.506 -0.77 . . . . 0.12 110.547 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 8.4 tp -90.91 117.74 29.75 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.067 -0.97 . . . . 0.23 110.38 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.73 HD11 HG11 ' A' ' 312' ' ' VAL . 2.4 mm -94.7 168.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 115.573 -0.739 . . . . 1.63 109.524 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -139.54 134.81 32.72 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.6 -1.636 . . . . 0.3 109.123 173.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 290' ' ' ILE . 14.1 mtp -152.13 164.12 37.95 Favored 'General case' 0 CA--C 1.481 -1.68 0 CA-C-O 123.336 1.541 . . . . 0.36 113.187 -171.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.698 ' HB2' ' CD ' ' A' ' 286' ' ' PRO . 0.3 OUTLIER -116.44 173.8 2.84 Favored Pre-proline 0 N--CA 1.418 -2.031 0 CA-C-N 110.957 -2.838 . . . . 1.45 111.931 -172.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 285' ' ' LEU . 74.6 Cg_exo -53.9 -8.43 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.801 3.667 . . . . 0.34 113.704 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.515 ' HB3' ' CD1' ' A' ' 285' ' ' LEU . 5.3 t70 -101.31 -20.48 15.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.706 -0.679 . . . . 0.55 110.157 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 321' ' ' MET . . . 98.13 -7.5 62.38 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.959 -1.019 . . . . 0.16 111.249 -172.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 1.6 m -57.94 120.1 7.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.142 0.973 . . . . 0.58 109.468 171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 6.7 mt -67.01 115.86 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.222 -1.808 . . . . 0.47 110.732 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -96.81 -26.1 15.24 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.641 -1.163 . . . . 0.22 110.065 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 16.9 t30 -151.48 169.81 21.14 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 116.018 -0.537 . . . . 0.61 109.741 173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -172.32 126.62 0.54 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.823 -1.08 . . . . 0.22 109.248 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.92 169.09 18.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 122.557 1.17 . . . . 0.17 110.832 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.5 t -80.07 115.07 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-N 112.873 -1.967 . . . . 0.16 108.485 168.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 1.4 p -86.46 -30.05 22.33 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.363 -1.744 . . . . 0.44 109.706 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -153.81 105.38 2.77 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.76 -1.109 . . . . 2.82 109.2 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.456 ' HB3' HG11 ' A' ' 295' ' ' VAL . 3.5 p -80.92 151.49 28.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.833 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 51.7 p -79.31 -16.09 56.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.77 -0.826 . . . . 0.59 108.77 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.81 -9.6 44.13 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.497 -1.041 . . . . 0.57 110.497 -174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -108.93 96.2 6.16 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.963 -0.618 . . . . 1.57 109.742 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 41.4 mmtt -55.69 -41.8 92.74 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 114.465 -1.243 . . . . 2.56 112.758 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 3.8 Cg_endo -49.34 -52.58 8.51 Favored 'Trans proline' 0 CA--C 1.504 -1.006 0 C-N-CA 122.064 1.842 . . . . 0.18 111.666 170.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 269' ' ' PRO . 42.3 t80 -63.24 -50.19 71.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.739 -0.664 . . . . 0.58 109.364 -175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 295' ' ' VAL . 56.5 m-20 -56.33 -57.99 9.91 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.94 -1.027 . . . . 2.31 111.388 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.707 ' HA ' HG23 ' A' ' 309' ' ' VAL . 49.1 m -70.58 -36.18 73.45 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 114.722 1.379 . . . . 0.92 114.722 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 88.9 p -53.0 -29.94 32.25 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.398 1.094 . . . . 0.11 109.169 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -85.53 -30.7 23.19 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.215 -1.811 . . . . 0.1 110.918 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 306' ' ' SER . 47.8 t -63.26 -40.41 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.622 1.677 . . . . 0.13 108.479 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.35 -16.16 60.92 Favored 'General case' 0 C--N 1.271 -2.842 0 CA-C-N 114.07 -1.423 . . . . 0.13 110.302 176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -74.77 -41.1 60.66 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.185 -1.413 . . . . 0.13 107.185 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.73 HG11 HD11 ' A' ' 282' ' ' ILE . 30.6 m -72.82 -54.55 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 121.43 0.633 . . . . 0.23 111.763 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 312' ' ' VAL . 13.5 mmt180 -55.74 -35.28 65.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.367 -0.833 . . . . 0.49 112.653 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.683 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 12.1 t-20 -71.29 -26.17 62.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.685 -0.406 . . . . 0.56 111.081 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.0 m -71.21 -43.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 122.461 1.124 . . . . 0.27 109.089 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 63.92 -16.85 0.11 Allowed Glycine 0 C--O 1.217 -0.91 0 CA-C-N 112.193 -2.276 . . . . 0.7 118.124 166.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -161.34 125.25 3.35 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 117.448 0.624 . . . . 3.49 110.063 175.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 258' ' ' ILE . 1.9 mp -103.07 130.9 22.76 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 112.694 0.627 . . . . 0.65 112.694 -177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 261' ' ' LEU . 5.7 Cg_exo -41.35 -70.08 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.842 1 C-N-CA 125.463 4.108 . . . . 0.57 117.222 -176.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.406 ' OE2' HD11 ' A' ' 257' ' ' LEU . 22.6 mt-10 -79.66 4.22 16.78 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.843 1.794 . . . . 1.9 115.843 -157.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.684 ' SD ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -58.69 -29.03 66.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.559 0.618 . . . . 1.16 112.167 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.49 4.88 19.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.613 -0.721 . . . . 0.72 112.444 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -93.43 -50.48 5.42 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.588 -1.634 . . . . 1.64 106.588 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.673 HD22 HG21 ' A' ' 328' ' ' THR . 78.8 mt -55.38 156.48 8.13 Favored Pre-proline 0 N--CA 1.414 -2.24 0 CA-C-N 113.039 -1.892 . . . . 1.07 114.996 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 63.3 Cg_exo -57.53 138.3 85.47 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 124.099 3.199 . . . . 0.36 109.191 163.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -50.87 -39.02 52.83 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 3.98 110.368 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.19 71.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.586 -1.188 . . . . 0.34 111.952 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.673 HG21 HD22 ' A' ' 324' ' ' LEU . 67.3 m -84.73 -35.57 22.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.202 1.001 . . . . 0.34 109.002 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -62.69 -43.93 97.56 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.211 -1.359 . . . . 0.71 109.227 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.4 t70 -59.2 -29.46 67.5 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.44 -0.8 . . . . 0.83 110.935 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.651 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.3 OUTLIER -69.56 -48.36 60.58 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.617 -1.174 . . . . 0.3 108.307 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 250' ' ' VAL . 9.4 mt -103.37 -61.75 1.38 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.978 -1.919 . . . . 0.33 115.345 -166.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.903 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 57.7 m-85 -106.36 -3.61 20.91 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.351 -0.386 . . . . 0.49 111.573 -162.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.495 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -53.72 -43.01 68.69 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.471 0.653 . . . . 2.41 109.568 171.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 30.4 mt-30 -129.81 116.64 19.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.076 -1.083 . . . . 0.45 108.076 164.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.63 ' O ' HG12 ' A' ' 282' ' ' ILE . 26.9 tpt180 -107.5 110.51 22.46 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.477 -0.564 . . . . 2.45 109.477 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 5.8 mmt180 -84.69 121.83 28.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.38 1.086 . . . . 1.07 112.313 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.497 HD11 ' CG2' ' A' ' 258' ' ' ILE . 5.8 mt -113.92 123.42 69.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.538 -1.665 . . . . 0.17 109.41 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -99.73 112.48 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.678 -0.86 . . . . 0.29 108.678 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 277' ' ' SER . 82.4 m-85 -89.56 101.68 14.36 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.766 -0.827 . . . . 0.54 108.766 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.634 ' HB3' HG13 ' B' ' 5' ' ' VAL . 12.9 ttmt -140.73 125.22 10.71 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.912 -0.585 . . . . 1.34 109.551 -173.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.775 ' HD3' ' O ' ' A' ' 276' ' ' MET . 16.1 Cg_exo -72.97 -179.01 3.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.737 2.958 . . . . 0.5 116.056 -167.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -151.71 105.39 3.13 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 112.51 -2.132 . . . . 2.54 107.761 165.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 37.6 t70 65.33 84.09 0.16 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.158 -0.928 . . . . 2.26 112.05 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 345' ' ' LEU . 0.1 OUTLIER -78.46 -165.84 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 1.22 109.785 168.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.3 t -69.93 -44.07 70.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.282 1.039 . . . . 1.77 108.83 172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.304 -1.375 0 CA-C-N 113.399 -1.728 . . . . 2.89 110.835 -176.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.45 0.167 . . . . 1.84 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 61.89 107.77 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 124.067 0.854 . . . . 1.1 111.18 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.11 118.95 5.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.47 2.113 . . . . 0.48 111.412 -175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 259' ' ' VAL . 59.3 tp -92.64 138.0 31.88 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.033 0.444 . . . . 1.26 110.79 -172.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 341' ' ' LYS . 61.3 t -77.72 101.76 3.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.036 -0.984 . . . . 1.01 110.395 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 263' ' ' SER . 8.4 tt -90.44 129.98 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.179 -0.674 . . . . 0.34 109.179 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 342' ' ' PRO . 3.2 p -70.8 -68.61 0.42 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 1.05 111.08 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.611 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 65.4 p -149.35 -177.59 5.93 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.481 -0.488 . . . . 2.56 111.264 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' A' ' 266' ' ' TRP . . . -85.49 -123.1 1.26 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.547 -0.751 . . . . 1.85 113.367 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' B' ' 12' ' ' ARG . 64.6 t30 -64.28 168.45 5.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.692 -0.754 . . . . 3.21 111.635 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.96 8.58 0.69 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.998 -1.001 . . . . 5.81 111.873 -175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' B' ' 10' ' ' ASN . 68.2 mtt180 59.67 -163.11 0.24 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.858 -1.065 . . . . 5.3 112.182 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.441 -0.79 . . . . 7.77 109.518 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.841 0.353 . . . . 40.22 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -117.0 -32.46 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 40.04 110.707 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 74.11 -49.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.658 0.783 . . . . 39.27 111.361 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -118.59 69.4 0.8 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.093 0.473 . . . . 37.29 111.031 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.87 44.22 2.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.305 -0.628 . . . . 36.13 109.305 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -145.16 140.43 27.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 34.41 110.703 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.24 117.35 25.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.171 -0.468 . . . . 32.45 109.898 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.52 68.85 10.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 30.94 111.193 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp 61.64 -170.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.444 0.64 . . . . 30.21 111.922 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.4 t -104.11 149.08 25.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 27.83 109.18 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -59.85 -34.39 73.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.224 0.535 . . . . 27.14 109.592 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.8 p -144.22 130.16 19.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.11 -0.95 . . . . 25.54 109.868 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 19.4 p -101.6 -37.33 8.42 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.285 0.564 . . . . 23.93 110.876 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.39 97.36 9.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.441 -0.799 . . . . 24.03 109.867 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 5.5 mmp_? -126.85 138.51 53.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.021 -0.536 . . . . 22.83 111.038 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.64 -0.22 57.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.668 -0.696 . . . . 21.0 110.694 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 63.31 44.37 5.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.037 -0.983 . . . . 19.72 110.811 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.84 -150.41 0.07 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 17.66 111.331 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.4 106.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.353 0.597 . . . . 16.08 110.828 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -105.36 159.97 15.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.548 -0.751 . . . . 14.08 109.899 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.41 164.13 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 13.03 110.486 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.49 55.73 3.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.386 1.088 . . . . 12.06 112.197 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.09 -4.04 9.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 124.752 2.215 . . . . 9.73 108.505 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 169.46 56.97 0.03 OUTLIER Glycine 0 C--N 1.266 -3.309 0 CA-C-N 108.641 -3.891 . . . . 7.65 110.373 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 p -57.61 -64.56 0.86 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 6.51 110.944 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.421 ' C ' HG22 ' A' ' 250' ' ' VAL . 4.6 pt-20 -128.25 -111.3 0.28 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.642 -0.708 . . . . 4.79 110.249 171.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.421 HG22 ' C ' ' A' ' 249' ' ' GLU . 7.3 m 50.31 172.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 115.544 1.683 . . . . 2.23 115.544 167.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.56 93.46 5.62 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.411 -1.722 . . . . 1.43 108.102 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 254' ' ' LEU . . . -72.3 -139.4 0.29 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 113.575 -1.648 . . . . 1.61 113.112 -173.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.874 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 1.2 m -71.18 9.81 0.68 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.447 0.642 . . . . 1.62 110.946 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.9 mp -79.56 -45.89 18.37 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.517 -1.219 . . . . 0.47 110.249 -166.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 336' ' ' ARG . 2.0 p-10 -55.01 -44.62 74.74 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.881 0.848 . . . . 2.08 110.726 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 260' ' ' ASN . 6.9 t70 -66.6 -33.7 76.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.672 -1.604 . . . . 0.89 110.923 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 253' ' ' SER . 11.3 mt -60.2 -52.57 64.74 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.997 -0.547 . . . . 0.46 111.307 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.641 HG13 HG12 ' A' ' 318' ' ' ILE . 1.0 OUTLIER -47.39 -46.87 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.72 1.248 . . . . 0.27 110.258 174.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.794 HG21 HD23 ' B' ' 4' ' ' LEU . 6.4 t -71.35 -32.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 112.834 -1.984 . . . . 0.15 110.742 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.7 t30 -63.29 -48.98 75.85 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 123.862 1.791 . . . . 0.52 107.135 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 55.0 mt -62.15 -48.96 77.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 110.357 -3.111 . . . . 0.24 111.785 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.66 ' CG1' HD13 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -60.04 -34.27 55.99 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 CA-C-N 115.649 -0.705 . . . . 0.17 111.836 -172.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.826 ' HB3' HD11 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -80.53 -26.84 37.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.703 0.287 . . . . 0.69 111.145 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 264' ' ' GLN . 0.0 OUTLIER -65.01 -32.42 74.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 105.797 -1.927 . . . . 1.21 105.797 178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.578 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 1.7 mp0 -90.23 -20.46 22.97 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 111.989 -2.369 . . . . 1.53 114.461 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' B' ' 8' ' ' SER . 12.2 t90 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.987 1.375 . . . . 0.21 110.752 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 36.5 ttt180 -155.1 128.73 8.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 111.964 -2.38 . . . . 3.65 109.722 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 26.5 ptt180 -79.33 149.5 72.48 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 119.777 -0.769 . . . . 2.92 109.177 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 74.5 Cg_endo -100.72 170.96 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.84 3.027 . . . . 0.57 111.45 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.01 -10.3 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.394 2.729 . . . . 0.88 109.719 176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 11.3 p -83.92 -22.82 31.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 113.625 -1.625 . . . . 0.52 111.671 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 1.024 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -68.7 128.41 36.55 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 120.38 -0.528 . . . . 0.34 110.078 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 347' ' ' LEU . 13.5 mmt180 -114.53 110.93 20.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.732 0.271 . . . . 2.49 111.732 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 344' ' ' ASP . 0.7 OUTLIER 21.06 35.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.598 2.444 . . . . 1.62 117.598 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 273' ' ' ARG . . . 129.42 48.03 0.15 Allowed Glycine 0 C--N 1.301 -1.369 0 CA-C-O 121.584 0.547 . . . . 0.46 111.963 174.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 1.024 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.3 ptm -86.76 152.58 22.4 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 106.153 -1.795 . . . . 1.08 106.153 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 88.3 p -146.48 161.74 39.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 122.313 1.054 . . . . 0.69 113.187 -172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 339' ' ' ILE . 2.1 t -134.65 124.58 44.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 113.466 -1.697 . . . . 0.94 109.025 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.631 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 4.5 tt0 -86.91 120.51 28.26 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.949 -1.5 . . . . 1.39 106.949 166.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 282' ' ' ILE . 70.9 t -121.42 119.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.995 -0.548 . . . . 0.12 110.683 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 335' ' ' GLN . 9.4 tp -89.78 117.1 28.37 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.419 -0.81 . . . . 0.23 110.273 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 312' ' ' VAL . 2.7 mm -95.69 167.56 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.859 -0.61 . . . . 1.63 109.786 176.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 22.2 mt-10 -140.54 137.95 34.16 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.578 -1.647 . . . . 0.3 109.446 173.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 12.6 mtp -148.42 161.75 40.97 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 123.605 1.669 . . . . 0.36 113.333 -169.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 291' ' ' THR . 0.8 OUTLIER -93.57 160.82 32.14 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 110.834 -2.894 . . . . 1.45 108.856 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -59.34 1.45 0.35 Allowed 'Trans proline' 0 N--CA 1.471 0.189 0 C-N-CA 123.311 2.674 . . . . 0.34 113.014 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 285' ' ' LEU . 12.7 t70 -101.14 -17.78 16.49 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.604 -0.888 . . . . 0.55 108.604 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.635 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 101.45 -15.73 57.2 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 114.138 -1.392 . . . . 0.16 110.607 -172.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 2.9 m -51.1 114.49 1.2 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.865 0.84 . . . . 0.58 110.752 174.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.554 HD12 HG22 ' A' ' 315' ' ' VAL . 3.2 mt -66.91 114.31 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 113.89 -1.505 . . . . 0.47 110.506 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.564 ' CG2' ' HG ' ' A' ' 285' ' ' LEU . 66.4 p -96.83 -26.9 14.94 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.311 -1.313 . . . . 0.22 110.168 -176.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 21.4 t30 -150.57 170.33 19.39 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.256 0.551 . . . . 0.61 110.847 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 312' ' ' VAL . . . -171.7 127.09 0.62 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.768 -1.106 . . . . 0.22 109.861 175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -138.37 168.5 19.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.272 1.034 . . . . 0.17 111.224 175.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -79.63 115.71 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-N 113.332 -1.758 . . . . 0.16 108.958 168.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.631 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 14.6 p -87.11 -26.37 23.67 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.595 -1.638 . . . . 0.44 109.615 -177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -156.47 114.92 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 2.82 108.997 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 21.9 p -88.26 150.9 23.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.13 0.491 . . . . 0.67 111.422 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.731 ' HB3' ' O ' ' A' ' 277' ' ' SER . 26.7 p -80.88 -16.1 54.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.718 0.77 . . . . 0.59 109.853 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.38 -10.85 50.71 Favored Glycine 0 N--CA 1.435 -1.407 0 CA-C-N 114.743 -1.117 . . . . 0.57 110.764 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.415 ' HB2' ' HE1' ' A' ' 276' ' ' MET . 2.7 m-20 -111.97 101.63 9.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.127 -0.694 . . . . 1.57 109.127 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.732 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 43.4 mtmt -60.95 -42.67 88.14 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.636 -1.166 . . . . 2.56 113.637 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 1.9 Cg_endo -48.57 -48.74 16.47 Favored 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 121.626 1.551 . . . . 0.18 110.945 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 276' ' ' MET . 58.8 t80 -61.82 -47.88 83.07 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.431 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.732 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -57.63 -59.29 5.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.561 -0.745 . . . . 2.31 111.821 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.639 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 66.5 m -68.87 -36.75 78.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 114.856 1.428 . . . . 0.92 114.856 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.4 p -54.03 -29.22 42.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.221 1.01 . . . . 0.11 109.252 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.609 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -87.12 -31.12 20.6 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.41 -1.723 . . . . 0.1 111.214 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.639 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.9 t -63.24 -39.73 86.35 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-O 123.586 1.66 . . . . 0.13 108.831 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.85 -11.24 59.8 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.139 -1.391 . . . . 0.13 110.677 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.82 -43.45 36.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.399 -1.334 . . . . 0.13 107.399 170.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 282' ' ' ILE . 31.5 m -71.13 -54.03 19.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.552 0.691 . . . . 0.23 111.655 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 312' ' ' VAL . 9.9 mmt180 -58.24 -32.28 68.19 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.724 -1.126 . . . . 0.49 112.272 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 50.3 t30 -72.8 -22.69 60.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.903 -0.319 . . . . 0.56 111.811 -175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.554 HG22 HD12 ' A' ' 290' ' ' ILE . 1.0 OUTLIER -75.12 -47.86 34.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.634 1.207 . . . . 0.27 110.052 178.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 76.62 -88.51 0.94 Allowed Glycine 0 CA--C 1.488 -1.624 0 CA-C-N 112.859 -1.973 . . . . 0.7 111.942 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.646 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 64.9 mtp180 -90.86 126.96 36.19 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.731 -0.734 . . . . 3.49 112.517 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.641 HG12 HG13 ' A' ' 258' ' ' ILE . 1.6 mp -100.54 120.79 55.12 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-O 121.169 0.509 . . . . 0.65 112.278 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 261' ' ' LEU . 47.9 Cg_exo -40.54 -77.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.328 -0.52 0 C-N-CA 124.953 3.769 . . . . 0.57 116.856 -176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.443 ' OE2' HD11 ' A' ' 257' ' ' LEU . 25.4 mt-10 -68.1 6.78 0.67 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.158 -1.383 . . . . 1.9 114.134 -161.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.635 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 13.5 mmt -61.78 -28.36 69.4 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.491 -0.884 . . . . 1.16 112.066 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -80.18 8.67 6.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.494 0.553 . . . . 0.72 112.494 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.12 -18.21 15.04 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.718 0.77 . . . . 1.64 109.197 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.753 HD22 HG21 ' A' ' 328' ' ' THR . 75.1 mt -92.53 164.58 22.0 Favored Pre-proline 0 N--CA 1.417 -2.119 0 CA-C-O 123.078 1.418 . . . . 1.07 113.617 -177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 52.2 Cg_exo -61.21 136.15 62.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 124.426 3.417 . . . . 0.36 109.211 160.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -52.78 -39.04 61.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.716 0.77 . . . . 3.98 110.962 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.21 70.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.229 -1.351 . . . . 0.34 111.757 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.753 HG21 HD22 ' A' ' 324' ' ' LEU . 51.7 m -82.05 -40.46 21.99 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 122.005 0.907 . . . . 0.34 108.9 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -57.24 -47.44 81.37 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.015 -1.448 . . . . 0.71 109.488 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 22.7 t70 -57.94 -33.63 69.01 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.554 -0.748 . . . . 0.83 111.218 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -69.36 -49.02 59.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.387 -1.279 . . . . 0.3 109.036 -176.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 5.8 mt -103.21 -61.54 1.4 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.223 -1.808 . . . . 0.33 114.686 -168.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 254' ' ' LEU . 78.1 m-85 -103.86 -7.72 20.27 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.66 0.615 . . . . 0.49 112.66 -163.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.498 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -50.65 -44.07 57.41 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.754 0.788 . . . . 2.41 109.627 175.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.782 ' HB3' HD11 ' A' ' 281' ' ' LEU . 33.1 mt-30 -126.48 115.82 20.16 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 107.014 -1.476 . . . . 0.45 107.014 163.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 282' ' ' ILE . 0.0 OUTLIER -115.24 120.43 39.67 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.71 -1.218 . . . . 2.45 107.71 -173.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 8.1 mtt180 -89.87 142.73 27.42 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.22 1.01 . . . . 1.07 112.039 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 258' ' ' ILE . 11.6 mt -130.91 119.74 45.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 113.345 -1.752 . . . . 0.17 109.07 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 0.2 OUTLIER -98.78 119.01 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 C-N-CA 119.787 -0.765 . . . . 0.29 108.985 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.772 ' O ' ' HA ' ' A' ' 277' ' ' SER . 46.1 m-85 -94.49 102.85 14.81 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.12 -1.067 . . . . 0.54 108.12 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 277' ' ' SER . 24.4 ttpt -143.16 97.13 5.75 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 115.955 -0.566 . . . . 1.34 109.569 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 276' ' ' MET . 6.7 Cg_exo -45.47 178.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 124.019 3.146 . . . . 0.5 115.198 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -139.88 107.33 5.56 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.716 -1.583 . . . . 2.54 108.373 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 274' ' ' ASN . 33.7 t70 54.44 86.63 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.17 -0.923 . . . . 2.26 113.155 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 272' ' ' ALA . 3.6 mm? -79.55 -169.05 1.76 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.342 -0.614 . . . . 1.22 109.342 166.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.675 ' HB3' HD13 ' A' ' 347' ' ' LEU . 1.0 OUTLIER -68.93 -45.99 69.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 123.119 1.438 . . . . 1.77 108.078 168.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.85 0 CA-C-N 112.013 -2.358 . . . . 2.89 111.195 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.677 0.275 . . . . 1.84 111.329 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.51 90.13 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.339 -0.846 . . . . 1.1 111.555 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 337' ' ' ARG . 84.4 Cg_exo -43.73 128.4 6.75 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.859 3.04 . . . . 0.48 112.716 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 259' ' ' VAL . 38.1 tp -103.75 150.09 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.717 -0.393 . . . . 1.26 111.245 -170.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 341' ' ' LYS . 71.9 t -80.43 103.69 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.61 -0.723 . . . . 1.01 110.788 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.752 HG23 ' HA ' ' A' ' 340' ' ' PHE . 5.5 tp -95.58 105.23 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.216 1.008 . . . . 0.34 108.348 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' ' HD3' ' A' ' 268' ' ' ARG . 6.4 p -98.29 -19.93 17.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.451 -1.249 . . . . 1.05 112.08 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 263' ' ' SER . 8.7 m -110.62 162.04 15.13 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.119 -0.491 . . . . 2.56 111.117 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.59 -124.62 2.17 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.359 -1.096 . . . . 1.85 110.359 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -60.5 149.49 34.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.322 0.561 . . . . 3.21 110.117 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.26 -12.64 59.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.591 -0.731 . . . . 5.81 111.013 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 49.55 -157.74 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.529 -0.76 . . . . 5.3 112.181 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.901 0 CA-C-O 118.43 -0.795 . . . . 7.77 110.02 174.078 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.749 -0.463 . . . . 40.22 109.749 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 88.2 mtp 64.99 93.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.878 -0.601 . . . . 40.04 111.568 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -90.97 64.06 5.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 39.27 109.595 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -141.56 82.08 1.8 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.656 . . . . 37.29 110.158 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 29.4 tp -77.83 -29.06 50.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 36.13 110.052 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -120.49 97.59 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.879 -0.6 . . . . 34.41 110.869 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 230' ' ' GLU . 0.9 OUTLIER -84.39 126.28 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.243 0.544 . . . . 32.45 109.913 176.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.57 -36.15 73.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.608 . . . . 30.94 111.082 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.46 71.09 9.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.1 0.476 . . . . 30.21 110.684 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.1 p -149.57 25.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.592 0.71 . . . . 27.83 110.147 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.82 20.43 4.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.384 -0.825 . . . . 27.14 110.603 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.5 p -83.33 129.79 35.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.564 -0.744 . . . . 25.54 110.317 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 16.0 p -128.82 99.02 5.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.002 0.429 . . . . 23.93 111.567 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.56 87.68 4.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.287 0.565 . . . . 24.03 109.752 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 4.8 mmp_? -124.44 29.63 6.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.616 -0.72 . . . . 22.83 111.043 -173.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.54 129.61 47.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.843 0.354 . . . . 21.0 110.325 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -138.7 151.53 47.23 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.777 -0.647 . . . . 19.72 110.178 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -111.88 124.03 51.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.4 -0.364 . . . . 17.66 110.816 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.85 -58.73 2.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.117 -0.697 . . . . 16.08 109.117 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 59.01 124.25 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.952 0.882 . . . . 14.08 113.181 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -81.25 163.27 23.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.318 -0.855 . . . . 13.03 111.231 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.49 161.32 17.87 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.979 -1.01 . . . . 12.06 111.2 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 247' ' ' GLY . 9.4 p -65.48 159.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.247 0.546 . . . . 9.73 111.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 246' ' ' VAL . . . 80.08 58.78 2.72 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.054 -0.976 . . . . 7.65 110.942 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.4 p -56.52 -58.92 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 6.51 111.289 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.492 ' HB2' HG22 ' A' ' 250' ' ' VAL . 1.4 pt-20 -106.16 -85.67 0.49 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.308 0.575 . . . . 4.79 112.127 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 332' ' ' LEU . 5.6 m -146.38 -157.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.986 -1.006 . . . . 2.23 111.697 -169.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.523 ' HA ' ' OH ' ' A' ' 333' ' ' TYR . 18.4 p 60.15 64.08 1.31 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.369 1.081 . . . . 1.43 110.032 -172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' CA ' HD12 ' A' ' 254' ' ' LEU . . . -68.26 66.53 0.37 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 113.745 -1.57 . . . . 1.61 115.329 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.743 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 64.4 m 57.8 10.55 1.12 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.579 1.18 . . . . 1.62 112.593 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.784 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 0.3 OUTLIER -84.23 -37.93 21.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 113.306 -1.77 . . . . 0.47 110.285 -171.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.532 ' CG ' HH21 ' A' ' 336' ' ' ARG . 5.7 t0 -52.86 -55.01 26.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.865 0.841 . . . . 2.08 111.158 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.81 -30.31 70.0 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.143 -1.389 . . . . 0.89 110.324 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 254' ' ' LEU . 8.7 mt -62.78 -54.49 38.15 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.558 -0.746 . . . . 0.46 111.905 173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.613 HG13 HG12 ' A' ' 318' ' ' ILE . 0.9 OUTLIER -47.21 -48.11 8.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.697 1.237 . . . . 0.27 110.755 174.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.698 HG21 HD23 ' B' ' 4' ' ' LEU 0.266 12.8 t -66.9 -37.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-N 112.797 -2.002 . . . . 0.15 111.525 177.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 5.5 t30 -59.75 -50.59 73.22 Favored 'General case' 0 CA--C 1.48 -1.738 0 CA-C-O 123.965 1.84 . . . . 0.52 107.642 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 71.4 mt -60.35 -47.58 85.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 109.79 -3.368 . . . . 0.24 112.189 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.3 OUTLIER -61.54 -37.21 77.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.832 -0.622 . . . . 0.17 112.178 -171.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' B' ' 8' ' ' SER . 0.9 OUTLIER -79.59 -21.15 45.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.69 111.259 -178.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -66.46 -29.31 69.41 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.325 -1.732 . . . . 1.21 106.325 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.604 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.0 mp0 -98.78 -11.37 21.91 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 111.942 -2.39 . . . . 1.53 114.672 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.516 ' HB3' ' HA ' ' A' ' 263' ' ' SER . 13.8 t90 -93.09 172.6 8.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.21 111.358 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.489 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 24.1 ttp180 -153.97 114.77 4.03 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.128 -2.305 . . . . 3.65 109.76 -175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 7' ' ' SER . 17.5 mtm180 -81.3 137.41 48.89 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 119.792 -0.763 . . . . 2.92 110.454 175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 270' ' ' PRO . 39.5 Cg_endo -90.85 146.45 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.305 2.67 . . . . 0.57 111.666 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -54.35 -8.05 0.98 Allowed 'Trans proline' 0 C--N 1.331 -0.373 0 C-N-CA 124.012 3.141 . . . . 0.88 113.34 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 33.6 p -91.77 -21.98 20.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.517 -0.31 . . . . 0.52 111.213 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.911 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -60.48 148.11 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.171 0.51 . . . . 0.34 111.955 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.596 ' CD ' ' HG ' ' A' ' 347' ' ' LEU . 18.2 mmt180 -123.47 168.83 12.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.688 -0.856 . . . . 2.49 108.688 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -76.03 56.44 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.521 1.153 . . . . 1.62 113.537 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 150.62 27.09 0.05 OUTLIER Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.116 -1.856 . . . . 0.46 113.607 170.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.911 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 0.4 OUTLIER -80.85 146.03 31.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 105.506 -2.035 . . . . 1.08 105.506 164.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.762 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 7.2 p -159.69 148.43 17.66 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.1 -1.04 . . . . 0.69 112.649 -170.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 305' ' ' ASP . 1.7 t -121.76 123.75 70.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.09 -1.413 . . . . 0.94 109.099 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -88.7 110.86 21.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.55 -1.648 . . . . 1.39 106.55 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 282' ' ' ILE . 73.6 t -111.97 117.57 55.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.161 -0.927 . . . . 0.12 110.884 -175.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' A' ' 335' ' ' GLN . 4.3 tp -90.9 105.08 17.58 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.102 -0.954 . . . . 0.23 109.81 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -100.02 157.9 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.742 0 N-CA-C 106.728 -1.582 . . . . 1.63 106.728 175.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 13.1 mt-10 -126.68 142.29 51.59 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 -172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 283' ' ' GLU . 5.4 mtp -150.63 162.39 40.76 Favored 'General case' 0 CA--C 1.482 -1.65 0 CA-C-O 123.048 1.404 . . . . 0.36 112.081 -173.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.93 170.14 5.87 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 111.357 -2.656 . . . . 1.45 110.31 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.08 -1.17 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.994 3.129 . . . . 0.34 113.777 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.498 ' H ' HD22 ' A' ' 285' ' ' LEU . 15.5 t70 -101.68 -13.56 17.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 119.638 -0.825 . . . . 0.55 110.167 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.616 ' HA2' ' HG3' ' A' ' 321' ' ' MET . . . 90.57 -11.42 71.6 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.34 -0.845 . . . . 0.16 112.087 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 317' ' ' ARG . 0.2 OUTLIER -58.8 123.75 17.5 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.661 1.22 . . . . 0.58 110.191 172.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 284' ' ' MET . 2.3 mt -71.76 117.96 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.47 110.561 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.6 p -98.85 -23.76 15.24 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.681 -1.599 . . . . 0.22 110.135 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 7.6 t-20 -153.0 172.78 16.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.058 0.456 . . . . 0.61 110.494 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -175.17 134.23 0.33 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.232 -0.894 . . . . 0.22 110.033 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.96 171.01 14.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 122.363 1.078 . . . . 0.17 110.806 177.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.658 HG21 ' HB3' ' A' ' 305' ' ' ASP . 3.0 t -81.26 115.22 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 CA-C-N 112.831 -1.986 . . . . 0.16 108.172 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -28.41 18.59 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.563 -1.653 . . . . 0.44 109.74 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.14 103.67 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.99 -1.005 . . . . 2.82 109.281 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.2 p -73.06 148.95 43.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.67 112.238 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.55 -6.29 59.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.59 109.534 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 79.5 24.63 60.38 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 114.821 -1.081 . . . . 0.57 110.953 -170.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 304' ' ' PHE . 0.4 OUTLIER -140.63 90.76 2.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 303' ' ' PRO . 30.7 mmmt -54.09 -44.2 98.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 112.797 0.665 . . . . 2.56 112.797 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 302' ' ' LYS . 2.8 Cg_endo -51.14 -51.46 11.15 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 121.926 1.751 . . . . 0.18 111.656 170.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 301' ' ' ASP . 74.8 t80 -61.32 -52.99 62.36 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.179 -0.674 . . . . 0.58 109.179 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 295' ' ' VAL . 69.2 m-20 -51.5 -63.75 1.03 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.798 -1.092 . . . . 2.31 111.581 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.687 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 50.6 m -65.09 -36.97 86.0 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.79 1.404 . . . . 0.92 114.79 -176.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 91.0 p -52.35 -30.01 26.57 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.148 0.975 . . . . 0.11 109.616 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.633 ' HB1' ' CE1' ' A' ' 340' ' ' PHE . . . -88.88 -28.7 20.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.563 -1.653 . . . . 0.1 110.686 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.687 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 46.2 t -62.44 -41.0 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 CA-C-O 123.524 1.63 . . . . 0.13 108.463 168.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -76.97 -10.78 59.6 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.228 -1.351 . . . . 0.13 110.858 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -76.92 -43.6 34.93 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.155 -1.424 . . . . 0.13 107.155 169.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 309' ' ' VAL . 30.6 m -70.28 -55.63 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.386 0.613 . . . . 0.23 111.476 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 312' ' ' VAL . 11.8 mmt180 -55.2 -37.89 67.67 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.085 -0.961 . . . . 0.49 112.325 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.604 ' HB3' ' CG ' ' A' ' 265' ' ' GLN . 56.8 t30 -67.93 -29.06 68.04 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 121.185 -0.206 . . . . 0.56 111.334 -173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 311' ' ' ALA . 1.5 m -69.71 -45.1 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.634 1.207 . . . . 0.27 109.265 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.495 ' N ' ' CG2' ' A' ' 315' ' ' VAL . . . 71.02 -81.2 0.45 Allowed Glycine 0 CA--C 1.486 -1.72 0 CA-C-N 112.329 -2.214 . . . . 0.7 112.772 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 0.1 OUTLIER -106.71 104.76 14.52 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 122.987 1.375 . . . . 3.49 111.439 -165.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 258' ' ' ILE . 1.8 mp -74.38 124.71 90.07 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.714 -1.585 . . . . 0.65 110.667 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -64.38 -47.49 5.84 Favored 'Trans proline' 0 C--N 1.33 -0.422 0 C-N-CA 124.373 3.382 . . . . 0.57 116.055 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -80.3 5.31 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.794 1.035 . . . . 1.9 113.794 -165.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.616 ' HG3' ' HA2' ' A' ' 288' ' ' GLY . 14.7 mmt -69.38 -26.48 64.68 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.797 -0.564 . . . . 1.16 111.944 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -74.8 1.56 12.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.767 -0.651 . . . . 0.72 111.233 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.95 -50.29 4.24 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.815 -1.18 . . . . 1.64 107.815 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 328' ' ' THR . 89.5 mt -55.94 157.17 8.63 Favored Pre-proline 0 N--CA 1.42 -1.967 0 N-CA-C 115.783 1.772 . . . . 1.07 115.783 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 50.6 Cg_exo -59.59 136.81 73.57 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 124.24 3.293 . . . . 0.36 107.862 160.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -55.34 -39.41 69.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.651 0.739 . . . . 3.98 110.51 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.33 73.72 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.561 -1.2 . . . . 0.34 112.101 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.678 HG21 HD22 ' A' ' 324' ' ' LEU . 48.9 m -78.91 -40.55 31.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.34 108.646 -178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.503 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 3.7 t80 -58.56 -49.0 79.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.029 -1.442 . . . . 0.71 109.732 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 24.2 t70 -56.97 -34.33 67.97 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.838 0.828 . . . . 0.83 110.964 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.691 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -66.17 -49.48 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.541 1.162 . . . . 0.3 108.84 -177.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.692 HD11 ' HB ' ' A' ' 250' ' ' VAL . 8.6 mt -102.31 -61.57 1.38 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.048 -1.887 . . . . 0.33 114.831 -166.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.523 ' OH ' ' HA ' ' A' ' 251' ' ' THR . 49.0 m-85 -109.94 0.68 18.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.727 -0.67 . . . . 0.49 112.431 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.699 ' HD3' ' O ' ' A' ' 330' ' ' ASP . 1.4 ptt180 -52.81 -41.59 64.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.391 1.091 . . . . 2.41 108.325 170.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.952 ' HB3' HD11 ' A' ' 281' ' ' LEU . 21.5 mt-30 -135.09 108.61 7.9 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 112.799 -2.0 . . . . 0.45 106.663 167.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.754 ' H ' HD13 ' A' ' 282' ' ' ILE . 15.3 tpt180 -101.25 111.67 23.95 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.312 -1.366 . . . . 2.45 107.312 -172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.563 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.7 mmt180 -79.93 108.08 13.22 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.729 1.252 . . . . 1.07 110.664 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 258' ' ' ILE . 8.9 mt -97.08 123.6 49.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 112.283 -2.235 . . . . 0.17 108.271 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.503 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -103.18 109.91 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 108.787 -0.82 . . . . 0.29 108.787 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 277' ' ' SER . 87.6 m-85 -86.81 100.99 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.47 -0.937 . . . . 0.54 108.47 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.546 ' HB3' HG13 ' B' ' 5' ' ' VAL . 16.6 ttmt -136.27 93.55 14.71 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 120.938 0.399 . . . . 1.34 110.271 -171.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.574 ' HB3' ' CD2' ' A' ' 345' ' ' LEU . 32.2 Cg_exo -28.51 161.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 1 C-N-CA 126.75 4.966 . . . . 0.5 118.35 176.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -153.57 118.0 4.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.746 -2.024 . . . . 2.54 108.074 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.02 68.73 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.341 -0.845 . . . . 2.26 113.221 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 342' ' ' PRO . 0.9 OUTLIER -80.17 -166.7 1.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.858 0.361 . . . . 1.22 110.442 168.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -57.23 -32.14 66.23 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.986 0.898 . . . . 1.77 111.51 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.596 ' HG ' ' CD ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 CA-C-N 114.365 -1.289 . . . . 2.89 111.783 -163.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 332' ' ' LEU . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.451 -0.574 . . . . 1.84 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.08 126.47 87.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 123.306 0.379 . . . . 1.1 110.855 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 337' ' ' ARG . 57.2 Cg_exo -52.76 119.98 6.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.718 2.279 . . . . 0.48 111.592 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.67 HD23 HG21 ' A' ' 259' ' ' VAL . 55.0 tp -100.31 139.41 36.02 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.485 -0.486 . . . . 1.26 110.493 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 341' ' ' LYS . 94.9 t -71.85 105.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 1.01 111.423 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.769 HD13 HG13 ' A' ' 259' ' ' VAL . 6.4 tp -97.7 112.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.934 -0.765 . . . . 0.34 108.934 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 343' ' ' GLU . 57.6 p -105.67 -13.59 15.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.121 -177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.609 ' O ' ' HE3' ' A' ' 266' ' ' TRP . 8.6 t -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.648 -1.16 . . . . 2.56 109.844 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.23 109.96 0.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.72 -0.752 . . . . 1.85 111.397 173.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -155.1 160.81 41.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.312 -0.625 . . . . 3.21 109.312 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -49.17 -61.96 1.79 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.344 0.403 . . . . 5.81 110.9 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 53.82 174.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.419 0.896 . . . . 5.3 113.419 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.638 -0.71 . . . . 7.77 109.461 177.019 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.998 0.428 . . . . 40.22 110.445 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.1 mmt -111.58 25.56 11.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.128 0.49 . . . . 40.04 110.78 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -105.57 -28.71 10.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.549 -0.751 . . . . 39.27 110.139 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . 48.05 58.31 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.86 0.725 . . . . 37.29 111.14 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.81 76.27 10.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 36.13 110.992 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -118.64 -78.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.573 -0.74 . . . . 34.41 109.767 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.08 100.0 4.16 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.679 -0.692 . . . . 32.45 109.49 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.97 87.77 4.78 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.792 -1.095 . . . . 30.94 109.929 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 79.8 mt -82.92 48.47 1.36 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.443 -0.798 . . . . 30.21 110.951 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 33.9 m -98.27 10.25 41.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.385 0.612 . . . . 27.83 110.207 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.63 77.94 5.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 27.14 110.536 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.9 m -98.16 -70.75 0.71 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.411 -0.813 . . . . 25.54 110.118 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 2.9 m 56.38 56.93 5.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.387 0.613 . . . . 23.93 110.953 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.47 -12.02 3.51 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.571 -0.741 . . . . 24.03 112.214 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 238' ' ' ARG . 3.4 mmp_? -70.89 133.98 46.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.149 -0.478 . . . . 22.83 110.744 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -97.68 -165.82 1.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.516 -0.311 . . . . 21.0 110.421 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 67.67 72.24 0.33 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.86 0.725 . . . . 19.72 111.776 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -92.32 -152.23 0.3 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.895 -0.593 . . . . 17.66 110.593 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 242' ' ' LEU . 3.5 tm? -71.63 113.1 8.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.133 0.492 . . . . 16.08 109.863 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -94.31 145.11 24.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.025 -0.534 . . . . 14.08 110.701 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -69.28 160.0 32.04 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.423 0.63 . . . . 13.03 110.073 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.04 139.95 40.2 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.066 -0.97 . . . . 12.06 112.11 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 247' ' ' GLY . 10.0 p -109.52 168.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.939 -1.028 . . . . 9.73 109.691 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 246' ' ' VAL . . . -96.21 112.18 4.38 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 114.557 -1.201 . . . . 7.65 111.572 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -40.9 99.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.101 0.477 . . . . 6.51 110.635 176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -94.29 127.46 40.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.927 -0.579 . . . . 4.79 111.274 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 252' ' ' GLY . 19.8 m 34.81 -146.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 112.893 -1.958 . . . . 2.23 114.623 171.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.423 ' HB ' ' OH ' ' A' ' 333' ' ' TYR . 1.3 p 65.43 -16.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.606 1.162 . . . . 1.43 112.336 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 250' ' ' VAL . . . 57.13 -121.8 26.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.528 -0.368 . . . . 1.61 112.484 176.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.748 ' O ' ' HG ' ' A' ' 257' ' ' LEU . 3.3 m -125.31 23.76 7.52 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.01 1.385 . . . . 1.62 108.38 169.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 257' ' ' LEU . 1.4 mp -87.11 -35.13 18.84 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 112.392 -2.185 . . . . 0.47 109.5 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . 0.63 ' HB2' HH21 ' A' ' 336' ' ' ARG . 3.2 p-10 -54.01 -50.21 67.15 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.536 0.684 . . . . 2.08 110.726 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 260' ' ' ASN . 14.3 t70 -66.86 -32.51 73.83 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 113.818 -1.537 . . . . 0.89 111.018 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 253' ' ' SER . 9.6 mt -61.31 -56.02 25.2 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.763 0.664 . . . . 0.46 112.363 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -47.83 -46.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.539 1.161 . . . . 0.27 110.38 175.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.769 HG13 HD13 ' B' ' 6' ' ' ILE 0.269 6.1 t -66.58 -37.15 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.083 -1.871 . . . . 0.15 111.887 177.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 257' ' ' LEU . 6.7 t30 -60.85 -49.91 75.56 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-O 124.086 1.898 . . . . 0.52 107.618 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 257' ' ' LEU . 76.9 mt -63.07 -47.8 81.39 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 110.16 -3.2 . . . . 0.24 112.4 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.674 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 0.6 OUTLIER -59.92 -37.04 70.39 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 CA-C-N 116.249 -0.432 . . . . 0.17 111.46 -171.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.544 ' HB3' HD11 ' B' ' 6' ' ' ILE . 3.2 p -81.55 -19.97 40.95 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.69 112.062 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -70.78 -33.15 70.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.497 -1.668 . . . . 1.21 106.497 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.644 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 2.1 mp0 -89.6 -15.8 31.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.858 -2.428 . . . . 1.53 113.955 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.609 ' HE3' ' O ' ' B' ' 8' ' ' SER . 12.7 t90 -89.42 170.04 10.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.486 1.136 . . . . 0.21 109.424 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 266' ' ' TRP . 72.3 ttt180 -157.52 110.58 2.49 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 112.065 -2.334 . . . . 3.65 109.675 -176.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 269' ' ' PRO . 21.7 ptt180 -75.0 146.55 82.66 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 120.017 -0.673 . . . . 2.92 109.584 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 268' ' ' ARG . 39.2 Cg_endo -100.37 152.56 0.46 Allowed 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 124.234 3.289 . . . . 0.57 112.389 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 269' ' ' PRO . 18.0 Cg_endo -53.81 -12.22 3.05 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.978 3.119 . . . . 0.88 113.09 167.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 19.6 p -85.68 -16.6 38.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.586 0.231 . . . . 0.52 110.505 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.923 ' HA ' ' SD ' ' A' ' 276' ' ' MET . . . -77.25 146.38 36.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.316 0.579 . . . . 0.34 111.881 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -117.63 169.71 9.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.421 -0.808 . . . . 2.49 109.872 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -76.08 45.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.741 0.781 . . . . 1.62 112.784 -169.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 158.91 30.78 0.02 OUTLIER Glycine 0 C--N 1.291 -1.922 0 CA-C-N 114.391 -1.277 . . . . 0.46 112.794 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 272' ' ' ALA . 2.1 ptm -84.28 154.34 23.02 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 105.779 -1.934 . . . . 1.08 105.779 167.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 340' ' ' PHE . 32.6 p -158.56 155.7 28.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 120.002 1.274 . . . . 0.69 113.275 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 304' ' ' PHE . 2.6 t -128.4 126.11 65.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.318 -1.765 . . . . 0.94 109.178 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.584 ' HB3' ' OG ' ' A' ' 296' ' ' SER . 8.4 tt0 -89.24 118.26 28.8 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.482 -1.673 . . . . 1.39 106.482 165.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 282' ' ' ILE . 52.9 t -116.92 119.54 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.555 -0.748 . . . . 0.12 110.504 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 335' ' ' GLN . 5.9 tp -92.73 104.05 16.36 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.032 -0.986 . . . . 0.23 109.775 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.71 HD13 ' H ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -102.35 155.32 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.821 0 N-CA-C 106.749 -1.574 . . . . 1.63 106.749 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 292' ' ' ASN . 15.8 mt-10 -123.07 138.98 54.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.117 -0.697 . . . . 0.3 109.117 -171.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.549 ' CG ' HG12 ' A' ' 290' ' ' ILE . 8.3 mtp -147.76 160.46 42.7 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-O 122.945 1.355 . . . . 0.36 112.235 -173.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 289' ' ' THR . 0.0 OUTLIER -107.81 170.05 5.99 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 111.579 -2.555 . . . . 1.45 110.583 -177.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.91 -0.75 0.1 Allowed 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.607 3.538 . . . . 0.34 113.548 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 285' ' ' LEU . 2.5 t70 -102.34 -17.39 15.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.513 0.673 . . . . 0.55 110.458 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.478 ' CA ' ' HG3' ' A' ' 321' ' ' MET . . . 93.25 -12.27 70.11 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.095 -0.957 . . . . 0.16 112.806 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.695 ' O ' HD12 ' A' ' 285' ' ' LEU . 85.4 m -55.41 122.85 12.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.344 1.069 . . . . 0.58 110.197 169.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 284' ' ' MET . 3.7 mt -71.84 116.2 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.537 -1.665 . . . . 0.47 109.94 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 53.0 p -100.71 -19.91 15.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.582 -1.19 . . . . 0.22 111.025 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 283' ' ' GLU . 25.7 t30 -152.83 171.4 18.32 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 120.855 0.359 . . . . 0.61 110.324 173.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 282' ' ' ILE . . . -171.09 135.51 1.01 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.326 -0.852 . . . . 0.22 110.962 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -144.44 170.08 16.71 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 122.243 1.02 . . . . 0.17 111.294 175.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 305' ' ' ASP . 2.9 t -82.01 118.63 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 CA-C-N 113.095 -1.866 . . . . 0.16 108.315 166.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.584 ' OG ' ' HB3' ' A' ' 279' ' ' GLU . 5.5 p -90.97 -31.02 16.51 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.164 -1.38 . . . . 0.44 109.593 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -144.07 117.35 9.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.716 -1.129 . . . . 2.82 108.841 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 2.9 p -93.97 137.82 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.212 0.53 . . . . 0.67 111.752 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 277' ' ' SER . 31.6 p -83.44 -12.88 55.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.59 110.023 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.97 -13.16 45.41 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.467 -1.242 . . . . 0.57 111.236 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 303' ' ' PRO . 12.7 t70 -107.68 103.78 13.15 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.569 0.7 . . . . 1.57 109.562 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 305' ' ' ASP . 0.2 OUTLIER -63.84 -44.74 80.24 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 114.489 -1.232 . . . . 2.56 112.726 -177.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.592 ' HG2' ' OD2' ' A' ' 301' ' ' ASP . 1.7 Cg_endo -49.03 -48.88 16.74 Favored 'Trans proline' 0 CA--C 1.493 -1.525 0 C-N-CA 121.137 1.224 . . . . 0.18 110.602 169.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.519 ' CE1' HG23 ' A' ' 278' ' ' VAL . 39.7 t80 -59.13 -50.49 73.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 123.694 0.621 . . . . 0.58 109.467 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.454 -0.794 . . . . 2.31 111.209 -179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.681 ' HA ' ' CG2' ' A' ' 309' ' ' VAL . 58.0 m -68.4 -33.76 74.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 114.828 1.418 . . . . 0.92 114.828 -174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 87.6 p -54.09 -30.67 49.35 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.198 0.999 . . . . 0.11 108.811 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.614 ' HB1' ' CZ ' ' A' ' 340' ' ' PHE . . . -89.51 -29.51 18.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.623 -1.626 . . . . 0.1 111.093 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 306' ' ' SER . 60.4 t -63.13 -40.89 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 CA-C-O 123.582 1.658 . . . . 0.13 108.563 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 314' ' ' ASN . . . -74.85 -14.34 60.66 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 114.021 -1.445 . . . . 0.13 110.329 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.674 ' HB1' ' O ' ' A' ' 262' ' ' VAL . . . -75.09 -42.34 56.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.179 -1.415 . . . . 0.13 107.179 171.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 315' ' ' VAL . 30.4 m -72.67 -52.88 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.513 0.673 . . . . 0.23 111.827 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 312' ' ' VAL . 12.7 mmt180 -56.99 -36.69 70.65 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.305 -0.861 . . . . 0.49 112.503 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 310' ' ' ALA . 7.7 t-20 -71.77 -25.33 61.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.858 -0.337 . . . . 0.56 111.476 -172.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 312' ' ' VAL . 2.8 m -70.55 -45.43 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 122.248 1.023 . . . . 0.27 108.895 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 289' ' ' THR . . . 57.68 -18.06 0.01 OUTLIER Glycine 0 C--O 1.218 -0.893 0 CA-C-N 112.255 -2.248 . . . . 0.7 118.025 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 289' ' ' THR . 1.8 mpt_? -150.41 109.77 3.98 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 117.687 0.744 . . . . 3.49 111.037 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.572 HG23 ' HD2' ' A' ' 319' ' ' PRO . 1.6 mp -101.06 133.36 21.05 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-O 121.746 0.784 . . . . 0.65 111.014 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 318' ' ' ILE . 61.3 Cg_endo -61.11 -57.76 0.56 Allowed 'Trans proline' 0 CA--C 1.539 0.744 1 C-N-CA 125.488 4.125 . . . . 0.57 117.985 -171.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.11 4.63 37.41 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.537 0.94 . . . . 1.9 113.537 -165.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.641 ' HE1' ' CG ' ' A' ' 333' ' ' TYR . 13.2 mmm -63.98 -25.35 68.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.317 0.579 . . . . 1.16 111.022 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.5 2.76 17.95 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.852 -1.067 . . . . 0.72 112.213 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.5 -45.76 5.71 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.472 -0.936 . . . . 1.64 108.472 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 328' ' ' THR . 88.3 mt -51.83 155.67 2.87 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 115.784 1.772 . . . . 1.07 115.784 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 328' ' ' THR . 51.8 Cg_exo -59.42 136.07 69.26 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 124.698 3.599 . . . . 0.36 109.694 163.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -47.65 -36.28 10.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.489 0.662 . . . . 3.98 111.473 174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -76.95 -27.75 54.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.854 -1.066 . . . . 0.34 111.872 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . 0.712 HG21 HD22 ' A' ' 324' ' ' LEU . 60.9 m -82.24 -37.53 25.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.147 -1.057 . . . . 0.34 108.147 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.422 ' HZ ' ' O ' ' A' ' 284' ' ' MET . 9.4 t80 -59.92 -51.48 69.5 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.84 -1.527 . . . . 0.71 109.632 173.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 334' ' ' ARG . 18.7 t70 -59.82 -33.65 72.03 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.688 0.756 . . . . 0.83 111.067 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . 0.721 ' HB3' ' HG ' ' A' ' 332' ' ' LEU . 0.2 OUTLIER -67.09 -51.22 57.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.492 1.139 . . . . 0.3 109.019 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.721 ' HG ' ' HB3' ' A' ' 331' ' ' SER . 13.0 mt -103.07 -55.65 2.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.348 -1.751 . . . . 0.33 115.331 -164.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.641 ' CG ' ' HE1' ' A' ' 321' ' ' MET . 73.7 m-85 -112.05 -3.51 14.73 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.775 -0.648 . . . . 0.49 112.236 -162.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -55.06 -43.33 73.74 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.842 0.83 . . . . 2.41 109.082 170.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.871 ' HB3' HD11 ' A' ' 281' ' ' LEU . 3.0 mt-30 -131.3 113.95 14.42 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.049 -1.432 . . . . 0.45 107.497 160.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.71 ' H ' HD13 ' A' ' 282' ' ' ILE . 12.4 tpt85 -106.04 116.59 32.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.609 -1.256 . . . . 2.45 107.609 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ARG . . . . . 0.569 ' CD ' HD13 ' A' ' 281' ' ' LEU . 7.4 mmt180 -82.45 111.28 18.33 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 121.033 -1.042 . . . . 1.07 111.216 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 282' ' ' ILE . 8.9 mt -97.87 122.0 49.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 113.972 -1.467 . . . . 0.17 108.843 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ILE . . . . . 0.571 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -99.42 111.92 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 108.55 -0.908 . . . . 0.29 108.55 178.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 277' ' ' SER . 94.3 m-85 -88.64 100.53 13.17 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.099 -1.074 . . . . 0.54 108.099 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . 0.503 ' HA ' ' HD2' ' A' ' 342' ' ' PRO . 14.8 ttmt -133.3 92.4 24.74 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-O 121.18 0.514 . . . . 1.34 109.91 -174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 341' ' ' LYS . 24.4 Cg_exo -29.22 163.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 1 C-N-CA 127.029 5.153 . . . . 0.5 118.309 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 7' ' ' SER . 11.1 mm-40 -159.24 126.44 4.75 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.027 -2.351 . . . . 2.54 107.434 172.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.59 60.07 0.38 Allowed 'General case' 0 C--N 1.316 -0.866 0 O-C-N 124.282 0.988 . . . . 2.26 112.464 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 342' ' ' PRO . 1.8 mm? -80.97 -172.08 3.54 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.79 -0.448 . . . . 1.22 109.79 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 23.3 t -74.46 -30.64 61.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.119 0.961 . . . . 1.77 109.931 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.131 -1.395 . . . . 2.89 110.965 -171.49 . . . . . . . . 0 0 . 1 stop_ save_